id	sid	tid	token	lemma	pos
ajcp-3197	1	1	pa	pa	PROPN
ajcp-3197	1	2	ge	ge	PROPN
ajcp-3197	1	3	1	1	NUM
ajcp-3197	1	4	pa	pa	PROPN
ajcp-3197	1	5	ge	ge	PROPN
ajcp-3197	1	6	1	1	NUM
ajcp-3197	1	7	american	american	PROPN
ajcp-3197	1	8	journal	journal	PROPN
ajcp-3197	1	9	of	of	ADP
ajcp-3197	1	10	chemistry	chemistry	NOUN
ajcp-3197	1	11	and	and	CCONJ
ajcp-3197	1	12	pharmacy	pharmacy	NOUN
ajcp-3197	1	13	(	(	PUNCT
ajcp-3197	1	14	ajcp	ajcp	NOUN
ajcp-3197	1	15	)	)	PUNCT
ajcp-3197	1	16	adverse	adverse	ADJ
ajcp-3197	1	17	drug	drug	NOUN
ajcp-3197	1	18	reactions	reaction	NOUN
ajcp-3197	1	19	in	in	ADP
ajcp-3197	1	20	nigeria	nigeria	PROPN
ajcp-3197	1	21	’s	’s	PART
ajcp-3197	1	22	geriatric	geriatric	ADJ
ajcp-3197	1	23	population	population	NOUN
ajcp-3197	1	24	and	and	CCONJ
ajcp-3197	1	25	its	its	PRON
ajcp-3197	1	26	prevalence	prevalence	NOUN
ajcp-3197	1	27	,	,	PUNCT
ajcp-3197	1	28	etiologies	etiology	NOUN
ajcp-3197	1	29	,	,	PUNCT
ajcp-3197	1	30	implications	implication	NOUN
ajcp-3197	1	31	:	:	PUNCT
ajcp-3197	1	32	a	a	DET
ajcp-3197	1	33	systematic	systematic	ADJ
ajcp-3197	1	34	review	review	NOUN
ajcp-3197	1	35	uyiose	uyiose	NOUN
ajcp-3197	1	36	fortress	fortress	NOUN
ajcp-3197	1	37	ufuah1	ufuah1	ADJ
ajcp-3197	1	38	,	,	PUNCT
ajcp-3197	1	39	aloysius	aloysius	PROPN
ajcp-3197	1	40	obinna	obinna	PROPN
ajcp-3197	1	41	ikwuka2	ikwuka2	PROPN
ajcp-3197	1	42	*	*	PUNCT
ajcp-3197	1	43	,	,	PUNCT
ajcp-3197	1	44	angus	angus	ADJ
ajcp-3197	1	45	nnamdi	nnamdi	PROPN
ajcp-3197	1	46	oli3	oli3	PROPN
ajcp-3197	1	47	,	,	PUNCT
ajcp-3197	1	48	brian	brian	PROPN
ajcp-3197	1	49	ogbonna3	ogbonna3	PROPN
ajcp-3197	1	50	volume	volume	NOUN
ajcp-3197	1	51	3	3	NUM
ajcp-3197	1	52	issue	issue	NOUN
ajcp-3197	1	53	1	1	NUM
ajcp-3197	1	54	,	,	PUNCT
ajcp-3197	1	55	year	year	NOUN
ajcp-3197	1	56	2024	2024	NUM
ajcp-3197	1	57	issn	issn	X
ajcp-3197	1	58	:	:	PUNCT
ajcp-3197	1	59	2834	2834	NUM
ajcp-3197	1	60	-	-	SYM
ajcp-3197	1	61	0116	0116	NUM
ajcp-3197	1	62	(	(	PUNCT
ajcp-3197	1	63	online	online	ADJ
ajcp-3197	1	64	)	)	PUNCT
ajcp-3197	1	65	doi	doi	NOUN
ajcp-3197	1	66	:	:	PUNCT
ajcp-3197	1	67	https://doi.org/10.54536/ajcp.v3i1.3197	https://doi.org/10.54536/ajcp.v3i1.3197	PROPN
ajcp-3197	2	1	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	NOUN
ajcp-3197	2	2	article	article	NOUN
ajcp-3197	2	3	information	information	NOUN
ajcp-3197	2	4	abstract	abstract	ADV
ajcp-3197	2	5	received	receive	VERB
ajcp-3197	2	6	:	:	PUNCT
ajcp-3197	2	7	july	july	PROPN
ajcp-3197	2	8	23	23	NUM
ajcp-3197	2	9	,	,	PUNCT
ajcp-3197	2	10	2024	2024	NUM
ajcp-3197	2	11	accepted	accept	VERB
ajcp-3197	2	12	:	:	PUNCT
ajcp-3197	2	13	august	august	PROPN
ajcp-3197	2	14	18	18	NUM
ajcp-3197	2	15	,	,	PUNCT
ajcp-3197	2	16	2024	2024	NUM
ajcp-3197	2	17	published	publish	VERB
ajcp-3197	2	18	:	:	PUNCT
ajcp-3197	2	19	august	august	PROPN
ajcp-3197	2	20	21	21	NUM
ajcp-3197	2	21	,	,	PUNCT
ajcp-3197	2	22	2024	2024	NUM
ajcp-3197	2	23	adverse	adverse	ADJ
ajcp-3197	2	24	drug	drug	NOUN
ajcp-3197	2	25	reactions	reaction	NOUN
ajcp-3197	2	26	(	(	PUNCT
ajcp-3197	2	27	adrs	adrs	PROPN
ajcp-3197	2	28	)	)	PUNCT
ajcp-3197	2	29	are	be	AUX
ajcp-3197	2	30	a	a	DET
ajcp-3197	2	31	significant	significant	ADJ
ajcp-3197	2	32	public	public	ADJ
ajcp-3197	2	33	health	health	NOUN
ajcp-3197	2	34	concern	concern	NOUN
ajcp-3197	2	35	.	.	PUNCT
ajcp-3197	3	1	although	although	SCONJ
ajcp-3197	3	2	the	the	DET
ajcp-3197	3	3	prevalence	prevalence	NOUN
ajcp-3197	3	4	of	of	ADP
ajcp-3197	3	5	adrs	adr	NOUN
ajcp-3197	3	6	in	in	ADP
ajcp-3197	3	7	the	the	DET
ajcp-3197	3	8	general	general	ADJ
ajcp-3197	3	9	adult	adult	NOUN
ajcp-3197	3	10	population	population	NOUN
ajcp-3197	3	11	in	in	ADP
ajcp-3197	3	12	nigeria	nigeria	PROPN
ajcp-3197	3	13	has	have	AUX
ajcp-3197	3	14	been	be	AUX
ajcp-3197	3	15	studied	study	VERB
ajcp-3197	3	16	and	and	CCONJ
ajcp-3197	3	17	documented	document	VERB
ajcp-3197	3	18	,	,	PUNCT
ajcp-3197	3	19	there	there	PRON
ajcp-3197	3	20	is	be	VERB
ajcp-3197	3	21	limited	limited	ADJ
ajcp-3197	3	22	research	research	NOUN
ajcp-3197	3	23	on	on	ADP
ajcp-3197	3	24	adrs	adr	NOUN
ajcp-3197	3	25	among	among	ADP
ajcp-3197	3	26	the	the	DET
ajcp-3197	3	27	geriatric	geriatric	ADJ
ajcp-3197	3	28	population	population	NOUN
ajcp-3197	3	29	.	.	PUNCT
ajcp-3197	4	1	this	this	DET
ajcp-3197	4	2	study	study	NOUN
ajcp-3197	4	3	conducted	conduct	VERB
ajcp-3197	4	4	a	a	DET
ajcp-3197	4	5	systematic	systematic	ADJ
ajcp-3197	4	6	review	review	NOUN
ajcp-3197	4	7	of	of	ADP
ajcp-3197	4	8	existing	exist	VERB
ajcp-3197	4	9	research	research	NOUN
ajcp-3197	4	10	to	to	PART
ajcp-3197	4	11	determine	determine	VERB
ajcp-3197	4	12	the	the	DET
ajcp-3197	4	13	prevalence	prevalence	NOUN
ajcp-3197	4	14	,	,	PUNCT
ajcp-3197	4	15	etiologies	etiology	NOUN
ajcp-3197	4	16	and	and	CCONJ
ajcp-3197	4	17	implications	implication	NOUN
ajcp-3197	4	18	of	of	ADP
ajcp-3197	4	19	adrs	adr	NOUN
ajcp-3197	4	20	among	among	ADP
ajcp-3197	4	21	nigerian	nigerian	ADJ
ajcp-3197	4	22	geriatric	geriatric	ADJ
ajcp-3197	4	23	population	population	NOUN
ajcp-3197	4	24	.	.	PUNCT
ajcp-3197	5	1	a	a	DET
ajcp-3197	5	2	comprehensive	comprehensive	ADJ
ajcp-3197	5	3	search	search	NOUN
ajcp-3197	5	4	was	be	AUX
ajcp-3197	5	5	undertaken	undertake	VERB
ajcp-3197	5	6	using	use	VERB
ajcp-3197	5	7	pubmed	pubmed	PROPN
ajcp-3197	5	8	,	,	PUNCT
ajcp-3197	5	9	researchgate	researchgate	ADJ
ajcp-3197	5	10	,	,	PUNCT
ajcp-3197	5	11	and	and	CCONJ
ajcp-3197	5	12	google	google	PROPN
ajcp-3197	5	13	scholar	scholar	NOUN
ajcp-3197	5	14	databases	database	NOUN
ajcp-3197	5	15	.	.	PUNCT
ajcp-3197	6	1	the	the	DET
ajcp-3197	6	2	preferred	preferred	ADJ
ajcp-3197	6	3	reporting	reporting	NOUN
ajcp-3197	6	4	items	item	NOUN
ajcp-3197	6	5	for	for	ADP
ajcp-3197	6	6	systematic	systematic	ADJ
ajcp-3197	6	7	reviews	review	NOUN
ajcp-3197	6	8	and	and	CCONJ
ajcp-3197	6	9	meta	meta	ADJ
ajcp-3197	6	10	-	-	PUNCT
ajcp-3197	6	11	analysis	analysis	NOUN
ajcp-3197	6	12	(	(	PUNCT
ajcp-3197	6	13	prisma	prisma	NOUN
ajcp-3197	6	14	)	)	PUNCT
ajcp-3197	6	15	guideline	guideline	NOUN
ajcp-3197	6	16	was	be	AUX
ajcp-3197	6	17	used	use	VERB
ajcp-3197	6	18	for	for	ADP
ajcp-3197	6	19	reporting	report	VERB
ajcp-3197	6	20	this	this	DET
ajcp-3197	6	21	systematic	systematic	ADJ
ajcp-3197	6	22	review	review	NOUN
ajcp-3197	6	23	.	.	PUNCT
ajcp-3197	7	1	six	six	NUM
ajcp-3197	7	2	studies	study	NOUN
ajcp-3197	7	3	met	meet	VERB
ajcp-3197	7	4	the	the	DET
ajcp-3197	7	5	eligibility	eligibility	NOUN
ajcp-3197	7	6	criteria	criterion	NOUN
ajcp-3197	7	7	for	for	ADP
ajcp-3197	7	8	inclusion	inclusion	NOUN
ajcp-3197	7	9	in	in	ADP
ajcp-3197	7	10	this	this	DET
ajcp-3197	7	11	review	review	NOUN
ajcp-3197	7	12	.	.	PUNCT
ajcp-3197	8	1	the	the	DET
ajcp-3197	8	2	prevalence	prevalence	NOUN
ajcp-3197	8	3	of	of	ADP
ajcp-3197	8	4	adrs	adr	NOUN
ajcp-3197	8	5	among	among	ADP
ajcp-3197	8	6	the	the	DET
ajcp-3197	8	7	geriatrics	geriatric	NOUN
ajcp-3197	8	8	ranged	range	VERB
ajcp-3197	8	9	from	from	ADP
ajcp-3197	8	10	4.4	4.4	NUM
ajcp-3197	8	11	%	%	NOUN
ajcp-3197	8	12	to	to	ADP
ajcp-3197	8	13	31.1	31.1	NUM
ajcp-3197	8	14	%	%	NOUN
ajcp-3197	8	15	.	.	PUNCT
ajcp-3197	9	1	the	the	DET
ajcp-3197	9	2	gastrointestinal	gastrointestinal	ADJ
ajcp-3197	9	3	system	system	NOUN
ajcp-3197	9	4	was	be	AUX
ajcp-3197	9	5	the	the	DET
ajcp-3197	9	6	most	most	ADV
ajcp-3197	9	7	commonly	commonly	ADV
ajcp-3197	9	8	affected	affect	VERB
ajcp-3197	9	9	system	system	NOUN
ajcp-3197	9	10	,	,	PUNCT
ajcp-3197	9	11	with	with	ADP
ajcp-3197	9	12	non	non	ADJ
ajcp-3197	9	13	-	-	ADJ
ajcp-3197	9	14	steroidal	steroidal	ADJ
ajcp-3197	9	15	anti	anti	ADJ
ajcp-3197	9	16	-	-	ADJ
ajcp-3197	9	17	inflammatory	inflammatory	ADJ
ajcp-3197	9	18	drugs	drug	NOUN
ajcp-3197	9	19	(	(	PUNCT
ajcp-3197	9	20	nsaids	nsaid	NOUN
ajcp-3197	9	21	)	)	PUNCT
ajcp-3197	9	22	being	be	AUX
ajcp-3197	9	23	the	the	DET
ajcp-3197	9	24	most	most	ADV
ajcp-3197	9	25	frequently	frequently	ADV
ajcp-3197	9	26	implicated	implicate	VERB
ajcp-3197	9	27	class	class	NOUN
ajcp-3197	9	28	of	of	ADP
ajcp-3197	9	29	drugs	drug	NOUN
ajcp-3197	9	30	contributing	contribute	VERB
ajcp-3197	9	31	to	to	ADP
ajcp-3197	9	32	adrs	adr	NOUN
ajcp-3197	9	33	.	.	PUNCT
ajcp-3197	10	1	the	the	DET
ajcp-3197	10	2	prevalence	prevalence	NOUN
ajcp-3197	10	3	of	of	ADP
ajcp-3197	10	4	adrs	adrs	PROPN
ajcp-3197	10	5	in	in	ADP
ajcp-3197	10	6	the	the	DET
ajcp-3197	10	7	nigerian	nigerian	ADJ
ajcp-3197	10	8	geriatric	geriatric	ADJ
ajcp-3197	10	9	population	population	NOUN
ajcp-3197	10	10	is	be	AUX
ajcp-3197	10	11	underreported	underreported	ADJ
ajcp-3197	10	12	.	.	PUNCT
ajcp-3197	11	1	there	there	PRON
ajcp-3197	11	2	are	be	VERB
ajcp-3197	11	3	insufficient	insufficient	ADJ
ajcp-3197	11	4	policies	policy	NOUN
ajcp-3197	11	5	and	and	CCONJ
ajcp-3197	11	6	healthcare	healthcare	NOUN
ajcp-3197	11	7	personnel	personnel	NOUN
ajcp-3197	11	8	specialized	specialize	VERB
ajcp-3197	11	9	in	in	ADP
ajcp-3197	11	10	caring	care	VERB
ajcp-3197	11	11	for	for	ADP
ajcp-3197	11	12	geriatric	geriatric	ADJ
ajcp-3197	11	13	patients	patient	NOUN
ajcp-3197	11	14	.	.	PUNCT
ajcp-3197	12	1	strategies	strategy	NOUN
ajcp-3197	12	2	should	should	AUX
ajcp-3197	12	3	be	be	AUX
ajcp-3197	12	4	implemented	implement	VERB
ajcp-3197	12	5	to	to	PART
ajcp-3197	12	6	reduce	reduce	VERB
ajcp-3197	12	7	the	the	DET
ajcp-3197	12	8	incidence	incidence	NOUN
ajcp-3197	12	9	of	of	ADP
ajcp-3197	12	10	adrs	adr	NOUN
ajcp-3197	12	11	among	among	ADP
ajcp-3197	12	12	geriatric	geriatric	ADJ
ajcp-3197	12	13	patients	patient	NOUN
ajcp-3197	12	14	.	.	PUNCT
ajcp-3197	13	1	keywords	keyword	VERB
ajcp-3197	13	2	adverse	adverse	ADJ
ajcp-3197	13	3	drug	drug	NOUN
ajcp-3197	13	4	reactions	reaction	NOUN
ajcp-3197	13	5	,	,	PUNCT
ajcp-3197	13	6	adrs	adrs	PROPN
ajcp-3197	13	7	,	,	PUNCT
ajcp-3197	13	8	nigeria	nigeria	PROPN
ajcp-3197	13	9	,	,	PUNCT
ajcp-3197	13	10	geriatric	geriatric	ADJ
ajcp-3197	13	11	,	,	PUNCT
ajcp-3197	13	12	population	population	NOUN
ajcp-3197	13	13	,	,	PUNCT
ajcp-3197	13	14	prevalence	prevalence	NOUN
ajcp-3197	13	15	,	,	PUNCT
ajcp-3197	13	16	etiologies	etiology	NOUN
ajcp-3197	13	17	,	,	PUNCT
ajcp-3197	13	18	implications	implication	NOUN
ajcp-3197	13	19	,	,	PUNCT
ajcp-3197	13	20	systematic	systematic	ADJ
ajcp-3197	13	21	review	review	NOUN
ajcp-3197	13	22	1	1	NUM
ajcp-3197	13	23	faculty	faculty	NOUN
ajcp-3197	13	24	of	of	ADP
ajcp-3197	13	25	pharmacy	pharmacy	NOUN
ajcp-3197	13	26	,	,	PUNCT
ajcp-3197	13	27	university	university	PROPN
ajcp-3197	13	28	of	of	ADP
ajcp-3197	13	29	ibadan	ibadan	PROPN
ajcp-3197	13	30	,	,	PUNCT
ajcp-3197	13	31	ibadan	ibadan	PROPN
ajcp-3197	13	32	,	,	PUNCT
ajcp-3197	13	33	nigeria	nigeria	PROPN
ajcp-3197	13	34	2	2	NUM
ajcp-3197	13	35	college	college	NOUN
ajcp-3197	13	36	of	of	ADP
ajcp-3197	13	37	medicine	medicine	NOUN
ajcp-3197	13	38	and	and	CCONJ
ajcp-3197	13	39	health	health	NOUN
ajcp-3197	13	40	sciences	science	NOUN
ajcp-3197	13	41	,	,	PUNCT
ajcp-3197	13	42	american	american	PROPN
ajcp-3197	13	43	international	international	PROPN
ajcp-3197	13	44	university	university	PROPN
ajcp-3197	13	45	west	west	PROPN
ajcp-3197	13	46	africa	africa	PROPN
ajcp-3197	13	47	,	,	PUNCT
ajcp-3197	13	48	banjul	banjul	PROPN
ajcp-3197	13	49	,	,	PUNCT
ajcp-3197	13	50	the	the	DET
ajcp-3197	13	51	gambia	gambia	NOUN
ajcp-3197	13	52	3	3	NUM
ajcp-3197	13	53	faculty	faculty	NOUN
ajcp-3197	13	54	of	of	ADP
ajcp-3197	13	55	pharmacy	pharmacy	NOUN
ajcp-3197	13	56	,	,	PUNCT
ajcp-3197	13	57	nnamdi	nnamdi	PROPN
ajcp-3197	13	58	azikiwe	azikiwe	PROPN
ajcp-3197	13	59	university	university	PROPN
ajcp-3197	13	60	,	,	PUNCT
ajcp-3197	13	61	awka	awka	NOUN
ajcp-3197	13	62	,	,	PUNCT
ajcp-3197	13	63	nigeria	nigeria	PROPN
ajcp-3197	13	64	*	*	PUNCT
ajcp-3197	13	65	corresponding	correspond	VERB
ajcp-3197	13	66	author	author	NOUN
ajcp-3197	13	67	’s	’s	PART
ajcp-3197	13	68	e	e	NOUN
ajcp-3197	13	69	-	-	NOUN
ajcp-3197	13	70	mail	mail	NOUN
ajcp-3197	13	71	:	:	PUNCT
ajcp-3197	13	72	momohshaibu3@gmail.com	momohshaibu3@gmail.com	X
ajcp-3197	13	73	introduction	introduction	NOUN
ajcp-3197	13	74	the	the	DET
ajcp-3197	13	75	health	health	NOUN
ajcp-3197	13	76	and	and	CCONJ
ajcp-3197	13	77	well	well	ADV
ajcp-3197	13	78	-	-	PUNCT
ajcp-3197	13	79	being	being	NOUN
ajcp-3197	13	80	of	of	ADP
ajcp-3197	13	81	the	the	DET
ajcp-3197	13	82	elderly	elderly	ADJ
ajcp-3197	13	83	have	have	AUX
ajcp-3197	13	84	become	become	VERB
ajcp-3197	13	85	significant	significant	ADJ
ajcp-3197	13	86	concerns	concern	NOUN
ajcp-3197	13	87	in	in	ADP
ajcp-3197	13	88	public	public	ADJ
ajcp-3197	13	89	health	health	NOUN
ajcp-3197	13	90	.	.	PUNCT
ajcp-3197	14	1	globally	globally	ADV
ajcp-3197	14	2	,	,	PUNCT
ajcp-3197	14	3	the	the	DET
ajcp-3197	14	4	population	population	NOUN
ajcp-3197	14	5	is	be	AUX
ajcp-3197	14	6	aging	age	VERB
ajcp-3197	14	7	rapidly	rapidly	ADV
ajcp-3197	14	8	,	,	PUNCT
ajcp-3197	14	9	resulting	result	VERB
ajcp-3197	14	10	in	in	ADP
ajcp-3197	14	11	a	a	DET
ajcp-3197	14	12	decline	decline	NOUN
ajcp-3197	14	13	in	in	ADP
ajcp-3197	14	14	health	health	NOUN
ajcp-3197	14	15	as	as	SCONJ
ajcp-3197	14	16	individuals	individual	NOUN
ajcp-3197	14	17	grow	grow	VERB
ajcp-3197	14	18	older	old	ADJ
ajcp-3197	14	19	.	.	PUNCT
ajcp-3197	15	1	in	in	ADP
ajcp-3197	15	2	developing	develop	VERB
ajcp-3197	15	3	countries	country	NOUN
ajcp-3197	15	4	,	,	PUNCT
ajcp-3197	15	5	the	the	DET
ajcp-3197	15	6	elderly	elderly	ADJ
ajcp-3197	15	7	population	population	NOUN
ajcp-3197	15	8	faces	face	VERB
ajcp-3197	15	9	significant	significant	ADJ
ajcp-3197	15	10	morbidity	morbidity	NOUN
ajcp-3197	15	11	and	and	CCONJ
ajcp-3197	15	12	disability	disability	NOUN
ajcp-3197	15	13	burdens	burden	NOUN
ajcp-3197	15	14	due	due	ADP
ajcp-3197	15	15	to	to	ADP
ajcp-3197	15	16	poverty	poverty	NOUN
ajcp-3197	15	17	,	,	PUNCT
ajcp-3197	15	18	inadequate	inadequate	ADJ
ajcp-3197	15	19	health	health	NOUN
ajcp-3197	15	20	facilities	facility	NOUN
ajcp-3197	15	21	,	,	PUNCT
ajcp-3197	15	22	and	and	CCONJ
ajcp-3197	15	23	insufficient	insufficient	ADJ
ajcp-3197	15	24	care	care	NOUN
ajcp-3197	15	25	policies	policy	NOUN
ajcp-3197	15	26	.	.	PUNCT
ajcp-3197	16	1	the	the	DET
ajcp-3197	16	2	geriatric	geriatric	ADJ
ajcp-3197	16	3	population	population	NOUN
ajcp-3197	16	4	defined	define	VERB
ajcp-3197	16	5	as	as	ADP
ajcp-3197	16	6	individuals	individual	NOUN
ajcp-3197	16	7	aged	aged	ADJ
ajcp-3197	16	8	65	65	NUM
ajcp-3197	16	9	and	and	CCONJ
ajcp-3197	16	10	above	above	ADV
ajcp-3197	16	11	,	,	PUNCT
ajcp-3197	16	12	is	be	AUX
ajcp-3197	16	13	considered	consider	VERB
ajcp-3197	16	14	a	a	DET
ajcp-3197	16	15	special	special	ADJ
ajcp-3197	16	16	population	population	NOUN
ajcp-3197	16	17	as	as	SCONJ
ajcp-3197	16	18	they	they	PRON
ajcp-3197	16	19	differ	differ	VERB
ajcp-3197	16	20	greatly	greatly	ADV
ajcp-3197	16	21	from	from	ADP
ajcp-3197	16	22	other	other	ADJ
ajcp-3197	16	23	age	age	NOUN
ajcp-3197	16	24	groups	group	NOUN
ajcp-3197	16	25	.	.	PUNCT
ajcp-3197	17	1	they	they	PRON
ajcp-3197	17	2	are	be	AUX
ajcp-3197	17	3	more	more	ADV
ajcp-3197	17	4	vulnerable	vulnerable	ADJ
ajcp-3197	17	5	to	to	ADP
ajcp-3197	17	6	comorbidities	comorbiditie	NOUN
ajcp-3197	17	7	,	,	PUNCT
ajcp-3197	17	8	drug	drug	NOUN
ajcp-3197	17	9	interactions	interaction	NOUN
ajcp-3197	17	10	,	,	PUNCT
ajcp-3197	17	11	polypharmacy	polypharmacy	NOUN
ajcp-3197	17	12	,	,	PUNCT
ajcp-3197	17	13	and	and	CCONJ
ajcp-3197	17	14	adverse	adverse	ADJ
ajcp-3197	17	15	drug	drug	NOUN
ajcp-3197	17	16	reactions	reaction	NOUN
ajcp-3197	17	17	(	(	PUNCT
ajcp-3197	17	18	adrs	adrs	PROPN
ajcp-3197	17	19	)	)	PUNCT
ajcp-3197	17	20	(	(	PUNCT
ajcp-3197	17	21	who	who	PRON
ajcp-3197	17	22	,	,	PUNCT
ajcp-3197	17	23	2019	2019	NUM
ajcp-3197	17	24	)	)	PUNCT
ajcp-3197	17	25	.	.	PUNCT
ajcp-3197	18	1	diabetes	diabetes	NOUN
ajcp-3197	18	2	mellitus	mellitus	NOUN
ajcp-3197	18	3	and	and	CCONJ
ajcp-3197	18	4	arterial	arterial	ADJ
ajcp-3197	18	5	hypertension	hypertension	NOUN
ajcp-3197	18	6	remain	remain	VERB
ajcp-3197	18	7	two	two	NUM
ajcp-3197	18	8	of	of	ADP
ajcp-3197	18	9	the	the	DET
ajcp-3197	18	10	most	most	ADV
ajcp-3197	18	11	common	common	ADJ
ajcp-3197	18	12	diseases	disease	NOUN
ajcp-3197	18	13	in	in	ADP
ajcp-3197	18	14	the	the	DET
ajcp-3197	18	15	world	world	NOUN
ajcp-3197	18	16	.	.	PUNCT
ajcp-3197	19	1	today	today	NOUN
ajcp-3197	19	2	,	,	PUNCT
ajcp-3197	19	3	diabetes	diabetes	NOUN
ajcp-3197	19	4	mellitus	mellitus	NOUN
ajcp-3197	19	5	(	(	PUNCT
ajcp-3197	19	6	dm	dm	NOUN
ajcp-3197	19	7	)	)	PUNCT
ajcp-3197	19	8	ranks	rank	VERB
ajcp-3197	19	9	third	third	ADV
ajcp-3197	19	10	in	in	ADP
ajcp-3197	19	11	the	the	DET
ajcp-3197	19	12	overall	overall	ADJ
ajcp-3197	19	13	structure	structure	NOUN
ajcp-3197	19	14	of	of	ADP
ajcp-3197	19	15	morbidity	morbidity	NOUN
ajcp-3197	19	16	and	and	CCONJ
ajcp-3197	19	17	mortality	mortality	NOUN
ajcp-3197	19	18	after	after	ADP
ajcp-3197	19	19	cardiovascular	cardiovascular	ADJ
ajcp-3197	19	20	diseases	disease	NOUN
ajcp-3197	19	21	and	and	CCONJ
ajcp-3197	19	22	oncological	oncological	ADJ
ajcp-3197	19	23	diseases	disease	NOUN
ajcp-3197	19	24	(	(	PUNCT
ajcp-3197	19	25	virstyuk	virstyuk	NOUN
ajcp-3197	19	26	&	&	CCONJ
ajcp-3197	19	27	ikwuka	ikwuka	PROPN
ajcp-3197	19	28	,	,	PUNCT
ajcp-3197	19	29	2021a	2021a	NUM
ajcp-3197	19	30	)	)	PUNCT
ajcp-3197	19	31	.	.	PUNCT
ajcp-3197	20	1	moreover	moreover	ADV
ajcp-3197	20	2	,	,	PUNCT
ajcp-3197	20	3	the	the	DET
ajcp-3197	20	4	nexus	nexus	NOUN
ajcp-3197	20	5	,	,	PUNCT
ajcp-3197	20	6	pathogenetic	pathogenetic	ADJ
ajcp-3197	20	7	mechanisms	mechanism	NOUN
ajcp-3197	20	8	,	,	PUNCT
ajcp-3197	20	9	roles	role	NOUN
ajcp-3197	20	10	,	,	PUNCT
ajcp-3197	20	11	and	and	CCONJ
ajcp-3197	20	12	effects	effect	NOUN
ajcp-3197	20	13	of	of	ADP
ajcp-3197	20	14	metabolic	metabolic	NOUN
ajcp-3197	20	15	syndrome	syndrome	NOUN
ajcp-3197	20	16	diseases	disease	NOUN
ajcp-3197	20	17	on	on	ADP
ajcp-3197	20	18	aging	age	VERB
ajcp-3197	20	19	(	(	PUNCT
ajcp-3197	20	20	and	and	CCONJ
ajcp-3197	20	21	vice	vice	ADV
ajcp-3197	20	22	versa	versa	ADV
ajcp-3197	20	23	)	)	PUNCT
ajcp-3197	20	24	are	be	AUX
ajcp-3197	20	25	still	still	ADV
ajcp-3197	20	26	being	be	AUX
ajcp-3197	20	27	investigated	investigate	VERB
ajcp-3197	20	28	by	by	ADP
ajcp-3197	20	29	different	different	ADJ
ajcp-3197	20	30	researchers	researcher	NOUN
ajcp-3197	20	31	.	.	PUNCT
ajcp-3197	21	1	metabolic	metabolic	NOUN
ajcp-3197	21	2	disorders	disorder	NOUN
ajcp-3197	21	3	,	,	PUNCT
ajcp-3197	21	4	e.g.	e.g.	ADV
ajcp-3197	21	5	hypertension	hypertension	NOUN
ajcp-3197	21	6	,	,	PUNCT
ajcp-3197	21	7	adiposity	adiposity	NOUN
ajcp-3197	21	8	,	,	PUNCT
ajcp-3197	21	9	diabetes	diabetes	NOUN
ajcp-3197	21	10	mellitus	mellitus	NOUN
ajcp-3197	21	11	and	and	CCONJ
ajcp-3197	21	12	dyslipidemia	dyslipidemia	VERB
ajcp-3197	21	13	,	,	PUNCT
ajcp-3197	21	14	collectively	collectively	ADV
ajcp-3197	21	15	known	know	VERB
ajcp-3197	21	16	as	as	ADP
ajcp-3197	21	17	metabolic	metabolic	NOUN
ajcp-3197	21	18	syndrome	syndrome	NOUN
ajcp-3197	21	19	diseases	disease	NOUN
ajcp-3197	21	20	(	(	PUNCT
ajcp-3197	21	21	msds	msds	NOUN
ajcp-3197	21	22	)	)	PUNCT
ajcp-3197	21	23	are	be	AUX
ajcp-3197	21	24	diseases	disease	NOUN
ajcp-3197	21	25	related	relate	VERB
ajcp-3197	21	26	to	to	ADP
ajcp-3197	21	27	one	one	NUM
ajcp-3197	21	28	another	another	DET
ajcp-3197	21	29	(	(	PUNCT
ajcp-3197	21	30	ikwuka	ikwuka	NOUN
ajcp-3197	21	31	,	,	PUNCT
ajcp-3197	21	32	2015	2015	NUM
ajcp-3197	21	33	;	;	PUNCT
ajcp-3197	21	34	ikwuka	ikwuka	PROPN
ajcp-3197	21	35	,	,	PUNCT
ajcp-3197	21	36	2017a	2017a	NUM
ajcp-3197	21	37	;	;	PUNCT
ajcp-3197	21	38	ikwuka	ikwuka	PROPN
ajcp-3197	21	39	,	,	PUNCT
ajcp-3197	21	40	2017c	2017c	NUM
ajcp-3197	21	41	;	;	PUNCT
ajcp-3197	21	42	ikwuka	ikwuka	PROPN
ajcp-3197	21	43	&	&	CCONJ
ajcp-3197	21	44	virstyuk	virstyuk	PROPN
ajcp-3197	21	45	,	,	PUNCT
ajcp-3197	21	46	2023c	2023c	NUM
ajcp-3197	21	47	;	;	PUNCT
ajcp-3197	21	48	ikwuka	ikwuka	VERB
ajcp-3197	21	49	et	et	PROPN
ajcp-3197	21	50	al	al	PROPN
ajcp-3197	21	51	.	.	PROPN
ajcp-3197	21	52	,	,	PUNCT
ajcp-3197	21	53	2023f	2023f	NUM
ajcp-3197	21	54	;	;	PUNCT
ajcp-3197	21	55	virstyuk	virstyuk	PROPN
ajcp-3197	21	56	et	et	PROPN
ajcp-3197	21	57	al	al	PROPN
ajcp-3197	21	58	.	.	PROPN
ajcp-3197	21	59	,	,	PUNCT
ajcp-3197	21	60	2016	2016	NUM
ajcp-3197	21	61	)	)	PUNCT
ajcp-3197	21	62	.	.	PUNCT
ajcp-3197	22	1	t	t	PROPN
ajcp-3197	22	2	-	-	PUNCT
ajcp-3197	22	3	helper	helper	NOUN
ajcp-3197	22	4	17	17	NUM
ajcp-3197	22	5	(	(	PUNCT
ajcp-3197	22	6	th17	th17	NOUN
ajcp-3197	22	7	)	)	PUNCT
ajcp-3197	22	8	cells	cell	NOUN
ajcp-3197	22	9	secrete	secrete	VERB
ajcp-3197	22	10	interleukin-17	interleukin-17	PROPN
ajcp-3197	22	11	(	(	PUNCT
ajcp-3197	22	12	il-17	il-17	NUM
ajcp-3197	22	13	)	)	PUNCT
ajcp-3197	22	14	which	which	PRON
ajcp-3197	22	15	act	act	VERB
ajcp-3197	22	16	on	on	ADP
ajcp-3197	22	17	fibroblasts	fibroblast	NOUN
ajcp-3197	22	18	and	and	CCONJ
ajcp-3197	22	19	endothelial	endothelial	ADJ
ajcp-3197	22	20	cells	cell	NOUN
ajcp-3197	22	21	to	to	PART
ajcp-3197	22	22	increase	increase	VERB
ajcp-3197	22	23	inflammation	inflammation	NOUN
ajcp-3197	22	24	(	(	PUNCT
ajcp-3197	22	25	ikwuka	ikwuka	ADJ
ajcp-3197	22	26	,	,	PUNCT
ajcp-3197	22	27	2023b	2023b	NUM
ajcp-3197	22	28	)	)	PUNCT
ajcp-3197	22	29	.	.	PUNCT
ajcp-3197	23	1	different	different	ADJ
ajcp-3197	23	2	studies	study	NOUN
ajcp-3197	23	3	have	have	AUX
ajcp-3197	23	4	shown	show	VERB
ajcp-3197	23	5	that	that	SCONJ
ajcp-3197	23	6	msds	msds	PROPN
ajcp-3197	23	7	are	be	AUX
ajcp-3197	23	8	associated	associate	VERB
ajcp-3197	23	9	with	with	ADP
ajcp-3197	23	10	asymptomatic	asymptomatic	ADJ
ajcp-3197	23	11	hyperuricemia	hyperuricemia	NOUN
ajcp-3197	23	12	,	,	PUNCT
ajcp-3197	23	13	systemic	systemic	ADJ
ajcp-3197	23	14	immune	immune	ADJ
ajcp-3197	23	15	inflammatory	inflammatory	ADJ
ajcp-3197	23	16	processes	process	NOUN
ajcp-3197	23	17	,	,	PUNCT
ajcp-3197	23	18	and	and	CCONJ
ajcp-3197	23	19	fibrogenesis	fibrogenesis	VERB
ajcp-3197	23	20	all	all	PRON
ajcp-3197	23	21	of	of	ADP
ajcp-3197	23	22	which	which	PRON
ajcp-3197	23	23	can	can	AUX
ajcp-3197	23	24	lead	lead	VERB
ajcp-3197	23	25	to	to	ADP
ajcp-3197	23	26	nephropathy	nephropathy	NOUN
ajcp-3197	23	27	(	(	PUNCT
ajcp-3197	23	28	ikwuka	ikwuka	PROPN
ajcp-3197	23	29	&	&	CCONJ
ajcp-3197	23	30	haman	haman	NOUN
ajcp-3197	23	31	,	,	PUNCT
ajcp-3197	23	32	2017d	2017d	NUM
ajcp-3197	23	33	;	;	PUNCT
ajcp-3197	23	34	ikwuka	ikwuka	VERB
ajcp-3197	23	35	et	et	PROPN
ajcp-3197	23	36	al	al	PROPN
ajcp-3197	23	37	.	.	PROPN
ajcp-3197	23	38	,	,	PUNCT
ajcp-3197	23	39	2017e	2017e	NUM
ajcp-3197	23	40	;	;	PUNCT
ajcp-3197	23	41	ikwuka	ikwuka	PROPN
ajcp-3197	23	42	,	,	PUNCT
ajcp-3197	23	43	2018c	2018c	NUM
ajcp-3197	23	44	;	;	PUNCT
ajcp-3197	23	45	ikwuka	ikwuka	PROPN
ajcp-3197	23	46	&	&	CCONJ
ajcp-3197	23	47	paliy	paliy	PROPN
ajcp-3197	23	48	,	,	PUNCT
ajcp-3197	23	49	2018d	2018d	NUM
ajcp-3197	23	50	;	;	PUNCT
ajcp-3197	23	51	ikwuka	ikwuka	NOUN
ajcp-3197	23	52	,	,	PUNCT
ajcp-3197	23	53	2019a	2019a	NUM
ajcp-3197	23	54	;	;	PUNCT
ajcp-3197	23	55	ikwuka	ikwuka	PROPN
ajcp-3197	23	56	&	&	CCONJ
ajcp-3197	23	57	virstyuk	virstyuk	PROPN
ajcp-3197	23	58	,	,	PUNCT
ajcp-3197	23	59	2019c	2019c	NUM
ajcp-3197	23	60	;	;	PUNCT
ajcp-3197	23	61	ikwuka	ikwuka	PROPN
ajcp-3197	23	62	&	&	CCONJ
ajcp-3197	23	63	virstyuk	virstyuk	PROPN
ajcp-3197	23	64	,	,	PUNCT
ajcp-3197	23	65	2022	2022	NUM
ajcp-3197	23	66	;	;	PUNCT
ajcp-3197	23	67	ikwuka	ikwuka	VERB
ajcp-3197	23	68	et	et	PROPN
ajcp-3197	23	69	al	al	PROPN
ajcp-3197	23	70	.	.	PROPN
ajcp-3197	23	71	,	,	PUNCT
ajcp-3197	23	72	2023d	2023d	NUM
ajcp-3197	23	73	;	;	PUNCT
ajcp-3197	23	74	virstyuk	virstyuk	PROPN
ajcp-3197	23	75	&	&	CCONJ
ajcp-3197	23	76	ikwuka	ikwuka	PROPN
ajcp-3197	23	77	,	,	PUNCT
ajcp-3197	23	78	2017a	2017a	NUM
ajcp-3197	23	79	;	;	PUNCT
ajcp-3197	23	80	virstyuk	virstyuk	PROPN
ajcp-3197	23	81	&	&	CCONJ
ajcp-3197	23	82	ikwuka	ikwuka	PROPN
ajcp-3197	23	83	,	,	PUNCT
ajcp-3197	23	84	2018a	2018a	NUM
ajcp-3197	23	85	;	;	PUNCT
ajcp-3197	23	86	virstyuk	virstyuk	PROPN
ajcp-3197	23	87	&	&	CCONJ
ajcp-3197	23	88	ikwuka	ikwuka	PROPN
ajcp-3197	23	89	,	,	PUNCT
ajcp-3197	23	90	2019	2019	NUM
ajcp-3197	23	91	;	;	PUNCT
ajcp-3197	23	92	virstyuk	virstyuk	PROPN
ajcp-3197	23	93	&	&	CCONJ
ajcp-3197	23	94	ikwuka	ikwuka	PROPN
ajcp-3197	23	95	,	,	PUNCT
ajcp-3197	23	96	2021a	2021a	NUM
ajcp-3197	23	97	;	;	PUNCT
ajcp-3197	23	98	virstyuk	virstyuk	PROPN
ajcp-3197	23	99	et	et	PROPN
ajcp-3197	23	100	al	al	PROPN
ajcp-3197	23	101	.	.	PROPN
ajcp-3197	23	102	,	,	PUNCT
ajcp-3197	23	103	2021b	2021b	NUM
ajcp-3197	23	104	)	)	PUNCT
ajcp-3197	23	105	and	and	CCONJ
ajcp-3197	23	106	different	different	ADJ
ajcp-3197	23	107	rheumatological	rheumatological	ADJ
ajcp-3197	23	108	disorders	disorder	NOUN
ajcp-3197	23	109	in	in	ADP
ajcp-3197	23	110	the	the	DET
ajcp-3197	23	111	elderly	elderly	ADJ
ajcp-3197	23	112	e.g.	e.g.	ADJ
ajcp-3197	23	113	gouty	gouty	ADJ
ajcp-3197	23	114	arthritis	arthritis	NOUN
ajcp-3197	23	115	,	,	PUNCT
ajcp-3197	23	116	osteoarthritis	osteoarthritis	NOUN
ajcp-3197	23	117	,	,	PUNCT
ajcp-3197	23	118	etc	etc	X
ajcp-3197	23	119	.	.	X
ajcp-3197	23	120	thus	thus	ADV
ajcp-3197	23	121	,	,	PUNCT
ajcp-3197	23	122	age	age	NOUN
ajcp-3197	23	123	is	be	AUX
ajcp-3197	23	124	an	an	DET
ajcp-3197	23	125	independent	independent	ADJ
ajcp-3197	23	126	risk	risk	NOUN
ajcp-3197	23	127	factor	factor	NOUN
ajcp-3197	23	128	for	for	ADP
ajcp-3197	23	129	chronic	chronic	ADJ
ajcp-3197	23	130	noncommunicable	noncommunicable	ADJ
ajcp-3197	23	131	diseases	disease	NOUN
ajcp-3197	23	132	,	,	PUNCT
ajcp-3197	23	133	which	which	PRON
ajcp-3197	23	134	have	have	VERB
ajcp-3197	23	135	high	high	ADJ
ajcp-3197	23	136	morbidity	morbidity	NOUN
ajcp-3197	23	137	and	and	CCONJ
ajcp-3197	23	138	mortality	mortality	NOUN
ajcp-3197	23	139	rates	rate	NOUN
ajcp-3197	23	140	(	(	PUNCT
ajcp-3197	23	141	jaspinder	jaspinder	NOUN
ajcp-3197	23	142	et	et	PROPN
ajcp-3197	23	143	al	al	PROPN
ajcp-3197	23	144	.	.	PROPN
ajcp-3197	23	145	,	,	PUNCT
ajcp-3197	23	146	2014	2014	NUM
ajcp-3197	23	147	)	)	PUNCT
ajcp-3197	23	148	.	.	PUNCT
ajcp-3197	24	1	aging	aging	NOUN
ajcp-3197	24	2	is	be	AUX
ajcp-3197	24	3	associated	associate	VERB
ajcp-3197	24	4	with	with	ADP
ajcp-3197	24	5	increasing	increase	VERB
ajcp-3197	24	6	oxidative	oxidative	ADJ
ajcp-3197	24	7	stress	stress	NOUN
ajcp-3197	24	8	.	.	PUNCT
ajcp-3197	25	1	linked	link	VERB
ajcp-3197	25	2	to	to	ADP
ajcp-3197	25	3	the	the	DET
ajcp-3197	25	4	induction	induction	NOUN
ajcp-3197	25	5	of	of	ADP
ajcp-3197	25	6	oxidative	oxidative	ADJ
ajcp-3197	25	7	stress	stress	NOUN
ajcp-3197	25	8	are	be	AUX
ajcp-3197	25	9	major	major	ADJ
ajcp-3197	25	10	free	free	ADJ
ajcp-3197	25	11	radicals	radical	NOUN
ajcp-3197	25	12	.	.	PUNCT
ajcp-3197	26	1	among	among	ADP
ajcp-3197	26	2	these	these	DET
ajcp-3197	26	3	major	major	ADJ
ajcp-3197	26	4	free	free	ADJ
ajcp-3197	26	5	radicals	radical	NOUN
ajcp-3197	26	6	,	,	PUNCT
ajcp-3197	26	7	superoxide	superoxide	NOUN
ajcp-3197	26	8	anions	anion	NOUN
ajcp-3197	26	9	,	,	PUNCT
ajcp-3197	26	10	hydroxyl	hydroxyl	NOUN
ajcp-3197	26	11	radicals	radical	NOUN
ajcp-3197	26	12	,	,	PUNCT
ajcp-3197	26	13	and	and	CCONJ
ajcp-3197	26	14	hydroperoxyl	hydroperoxyl	PROPN
ajcp-3197	26	15	radicals	radical	NOUN
ajcp-3197	26	16	are	be	AUX
ajcp-3197	26	17	of	of	ADP
ajcp-3197	26	18	physiological	physiological	ADJ
ajcp-3197	26	19	significance	significance	NOUN
ajcp-3197	26	20	.	.	PUNCT
ajcp-3197	27	1	a	a	DET
ajcp-3197	27	2	non	non	ADJ
ajcp-3197	27	3	-	-	ADJ
ajcp-3197	27	4	radical	radical	ADJ
ajcp-3197	27	5	of	of	ADP
ajcp-3197	27	6	physiological	physiological	ADJ
ajcp-3197	27	7	significance	significance	NOUN
ajcp-3197	27	8	is	be	AUX
ajcp-3197	27	9	hydrogen	hydrogen	NOUN
ajcp-3197	27	10	peroxide	peroxide	NOUN
ajcp-3197	27	11	(	(	PUNCT
ajcp-3197	27	12	ama	ama	X
ajcp-3197	27	13	et	et	NOUN
ajcp-3197	27	14	al	al	PROPN
ajcp-3197	27	15	.	.	PROPN
ajcp-3197	27	16	,	,	PUNCT
ajcp-3197	27	17	2023	2023	NUM
ajcp-3197	27	18	;	;	PUNCT
ajcp-3197	27	19	baysah	baysah	PROPN
ajcp-3197	27	20	et	et	PROPN
ajcp-3197	27	21	al	al	PROPN
ajcp-3197	27	22	.	.	PROPN
ajcp-3197	27	23	,	,	PUNCT
ajcp-3197	27	24	2023	2023	NUM
ajcp-3197	27	25	;	;	PUNCT
ajcp-3197	27	26	ekechi	ekechi	NOUN
ajcp-3197	27	27	et	et	PROPN
ajcp-3197	27	28	al	al	PROPN
ajcp-3197	27	29	.	.	PROPN
ajcp-3197	27	30	,	,	PUNCT
ajcp-3197	27	31	2023a	2023a	NUM
ajcp-3197	27	32	;	;	PUNCT
ajcp-3197	27	33	uche	uche	PROPN
ajcp-3197	27	34	et	et	PROPN
ajcp-3197	27	35	al	al	PROPN
ajcp-3197	27	36	.	.	PROPN
ajcp-3197	27	37	,	,	PUNCT
ajcp-3197	27	38	2023	2023	NUM
ajcp-3197	27	39	)	)	PUNCT
ajcp-3197	27	40	.	.	PUNCT
ajcp-3197	28	1	increased	increase	VERB
ajcp-3197	28	2	oxidative	oxidative	ADJ
ajcp-3197	28	3	stress	stress	NOUN
ajcp-3197	28	4	can	can	AUX
ajcp-3197	28	5	lead	lead	VERB
ajcp-3197	28	6	to	to	ADP
ajcp-3197	28	7	mutation	mutation	NOUN
ajcp-3197	28	8	which	which	PRON
ajcp-3197	28	9	is	be	AUX
ajcp-3197	28	10	an	an	DET
ajcp-3197	28	11	alteration	alteration	NOUN
ajcp-3197	28	12	in	in	ADP
ajcp-3197	28	13	the	the	DET
ajcp-3197	28	14	dna	dna	PROPN
ajcp-3197	28	15	sequence	sequence	NOUN
ajcp-3197	28	16	which	which	PRON
ajcp-3197	28	17	produces	produce	VERB
ajcp-3197	28	18	new	new	ADJ
ajcp-3197	28	19	alleles	allele	NOUN
ajcp-3197	28	20	.	.	PUNCT
ajcp-3197	29	1	one	one	NUM
ajcp-3197	29	2	common	common	ADJ
ajcp-3197	29	3	type	type	NOUN
ajcp-3197	29	4	of	of	ADP
ajcp-3197	29	5	single	single	ADJ
ajcp-3197	29	6	gene	gene	NOUN
ajcp-3197	29	7	mutation	mutation	NOUN
ajcp-3197	29	8	is	be	AUX
ajcp-3197	29	9	the	the	DET
ajcp-3197	29	10	missense	missense	NOUN
ajcp-3197	29	11	mutation	mutation	NOUN
ajcp-3197	29	12	which	which	PRON
ajcp-3197	29	13	results	result	VERB
ajcp-3197	29	14	in	in	ADP
ajcp-3197	29	15	the	the	DET
ajcp-3197	29	16	substitution	substitution	NOUN
ajcp-3197	29	17	or	or	CCONJ
ajcp-3197	29	18	replication	replication	NOUN
ajcp-3197	29	19	of	of	ADP
ajcp-3197	29	20	a	a	DET
ajcp-3197	29	21	single	single	ADJ
ajcp-3197	29	22	amino	amino	NOUN
ajcp-3197	29	23	acid	acid	NOUN
ajcp-3197	29	24	in	in	ADP
ajcp-3197	29	25	the	the	DET
ajcp-3197	29	26	polypeptide	polypeptide	ADJ
ajcp-3197	29	27	chain	chain	NOUN
ajcp-3197	29	28	e.g.	e.g.	ADV
ajcp-3197	29	29	sickle	sickle	NOUN
ajcp-3197	29	30	cell	cell	NOUN
ajcp-3197	29	31	disease	disease	NOUN
ajcp-3197	29	32	is	be	AUX
ajcp-3197	29	33	caused	cause	VERB
ajcp-3197	29	34	by	by	ADP
ajcp-3197	29	35	a	a	DET
ajcp-3197	29	36	missense	missense	NOUN
ajcp-3197	29	37	mutation	mutation	NOUN
ajcp-3197	29	38	that	that	PRON
ajcp-3197	29	39	produces	produce	VERB
ajcp-3197	29	40	a	a	DET
ajcp-3197	29	41	substitution	substitution	NOUN
ajcp-3197	29	42	of	of	ADP
ajcp-3197	29	43	valine	valine	NOUN
ajcp-3197	29	44	for	for	ADP
ajcp-3197	29	45	glutamate	glutamate	NOUN
ajcp-3197	29	46	in	in	ADP
ajcp-3197	29	47	the	the	DET
ajcp-3197	29	48	two	two	NUM
ajcp-3197	29	49	β	β	NOUN
ajcp-3197	29	50	-	-	ADJ
ajcp-3197	29	51	globin	globin	ADJ
ajcp-3197	29	52	polypeptide	polypeptide	ADJ
ajcp-3197	29	53	chains	chain	NOUN
ajcp-3197	29	54	(	(	PUNCT
ajcp-3197	29	55	ikwuka	ikwuka	ADJ
ajcp-3197	29	56	,	,	PUNCT
ajcp-3197	29	57	2023a	2023a	NUM
ajcp-3197	29	58	;	;	PUNCT
ajcp-3197	29	59	musa	musa	PROPN
ajcp-3197	29	60	et	et	PROPN
ajcp-3197	29	61	al	al	PROPN
ajcp-3197	29	62	.	.	PROPN
ajcp-3197	29	63	,	,	PUNCT
ajcp-3197	29	64	2023	2023	NUM
ajcp-3197	29	65	)	)	PUNCT
ajcp-3197	29	66	.	.	PUNCT
ajcp-3197	30	1	sickle	sickle	NOUN
ajcp-3197	30	2	cell	cell	NOUN
ajcp-3197	30	3	disease	disease	NOUN
ajcp-3197	30	4	is	be	AUX
ajcp-3197	30	5	characterized	characterize	VERB
ajcp-3197	30	6	with	with	ADP
ajcp-3197	30	7	different	different	ADJ
ajcp-3197	30	8	severities	severity	NOUN
ajcp-3197	30	9	of	of	ADP
ajcp-3197	30	10	anemia	anemia	NOUN
ajcp-3197	30	11	(	(	PUNCT
ajcp-3197	30	12	inya	inya	PROPN
ajcp-3197	30	13	et	et	PROPN
ajcp-3197	30	14	al	al	PROPN
ajcp-3197	30	15	.	.	PROPN
ajcp-3197	30	16	,	,	PUNCT
ajcp-3197	30	17	2023a	2023a	NUM
ajcp-3197	30	18	;	;	PUNCT
ajcp-3197	30	19	inya	inya	PROPN
ajcp-3197	30	20	et	et	PROPN
ajcp-3197	30	21	al	al	PROPN
ajcp-3197	30	22	.	.	PROPN
ajcp-3197	30	23	,	,	PUNCT
ajcp-3197	30	24	2023b	2023b	NUM
ajcp-3197	30	25	)	)	PUNCT
ajcp-3197	30	26	.	.	PUNCT
ajcp-3197	31	1	research	research	NOUN
ajcp-3197	31	2	also	also	ADV
ajcp-3197	31	3	shows	show	VERB
ajcp-3197	31	4	that	that	SCONJ
ajcp-3197	31	5	disorders	disorder	NOUN
ajcp-3197	31	6	in	in	ADP
ajcp-3197	31	7	individuals	individual	NOUN
ajcp-3197	31	8	aged	age	VERB
ajcp-3197	31	9	60	60	NUM
ajcp-3197	31	10	and	and	CCONJ
ajcp-3197	31	11	above	above	ADV
ajcp-3197	31	12	,	,	PUNCT
ajcp-3197	31	13	account	account	VERB
ajcp-3197	31	14	for	for	ADP
ajcp-3197	31	15	23	23	NUM
ajcp-3197	31	16	%	%	NOUN
ajcp-3197	31	17	of	of	ADP
ajcp-3197	31	18	the	the	DET
ajcp-3197	31	19	global	global	ADJ
ajcp-3197	31	20	disease	disease	NOUN
ajcp-3197	31	21	burden	burden	NOUN
ajcp-3197	31	22	(	(	PUNCT
ajcp-3197	31	23	prince	prince	PROPN
ajcp-3197	31	24	et	et	PROPN
ajcp-3197	31	25	al	al	PROPN
ajcp-3197	31	26	.	.	PROPN
ajcp-3197	31	27	,	,	PUNCT
ajcp-3197	31	28	2015	2015	NUM
ajcp-3197	31	29	)	)	PUNCT
ajcp-3197	31	30	.	.	PUNCT
ajcp-3197	32	1	60	60	NUM
ajcp-3197	32	2	years	year	NOUN
ajcp-3197	32	3	and	and	CCONJ
ajcp-3197	32	4	above	above	ADV
ajcp-3197	32	5	is	be	AUX
ajcp-3197	32	6	also	also	ADV
ajcp-3197	32	7	a	a	DET
ajcp-3197	32	8	risk	risk	NOUN
ajcp-3197	32	9	factor	factor	NOUN
ajcp-3197	32	10	for	for	ADP
ajcp-3197	32	11	the	the	DET
ajcp-3197	32	12	development	development	NOUN
ajcp-3197	32	13	of	of	ADP
ajcp-3197	32	14	different	different	ADJ
ajcp-3197	32	15	myeloand	myeloand	NOUN
ajcp-3197	32	16	lymphoproliferative	lymphoproliferative	ADJ
ajcp-3197	32	17	disorders	disorder	NOUN
ajcp-3197	32	18	such	such	ADJ
ajcp-3197	32	19	as	as	ADP
ajcp-3197	32	20	myelodysplastic	myelodysplastic	ADJ
ajcp-3197	32	21	pa	pa	PROPN
ajcp-3197	32	22	ge	ge	PROPN
ajcp-3197	32	23	2	2	NUM
ajcp-3197	32	24	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	32	25	am	be	AUX
ajcp-3197	32	26	.	.	PUNCT
ajcp-3197	33	1	j.	j.	PROPN
ajcp-3197	33	2	chem	chem	PROPN
ajcp-3197	33	3	.	.	PUNCT
ajcp-3197	34	1	pharm	pharm	PROPN
ajcp-3197	34	2	.	.	PUNCT
ajcp-3197	35	1	3(1	3(1	NUM
ajcp-3197	35	2	)	)	PUNCT
ajcp-3197	35	3	1	1	NUM
ajcp-3197	35	4	-	-	SYM
ajcp-3197	35	5	11	11	NUM
ajcp-3197	35	6	,	,	PUNCT
ajcp-3197	35	7	2024	2024	NUM
ajcp-3197	35	8	syndrome	syndrome	NOUN
ajcp-3197	35	9	,	,	PUNCT
ajcp-3197	35	10	multiple	multiple	ADJ
ajcp-3197	35	11	myeloma	myeloma	NOUN
ajcp-3197	35	12	,	,	PUNCT
ajcp-3197	35	13	and	and	CCONJ
ajcp-3197	35	14	non	non	ADJ
ajcp-3197	35	15	-	-	ADJ
ajcp-3197	35	16	hodgkin	hodgkin	ADJ
ajcp-3197	35	17	lymphoma	lymphoma	NOUN
ajcp-3197	35	18	(	(	PUNCT
ajcp-3197	35	19	ikwuka	ikwuka	NOUN
ajcp-3197	35	20	,	,	PUNCT
ajcp-3197	35	21	2023e	2023e	NUM
ajcp-3197	35	22	)	)	PUNCT
ajcp-3197	35	23	.	.	PUNCT
ajcp-3197	36	1	therefore	therefore	ADV
ajcp-3197	36	2	,	,	PUNCT
ajcp-3197	36	3	there	there	PRON
ajcp-3197	36	4	is	be	VERB
ajcp-3197	36	5	a	a	DET
ajcp-3197	36	6	high	high	ADJ
ajcp-3197	36	7	demand	demand	NOUN
ajcp-3197	36	8	for	for	ADP
ajcp-3197	36	9	health	health	NOUN
ajcp-3197	36	10	services	service	NOUN
ajcp-3197	36	11	to	to	PART
ajcp-3197	36	12	meet	meet	VERB
ajcp-3197	36	13	the	the	DET
ajcp-3197	36	14	needs	need	NOUN
ajcp-3197	36	15	of	of	ADP
ajcp-3197	36	16	this	this	DET
ajcp-3197	36	17	age	age	NOUN
ajcp-3197	36	18	group	group	NOUN
ajcp-3197	36	19	,	,	PUNCT
ajcp-3197	36	20	requiring	require	VERB
ajcp-3197	36	21	special	special	ADJ
ajcp-3197	36	22	attention	attention	NOUN
ajcp-3197	36	23	to	to	ADP
ajcp-3197	36	24	their	their	PRON
ajcp-3197	36	25	treatment	treatment	NOUN
ajcp-3197	36	26	process	process	NOUN
ajcp-3197	36	27	(	(	PUNCT
ajcp-3197	36	28	davies	davy	NOUN
ajcp-3197	36	29	&	&	CCONJ
ajcp-3197	36	30	o’mahony	o’mahony	PROPN
ajcp-3197	36	31	,	,	PUNCT
ajcp-3197	36	32	2015	2015	NUM
ajcp-3197	36	33	)	)	PUNCT
ajcp-3197	36	34	.	.	PUNCT
ajcp-3197	37	1	in	in	ADP
ajcp-3197	37	2	addition	addition	NOUN
ajcp-3197	37	3	,	,	PUNCT
ajcp-3197	37	4	there	there	PRON
ajcp-3197	37	5	is	be	VERB
ajcp-3197	37	6	also	also	ADV
ajcp-3197	37	7	a	a	DET
ajcp-3197	37	8	need	need	NOUN
ajcp-3197	37	9	for	for	ADP
ajcp-3197	37	10	new	new	ADJ
ajcp-3197	37	11	and	and	CCONJ
ajcp-3197	37	12	effective	effective	ADJ
ajcp-3197	37	13	treatment	treatment	NOUN
ajcp-3197	37	14	options	option	NOUN
ajcp-3197	37	15	in	in	ADP
ajcp-3197	37	16	patients	patient	NOUN
ajcp-3197	37	17	with	with	ADP
ajcp-3197	37	18	metabolic	metabolic	NOUN
ajcp-3197	37	19	syndrome	syndrome	NOUN
ajcp-3197	37	20	diseases	disease	NOUN
ajcp-3197	37	21	.	.	PUNCT
ajcp-3197	38	1	sodium	sodium	NOUN
ajcp-3197	38	2	-	-	PUNCT
ajcp-3197	38	3	glucose	glucose	NOUN
ajcp-3197	38	4	linked	link	VERB
ajcp-3197	38	5	transporter	transporter	NOUN
ajcp-3197	38	6	2	2	NUM
ajcp-3197	38	7	(	(	PUNCT
ajcp-3197	38	8	sglt-2	sglt-2	NOUN
ajcp-3197	38	9	)	)	PUNCT
ajcp-3197	38	10	inhibitors	inhibitor	NOUN
ajcp-3197	38	11	e.g.	e.g.	ADV
ajcp-3197	38	12	dapagliflozin	dapagliflozin	NOUN
ajcp-3197	38	13	and	and	CCONJ
ajcp-3197	38	14	glucagonlike	glucagonlike	NOUN
ajcp-3197	38	15	peptide	peptide	VERB
ajcp-3197	38	16	1	1	NUM
ajcp-3197	38	17	receptor	receptor	NOUN
ajcp-3197	38	18	agonists	agonist	NOUN
ajcp-3197	38	19	(	(	PUNCT
ajcp-3197	38	20	glp-1	glp-1	X
ajcp-3197	38	21	ras	ras	X
ajcp-3197	38	22	)	)	PUNCT
ajcp-3197	38	23	e.g.	e.g.	ADV
ajcp-3197	38	24	liraglutide	liraglutide	NOUN
ajcp-3197	38	25	have	have	AUX
ajcp-3197	38	26	been	be	AUX
ajcp-3197	38	27	found	find	VERB
ajcp-3197	38	28	to	to	PART
ajcp-3197	38	29	improve	improve	VERB
ajcp-3197	38	30	the	the	DET
ajcp-3197	38	31	efficacy	efficacy	NOUN
ajcp-3197	38	32	of	of	ADP
ajcp-3197	38	33	treatment	treatment	NOUN
ajcp-3197	38	34	and	and	CCONJ
ajcp-3197	38	35	clinical	clinical	ADJ
ajcp-3197	38	36	course	course	NOUN
ajcp-3197	38	37	of	of	ADP
ajcp-3197	38	38	type	type	NOUN
ajcp-3197	38	39	2	2	NUM
ajcp-3197	38	40	diabetes	diabetes	NOUN
ajcp-3197	38	41	mellitus	mellitus	NOUN
ajcp-3197	38	42	and	and	CCONJ
ajcp-3197	38	43	hypertension	hypertension	NOUN
ajcp-3197	38	44	in	in	ADP
ajcp-3197	38	45	patients	patient	NOUN
ajcp-3197	38	46	with	with	ADP
ajcp-3197	38	47	such	such	ADJ
ajcp-3197	38	48	comorbidities	comorbiditie	NOUN
ajcp-3197	38	49	(	(	PUNCT
ajcp-3197	38	50	ikwuka	ikwuka	NOUN
ajcp-3197	38	51	,	,	PUNCT
ajcp-3197	38	52	2017b	2017b	NUM
ajcp-3197	38	53	;	;	PUNCT
ajcp-3197	38	54	ikwuka	ikwuka	PROPN
ajcp-3197	38	55	,	,	PUNCT
ajcp-3197	38	56	2018a	2018a	NUM
ajcp-3197	38	57	;	;	PUNCT
ajcp-3197	38	58	ikwuka	ikwuka	PROPN
ajcp-3197	38	59	,	,	PUNCT
ajcp-3197	38	60	2018b	2018b	NUM
ajcp-3197	38	61	;	;	PUNCT
ajcp-3197	38	62	ikwuka	ikwuka	PROPN
ajcp-3197	38	63	,	,	PUNCT
ajcp-3197	38	64	2019b	2019b	NUM
ajcp-3197	38	65	;	;	PUNCT
ajcp-3197	38	66	ikwuka	ikwuka	PROPN
ajcp-3197	38	67	&	&	CCONJ
ajcp-3197	38	68	virstyuk	virstyuk	PROPN
ajcp-3197	38	69	,	,	PUNCT
ajcp-3197	38	70	2021	2021	NUM
ajcp-3197	38	71	;	;	PUNCT
ajcp-3197	38	72	ikwuka	ikwuka	VERB
ajcp-3197	38	73	,	,	PUNCT
ajcp-3197	38	74	2024	2024	NUM
ajcp-3197	38	75	;	;	PUNCT
ajcp-3197	38	76	virstyuk	virstyuk	PROPN
ajcp-3197	38	77	et	et	PROPN
ajcp-3197	38	78	al	al	PROPN
ajcp-3197	38	79	.	.	PROPN
ajcp-3197	38	80	,	,	PUNCT
ajcp-3197	38	81	2017b	2017b	NUM
ajcp-3197	38	82	;	;	PUNCT
ajcp-3197	38	83	virstyuk	virstyuk	PROPN
ajcp-3197	38	84	et	et	PROPN
ajcp-3197	38	85	al	al	PROPN
ajcp-3197	38	86	.	.	PROPN
ajcp-3197	38	87	,	,	PUNCT
ajcp-3197	38	88	2018b	2018b	NUM
ajcp-3197	38	89	;	;	PUNCT
ajcp-3197	38	90	virstyuk	virstyuk	PROPN
ajcp-3197	38	91	&	&	CCONJ
ajcp-3197	38	92	ikwuka	ikwuka	PROPN
ajcp-3197	38	93	,	,	PUNCT
ajcp-3197	38	94	2018c	2018c	NUM
ajcp-3197	38	95	)	)	PUNCT
ajcp-3197	38	96	.	.	PUNCT
ajcp-3197	39	1	it	it	PRON
ajcp-3197	39	2	has	have	AUX
ajcp-3197	39	3	also	also	ADV
ajcp-3197	39	4	been	be	AUX
ajcp-3197	39	5	reported	report	VERB
ajcp-3197	39	6	that	that	SCONJ
ajcp-3197	39	7	coconut	coconut	NOUN
ajcp-3197	39	8	water	water	NOUN
ajcp-3197	39	9	has	have	VERB
ajcp-3197	39	10	hepatorenal	hepatorenal	ADJ
ajcp-3197	39	11	protective	protective	ADJ
ajcp-3197	39	12	functions	function	NOUN
ajcp-3197	39	13	against	against	ADP
ajcp-3197	39	14	alloxan	alloxan	NOUN
ajcp-3197	39	15	-	-	PUNCT
ajcp-3197	39	16	induced	induce	VERB
ajcp-3197	39	17	type	type	NOUN
ajcp-3197	39	18	1	1	NUM
ajcp-3197	39	19	diabetes	diabetes	NOUN
ajcp-3197	39	20	mellitus	mellitus	NOUN
ajcp-3197	39	21	(	(	PUNCT
ajcp-3197	39	22	ekechi	ekechi	NOUN
ajcp-3197	39	23	et	et	PROPN
ajcp-3197	39	24	al	al	PROPN
ajcp-3197	39	25	.	.	PROPN
ajcp-3197	39	26	,	,	PUNCT
ajcp-3197	39	27	2023b	2023b	NUM
ajcp-3197	39	28	)	)	PUNCT
ajcp-3197	39	29	.	.	PUNCT
ajcp-3197	40	1	adverse	adverse	ADJ
ajcp-3197	40	2	drug	drug	NOUN
ajcp-3197	40	3	reaction	reaction	NOUN
ajcp-3197	40	4	(	(	PUNCT
ajcp-3197	40	5	adr	adr	PROPN
ajcp-3197	40	6	)	)	PUNCT
ajcp-3197	40	7	is	be	AUX
ajcp-3197	40	8	defined	define	VERB
ajcp-3197	40	9	as	as	ADP
ajcp-3197	40	10	“	"	PUNCT
ajcp-3197	40	11	an	an	DET
ajcp-3197	40	12	appreciably	appreciably	ADV
ajcp-3197	40	13	harmful	harmful	ADJ
ajcp-3197	40	14	or	or	CCONJ
ajcp-3197	40	15	unpleasant	unpleasant	ADJ
ajcp-3197	40	16	reaction	reaction	NOUN
ajcp-3197	40	17	resulting	result	VERB
ajcp-3197	40	18	from	from	ADP
ajcp-3197	40	19	the	the	DET
ajcp-3197	40	20	use	use	NOUN
ajcp-3197	40	21	of	of	ADP
ajcp-3197	40	22	a	a	DET
ajcp-3197	40	23	medicinal	medicinal	ADJ
ajcp-3197	40	24	product	product	NOUN
ajcp-3197	40	25	;	;	PUNCT
ajcp-3197	40	26	adverse	adverse	ADJ
ajcp-3197	40	27	effects	effect	NOUN
ajcp-3197	40	28	usually	usually	ADV
ajcp-3197	40	29	predict	predict	VERB
ajcp-3197	40	30	future	future	ADJ
ajcp-3197	40	31	hazards	hazard	NOUN
ajcp-3197	40	32	and	and	CCONJ
ajcp-3197	40	33	require	require	VERB
ajcp-3197	40	34	prevention	prevention	NOUN
ajcp-3197	40	35	,	,	PUNCT
ajcp-3197	40	36	specific	specific	ADJ
ajcp-3197	40	37	treatment	treatment	NOUN
ajcp-3197	40	38	,	,	PUNCT
ajcp-3197	40	39	alteration	alteration	NOUN
ajcp-3197	40	40	of	of	ADP
ajcp-3197	40	41	dosage	dosage	NOUN
ajcp-3197	40	42	regimen	regiman	NOUN
ajcp-3197	40	43	,	,	PUNCT
ajcp-3197	40	44	or	or	CCONJ
ajcp-3197	40	45	withdrawal	withdrawal	NOUN
ajcp-3197	40	46	of	of	ADP
ajcp-3197	40	47	the	the	DET
ajcp-3197	40	48	product	product	NOUN
ajcp-3197	40	49	”	"	PUNCT
ajcp-3197	40	50	(	(	PUNCT
ajcp-3197	40	51	aronson	aronson	PROPN
ajcp-3197	40	52	&	&	CCONJ
ajcp-3197	40	53	ferner	ferner	NOUN
ajcp-3197	40	54	,	,	PUNCT
ajcp-3197	40	55	2005	2005	NUM
ajcp-3197	40	56	)	)	PUNCT
ajcp-3197	40	57	.	.	PUNCT
ajcp-3197	41	1	adrs	adr	NOUN
ajcp-3197	41	2	are	be	AUX
ajcp-3197	41	3	common	common	ADJ
ajcp-3197	41	4	in	in	ADP
ajcp-3197	41	5	clinical	clinical	ADJ
ajcp-3197	41	6	practice	practice	NOUN
ajcp-3197	41	7	,	,	PUNCT
ajcp-3197	41	8	with	with	ADP
ajcp-3197	41	9	some	some	DET
ajcp-3197	41	10	cases	case	NOUN
ajcp-3197	41	11	being	be	AUX
ajcp-3197	41	12	severe	severe	ADJ
ajcp-3197	41	13	and	and	CCONJ
ajcp-3197	41	14	leading	lead	VERB
ajcp-3197	41	15	to	to	ADP
ajcp-3197	41	16	unscheduled	unscheduled	ADJ
ajcp-3197	41	17	hospital	hospital	NOUN
ajcp-3197	41	18	admissions	admission	NOUN
ajcp-3197	41	19	and	and	CCONJ
ajcp-3197	41	20	even	even	ADV
ajcp-3197	41	21	death	death	NOUN
ajcp-3197	41	22	(	(	PUNCT
ajcp-3197	41	23	coleman	coleman	PROPN
ajcp-3197	41	24	&	&	CCONJ
ajcp-3197	41	25	pontefract	pontefract	PROPN
ajcp-3197	41	26	,	,	PUNCT
ajcp-3197	41	27	2016	2016	NUM
ajcp-3197	41	28	;	;	PUNCT
ajcp-3197	41	29	alhawassi	alhawassi	PROPN
ajcp-3197	41	30	et	et	PROPN
ajcp-3197	41	31	al	al	PROPN
ajcp-3197	41	32	.	.	PROPN
ajcp-3197	41	33	,	,	PUNCT
ajcp-3197	41	34	2014	2014	NUM
ajcp-3197	41	35	)	)	PUNCT
ajcp-3197	41	36	.	.	PUNCT
ajcp-3197	42	1	adverse	adverse	ADJ
ajcp-3197	42	2	drug	drug	NOUN
ajcp-3197	42	3	reactions	reaction	NOUN
ajcp-3197	42	4	in	in	ADP
ajcp-3197	42	5	the	the	DET
ajcp-3197	42	6	geriatric	geriatric	ADJ
ajcp-3197	42	7	population	population	NOUN
ajcp-3197	42	8	pose	pose	VERB
ajcp-3197	42	9	a	a	DET
ajcp-3197	42	10	significant	significant	ADJ
ajcp-3197	42	11	problem	problem	NOUN
ajcp-3197	42	12	in	in	ADP
ajcp-3197	42	13	managing	manage	VERB
ajcp-3197	42	14	elderly	elderly	ADJ
ajcp-3197	42	15	patients	patient	NOUN
ajcp-3197	42	16	.	.	PUNCT
ajcp-3197	43	1	this	this	PRON
ajcp-3197	43	2	is	be	AUX
ajcp-3197	43	3	due	due	ADJ
ajcp-3197	43	4	to	to	ADP
ajcp-3197	43	5	the	the	DET
ajcp-3197	43	6	decline	decline	NOUN
ajcp-3197	43	7	in	in	ADP
ajcp-3197	43	8	physiological	physiological	ADJ
ajcp-3197	43	9	functions	function	NOUN
ajcp-3197	43	10	(	(	PUNCT
ajcp-3197	43	11	such	such	ADJ
ajcp-3197	43	12	as	as	ADP
ajcp-3197	43	13	decreased	decrease	VERB
ajcp-3197	43	14	renal	renal	ADJ
ajcp-3197	43	15	and	and	CCONJ
ajcp-3197	43	16	hepatic	hepatic	ADJ
ajcp-3197	43	17	clearance	clearance	NOUN
ajcp-3197	43	18	)	)	PUNCT
ajcp-3197	43	19	,	,	PUNCT
ajcp-3197	43	20	co	co	NOUN
ajcp-3197	43	21	-	-	NOUN
ajcp-3197	43	22	morbidity	morbidity	NOUN
ajcp-3197	43	23	,	,	PUNCT
ajcp-3197	43	24	pharmacodynamic	pharmacodynamic	ADJ
ajcp-3197	43	25	and	and	CCONJ
ajcp-3197	43	26	pharmacokinetic	pharmacokinetic	ADJ
ajcp-3197	43	27	changes	change	NOUN
ajcp-3197	43	28	,	,	PUNCT
ajcp-3197	43	29	frailty	frailty	NOUN
ajcp-3197	43	30	,	,	PUNCT
ajcp-3197	43	31	polypharmacy	polypharmacy	NOUN
ajcp-3197	43	32	,	,	PUNCT
ajcp-3197	43	33	and	and	CCONJ
ajcp-3197	43	34	memory	memory	NOUN
ajcp-3197	43	35	problems	problem	NOUN
ajcp-3197	43	36	commonly	commonly	ADV
ajcp-3197	43	37	observed	observe	VERB
ajcp-3197	43	38	in	in	ADP
ajcp-3197	43	39	this	this	DET
ajcp-3197	43	40	population	population	NOUN
ajcp-3197	43	41	.	.	PUNCT
ajcp-3197	44	1	multiple	multiple	ADJ
ajcp-3197	44	2	drug	drug	NOUN
ajcp-3197	44	3	therapies	therapy	NOUN
ajcp-3197	44	4	for	for	ADP
ajcp-3197	44	5	co	co	NOUN
ajcp-3197	44	6	-	-	NOUN
ajcp-3197	44	7	morbidities	morbidity	NOUN
ajcp-3197	44	8	increase	increase	VERB
ajcp-3197	44	9	the	the	DET
ajcp-3197	44	10	risk	risk	NOUN
ajcp-3197	44	11	of	of	ADP
ajcp-3197	44	12	drug	drug	NOUN
ajcp-3197	44	13	interactions	interaction	NOUN
ajcp-3197	44	14	and	and	CCONJ
ajcp-3197	44	15	inappropriate	inappropriate	ADJ
ajcp-3197	44	16	medication	medication	NOUN
ajcp-3197	44	17	prescribing	prescribing	NOUN
ajcp-3197	44	18	.	.	PUNCT
ajcp-3197	45	1	studies	study	NOUN
ajcp-3197	45	2	have	have	AUX
ajcp-3197	45	3	shown	show	VERB
ajcp-3197	45	4	that	that	SCONJ
ajcp-3197	45	5	prescription	prescription	NOUN
ajcp-3197	45	6	medication	medication	NOUN
ajcp-3197	45	7	use	use	NOUN
ajcp-3197	45	8	among	among	ADP
ajcp-3197	45	9	elderly	elderly	ADJ
ajcp-3197	45	10	patients	patient	NOUN
ajcp-3197	45	11	has	have	AUX
ajcp-3197	45	12	doubled	double	VERB
ajcp-3197	45	13	in	in	ADP
ajcp-3197	45	14	recent	recent	ADJ
ajcp-3197	45	15	years	year	NOUN
ajcp-3197	45	16	(	(	PUNCT
ajcp-3197	45	17	charlesworth	charlesworth	NOUN
ajcp-3197	45	18	et	et	PROPN
ajcp-3197	45	19	al	al	PROPN
ajcp-3197	45	20	.	.	PROPN
ajcp-3197	45	21	,	,	PUNCT
ajcp-3197	45	22	2015	2015	NUM
ajcp-3197	45	23	)	)	PUNCT
ajcp-3197	45	24	.	.	PUNCT
ajcp-3197	46	1	the	the	DET
ajcp-3197	46	2	prevalence	prevalence	NOUN
ajcp-3197	46	3	of	of	ADP
ajcp-3197	46	4	adrs	adrs	PROPN
ajcp-3197	46	5	in	in	ADP
ajcp-3197	46	6	older	old	ADJ
ajcp-3197	46	7	adults	adult	NOUN
ajcp-3197	46	8	has	have	AUX
ajcp-3197	46	9	been	be	AUX
ajcp-3197	46	10	documented	document	VERB
ajcp-3197	46	11	in	in	ADP
ajcp-3197	46	12	african	african	ADJ
ajcp-3197	46	13	countries	country	NOUN
ajcp-3197	46	14	with	with	ADP
ajcp-3197	46	15	several	several	ADJ
ajcp-3197	46	16	studies	study	NOUN
ajcp-3197	46	17	highlighting	highlight	VERB
ajcp-3197	46	18	the	the	DET
ajcp-3197	46	19	major	major	ADJ
ajcp-3197	46	20	drug	drug	NOUN
ajcp-3197	46	21	classes	class	NOUN
ajcp-3197	46	22	responsible	responsible	ADJ
ajcp-3197	46	23	for	for	ADP
ajcp-3197	46	24	adrs	adr	NOUN
ajcp-3197	46	25	.	.	PUNCT
ajcp-3197	47	1	however	however	ADV
ajcp-3197	47	2	,	,	PUNCT
ajcp-3197	47	3	global	global	ADJ
ajcp-3197	47	4	studies	study	NOUN
ajcp-3197	47	5	on	on	ADP
ajcp-3197	47	6	the	the	DET
ajcp-3197	47	7	prevalence	prevalence	NOUN
ajcp-3197	47	8	of	of	ADP
ajcp-3197	47	9	adrs	adr	NOUN
ajcp-3197	47	10	in	in	ADP
ajcp-3197	47	11	the	the	DET
ajcp-3197	47	12	general	general	ADJ
ajcp-3197	47	13	adult	adult	NOUN
ajcp-3197	47	14	population	population	NOUN
ajcp-3197	47	15	are	be	AUX
ajcp-3197	47	16	more	more	ADV
ajcp-3197	47	17	extensive	extensive	ADJ
ajcp-3197	47	18	than	than	ADP
ajcp-3197	47	19	those	those	PRON
ajcp-3197	47	20	focused	focus	VERB
ajcp-3197	47	21	on	on	ADP
ajcp-3197	47	22	the	the	DET
ajcp-3197	47	23	elderly	elderly	ADJ
ajcp-3197	47	24	population	population	NOUN
ajcp-3197	47	25	,	,	PUNCT
ajcp-3197	47	26	despite	despite	SCONJ
ajcp-3197	47	27	their	their	PRON
ajcp-3197	47	28	higher	high	ADJ
ajcp-3197	47	29	susceptibility	susceptibility	NOUN
ajcp-3197	47	30	to	to	ADP
ajcp-3197	47	31	adrs	adrs	PROPN
ajcp-3197	47	32	(	(	PUNCT
ajcp-3197	47	33	alhawassi	alhawassi	INTJ
ajcp-3197	47	34	et	et	PROPN
ajcp-3197	47	35	al	al	PROPN
ajcp-3197	47	36	.	.	PROPN
ajcp-3197	47	37	,	,	PUNCT
ajcp-3197	47	38	2014	2014	NUM
ajcp-3197	47	39	;	;	PUNCT
ajcp-3197	47	40	saka	saka	PROPN
ajcp-3197	47	41	et	et	PROPN
ajcp-3197	47	42	al	al	PROPN
ajcp-3197	47	43	.	.	PROPN
ajcp-3197	47	44	,	,	PUNCT
ajcp-3197	47	45	2017	2017	NUM
ajcp-3197	47	46	;	;	PUNCT
ajcp-3197	47	47	mekonnen	mekonnen	NOUN
ajcp-3197	47	48	et	et	NOUN
ajcp-3197	47	49	al	al	PROPN
ajcp-3197	47	50	.	.	PROPN
ajcp-3197	47	51	,	,	PUNCT
ajcp-3197	47	52	2018	2018	NUM
ajcp-3197	47	53	;	;	PUNCT
ajcp-3197	47	54	zazzara	zazzara	PROPN
ajcp-3197	47	55	et	et	PROPN
ajcp-3197	47	56	al	al	PROPN
ajcp-3197	47	57	.	.	PROPN
ajcp-3197	47	58	,	,	PUNCT
ajcp-3197	47	59	2021	2021	NUM
ajcp-3197	47	60	)	)	PUNCT
ajcp-3197	47	61	.	.	PUNCT
ajcp-3197	48	1	systematic	systematic	ADJ
ajcp-3197	48	2	reviews	review	NOUN
ajcp-3197	48	3	conducted	conduct	VERB
ajcp-3197	48	4	on	on	ADP
ajcp-3197	48	5	the	the	DET
ajcp-3197	48	6	prevalence	prevalence	NOUN
ajcp-3197	48	7	of	of	ADP
ajcp-3197	48	8	adverse	adverse	ADJ
ajcp-3197	48	9	drug	drug	NOUN
ajcp-3197	48	10	reactions	reaction	NOUN
ajcp-3197	48	11	in	in	ADP
ajcp-3197	48	12	elderly	elderly	ADJ
ajcp-3197	48	13	patients	patient	NOUN
ajcp-3197	48	14	in	in	ADP
ajcp-3197	48	15	other	other	ADJ
ajcp-3197	48	16	parts	part	NOUN
ajcp-3197	48	17	of	of	ADP
ajcp-3197	48	18	the	the	DET
ajcp-3197	48	19	globe	globe	NOUN
ajcp-3197	48	20	reported	report	VERB
ajcp-3197	48	21	adr	adr	PROPN
ajcp-3197	48	22	prevalence	prevalence	NOUN
ajcp-3197	48	23	of	of	ADP
ajcp-3197	48	24	11%-22	11%-22	NUM
ajcp-3197	48	25	%	%	NOUN
ajcp-3197	48	26	(	(	PUNCT
ajcp-3197	48	27	alhawassi	alhawassi	INTJ
ajcp-3197	48	28	et	et	PROPN
ajcp-3197	48	29	al	al	PROPN
ajcp-3197	48	30	.	.	PROPN
ajcp-3197	48	31	,	,	PUNCT
ajcp-3197	48	32	2014	2014	NUM
ajcp-3197	48	33	;	;	PUNCT
ajcp-3197	48	34	jennings	jennings	PROPN
ajcp-3197	48	35	et	et	PROPN
ajcp-3197	48	36	al	al	PROPN
ajcp-3197	48	37	.	.	PROPN
ajcp-3197	48	38	,	,	PUNCT
ajcp-3197	48	39	2020	2020	NUM
ajcp-3197	48	40	;	;	PUNCT
ajcp-3197	48	41	yadesa	yadesa	PROPN
ajcp-3197	48	42	et	et	PROPN
ajcp-3197	48	43	al	al	PROPN
ajcp-3197	48	44	.	.	PROPN
ajcp-3197	48	45	,	,	PUNCT
ajcp-3197	48	46	2021	2021	NUM
ajcp-3197	48	47	)	)	PUNCT
ajcp-3197	48	48	.	.	PUNCT
ajcp-3197	49	1	there	there	PRON
ajcp-3197	49	2	is	be	VERB
ajcp-3197	49	3	paucity	paucity	NOUN
ajcp-3197	49	4	of	of	ADP
ajcp-3197	49	5	systematic	systematic	ADJ
ajcp-3197	49	6	reviews	review	NOUN
ajcp-3197	49	7	conducted	conduct	VERB
ajcp-3197	49	8	on	on	ADP
ajcp-3197	49	9	the	the	DET
ajcp-3197	49	10	elderly	elderly	ADJ
ajcp-3197	49	11	in	in	ADP
ajcp-3197	49	12	africa	africa	PROPN
ajcp-3197	49	13	.	.	PUNCT
ajcp-3197	50	1	a	a	DET
ajcp-3197	50	2	systematic	systematic	ADJ
ajcp-3197	50	3	review	review	NOUN
ajcp-3197	50	4	on	on	ADP
ajcp-3197	50	5	adrs	adr	NOUN
ajcp-3197	50	6	in	in	ADP
ajcp-3197	50	7	both	both	DET
ajcp-3197	50	8	children	child	NOUN
ajcp-3197	50	9	and	and	CCONJ
ajcp-3197	50	10	adults	adult	NOUN
ajcp-3197	50	11	in	in	ADP
ajcp-3197	50	12	african	african	ADJ
ajcp-3197	50	13	hospitals	hospital	NOUN
ajcp-3197	50	14	reported	report	VERB
ajcp-3197	50	15	that	that	SCONJ
ajcp-3197	50	16	8.4	8.4	NUM
ajcp-3197	50	17	%	%	NOUN
ajcp-3197	50	18	of	of	ADP
ajcp-3197	50	19	patients	patient	NOUN
ajcp-3197	50	20	have	have	AUX
ajcp-3197	50	21	experienced	experience	VERB
ajcp-3197	50	22	an	an	DET
ajcp-3197	50	23	adverse	adverse	ADJ
ajcp-3197	50	24	drug	drug	NOUN
ajcp-3197	50	25	reaction	reaction	NOUN
ajcp-3197	50	26	at	at	ADP
ajcp-3197	50	27	hospital	hospital	NOUN
ajcp-3197	50	28	admission	admission	NOUN
ajcp-3197	50	29	while	while	SCONJ
ajcp-3197	50	30	2.8	2.8	NUM
ajcp-3197	50	31	%	%	NOUN
ajcp-3197	50	32	of	of	ADP
ajcp-3197	50	33	admissions	admission	NOUN
ajcp-3197	50	34	were	be	AUX
ajcp-3197	50	35	caused	cause	VERB
ajcp-3197	50	36	by	by	ADP
ajcp-3197	50	37	adverse	adverse	ADJ
ajcp-3197	50	38	drug	drug	NOUN
ajcp-3197	50	39	reactions	reaction	NOUN
ajcp-3197	50	40	(	(	PUNCT
ajcp-3197	50	41	mekonnen	mekonnen	NOUN
ajcp-3197	50	42	et	et	NOUN
ajcp-3197	50	43	al	al	PROPN
ajcp-3197	50	44	.	.	PROPN
ajcp-3197	50	45	,	,	PUNCT
ajcp-3197	50	46	2018	2018	NUM
ajcp-3197	50	47	)	)	PUNCT
ajcp-3197	50	48	.	.	PUNCT
ajcp-3197	51	1	in	in	ADP
ajcp-3197	51	2	nigeria	nigeria	PROPN
ajcp-3197	51	3	,	,	PUNCT
ajcp-3197	51	4	very	very	ADV
ajcp-3197	51	5	few	few	ADJ
ajcp-3197	51	6	studies	study	NOUN
ajcp-3197	51	7	focused	focus	VERB
ajcp-3197	51	8	on	on	ADP
ajcp-3197	51	9	the	the	DET
ajcp-3197	51	10	general	general	ADJ
ajcp-3197	51	11	adult	adult	NOUN
ajcp-3197	51	12	population	population	NOUN
ajcp-3197	51	13	with	with	ADP
ajcp-3197	51	14	none	none	NOUN
ajcp-3197	51	15	on	on	ADP
ajcp-3197	51	16	the	the	DET
ajcp-3197	51	17	geriatric	geriatric	ADJ
ajcp-3197	51	18	population	population	NOUN
ajcp-3197	51	19	that	that	PRON
ajcp-3197	51	20	suffers	suffer	VERB
ajcp-3197	51	21	adrs	adr	VERB
ajcp-3197	51	22	the	the	DET
ajcp-3197	51	23	most	most	ADJ
ajcp-3197	51	24	.	.	PUNCT
ajcp-3197	52	1	therefore	therefore	ADV
ajcp-3197	52	2	,	,	PUNCT
ajcp-3197	52	3	this	this	DET
ajcp-3197	52	4	study	study	NOUN
ajcp-3197	52	5	aimed	aim	VERB
ajcp-3197	52	6	to	to	PART
ajcp-3197	52	7	systematically	systematically	ADV
ajcp-3197	52	8	review	review	VERB
ajcp-3197	52	9	the	the	DET
ajcp-3197	52	10	published	publish	VERB
ajcp-3197	52	11	literature	literature	NOUN
ajcp-3197	52	12	to	to	PART
ajcp-3197	52	13	determine	determine	VERB
ajcp-3197	52	14	the	the	DET
ajcp-3197	52	15	prevalence	prevalence	NOUN
ajcp-3197	52	16	,	,	PUNCT
ajcp-3197	52	17	etiologies	etiology	NOUN
ajcp-3197	52	18	,	,	PUNCT
ajcp-3197	52	19	and	and	CCONJ
ajcp-3197	52	20	implications	implication	NOUN
ajcp-3197	52	21	of	of	ADP
ajcp-3197	52	22	adrs	adr	NOUN
ajcp-3197	52	23	in	in	ADP
ajcp-3197	52	24	the	the	DET
ajcp-3197	52	25	nigerian	nigerian	ADJ
ajcp-3197	52	26	geriatric	geriatric	ADJ
ajcp-3197	52	27	population	population	NOUN
ajcp-3197	52	28	.	.	PUNCT
ajcp-3197	53	1	methodology	methodology	NOUN
ajcp-3197	53	2	information	information	NOUN
ajcp-3197	53	3	sources	source	NOUN
ajcp-3197	53	4	online	online	ADJ
ajcp-3197	53	5	databases	database	NOUN
ajcp-3197	53	6	and	and	CCONJ
ajcp-3197	53	7	prospero	prospero	NOUN
ajcp-3197	53	8	were	be	AUX
ajcp-3197	53	9	searched	search	VERB
ajcp-3197	53	10	initially	initially	ADV
ajcp-3197	53	11	to	to	PART
ajcp-3197	53	12	ensure	ensure	VERB
ajcp-3197	53	13	that	that	SCONJ
ajcp-3197	53	14	the	the	DET
ajcp-3197	53	15	review	review	NOUN
ajcp-3197	53	16	topic	topic	NOUN
ajcp-3197	53	17	had	have	AUX
ajcp-3197	53	18	not	not	PART
ajcp-3197	53	19	been	be	AUX
ajcp-3197	53	20	researched	research	VERB
ajcp-3197	53	21	earlier	early	ADV
ajcp-3197	53	22	.	.	PUNCT
ajcp-3197	54	1	when	when	SCONJ
ajcp-3197	54	2	that	that	PRON
ajcp-3197	54	3	was	be	AUX
ajcp-3197	54	4	established	establish	VERB
ajcp-3197	54	5	,	,	PUNCT
ajcp-3197	54	6	the	the	DET
ajcp-3197	54	7	research	research	NOUN
ajcp-3197	54	8	question	question	NOUN
ajcp-3197	54	9	,	,	PUNCT
ajcp-3197	54	10	selection	selection	NOUN
ajcp-3197	54	11	strategy	strategy	NOUN
ajcp-3197	54	12	,	,	PUNCT
ajcp-3197	54	13	and	and	CCONJ
ajcp-3197	54	14	selection	selection	NOUN
ajcp-3197	54	15	criteria	criterion	NOUN
ajcp-3197	54	16	were	be	AUX
ajcp-3197	54	17	defined	define	VERB
ajcp-3197	54	18	.	.	PUNCT
ajcp-3197	55	1	the	the	DET
ajcp-3197	55	2	data	data	NOUN
ajcp-3197	55	3	collection	collection	NOUN
ajcp-3197	55	4	form	form	NOUN
ajcp-3197	55	5	was	be	AUX
ajcp-3197	55	6	designed	design	VERB
ajcp-3197	55	7	in	in	ADP
ajcp-3197	55	8	microsoft	microsoft	PROPN
ajcp-3197	55	9	excel	excel	PROPN
ajcp-3197	55	10	,	,	PUNCT
ajcp-3197	55	11	the	the	DET
ajcp-3197	55	12	search	search	NOUN
ajcp-3197	55	13	strategies	strategy	NOUN
ajcp-3197	55	14	were	be	AUX
ajcp-3197	55	15	run	run	VERB
ajcp-3197	55	16	in	in	ADP
ajcp-3197	55	17	the	the	DET
ajcp-3197	55	18	databases	database	NOUN
ajcp-3197	55	19	,	,	PUNCT
ajcp-3197	55	20	and	and	CCONJ
ajcp-3197	55	21	all	all	DET
ajcp-3197	55	22	references	reference	NOUN
ajcp-3197	55	23	and	and	CCONJ
ajcp-3197	55	24	abstracts	abstract	NOUN
ajcp-3197	55	25	were	be	AUX
ajcp-3197	55	26	collected	collect	VERB
ajcp-3197	55	27	in	in	ADP
ajcp-3197	55	28	a	a	DET
ajcp-3197	55	29	single	single	ADJ
ajcp-3197	55	30	file	file	NOUN
ajcp-3197	55	31	.	.	PUNCT
ajcp-3197	56	1	search	search	NOUN
ajcp-3197	56	2	strings	string	NOUN
ajcp-3197	56	3	were	be	AUX
ajcp-3197	56	4	constructed	construct	VERB
ajcp-3197	56	5	using	use	VERB
ajcp-3197	56	6	boolean	boolean	ADJ
ajcp-3197	56	7	operators	operator	NOUN
ajcp-3197	56	8	ands	and	NOUN
ajcp-3197	56	9	and	and	CCONJ
ajcp-3197	56	10	ors	or	NOUN
ajcp-3197	56	11	.	.	PUNCT
ajcp-3197	57	1	using	use	VERB
ajcp-3197	57	2	subject	subject	ADJ
ajcp-3197	57	3	headings	heading	NOUN
ajcp-3197	57	4	obtained	obtain	VERB
ajcp-3197	57	5	from	from	ADP
ajcp-3197	57	6	journals	journal	NOUN
ajcp-3197	57	7	and	and	CCONJ
ajcp-3197	57	8	databases	database	NOUN
ajcp-3197	57	9	,	,	PUNCT
ajcp-3197	57	10	reference	reference	NOUN
ajcp-3197	57	11	lists	list	NOUN
ajcp-3197	57	12	for	for	ADP
ajcp-3197	57	13	primary	primary	ADJ
ajcp-3197	57	14	literature	literature	NOUN
ajcp-3197	57	15	,	,	PUNCT
ajcp-3197	57	16	grey	grey	PROPN
ajcp-3197	57	17	literature	literature	NOUN
ajcp-3197	57	18	and	and	CCONJ
ajcp-3197	57	19	proceedings	proceeding	NOUN
ajcp-3197	57	20	from	from	ADP
ajcp-3197	57	21	conferences	conference	NOUN
ajcp-3197	57	22	were	be	AUX
ajcp-3197	57	23	obtained	obtain	VERB
ajcp-3197	57	24	.	.	PUNCT
ajcp-3197	58	1	question	question	NOUN
ajcp-3197	58	2	structure	structure	NOUN
ajcp-3197	58	3	the	the	DET
ajcp-3197	58	4	population	population	NOUN
ajcp-3197	58	5	(	(	PUNCT
ajcp-3197	58	6	geriatric	geriatric	ADJ
ajcp-3197	58	7	/	/	SYM
ajcp-3197	58	8	elderly	elderly	ADJ
ajcp-3197	58	9	)	)	PUNCT
ajcp-3197	58	10	and	and	CCONJ
ajcp-3197	58	11	clinical	clinical	ADJ
ajcp-3197	58	12	outcomes	outcome	NOUN
ajcp-3197	58	13	(	(	PUNCT
ajcp-3197	58	14	adrs	adr	NOUN
ajcp-3197	58	15	,	,	PUNCT
ajcp-3197	58	16	drug	drug	NOUN
ajcp-3197	58	17	therapy	therapy	NOUN
ajcp-3197	58	18	problems	problem	NOUN
ajcp-3197	58	19	)	)	PUNCT
ajcp-3197	58	20	were	be	AUX
ajcp-3197	58	21	considered	consider	VERB
ajcp-3197	58	22	.	.	PUNCT
ajcp-3197	59	1	prevalence	prevalence	NOUN
ajcp-3197	59	2	studies	study	NOUN
ajcp-3197	59	3	and	and	CCONJ
ajcp-3197	59	4	those	those	PRON
ajcp-3197	59	5	focusing	focus	VERB
ajcp-3197	59	6	on	on	ADP
ajcp-3197	59	7	the	the	DET
ajcp-3197	59	8	challenges	challenge	NOUN
ajcp-3197	59	9	of	of	ADP
ajcp-3197	59	10	adrs	adr	NOUN
ajcp-3197	59	11	were	be	AUX
ajcp-3197	59	12	also	also	ADV
ajcp-3197	59	13	considered	consider	VERB
ajcp-3197	59	14	.	.	PUNCT
ajcp-3197	60	1	search	search	NOUN
ajcp-3197	60	2	strategy	strategy	NOUN
ajcp-3197	60	3	and	and	CCONJ
ajcp-3197	60	4	selection	selection	NOUN
ajcp-3197	60	5	process	process	NOUN
ajcp-3197	60	6	results	result	NOUN
ajcp-3197	60	7	from	from	ADP
ajcp-3197	60	8	the	the	DET
ajcp-3197	60	9	searches	search	NOUN
ajcp-3197	60	10	revealed	reveal	VERB
ajcp-3197	60	11	100	100	NUM
ajcp-3197	60	12	studies	study	NOUN
ajcp-3197	60	13	.	.	PUNCT
ajcp-3197	61	1	a	a	DET
ajcp-3197	61	2	total	total	NOUN
ajcp-3197	61	3	of	of	ADP
ajcp-3197	61	4	87	87	NUM
ajcp-3197	61	5	articles	article	NOUN
ajcp-3197	61	6	on	on	ADP
ajcp-3197	61	7	adr	adr	PROPN
ajcp-3197	61	8	in	in	ADP
ajcp-3197	61	9	specific	specific	ADJ
ajcp-3197	61	10	diseases	disease	NOUN
ajcp-3197	61	11	,	,	PUNCT
ajcp-3197	61	12	in	in	ADP
ajcp-3197	61	13	other	other	ADJ
ajcp-3197	61	14	african	african	ADJ
ajcp-3197	61	15	countries	country	NOUN
ajcp-3197	61	16	,	,	PUNCT
ajcp-3197	61	17	on	on	ADP
ajcp-3197	61	18	polypharmacy	polypharmacy	NOUN
ajcp-3197	61	19	,	,	PUNCT
ajcp-3197	61	20	and	and	CCONJ
ajcp-3197	61	21	potentially	potentially	ADV
ajcp-3197	61	22	inappropriate	inappropriate	ADJ
ajcp-3197	61	23	medications	medication	NOUN
ajcp-3197	61	24	(	(	PUNCT
ajcp-3197	61	25	pims	pims	PROPN
ajcp-3197	61	26	)	)	PUNCT
ajcp-3197	61	27	were	be	AUX
ajcp-3197	61	28	eliminated	eliminate	VERB
ajcp-3197	61	29	leaving	leave	VERB
ajcp-3197	61	30	13	13	NUM
ajcp-3197	61	31	studies	study	NOUN
ajcp-3197	61	32	on	on	ADP
ajcp-3197	61	33	adr	adr	PROPN
ajcp-3197	61	34	in	in	ADP
ajcp-3197	61	35	the	the	DET
ajcp-3197	61	36	elderly	elderly	ADJ
ajcp-3197	61	37	in	in	ADP
ajcp-3197	61	38	nigeria	nigeria	PROPN
ajcp-3197	61	39	.	.	PUNCT
ajcp-3197	62	1	4	4	NUM
ajcp-3197	62	2	duplicate	duplicate	ADJ
ajcp-3197	62	3	studies	study	NOUN
ajcp-3197	62	4	and	and	CCONJ
ajcp-3197	62	5	3	3	NUM
ajcp-3197	62	6	incomplete	incomplete	ADJ
ajcp-3197	62	7	texts	text	NOUN
ajcp-3197	62	8	were	be	AUX
ajcp-3197	62	9	eliminated	eliminate	VERB
ajcp-3197	62	10	which	which	PRON
ajcp-3197	62	11	gave	give	VERB
ajcp-3197	62	12	rise	rise	NOUN
ajcp-3197	62	13	to	to	ADP
ajcp-3197	62	14	6	6	NUM
ajcp-3197	62	15	studies	study	NOUN
ajcp-3197	62	16	that	that	PRON
ajcp-3197	62	17	met	meet	VERB
ajcp-3197	62	18	the	the	DET
ajcp-3197	62	19	inclusion	inclusion	NOUN
ajcp-3197	62	20	criteria	criterion	NOUN
ajcp-3197	62	21	(	(	PUNCT
ajcp-3197	62	22	see	see	VERB
ajcp-3197	62	23	figure	figure	NOUN
ajcp-3197	62	24	1	1	NUM
ajcp-3197	62	25	)	)	PUNCT
ajcp-3197	62	26	.	.	PUNCT
ajcp-3197	63	1	inclusion	inclusion	NOUN
ajcp-3197	63	2	criteria	criterion	NOUN
ajcp-3197	63	3	and	and	CCONJ
ajcp-3197	63	4	its	its	PRON
ajcp-3197	63	5	reliability	reliability	NOUN
ajcp-3197	63	6	articles	article	NOUN
ajcp-3197	63	7	were	be	AUX
ajcp-3197	63	8	selected	select	VERB
ajcp-3197	63	9	for	for	ADP
ajcp-3197	63	10	the	the	DET
ajcp-3197	63	11	review	review	NOUN
ajcp-3197	63	12	if	if	SCONJ
ajcp-3197	63	13	they	they	PRON
ajcp-3197	63	14	:	:	PUNCT
ajcp-3197	63	15	(	(	PUNCT
ajcp-3197	63	16	1	1	X
ajcp-3197	63	17	)	)	PUNCT
ajcp-3197	63	18	are	be	AUX
ajcp-3197	63	19	research	research	NOUN
ajcp-3197	63	20	articles	article	NOUN
ajcp-3197	63	21	reporting	report	VERB
ajcp-3197	63	22	primary	primary	ADJ
ajcp-3197	63	23	data	datum	NOUN
ajcp-3197	63	24	collected	collect	VERB
ajcp-3197	63	25	by	by	ADP
ajcp-3197	63	26	the	the	DET
ajcp-3197	63	27	authors	author	NOUN
ajcp-3197	63	28	;	;	PUNCT
ajcp-3197	63	29	(	(	PUNCT
ajcp-3197	63	30	2	2	X
ajcp-3197	63	31	)	)	PUNCT
ajcp-3197	63	32	are	be	AUX
ajcp-3197	63	33	published	publish	VERB
ajcp-3197	63	34	in	in	ADP
ajcp-3197	63	35	english	english	PROPN
ajcp-3197	63	36	and	and	CCONJ
ajcp-3197	63	37	full	full	ADJ
ajcp-3197	63	38	-	-	PUNCT
ajcp-3197	63	39	text	text	NOUN
ajcp-3197	63	40	articles	article	NOUN
ajcp-3197	63	41	were	be	AUX
ajcp-3197	63	42	available	available	ADJ
ajcp-3197	63	43	;	;	PUNCT
ajcp-3197	63	44	(	(	PUNCT
ajcp-3197	63	45	3	3	X
ajcp-3197	63	46	)	)	PUNCT
ajcp-3197	63	47	cover	cover	VERB
ajcp-3197	63	48	geriatrics	geriatric	NOUN
ajcp-3197	63	49	in	in	ADP
ajcp-3197	63	50	nigeria	nigeria	PROPN
ajcp-3197	63	51	;	;	PUNCT
ajcp-3197	63	52	and	and	CCONJ
ajcp-3197	63	53	(	(	PUNCT
ajcp-3197	63	54	4	4	X
ajcp-3197	63	55	)	)	PUNCT
ajcp-3197	63	56	studied	study	VERB
ajcp-3197	63	57	populations	population	NOUN
ajcp-3197	63	58	are	be	AUX
ajcp-3197	63	59	60	60	NUM
ajcp-3197	63	60	years	year	NOUN
ajcp-3197	63	61	or	or	CCONJ
ajcp-3197	63	62	older	old	ADJ
ajcp-3197	63	63	.	.	PUNCT
ajcp-3197	64	1	cohen	cohen	PROPN
ajcp-3197	64	2	kappa	kappa	PROPN
ajcp-3197	64	3	statistics	statistics	PROPN
ajcp-3197	64	4	was	be	AUX
ajcp-3197	64	5	used	use	VERB
ajcp-3197	64	6	to	to	PART
ajcp-3197	64	7	discuss	discuss	VERB
ajcp-3197	64	8	and	and	CCONJ
ajcp-3197	64	9	resolve	resolve	VERB
ajcp-3197	64	10	disagreements	disagreement	NOUN
ajcp-3197	64	11	between	between	ADP
ajcp-3197	64	12	the	the	DET
ajcp-3197	64	13	authors	author	NOUN
ajcp-3197	64	14	who	who	PRON
ajcp-3197	64	15	reviewed	review	VERB
ajcp-3197	64	16	the	the	DET
ajcp-3197	64	17	articles	article	NOUN
ajcp-3197	64	18	during	during	ADP
ajcp-3197	64	19	selection	selection	NOUN
ajcp-3197	64	20	(	(	PUNCT
ajcp-3197	64	21	cohen	cohen	NOUN
ajcp-3197	64	22	,	,	PUNCT
ajcp-3197	64	23	1968	1968	NUM
ajcp-3197	64	24	)	)	PUNCT
ajcp-3197	64	25	.	.	PUNCT
ajcp-3197	65	1	exclusion	exclusion	NOUN
ajcp-3197	65	2	criteria	criterion	NOUN
ajcp-3197	65	3	all	all	DET
ajcp-3197	65	4	studies	study	NOUN
ajcp-3197	65	5	on	on	ADP
ajcp-3197	65	6	geriatric	geriatric	ADJ
ajcp-3197	65	7	adrs	adr	NOUN
ajcp-3197	65	8	in	in	ADP
ajcp-3197	65	9	nigeria	nigeria	PROPN
ajcp-3197	65	10	with	with	ADP
ajcp-3197	65	11	incomplete	incomplete	ADJ
ajcp-3197	65	12	information	information	NOUN
ajcp-3197	65	13	on	on	ADP
ajcp-3197	65	14	study	study	NOUN
ajcp-3197	65	15	methods	method	NOUN
ajcp-3197	65	16	or	or	CCONJ
ajcp-3197	65	17	unclear	unclear	ADJ
ajcp-3197	65	18	methodology	methodology	NOUN
ajcp-3197	65	19	were	be	AUX
ajcp-3197	65	20	excluded	exclude	VERB
ajcp-3197	65	21	,	,	PUNCT
ajcp-3197	65	22	including	include	VERB
ajcp-3197	65	23	studies	study	NOUN
ajcp-3197	65	24	without	without	ADP
ajcp-3197	65	25	comprehensive	comprehensive	ADJ
ajcp-3197	65	26	summaries	summary	NOUN
ajcp-3197	65	27	.	.	PUNCT
ajcp-3197	66	1	data	datum	NOUN
ajcp-3197	66	2	extraction	extraction	NOUN
ajcp-3197	66	3	eligible	eligible	ADJ
ajcp-3197	66	4	studies	study	NOUN
ajcp-3197	66	5	and	and	CCONJ
ajcp-3197	66	6	literature	literature	NOUN
ajcp-3197	66	7	were	be	AUX
ajcp-3197	66	8	assessed	assess	VERB
ajcp-3197	66	9	using	use	VERB
ajcp-3197	66	10	two	two	NUM
ajcp-3197	66	11	parallel	parallel	ADJ
ajcp-3197	66	12	reviewers	reviewer	NOUN
ajcp-3197	66	13	who	who	PRON
ajcp-3197	66	14	utilized	utilize	VERB
ajcp-3197	66	15	the	the	DET
ajcp-3197	66	16	eligibility	eligibility	NOUN
ajcp-3197	66	17	criteria	criterion	NOUN
ajcp-3197	66	18	consistently	consistently	ADV
ajcp-3197	66	19	.	.	PUNCT
ajcp-3197	67	1	all	all	DET
ajcp-3197	67	2	data	datum	NOUN
ajcp-3197	67	3	on	on	ADP
ajcp-3197	67	4	authors	author	NOUN
ajcp-3197	67	5	and	and	CCONJ
ajcp-3197	67	6	year	year	NOUN
ajcp-3197	67	7	conducted	conduct	VERB
ajcp-3197	67	8	,	,	PUNCT
ajcp-3197	67	9	age	age	NOUN
ajcp-3197	67	10	range	range	NOUN
ajcp-3197	67	11	,	,	PUNCT
ajcp-3197	67	12	setting	set	VERB
ajcp-3197	67	13	/	/	SYM
ajcp-3197	67	14	geographical	geographical	ADJ
ajcp-3197	67	15	zone	zone	NOUN
ajcp-3197	67	16	,	,	PUNCT
ajcp-3197	67	17	study	study	NOUN
ajcp-3197	67	18	design	design	NOUN
ajcp-3197	67	19	,	,	PUNCT
ajcp-3197	67	20	pa	pa	PROPN
ajcp-3197	67	21	ge	ge	PROPN
ajcp-3197	67	22	3	3	NUM
ajcp-3197	67	23	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	67	24	am	be	AUX
ajcp-3197	67	25	.	.	PUNCT
ajcp-3197	68	1	j.	j.	PROPN
ajcp-3197	68	2	chem	chem	PROPN
ajcp-3197	68	3	.	.	PUNCT
ajcp-3197	69	1	pharm	pharm	PROPN
ajcp-3197	69	2	.	.	PUNCT
ajcp-3197	70	1	3(1	3(1	NUM
ajcp-3197	70	2	)	)	PUNCT
ajcp-3197	70	3	1	1	NUM
ajcp-3197	70	4	-	-	SYM
ajcp-3197	70	5	11	11	NUM
ajcp-3197	70	6	,	,	PUNCT
ajcp-3197	70	7	2024	2024	NUM
ajcp-3197	70	8	prevalence	prevalence	NOUN
ajcp-3197	70	9	,	,	PUNCT
ajcp-3197	70	10	medications	medication	NOUN
ajcp-3197	70	11	implicated	implicate	VERB
ajcp-3197	70	12	,	,	PUNCT
ajcp-3197	70	13	system	system	NOUN
ajcp-3197	70	14	,	,	PUNCT
ajcp-3197	70	15	and	and	CCONJ
ajcp-3197	70	16	organ	organ	VERB
ajcp-3197	70	17	most	most	ADV
ajcp-3197	70	18	implicated	implicate	VERB
ajcp-3197	70	19	in	in	ADP
ajcp-3197	70	20	adrs	adr	NOUN
ajcp-3197	70	21	of	of	ADP
ajcp-3197	70	22	the	the	DET
ajcp-3197	70	23	population	population	NOUN
ajcp-3197	70	24	were	be	AUX
ajcp-3197	70	25	extracted	extract	VERB
ajcp-3197	70	26	to	to	PART
ajcp-3197	70	27	form	form	VERB
ajcp-3197	70	28	the	the	DET
ajcp-3197	70	29	evidence	evidence	NOUN
ajcp-3197	70	30	-	-	PUNCT
ajcp-3197	70	31	based	base	VERB
ajcp-3197	70	32	table	table	NOUN
ajcp-3197	70	33	.	.	PUNCT
ajcp-3197	71	1	data	datum	NOUN
ajcp-3197	71	2	was	be	AUX
ajcp-3197	71	3	summarized	summarize	VERB
ajcp-3197	71	4	using	use	VERB
ajcp-3197	71	5	microsoft	microsoft	PROPN
ajcp-3197	71	6	excel	excel	PROPN
ajcp-3197	71	7	.	.	PUNCT
ajcp-3197	72	1	comparisons	comparison	NOUN
ajcp-3197	72	2	of	of	ADP
ajcp-3197	72	3	extracted	extract	VERB
ajcp-3197	72	4	data	datum	NOUN
ajcp-3197	72	5	were	be	AUX
ajcp-3197	72	6	made	make	VERB
ajcp-3197	72	7	and	and	CCONJ
ajcp-3197	72	8	disagreements	disagreement	NOUN
ajcp-3197	72	9	were	be	AUX
ajcp-3197	72	10	resolved	resolve	VERB
ajcp-3197	72	11	with	with	ADP
ajcp-3197	72	12	sensitivity	sensitivity	NOUN
ajcp-3197	72	13	analysis	analysis	NOUN
ajcp-3197	72	14	,	,	PUNCT
ajcp-3197	72	15	predominantly	predominantly	ADV
ajcp-3197	72	16	by	by	ADP
ajcp-3197	72	17	further	further	ADJ
ajcp-3197	72	18	investigation	investigation	NOUN
ajcp-3197	72	19	and	and	CCONJ
ajcp-3197	72	20	arbitration	arbitration	NOUN
ajcp-3197	72	21	.	.	PUNCT
ajcp-3197	73	1	data	datum	NOUN
ajcp-3197	73	2	items	item	NOUN
ajcp-3197	73	3	(	(	PUNCT
ajcp-3197	73	4	outcomes	outcome	NOUN
ajcp-3197	73	5	)	)	PUNCT
ajcp-3197	73	6	data	datum	NOUN
ajcp-3197	73	7	items	item	NOUN
ajcp-3197	73	8	on	on	ADP
ajcp-3197	73	9	adrs	adr	NOUN
ajcp-3197	73	10	among	among	ADP
ajcp-3197	73	11	geriatrics	geriatrics	NOUN
ajcp-3197	73	12	covering	cover	VERB
ajcp-3197	73	13	1980	1980	NUM
ajcp-3197	73	14	to	to	ADP
ajcp-3197	73	15	2022	2022	NUM
ajcp-3197	73	16	were	be	AUX
ajcp-3197	73	17	searched	search	VERB
ajcp-3197	73	18	.	.	PUNCT
ajcp-3197	74	1	the	the	DET
ajcp-3197	74	2	geriatric	geriatric	ADJ
ajcp-3197	74	3	population	population	NOUN
ajcp-3197	74	4	was	be	AUX
ajcp-3197	74	5	searched	search	VERB
ajcp-3197	74	6	.	.	PUNCT
ajcp-3197	75	1	however	however	ADV
ajcp-3197	75	2	,	,	PUNCT
ajcp-3197	75	3	elderly	elderly	ADJ
ajcp-3197	75	4	and	and	CCONJ
ajcp-3197	75	5	older	old	ADJ
ajcp-3197	75	6	adults	adult	NOUN
ajcp-3197	75	7	were	be	AUX
ajcp-3197	75	8	also	also	ADV
ajcp-3197	75	9	searched	search	VERB
ajcp-3197	75	10	in	in	ADP
ajcp-3197	75	11	parallel	parallel	ADJ
ajcp-3197	75	12	and	and	CCONJ
ajcp-3197	75	13	in	in	ADP
ajcp-3197	75	14	series	series	NOUN
ajcp-3197	75	15	.	.	PUNCT
ajcp-3197	76	1	the	the	DET
ajcp-3197	76	2	etiologies	etiology	NOUN
ajcp-3197	76	3	of	of	ADP
ajcp-3197	76	4	adrs	adr	NOUN
ajcp-3197	76	5	and	and	CCONJ
ajcp-3197	76	6	their	their	PRON
ajcp-3197	76	7	implications	implication	NOUN
ajcp-3197	76	8	were	be	AUX
ajcp-3197	76	9	also	also	ADV
ajcp-3197	76	10	searched	search	VERB
ajcp-3197	76	11	.	.	PUNCT
ajcp-3197	77	1	publication	publication	NOUN
ajcp-3197	77	2	risk	risk	NOUN
ajcp-3197	77	3	of	of	ADP
ajcp-3197	77	4	bias	bias	NOUN
ajcp-3197	77	5	assessment	assessment	NOUN
ajcp-3197	77	6	grey	grey	PROPN
ajcp-3197	77	7	literature	literature	PROPN
ajcp-3197	77	8	and	and	CCONJ
ajcp-3197	77	9	conference	conference	NOUN
ajcp-3197	77	10	proceedings	proceeding	NOUN
ajcp-3197	77	11	scanning	scan	VERB
ajcp-3197	77	12	were	be	AUX
ajcp-3197	77	13	utilized	utilize	VERB
ajcp-3197	77	14	,	,	PUNCT
ajcp-3197	77	15	in	in	ADP
ajcp-3197	77	16	addition	addition	NOUN
ajcp-3197	77	17	to	to	ADP
ajcp-3197	77	18	the	the	DET
ajcp-3197	77	19	careful	careful	ADJ
ajcp-3197	77	20	use	use	NOUN
ajcp-3197	77	21	of	of	ADP
ajcp-3197	77	22	search	search	NOUN
ajcp-3197	77	23	terms	term	NOUN
ajcp-3197	77	24	in	in	ADP
ajcp-3197	77	25	parallel	parallel	ADJ
ajcp-3197	77	26	and	and	CCONJ
ajcp-3197	77	27	in	in	ADP
ajcp-3197	77	28	series	series	NOUN
ajcp-3197	77	29	to	to	PART
ajcp-3197	77	30	minimize	minimize	VERB
ajcp-3197	77	31	the	the	DET
ajcp-3197	77	32	risk	risk	NOUN
ajcp-3197	77	33	of	of	ADP
ajcp-3197	77	34	bias	bias	NOUN
ajcp-3197	77	35	.	.	PUNCT
ajcp-3197	78	1	quality	quality	NOUN
ajcp-3197	78	2	assessment	assessment	NOUN
ajcp-3197	78	3	/	/	SYM
ajcp-3197	78	4	risk	risk	NOUN
ajcp-3197	78	5	of	of	ADP
ajcp-3197	78	6	bias	bias	NOUN
ajcp-3197	78	7	the	the	DET
ajcp-3197	78	8	full	full	ADJ
ajcp-3197	78	9	texts	text	NOUN
ajcp-3197	78	10	were	be	AUX
ajcp-3197	78	11	screened	screen	VERB
ajcp-3197	78	12	further	far	ADV
ajcp-3197	78	13	for	for	ADP
ajcp-3197	78	14	explicit	explicit	ADJ
ajcp-3197	78	15	of	of	ADP
ajcp-3197	78	16	methodological	methodological	ADJ
ajcp-3197	78	17	descriptions	description	NOUN
ajcp-3197	78	18	of	of	ADP
ajcp-3197	78	19	adrs	adr	NOUN
ajcp-3197	78	20	,	,	PUNCT
ajcp-3197	78	21	drug	drug	NOUN
ajcp-3197	78	22	therapy	therapy	NOUN
ajcp-3197	78	23	problems	problem	NOUN
ajcp-3197	78	24	,	,	PUNCT
ajcp-3197	78	25	geriatrics	geriatric	NOUN
ajcp-3197	78	26	and	and	CCONJ
ajcp-3197	78	27	the	the	DET
ajcp-3197	78	28	elderly	elderly	ADJ
ajcp-3197	78	29	.	.	PUNCT
ajcp-3197	79	1	studies	study	NOUN
ajcp-3197	79	2	were	be	AUX
ajcp-3197	79	3	graded	grade	VERB
ajcp-3197	79	4	based	base	VERB
ajcp-3197	79	5	on	on	ADP
ajcp-3197	79	6	strong	strong	ADJ
ajcp-3197	79	7	and	and	CCONJ
ajcp-3197	79	8	weak	weak	ADJ
ajcp-3197	79	9	recommendations	recommendation	NOUN
ajcp-3197	79	10	of	of	ADP
ajcp-3197	79	11	the	the	DET
ajcp-3197	79	12	study	study	NOUN
ajcp-3197	79	13	characteristics	characteristic	NOUN
ajcp-3197	79	14	and	and	CCONJ
ajcp-3197	79	15	quality	quality	NOUN
ajcp-3197	79	16	to	to	PART
ajcp-3197	79	17	enhance	enhance	VERB
ajcp-3197	79	18	critical	critical	ADJ
ajcp-3197	79	19	appraisal	appraisal	NOUN
ajcp-3197	79	20	.	.	PUNCT
ajcp-3197	80	1	certainty	certainty	NOUN
ajcp-3197	80	2	assessment	assessment	NOUN
ajcp-3197	80	3	publication	publication	NOUN
ajcp-3197	80	4	bias	bias	NOUN
ajcp-3197	80	5	,	,	PUNCT
ajcp-3197	80	6	imprecision	imprecision	NOUN
ajcp-3197	80	7	,	,	PUNCT
ajcp-3197	80	8	inconsistency	inconsistency	NOUN
ajcp-3197	80	9	,	,	PUNCT
ajcp-3197	80	10	and	and	CCONJ
ajcp-3197	80	11	indirectness	indirectness	NOUN
ajcp-3197	80	12	of	of	ADP
ajcp-3197	80	13	evidence	evidence	NOUN
ajcp-3197	80	14	in	in	ADP
ajcp-3197	80	15	the	the	DET
ajcp-3197	80	16	assessment	assessment	NOUN
ajcp-3197	80	17	were	be	AUX
ajcp-3197	80	18	utilized	utilize	VERB
ajcp-3197	80	19	for	for	ADP
ajcp-3197	80	20	certainty	certainty	NOUN
ajcp-3197	80	21	of	of	ADP
ajcp-3197	80	22	the	the	DET
ajcp-3197	80	23	study	study	NOUN
ajcp-3197	80	24	.	.	PUNCT
ajcp-3197	81	1	data	datum	NOUN
ajcp-3197	81	2	collection	collection	NOUN
ajcp-3197	81	3	literatures	literature	NOUN
ajcp-3197	81	4	that	that	PRON
ajcp-3197	81	5	reported	report	VERB
ajcp-3197	81	6	the	the	DET
ajcp-3197	81	7	incidence	incidence	NOUN
ajcp-3197	81	8	of	of	ADP
ajcp-3197	81	9	adrs	adrs	PROPN
ajcp-3197	81	10	among	among	ADP
ajcp-3197	81	11	nigeria	nigeria	PROPN
ajcp-3197	81	12	’s	’s	PART
ajcp-3197	81	13	geriatric	geriatric	ADJ
ajcp-3197	81	14	population	population	NOUN
ajcp-3197	81	15	were	be	AUX
ajcp-3197	81	16	reviewed	review	VERB
ajcp-3197	81	17	.	.	PUNCT
ajcp-3197	82	1	the	the	DET
ajcp-3197	82	2	databases	database	NOUN
ajcp-3197	82	3	utilized	utilize	VERB
ajcp-3197	82	4	were	be	AUX
ajcp-3197	82	5	google	google	PROPN
ajcp-3197	82	6	scholar	scholar	NOUN
ajcp-3197	82	7	,	,	PUNCT
ajcp-3197	82	8	pubmed	pubmed	PROPN
ajcp-3197	82	9	,	,	PUNCT
ajcp-3197	82	10	and	and	CCONJ
ajcp-3197	82	11	researchgate	researchgate	VERB
ajcp-3197	82	12	with	with	ADP
ajcp-3197	82	13	no	no	DET
ajcp-3197	82	14	specific	specific	ADJ
ajcp-3197	82	15	gate	gate	NOUN
ajcp-3197	82	16	window	window	NOUN
ajcp-3197	82	17	.	.	PUNCT
ajcp-3197	83	1	the	the	DET
ajcp-3197	83	2	references	reference	NOUN
ajcp-3197	83	3	of	of	ADP
ajcp-3197	83	4	some	some	DET
ajcp-3197	83	5	articles	article	NOUN
ajcp-3197	83	6	were	be	AUX
ajcp-3197	83	7	also	also	ADV
ajcp-3197	83	8	manually	manually	ADV
ajcp-3197	83	9	searched	search	VERB
ajcp-3197	83	10	to	to	PART
ajcp-3197	83	11	identify	identify	VERB
ajcp-3197	83	12	more	more	ADJ
ajcp-3197	83	13	studies	study	NOUN
ajcp-3197	83	14	.	.	PUNCT
ajcp-3197	84	1	the	the	DET
ajcp-3197	84	2	keywords	keyword	NOUN
ajcp-3197	84	3	“	"	PUNCT
ajcp-3197	84	4	geriatric	geriatric	PROPN
ajcp-3197	84	5	”	"	PUNCT
ajcp-3197	84	6	[	[	X
ajcp-3197	84	7	mesh	mesh	NOUN
ajcp-3197	84	8	terms	term	NOUN
ajcp-3197	84	9	]	]	PUNCT
ajcp-3197	84	10	,	,	PUNCT
ajcp-3197	84	11	“	"	PUNCT
ajcp-3197	84	12	adverse	adverse	ADJ
ajcp-3197	84	13	drug	drug	NOUN
ajcp-3197	84	14	reaction	reaction	NOUN
ajcp-3197	84	15	”	"	PUNCT
ajcp-3197	85	1	[	[	X
ajcp-3197	85	2	mesh	mesh	NOUN
ajcp-3197	85	3	terms	term	NOUN
ajcp-3197	85	4	]	]	PUNCT
ajcp-3197	85	5	,	,	PUNCT
ajcp-3197	85	6	“	"	PUNCT
ajcp-3197	85	7	incidence	incidence	NOUN
ajcp-3197	85	8	”	"	PUNCT
ajcp-3197	86	1	[	[	PUNCT
ajcp-3197	86	2	mesh	mesh	NOUN
ajcp-3197	86	3	terms	term	NOUN
ajcp-3197	86	4	]	]	PUNCT
ajcp-3197	86	5	,	,	PUNCT
ajcp-3197	86	6	“	"	PUNCT
ajcp-3197	86	7	prevalence	prevalence	NOUN
ajcp-3197	86	8	”	"	PUNCT
ajcp-3197	87	1	[	[	X
ajcp-3197	87	2	mesh	mesh	NOUN
ajcp-3197	87	3	terms	term	NOUN
ajcp-3197	87	4	]	]	PUNCT
ajcp-3197	87	5	,	,	PUNCT
ajcp-3197	87	6	“	"	PUNCT
ajcp-3197	87	7	older	old	ADJ
ajcp-3197	87	8	adults	adult	NOUN
ajcp-3197	87	9	”	"	PUNCT
ajcp-3197	87	10	[	[	X
ajcp-3197	87	11	mesh	mesh	NOUN
ajcp-3197	87	12	terms	term	NOUN
ajcp-3197	87	13	]	]	PUNCT
ajcp-3197	87	14	,	,	PUNCT
ajcp-3197	87	15	and	and	CCONJ
ajcp-3197	87	16	“	"	PUNCT
ajcp-3197	87	17	elderly	elderly	ADJ
ajcp-3197	87	18	”	"	PUNCT
ajcp-3197	87	19	[	[	PUNCT
ajcp-3197	87	20	mesh	mesh	NOUN
ajcp-3197	87	21	terms	term	NOUN
ajcp-3197	87	22	]	]	PUNCT
ajcp-3197	87	23	were	be	AUX
ajcp-3197	87	24	used	use	VERB
ajcp-3197	87	25	.	.	PUNCT
ajcp-3197	88	1	the	the	DET
ajcp-3197	88	2	free	free	ADJ
ajcp-3197	88	3	text	text	NOUN
ajcp-3197	88	4	included	include	VERB
ajcp-3197	88	5	adverse	adverse	ADJ
ajcp-3197	88	6	drug	drug	NOUN
ajcp-3197	88	7	reactions	reaction	NOUN
ajcp-3197	88	8	in	in	ADP
ajcp-3197	88	9	the	the	DET
ajcp-3197	88	10	elderly	elderly	ADJ
ajcp-3197	88	11	in	in	ADP
ajcp-3197	88	12	nigeria	nigeria	PROPN
ajcp-3197	88	13	and	and	CCONJ
ajcp-3197	88	14	the	the	DET
ajcp-3197	88	15	incidence	incidence	NOUN
ajcp-3197	88	16	of	of	ADP
ajcp-3197	88	17	adverse	adverse	ADJ
ajcp-3197	88	18	drug	drug	NOUN
ajcp-3197	88	19	reactions	reaction	NOUN
ajcp-3197	88	20	in	in	ADP
ajcp-3197	88	21	nigeria	nigeria	PROPN
ajcp-3197	88	22	.	.	PUNCT
ajcp-3197	89	1	the	the	DET
ajcp-3197	89	2	selection	selection	NOUN
ajcp-3197	89	3	was	be	AUX
ajcp-3197	89	4	not	not	PART
ajcp-3197	89	5	restricted	restrict	VERB
ajcp-3197	89	6	to	to	ADP
ajcp-3197	89	7	a	a	DET
ajcp-3197	89	8	specific	specific	ADJ
ajcp-3197	89	9	study	study	NOUN
ajcp-3197	89	10	design	design	NOUN
ajcp-3197	89	11	.	.	PUNCT
ajcp-3197	90	1	however	however	ADV
ajcp-3197	90	2	,	,	PUNCT
ajcp-3197	90	3	the	the	DET
ajcp-3197	90	4	study	study	NOUN
ajcp-3197	90	5	was	be	AUX
ajcp-3197	90	6	restricted	restrict	VERB
ajcp-3197	90	7	to	to	ADP
ajcp-3197	90	8	geriatric	geriatric	ADJ
ajcp-3197	90	9	/	/	SYM
ajcp-3197	90	10	elderly	elderly	ADJ
ajcp-3197	90	11	population	population	NOUN
ajcp-3197	90	12	for	for	ADP
ajcp-3197	90	13	which	which	PRON
ajcp-3197	90	14	the	the	DET
ajcp-3197	90	15	study	study	NOUN
ajcp-3197	90	16	could	could	AUX
ajcp-3197	90	17	be	be	AUX
ajcp-3197	90	18	generalized	generalize	VERB
ajcp-3197	90	19	.	.	PUNCT
ajcp-3197	91	1	nonetheless	nonetheless	ADV
ajcp-3197	91	2	,	,	PUNCT
ajcp-3197	91	3	it	it	PRON
ajcp-3197	91	4	is	be	AUX
ajcp-3197	91	5	also	also	ADV
ajcp-3197	91	6	possible	possible	ADJ
ajcp-3197	91	7	that	that	SCONJ
ajcp-3197	91	8	some	some	DET
ajcp-3197	91	9	studies	study	NOUN
ajcp-3197	91	10	may	may	AUX
ajcp-3197	91	11	have	have	AUX
ajcp-3197	91	12	been	be	AUX
ajcp-3197	91	13	omitted	omit	VERB
ajcp-3197	91	14	due	due	ADP
ajcp-3197	91	15	to	to	ADP
ajcp-3197	91	16	this	this	DET
ajcp-3197	91	17	limitation	limitation	NOUN
ajcp-3197	91	18	and	and	CCONJ
ajcp-3197	91	19	restricting	restrict	VERB
ajcp-3197	91	20	the	the	DET
ajcp-3197	91	21	generalization	generalization	NOUN
ajcp-3197	91	22	.	.	PUNCT
ajcp-3197	92	1	the	the	DET
ajcp-3197	92	2	review	review	NOUN
ajcp-3197	92	3	concentrated	concentrate	VERB
ajcp-3197	92	4	on	on	ADP
ajcp-3197	92	5	the	the	DET
ajcp-3197	92	6	prevalence	prevalence	NOUN
ajcp-3197	92	7	,	,	PUNCT
ajcp-3197	92	8	incidence	incidence	NOUN
ajcp-3197	92	9	,	,	PUNCT
ajcp-3197	92	10	and	and	CCONJ
ajcp-3197	92	11	challenges	challenge	NOUN
ajcp-3197	92	12	of	of	ADP
ajcp-3197	92	13	adverse	adverse	ADJ
ajcp-3197	92	14	drug	drug	NOUN
ajcp-3197	92	15	reactions	reaction	NOUN
ajcp-3197	92	16	in	in	ADP
ajcp-3197	92	17	the	the	DET
ajcp-3197	92	18	elderly	elderly	ADJ
ajcp-3197	92	19	in	in	ADP
ajcp-3197	92	20	nigeria	nigeria	PROPN
ajcp-3197	92	21	.	.	PUNCT
ajcp-3197	93	1	other	other	ADJ
ajcp-3197	93	2	age	age	NOUN
ajcp-3197	93	3	groups	group	NOUN
ajcp-3197	93	4	,	,	PUNCT
ajcp-3197	93	5	however	however	ADV
ajcp-3197	93	6	,	,	PUNCT
ajcp-3197	93	7	were	be	AUX
ajcp-3197	93	8	not	not	PART
ajcp-3197	93	9	overlooked	overlook	VERB
ajcp-3197	93	10	.	.	PUNCT
ajcp-3197	94	1	the	the	DET
ajcp-3197	94	2	literature	literature	NOUN
ajcp-3197	94	3	and	and	CCONJ
ajcp-3197	94	4	research	research	NOUN
ajcp-3197	94	5	on	on	ADP
ajcp-3197	94	6	various	various	ADJ
ajcp-3197	94	7	elderly	elderly	ADJ
ajcp-3197	94	8	disease	disease	NOUN
ajcp-3197	94	9	states	state	NOUN
ajcp-3197	94	10	were	be	AUX
ajcp-3197	94	11	reviewed	review	VERB
ajcp-3197	94	12	.	.	PUNCT
ajcp-3197	95	1	author	author	NOUN
ajcp-3197	95	2	,	,	PUNCT
ajcp-3197	95	3	year	year	NOUN
ajcp-3197	95	4	of	of	ADP
ajcp-3197	95	5	publication	publication	NOUN
ajcp-3197	95	6	,	,	PUNCT
ajcp-3197	95	7	age	age	NOUN
ajcp-3197	95	8	range	range	NOUN
ajcp-3197	95	9	,	,	PUNCT
ajcp-3197	95	10	population	population	NOUN
ajcp-3197	95	11	size	size	NOUN
ajcp-3197	95	12	,	,	PUNCT
ajcp-3197	95	13	study	study	NOUN
ajcp-3197	95	14	design	design	NOUN
ajcp-3197	95	15	,	,	PUNCT
ajcp-3197	95	16	geopolitical	geopolitical	ADJ
ajcp-3197	95	17	zone	zone	NOUN
ajcp-3197	95	18	,	,	PUNCT
ajcp-3197	95	19	and	and	CCONJ
ajcp-3197	95	20	most	most	ADJ
ajcp-3197	95	21	implicated	implicated	ADJ
ajcp-3197	95	22	medication	medication	NOUN
ajcp-3197	95	23	were	be	AUX
ajcp-3197	95	24	all	all	PRON
ajcp-3197	95	25	extracted	extract	VERB
ajcp-3197	95	26	from	from	ADP
ajcp-3197	95	27	the	the	DET
ajcp-3197	95	28	publications	publication	NOUN
ajcp-3197	95	29	.	.	PUNCT
ajcp-3197	96	1	each	each	DET
ajcp-3197	96	2	conflict	conflict	NOUN
ajcp-3197	96	3	was	be	AUX
ajcp-3197	96	4	discussed	discuss	VERB
ajcp-3197	96	5	in	in	ADP
ajcp-3197	96	6	the	the	DET
ajcp-3197	96	7	cases	case	NOUN
ajcp-3197	96	8	of	of	ADP
ajcp-3197	96	9	disagreements	disagreement	NOUN
ajcp-3197	96	10	until	until	SCONJ
ajcp-3197	96	11	agreement	agreement	NOUN
ajcp-3197	96	12	was	be	AUX
ajcp-3197	96	13	reached	reach	VERB
ajcp-3197	96	14	.	.	PUNCT
ajcp-3197	97	1	the	the	DET
ajcp-3197	97	2	resulting	result	VERB
ajcp-3197	97	3	data	datum	NOUN
ajcp-3197	97	4	was	be	AUX
ajcp-3197	97	5	kept	keep	VERB
ajcp-3197	97	6	open	open	ADJ
ajcp-3197	97	7	and	and	CCONJ
ajcp-3197	97	8	detailed	detailed	ADJ
ajcp-3197	97	9	.	.	PUNCT
ajcp-3197	98	1	metaanalysis	metaanalysis	NOUN
ajcp-3197	98	2	was	be	AUX
ajcp-3197	98	3	not	not	PART
ajcp-3197	98	4	carried	carry	VERB
ajcp-3197	98	5	out	out	ADP
ajcp-3197	98	6	because	because	SCONJ
ajcp-3197	98	7	it	it	PRON
ajcp-3197	98	8	is	be	AUX
ajcp-3197	98	9	outside	outside	ADP
ajcp-3197	98	10	the	the	DET
ajcp-3197	98	11	scope	scope	NOUN
ajcp-3197	98	12	of	of	ADP
ajcp-3197	98	13	this	this	DET
ajcp-3197	98	14	study	study	NOUN
ajcp-3197	98	15	.	.	PUNCT
ajcp-3197	99	1	hence	hence	ADV
ajcp-3197	99	2	,	,	PUNCT
ajcp-3197	99	3	heterogeneity	heterogeneity	NOUN
ajcp-3197	99	4	was	be	AUX
ajcp-3197	99	5	not	not	PART
ajcp-3197	99	6	assessed	assess	VERB
ajcp-3197	99	7	.	.	PUNCT
ajcp-3197	100	1	data	datum	NOUN
ajcp-3197	100	2	synthesis	synthesis	NOUN
ajcp-3197	100	3	all	all	DET
ajcp-3197	100	4	the	the	DET
ajcp-3197	100	5	results	result	NOUN
ajcp-3197	100	6	of	of	ADP
ajcp-3197	100	7	the	the	DET
ajcp-3197	100	8	primary	primary	ADJ
ajcp-3197	100	9	studies	study	NOUN
ajcp-3197	100	10	were	be	AUX
ajcp-3197	100	11	collated	collate	VERB
ajcp-3197	100	12	and	and	CCONJ
ajcp-3197	100	13	summarized	summarize	VERB
ajcp-3197	100	14	.	.	PUNCT
ajcp-3197	101	1	a	a	DET
ajcp-3197	101	2	combination	combination	NOUN
ajcp-3197	101	3	of	of	ADP
ajcp-3197	101	4	descriptive	descriptive	ADJ
ajcp-3197	101	5	synthesis	synthesis	NOUN
ajcp-3197	101	6	with	with	ADP
ajcp-3197	101	7	quantitative	quantitative	ADJ
ajcp-3197	101	8	summary	summary	NOUN
ajcp-3197	101	9	was	be	AUX
ajcp-3197	101	10	utilized	utilize	VERB
ajcp-3197	101	11	.	.	PUNCT
ajcp-3197	102	1	the	the	DET
ajcp-3197	102	2	population	population	NOUN
ajcp-3197	102	3	,	,	PUNCT
ajcp-3197	102	4	causes	cause	NOUN
ajcp-3197	102	5	of	of	ADP
ajcp-3197	102	6	adr	adr	PROPN
ajcp-3197	102	7	,	,	PUNCT
ajcp-3197	102	8	comparisons	comparison	NOUN
ajcp-3197	102	9	,	,	PUNCT
ajcp-3197	102	10	and	and	CCONJ
ajcp-3197	102	11	outcomes	outcome	NOUN
ajcp-3197	102	12	were	be	AUX
ajcp-3197	102	13	used	use	VERB
ajcp-3197	102	14	as	as	ADP
ajcp-3197	102	15	a	a	DET
ajcp-3197	102	16	framework	framework	NOUN
ajcp-3197	102	17	.	.	PUNCT
ajcp-3197	103	1	the	the	DET
ajcp-3197	103	2	study	study	NOUN
ajcp-3197	103	3	characteristics	characteristic	NOUN
ajcp-3197	103	4	,	,	PUNCT
ajcp-3197	103	5	causes	cause	NOUN
ajcp-3197	103	6	of	of	ADP
ajcp-3197	103	7	adrs	adr	NOUN
ajcp-3197	103	8	,	,	PUNCT
ajcp-3197	103	9	and	and	CCONJ
ajcp-3197	103	10	comparisons	comparison	NOUN
ajcp-3197	103	11	of	of	ADP
ajcp-3197	103	12	implications	implication	NOUN
ajcp-3197	103	13	and	and	CCONJ
ajcp-3197	103	14	outcomes	outcome	NOUN
ajcp-3197	103	15	were	be	AUX
ajcp-3197	103	16	tabulated	tabulate	VERB
ajcp-3197	103	17	in	in	ADP
ajcp-3197	103	18	a	a	DET
ajcp-3197	103	19	spread	spread	ADJ
ajcp-3197	103	20	sheet	sheet	NOUN
ajcp-3197	103	21	.	.	PUNCT
ajcp-3197	104	1	summary	summary	NOUN
ajcp-3197	104	2	statistics	statistic	NOUN
ajcp-3197	104	3	of	of	ADP
ajcp-3197	104	4	studies	study	NOUN
ajcp-3197	104	5	were	be	AUX
ajcp-3197	104	6	also	also	ADV
ajcp-3197	104	7	tabulated	tabulate	VERB
ajcp-3197	104	8	,	,	PUNCT
ajcp-3197	104	9	while	while	SCONJ
ajcp-3197	104	10	those	those	PRON
ajcp-3197	104	11	without	without	ADP
ajcp-3197	104	12	comprehensive	comprehensive	ADJ
ajcp-3197	104	13	summaries	summary	NOUN
ajcp-3197	104	14	were	be	AUX
ajcp-3197	104	15	excluded	exclude	VERB
ajcp-3197	104	16	.	.	PUNCT
ajcp-3197	105	1	descriptive	descriptive	ADJ
ajcp-3197	105	2	statistics	statistic	NOUN
ajcp-3197	105	3	was	be	AUX
ajcp-3197	105	4	used	use	VERB
ajcp-3197	105	5	to	to	PART
ajcp-3197	105	6	summarize	summarize	VERB
ajcp-3197	105	7	the	the	DET
ajcp-3197	105	8	qualitative	qualitative	ADJ
ajcp-3197	105	9	and	and	CCONJ
ajcp-3197	105	10	quantitative	quantitative	ADJ
ajcp-3197	105	11	data	datum	NOUN
ajcp-3197	105	12	based	base	VERB
ajcp-3197	105	13	on	on	ADP
ajcp-3197	105	14	their	their	PRON
ajcp-3197	105	15	homoand	homoand	NOUN
ajcp-3197	105	16	heterogeneity	heterogeneity	NOUN
ajcp-3197	105	17	.	.	PUNCT
ajcp-3197	106	1	sub	sub	ADJ
ajcp-3197	106	2	-	-	NOUN
ajcp-3197	106	3	group	group	NOUN
ajcp-3197	106	4	analysis	analysis	NOUN
ajcp-3197	106	5	was	be	AUX
ajcp-3197	106	6	used	use	VERB
ajcp-3197	106	7	to	to	PART
ajcp-3197	106	8	explore	explore	VERB
ajcp-3197	106	9	heterogeneity	heterogeneity	NOUN
ajcp-3197	106	10	.	.	PUNCT
ajcp-3197	107	1	to	to	PART
ajcp-3197	107	2	assess	assess	VERB
ajcp-3197	107	3	the	the	DET
ajcp-3197	107	4	robustness	robustness	NOUN
ajcp-3197	107	5	of	of	ADP
ajcp-3197	107	6	the	the	DET
ajcp-3197	107	7	synthesized	synthesize	VERB
ajcp-3197	107	8	result	result	NOUN
ajcp-3197	107	9	,	,	PUNCT
ajcp-3197	107	10	range	range	NOUN
ajcp-3197	107	11	of	of	ADP
ajcp-3197	107	12	values	value	NOUN
ajcp-3197	107	13	and	and	CCONJ
ajcp-3197	107	14	alternatives	alternative	NOUN
ajcp-3197	107	15	were	be	AUX
ajcp-3197	107	16	substituted	substitute	VERB
ajcp-3197	107	17	for	for	ADP
ajcp-3197	107	18	arbitrary	arbitrary	ADJ
ajcp-3197	107	19	and	and	CCONJ
ajcp-3197	107	20	unclear	unclear	ADJ
ajcp-3197	107	21	decisions	decision	NOUN
ajcp-3197	107	22	to	to	PART
ajcp-3197	107	23	ensure	ensure	VERB
ajcp-3197	107	24	that	that	SCONJ
ajcp-3197	107	25	decisions	decision	NOUN
ajcp-3197	107	26	taken	take	VERB
ajcp-3197	107	27	were	be	AUX
ajcp-3197	107	28	rational	rational	ADJ
ajcp-3197	107	29	and	and	CCONJ
ajcp-3197	107	30	consistent	consistent	ADJ
ajcp-3197	107	31	.	.	PUNCT
ajcp-3197	108	1	data	datum	NOUN
ajcp-3197	108	2	analysis	analysis	NOUN
ajcp-3197	108	3	a	a	DET
ajcp-3197	108	4	descriptive	descriptive	ADJ
ajcp-3197	108	5	analysis	analysis	NOUN
ajcp-3197	108	6	was	be	AUX
ajcp-3197	108	7	performed	perform	VERB
ajcp-3197	108	8	to	to	PART
ajcp-3197	108	9	summarize	summarize	VERB
ajcp-3197	108	10	the	the	DET
ajcp-3197	108	11	published	publish	VERB
ajcp-3197	108	12	articles	article	NOUN
ajcp-3197	108	13	.	.	PUNCT
ajcp-3197	109	1	the	the	DET
ajcp-3197	109	2	studies	study	NOUN
ajcp-3197	109	3	and	and	CCONJ
ajcp-3197	109	4	their	their	PRON
ajcp-3197	109	5	characteristics	characteristic	NOUN
ajcp-3197	109	6	were	be	AUX
ajcp-3197	109	7	summarized	summarize	VERB
ajcp-3197	109	8	based	base	VERB
ajcp-3197	109	9	on	on	ADP
ajcp-3197	109	10	the	the	DET
ajcp-3197	109	11	following	following	NOUN
ajcp-3197	109	12	:	:	PUNCT
ajcp-3197	109	13	authors	author	NOUN
ajcp-3197	109	14	and	and	CCONJ
ajcp-3197	109	15	year	year	NOUN
ajcp-3197	109	16	conducted	conduct	VERB
ajcp-3197	109	17	,	,	PUNCT
ajcp-3197	109	18	age	age	NOUN
ajcp-3197	109	19	range	range	NOUN
ajcp-3197	109	20	,	,	PUNCT
ajcp-3197	109	21	setting	set	VERB
ajcp-3197	109	22	/	/	SYM
ajcp-3197	109	23	geographical	geographical	ADJ
ajcp-3197	109	24	zone	zone	NOUN
ajcp-3197	109	25	,	,	PUNCT
ajcp-3197	109	26	study	study	NOUN
ajcp-3197	109	27	design	design	NOUN
ajcp-3197	109	28	,	,	PUNCT
ajcp-3197	109	29	prevalence	prevalence	NOUN
ajcp-3197	109	30	,	,	PUNCT
ajcp-3197	109	31	medications	medication	NOUN
ajcp-3197	109	32	implicated	implicate	VERB
ajcp-3197	109	33	,	,	PUNCT
ajcp-3197	109	34	system	system	NOUN
ajcp-3197	109	35	,	,	PUNCT
ajcp-3197	109	36	and	and	CCONJ
ajcp-3197	109	37	organ	organ	VERB
ajcp-3197	109	38	most	most	ADV
ajcp-3197	109	39	implicated	implicate	VERB
ajcp-3197	109	40	in	in	ADP
ajcp-3197	109	41	adrs	adr	NOUN
ajcp-3197	109	42	.	.	PUNCT
ajcp-3197	110	1	the	the	DET
ajcp-3197	110	2	articles	article	NOUN
ajcp-3197	110	3	were	be	AUX
ajcp-3197	110	4	evaluated	evaluate	VERB
ajcp-3197	110	5	for	for	ADP
ajcp-3197	110	6	heterogeneities	heterogeneity	NOUN
ajcp-3197	110	7	among	among	ADP
ajcp-3197	110	8	the	the	DET
ajcp-3197	110	9	population	population	NOUN
ajcp-3197	110	10	group	group	NOUN
ajcp-3197	110	11	.	.	PUNCT
ajcp-3197	111	1	finally	finally	ADV
ajcp-3197	111	2	,	,	PUNCT
ajcp-3197	111	3	an	an	DET
ajcp-3197	111	4	evidence	evidence	NOUN
ajcp-3197	111	5	-	-	PUNCT
ajcp-3197	111	6	based	base	VERB
ajcp-3197	111	7	table	table	NOUN
ajcp-3197	111	8	was	be	AUX
ajcp-3197	111	9	synthesized	synthesize	VERB
ajcp-3197	111	10	.	.	PUNCT
ajcp-3197	112	1	ethical	ethical	ADJ
ajcp-3197	112	2	consideration	consideration	NOUN
ajcp-3197	112	3	published	publish	VERB
ajcp-3197	112	4	and	and	CCONJ
ajcp-3197	112	5	freely	freely	ADV
ajcp-3197	112	6	available	available	ADJ
ajcp-3197	112	7	online	online	ADJ
ajcp-3197	112	8	literature	literature	NOUN
ajcp-3197	112	9	and	and	CCONJ
ajcp-3197	112	10	data	datum	NOUN
ajcp-3197	112	11	on	on	ADP
ajcp-3197	112	12	adrs	adr	NOUN
ajcp-3197	112	13	among	among	ADP
ajcp-3197	112	14	geriatrics	geriatric	NOUN
ajcp-3197	112	15	in	in	ADP
ajcp-3197	112	16	nigeria	nigeria	PROPN
ajcp-3197	112	17	were	be	AUX
ajcp-3197	112	18	reviewed	review	VERB
ajcp-3197	112	19	online	online	ADV
ajcp-3197	112	20	.	.	PUNCT
ajcp-3197	113	1	hence	hence	ADV
ajcp-3197	113	2	,	,	PUNCT
ajcp-3197	113	3	ethical	ethical	ADJ
ajcp-3197	113	4	approval	approval	NOUN
ajcp-3197	113	5	does	do	AUX
ajcp-3197	113	6	not	not	PART
ajcp-3197	113	7	apply	apply	VERB
ajcp-3197	113	8	.	.	PUNCT
ajcp-3197	114	1	this	this	DET
ajcp-3197	114	2	study	study	NOUN
ajcp-3197	114	3	was	be	AUX
ajcp-3197	114	4	carried	carry	VERB
ajcp-3197	114	5	out	out	ADP
ajcp-3197	114	6	strictly	strictly	ADV
ajcp-3197	114	7	with	with	ADP
ajcp-3197	114	8	the	the	DET
ajcp-3197	114	9	prisma-2020	prisma-2020	ADJ
ajcp-3197	114	10	guideline	guideline	NOUN
ajcp-3197	114	11	for	for	ADP
ajcp-3197	114	12	systematic	systematic	ADJ
ajcp-3197	114	13	reviews	review	NOUN
ajcp-3197	114	14	.	.	PUNCT
ajcp-3197	115	1	results	result	NOUN
ajcp-3197	115	2	&	&	CCONJ
ajcp-3197	115	3	discussion	discussion	NOUN
ajcp-3197	115	4	figure	figure	NOUN
ajcp-3197	115	5	1	1	NUM
ajcp-3197	115	6	:	:	PUNCT
ajcp-3197	115	7	the	the	DET
ajcp-3197	115	8	prisma	prisma	PROPN
ajcp-3197	115	9	flow	flow	NOUN
ajcp-3197	115	10	diagram	diagram	NOUN
ajcp-3197	115	11	for	for	ADP
ajcp-3197	115	12	selection	selection	NOUN
ajcp-3197	115	13	of	of	ADP
ajcp-3197	115	14	articles	article	NOUN
ajcp-3197	115	15	pa	pa	PROPN
ajcp-3197	115	16	ge	ge	PROPN
ajcp-3197	115	17	4	4	NUM
ajcp-3197	115	18	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	115	19	am	be	AUX
ajcp-3197	115	20	.	.	PUNCT
ajcp-3197	116	1	j.	j.	PROPN
ajcp-3197	116	2	chem	chem	PROPN
ajcp-3197	116	3	.	.	PUNCT
ajcp-3197	117	1	pharm	pharm	PROPN
ajcp-3197	117	2	.	.	PUNCT
ajcp-3197	118	1	3(1	3(1	NUM
ajcp-3197	118	2	)	)	PUNCT
ajcp-3197	118	3	1	1	NUM
ajcp-3197	118	4	-	-	SYM
ajcp-3197	118	5	11	11	NUM
ajcp-3197	118	6	,	,	PUNCT
ajcp-3197	118	7	2024	2024	NUM
ajcp-3197	118	8	out	out	ADP
ajcp-3197	118	9	of	of	ADP
ajcp-3197	118	10	the	the	DET
ajcp-3197	118	11	100	100	NUM
ajcp-3197	118	12	reports	report	NOUN
ajcp-3197	118	13	initially	initially	ADV
ajcp-3197	118	14	identified	identify	VERB
ajcp-3197	118	15	,	,	PUNCT
ajcp-3197	118	16	only	only	ADV
ajcp-3197	118	17	thirteen	thirteen	NUM
ajcp-3197	118	18	reported	report	VERB
ajcp-3197	118	19	adverse	adverse	ADJ
ajcp-3197	118	20	drug	drug	NOUN
ajcp-3197	118	21	reactions	reaction	NOUN
ajcp-3197	118	22	in	in	ADP
ajcp-3197	118	23	elderly	elderly	ADJ
ajcp-3197	118	24	patients	patient	NOUN
ajcp-3197	118	25	in	in	ADP
ajcp-3197	118	26	nigeria	nigeria	PROPN
ajcp-3197	118	27	.	.	PUNCT
ajcp-3197	119	1	articles	article	NOUN
ajcp-3197	119	2	that	that	PRON
ajcp-3197	119	3	focused	focus	VERB
ajcp-3197	119	4	on	on	ADP
ajcp-3197	119	5	adverse	adverse	ADJ
ajcp-3197	119	6	drug	drug	NOUN
ajcp-3197	119	7	reactions	reaction	NOUN
ajcp-3197	119	8	in	in	ADP
ajcp-3197	119	9	specific	specific	ADJ
ajcp-3197	119	10	diseases	disease	NOUN
ajcp-3197	119	11	,	,	PUNCT
ajcp-3197	119	12	studies	study	NOUN
ajcp-3197	119	13	conducted	conduct	VERB
ajcp-3197	119	14	in	in	ADP
ajcp-3197	119	15	other	other	ADJ
ajcp-3197	119	16	african	african	ADJ
ajcp-3197	119	17	countries	country	NOUN
ajcp-3197	119	18	,	,	PUNCT
ajcp-3197	119	19	studies	study	NOUN
ajcp-3197	119	20	on	on	ADP
ajcp-3197	119	21	polypharmacy	polypharmacy	NOUN
ajcp-3197	119	22	,	,	PUNCT
ajcp-3197	119	23	potentially	potentially	ADV
ajcp-3197	119	24	inappropriate	inappropriate	ADJ
ajcp-3197	119	25	medications	medication	NOUN
ajcp-3197	119	26	(	(	PUNCT
ajcp-3197	119	27	pims	pims	PROPN
ajcp-3197	119	28	)	)	PUNCT
ajcp-3197	119	29	;	;	PUNCT
ajcp-3197	119	30	and	and	CCONJ
ajcp-3197	119	31	knowledge	knowledge	NOUN
ajcp-3197	119	32	,	,	PUNCT
ajcp-3197	119	33	attitude	attitude	NOUN
ajcp-3197	119	34	and	and	CCONJ
ajcp-3197	119	35	practice	practice	NOUN
ajcp-3197	119	36	(	(	PUNCT
ajcp-3197	119	37	kap	kap	NOUN
ajcp-3197	119	38	)	)	PUNCT
ajcp-3197	119	39	studies	study	NOUN
ajcp-3197	119	40	were	be	AUX
ajcp-3197	119	41	excluded	exclude	VERB
ajcp-3197	119	42	.	.	PUNCT
ajcp-3197	120	1	duplicate	duplicate	ADJ
ajcp-3197	120	2	studies	study	NOUN
ajcp-3197	120	3	and	and	CCONJ
ajcp-3197	120	4	studies	study	NOUN
ajcp-3197	120	5	without	without	ADP
ajcp-3197	120	6	full	full	ADJ
ajcp-3197	120	7	texts	text	NOUN
ajcp-3197	120	8	available	available	ADJ
ajcp-3197	120	9	were	be	AUX
ajcp-3197	120	10	also	also	ADV
ajcp-3197	120	11	removed	remove	VERB
ajcp-3197	120	12	.	.	PUNCT
ajcp-3197	121	1	finally	finally	ADV
ajcp-3197	121	2	,	,	PUNCT
ajcp-3197	121	3	six	six	NUM
ajcp-3197	121	4	studies	study	NOUN
ajcp-3197	121	5	were	be	AUX
ajcp-3197	121	6	included	include	VERB
ajcp-3197	121	7	in	in	ADP
ajcp-3197	121	8	the	the	DET
ajcp-3197	121	9	analysis	analysis	NOUN
ajcp-3197	121	10	.	.	PUNCT
ajcp-3197	122	1	study	study	NOUN
ajcp-3197	122	2	characteristics	characteristic	NOUN
ajcp-3197	122	3	two	two	NUM
ajcp-3197	122	4	of	of	ADP
ajcp-3197	122	5	the	the	DET
ajcp-3197	122	6	six	six	NUM
ajcp-3197	122	7	studies	study	NOUN
ajcp-3197	122	8	were	be	AUX
ajcp-3197	122	9	conducted	conduct	VERB
ajcp-3197	122	10	on	on	ADP
ajcp-3197	122	11	the	the	DET
ajcp-3197	122	12	general	general	ADJ
ajcp-3197	122	13	adult	adult	NOUN
ajcp-3197	122	14	population	population	NOUN
ajcp-3197	122	15	but	but	CCONJ
ajcp-3197	122	16	provided	provide	VERB
ajcp-3197	122	17	specific	specific	ADJ
ajcp-3197	122	18	information	information	NOUN
ajcp-3197	122	19	about	about	ADP
ajcp-3197	122	20	older	old	ADJ
ajcp-3197	122	21	adults	adult	NOUN
ajcp-3197	122	22	(	(	PUNCT
ajcp-3197	122	23	adedapo	adedapo	NOUN
ajcp-3197	122	24	et	et	PROPN
ajcp-3197	122	25	al	al	PROPN
ajcp-3197	122	26	.	.	PROPN
ajcp-3197	122	27	,	,	PUNCT
ajcp-3197	122	28	2021	2021	NUM
ajcp-3197	122	29	;	;	PUNCT
ajcp-3197	122	30	akhideno	akhideno	VERB
ajcp-3197	122	31	et	et	PROPN
ajcp-3197	122	32	al	al	PROPN
ajcp-3197	122	33	.	.	PROPN
ajcp-3197	122	34	,	,	PUNCT
ajcp-3197	122	35	2018	2018	NUM
ajcp-3197	122	36	)	)	PUNCT
ajcp-3197	122	37	.	.	PUNCT
ajcp-3197	123	1	all	all	DET
ajcp-3197	123	2	the	the	DET
ajcp-3197	123	3	studies	study	NOUN
ajcp-3197	123	4	were	be	AUX
ajcp-3197	123	5	conducted	conduct	VERB
ajcp-3197	123	6	among	among	ADP
ajcp-3197	123	7	hospitalized	hospitalize	VERB
ajcp-3197	123	8	patients	patient	NOUN
ajcp-3197	123	9	,	,	PUNCT
ajcp-3197	123	10	primarily	primarily	ADV
ajcp-3197	123	11	in	in	ADP
ajcp-3197	123	12	the	the	DET
ajcp-3197	123	13	internal	internal	ADJ
ajcp-3197	123	14	medicine	medicine	NOUN
ajcp-3197	123	15	wards	ward	NOUN
ajcp-3197	123	16	.	.	PUNCT
ajcp-3197	124	1	the	the	DET
ajcp-3197	124	2	studies	study	NOUN
ajcp-3197	124	3	had	have	VERB
ajcp-3197	124	4	a	a	DET
ajcp-3197	124	5	prospective	prospective	ADJ
ajcp-3197	124	6	,	,	PUNCT
ajcp-3197	124	7	retrospective	retrospective	ADJ
ajcp-3197	124	8	,	,	PUNCT
ajcp-3197	124	9	or	or	CCONJ
ajcp-3197	124	10	mixed	mixed	ADJ
ajcp-3197	124	11	design	design	NOUN
ajcp-3197	124	12	.	.	PUNCT
ajcp-3197	125	1	the	the	DET
ajcp-3197	125	2	incidence	incidence	NOUN
ajcp-3197	125	3	of	of	ADP
ajcp-3197	125	4	adrs	adr	NOUN
ajcp-3197	125	5	among	among	ADP
ajcp-3197	125	6	elderly	elderly	ADJ
ajcp-3197	125	7	patients	patient	NOUN
ajcp-3197	125	8	ranged	range	VERB
ajcp-3197	125	9	from	from	ADP
ajcp-3197	125	10	6.2	6.2	NUM
ajcp-3197	125	11	%	%	NOUN
ajcp-3197	125	12	to	to	ADP
ajcp-3197	125	13	31.1	31.1	NUM
ajcp-3197	125	14	%	%	NOUN
ajcp-3197	125	15	.	.	PUNCT
ajcp-3197	126	1	the	the	DET
ajcp-3197	126	2	gastrointestinal	gastrointestinal	ADJ
ajcp-3197	126	3	system	system	NOUN
ajcp-3197	126	4	was	be	AUX
ajcp-3197	126	5	the	the	DET
ajcp-3197	126	6	most	most	ADV
ajcp-3197	126	7	affected	affected	ADJ
ajcp-3197	126	8	,	,	PUNCT
ajcp-3197	126	9	and	and	CCONJ
ajcp-3197	126	10	non	non	ADJ
ajcp-3197	126	11	-	-	ADJ
ajcp-3197	126	12	steroidal	steroidal	ADJ
ajcp-3197	126	13	anti	anti	ADJ
ajcp-3197	126	14	-	-	ADJ
ajcp-3197	126	15	inflammatory	inflammatory	ADJ
ajcp-3197	126	16	drugs	drug	NOUN
ajcp-3197	126	17	(	(	PUNCT
ajcp-3197	126	18	nsaids	nsaid	NOUN
ajcp-3197	126	19	)	)	PUNCT
ajcp-3197	126	20	were	be	AUX
ajcp-3197	126	21	the	the	DET
ajcp-3197	126	22	most	most	ADV
ajcp-3197	126	23	commonly	commonly	ADV
ajcp-3197	126	24	implicated	implicate	VERB
ajcp-3197	126	25	group	group	NOUN
ajcp-3197	126	26	of	of	ADP
ajcp-3197	126	27	drugs	drug	NOUN
ajcp-3197	126	28	causing	cause	VERB
ajcp-3197	126	29	adrs	adr	NOUN
ajcp-3197	126	30	.	.	PUNCT
ajcp-3197	127	1	the	the	DET
ajcp-3197	127	2	majority	majority	NOUN
ajcp-3197	127	3	of	of	ADP
ajcp-3197	127	4	the	the	DET
ajcp-3197	127	5	studies	study	NOUN
ajcp-3197	127	6	were	be	AUX
ajcp-3197	127	7	conducted	conduct	VERB
ajcp-3197	127	8	in	in	ADP
ajcp-3197	127	9	a	a	DET
ajcp-3197	127	10	single	single	ADJ
ajcp-3197	127	11	center	center	NOUN
ajcp-3197	127	12	(	(	PUNCT
ajcp-3197	127	13	see	see	VERB
ajcp-3197	127	14	table	table	NOUN
ajcp-3197	127	15	1	1	NUM
ajcp-3197	127	16	)	)	PUNCT
ajcp-3197	127	17	.	.	PUNCT
ajcp-3197	128	1	a	a	DET
ajcp-3197	128	2	summary	summary	NOUN
ajcp-3197	128	3	of	of	ADP
ajcp-3197	128	4	the	the	DET
ajcp-3197	128	5	factors	factor	NOUN
ajcp-3197	128	6	responsible	responsible	ADJ
ajcp-3197	128	7	for	for	ADP
ajcp-3197	128	8	adrs	adr	NOUN
ajcp-3197	128	9	in	in	ADP
ajcp-3197	128	10	the	the	DET
ajcp-3197	128	11	included	include	VERB
ajcp-3197	128	12	studies	study	NOUN
ajcp-3197	128	13	is	be	AUX
ajcp-3197	128	14	shown	show	VERB
ajcp-3197	128	15	in	in	ADP
ajcp-3197	128	16	table	table	NOUN
ajcp-3197	128	17	2	2	NUM
ajcp-3197	128	18	.	.	PUNCT
ajcp-3197	128	19	table	table	NOUN
ajcp-3197	128	20	1	1	NUM
ajcp-3197	128	21	:	:	PUNCT
ajcp-3197	128	22	summary	summary	NOUN
ajcp-3197	128	23	of	of	ADP
ajcp-3197	128	24	studies	study	NOUN
ajcp-3197	128	25	on	on	ADP
ajcp-3197	128	26	the	the	DET
ajcp-3197	128	27	incidence	incidence	NOUN
ajcp-3197	128	28	of	of	ADP
ajcp-3197	128	29	adrs	adr	NOUN
ajcp-3197	128	30	among	among	ADP
ajcp-3197	128	31	the	the	DET
ajcp-3197	128	32	elderly	elderly	ADJ
ajcp-3197	128	33	in	in	ADP
ajcp-3197	128	34	nigeria	nigeria	PROPN
ajcp-3197	128	35	author	author	NOUN
ajcp-3197	128	36	(	(	PUNCT
ajcp-3197	128	37	year	year	NOUN
ajcp-3197	128	38	conducted	conduct	VERB
ajcp-3197	128	39	)	)	PUNCT
ajcp-3197	128	40	age	age	NOUN
ajcp-3197	128	41	range	range	NOUN
ajcp-3197	128	42	population	population	NOUN
ajcp-3197	128	43	size	size	NOUN
ajcp-3197	128	44	setting/	setting/	ADJ
ajcp-3197	128	45	geopolitical	geopolitical	ADJ
ajcp-3197	128	46	zone	zone	NOUN
ajcp-3197	128	47	study	study	NOUN
ajcp-3197	128	48	design	design	NOUN
ajcp-3197	128	49	prevalence	prevalence	NOUN
ajcp-3197	128	50	of	of	ADP
ajcp-3197	128	51	adrs	adrs	PROPN
ajcp-3197	128	52	three	three	NUM
ajcp-3197	128	53	most	most	ADV
ajcp-3197	128	54	implicated	implicated	ADJ
ajcp-3197	128	55	medications	medication	NOUN
ajcp-3197	128	56	system/	system/	NUM
ajcp-3197	128	57	organ	organ	NOUN
ajcp-3197	128	58	most	most	ADV
ajcp-3197	128	59	implicated	implicate	VERB
ajcp-3197	128	60	in	in	ADP
ajcp-3197	128	61	adr	adr	PROPN
ajcp-3197	128	62	a	a	PROPN
ajcp-3197	128	63	kh	kh	PROPN
ajcp-3197	129	1	i	i	PROPN
ajcp-3197	129	2	d	d	PROPN
ajcp-3197	129	3	en	en	X
ajcp-3197	129	4	o	o	X
ajcp-3197	129	5	et	et	PROPN
ajcp-3197	129	6	al	al	PROPN
ajcp-3197	129	7	.	.	PROPN
ajcp-3197	129	8	,	,	PUNCT
ajcp-3197	129	9	2	2	NUM
ajcp-3197	129	10	01	01	NUM
ajcp-3197	129	11	8	8	NUM
ajcp-3197	129	12	(	(	PUNCT
ajcp-3197	129	13	2	2	NUM
ajcp-3197	129	14	01	01	NUM
ajcp-3197	129	15	320	320	NUM
ajcp-3197	129	16	14	14	NUM
ajcp-3197	129	17	)	)	PUNCT
ajcp-3197	129	18	17	17	NUM
ajcp-3197	129	19	-8	-8	NUM
ajcp-3197	129	20	9	9	NUM
ajcp-3197	129	21	(	(	PUNCT
ajcp-3197	129	22	a	a	DET
ajcp-3197	129	23	du	du	X
ajcp-3197	129	24	lts	lts	PROPN
ajcp-3197	129	25	)	)	PUNCT
ajcp-3197	130	1	e	e	X
ajcp-3197	130	2	ld	ld	PROPN
ajcp-3197	130	3	er	er	INTJ
ajcp-3197	130	4	ly	ly	X
ajcp-3197	130	5	as	as	ADP
ajcp-3197	130	6	>	>	X
ajcp-3197	130	7	64	64	NUM
ajcp-3197	130	8	50	50	NUM
ajcp-3197	130	9	7	7	NUM
ajcp-3197	130	10	(	(	PUNCT
ajcp-3197	130	11	a	a	DET
ajcp-3197	130	12	du	du	X
ajcp-3197	130	13	lts	lts	PROPN
ajcp-3197	130	14	)	)	PUNCT
ajcp-3197	130	15	1	1	NUM
ajcp-3197	130	16	25	25	NUM
ajcp-3197	131	1	(	(	PUNCT
ajcp-3197	131	2	e	e	X
ajcp-3197	131	3	ld	ld	PROPN
ajcp-3197	131	4	er	er	INTJ
ajcp-3197	131	5	ly	ly	X
ajcp-3197	131	6	)	)	PUNCT
ajcp-3197	131	7	u	u	PROPN
ajcp-3197	131	8	ni	ni	PROPN
ajcp-3197	131	9	ve	ve	AUX
ajcp-3197	131	10	rs	rs	PROPN
ajcp-3197	131	11	ity	ity	PROPN
ajcp-3197	131	12	o	o	X
ajcp-3197	131	13	f	f	AUX
ajcp-3197	131	14	be	be	VERB
ajcp-3197	131	15	ni	ni	PROPN
ajcp-3197	131	16	n	n	X
ajcp-3197	131	17	te	te	INTJ
ajcp-3197	131	18	ac	ac	INTJ
ajcp-3197	132	1	hi	hi	INTJ
ajcp-3197	133	1	ng	ng	PROPN
ajcp-3197	134	1	h	h	PROPN
ajcp-3197	134	2	os	os	NOUN
ajcp-3197	135	1	pi	pi	NOUN
ajcp-3197	135	2	ta	ta	PROPN
ajcp-3197	136	1	l	l	NOUN
ajcp-3197	136	2	,	,	PUNCT
ajcp-3197	136	3	be	be	AUX
ajcp-3197	136	4	ni	ni	PROPN
ajcp-3197	136	5	n	n	PROPN
ajcp-3197	136	6	c	c	PROPN
ajcp-3197	136	7	ity	ity	PROPN
ajcp-3197	136	8	,	,	PUNCT
ajcp-3197	136	9	e	e	AUX
ajcp-3197	136	10	do	do	AUX
ajcp-3197	136	11	s	s	VERB
ajcp-3197	136	12	ta	ta	X
ajcp-3197	136	13	te	te	PROPN
ajcp-3197	136	14	/	/	PUNCT
ajcp-3197	136	15	so	so	ADV
ajcp-3197	136	16	ut	ut	PROPN
ajcp-3197	136	17	hso	hso	PROPN
ajcp-3197	136	18	ut	ut	PROPN
ajcp-3197	136	19	h	h	PROPN
ajcp-3197	136	20	pr	pr	INTJ
ajcp-3197	137	1	os	os	INTJ
ajcp-3197	138	1	pe	pe	INTJ
ajcp-3197	138	2	ct	ct	NUM
ajcp-3197	138	3	iv	iv	NUM
ajcp-3197	138	4	e	e	PROPN
ajcp-3197	138	5	st	st	PROPN
ajcp-3197	138	6	ud	ud	INTJ
ajcp-3197	138	7	y	y	PROPN
ajcp-3197	138	8	4	4	NUM
ajcp-3197	138	9	.	.	NOUN
ajcp-3197	138	10	4	4	NUM
ajcp-3197	138	11	%	%	NOUN
ajcp-3197	138	12	in	in	ADP
ajcp-3197	138	13	su	su	PROPN
ajcp-3197	138	14	lin	lin	PROPN
ajcp-3197	138	15	,	,	PUNCT
ajcp-3197	138	16	n	n	PROPN
ajcp-3197	138	17	sa	sa	PROPN
ajcp-3197	139	1	i	i	PROPN
ajcp-3197	139	2	d	d	PROPN
ajcp-3197	139	3	s	s	VERB
ajcp-3197	139	4	a	a	PRON
ajcp-3197	139	5	nd	nd	NOUN
ajcp-3197	139	6	an	an	DET
ajcp-3197	139	7	tih	tih	NOUN
ajcp-3197	140	1	yp	yp	PROPN
ajcp-3197	140	2	er	er	INTJ
ajcp-3197	140	3	te	te	INTJ
ajcp-3197	140	4	ns	ns	NUM
ajcp-3197	140	5	iv	iv	NOUN
ajcp-3197	140	6	es	es	NOUN
ajcp-3197	140	7	in	in	ADP
ajcp-3197	140	8	a	a	DET
ajcp-3197	140	9	du	du	X
ajcp-3197	140	10	lt	lt	X
ajcp-3197	140	11	po	po	PROPN
ajcp-3197	140	12	pu	pu	PROPN
ajcp-3197	140	13	la	la	PROPN
ajcp-3197	140	14	tio	tio	PROPN
ajcp-3197	140	15	n	n	PROPN
ajcp-3197	140	16	st	st	PROPN
ajcp-3197	140	17	ud	ud	INTJ
ajcp-3197	140	18	ie	ie	PROPN
ajcp-3197	140	19	d	d	PROPN
ajcp-3197	140	20	n	n	PROPN
ajcp-3197	140	21	eu	eu	PROPN
ajcp-3197	140	22	ro	ro	PROPN
ajcp-3197	141	1	lo	lo	NOUN
ajcp-3197	142	1	gi	gi	INTJ
ajcp-3197	142	2	ca	can	AUX
ajcp-3197	142	3	l.	l.	PROPN
ajcp-3197	142	4	g	g	PROPN
ajcp-3197	142	5	as	as	ADP
ajcp-3197	142	6	tro	tro	NOUN
ajcp-3197	142	7	in	in	ADP
ajcp-3197	142	8	te	te	PROPN
ajcp-3197	142	9	st	st	PROPN
ajcp-3197	142	10	in	in	ADP
ajcp-3197	142	11	al	al	PROPN
ajcp-3197	142	12	a	a	DET
ajcp-3197	142	13	nd	nd	PROPN
ajcp-3197	142	14	de	de	PROPN
ajcp-3197	142	15	rm	rm	PROPN
ajcp-3197	142	16	at	at	ADP
ajcp-3197	142	17	ol	ol	PROPN
ajcp-3197	142	18	og	og	PROPN
ajcp-3197	142	19	ic	ic	PROPN
ajcp-3197	142	20	al	al	PROPN
ajcp-3197	142	21	sy	sy	PROPN
ajcp-3197	143	1	st	st	PROPN
ajcp-3197	144	1	em	em	PRON
ajcp-3197	144	2	s	s	VERB
ajcp-3197	144	3	a	a	DET
ajcp-3197	144	4	m	m	NOUN
ajcp-3197	144	5	ad	ad	NOUN
ajcp-3197	145	1	i	i	NOUN
ajcp-3197	145	2	e	e	PROPN
ajcp-3197	145	3	t	t	PROPN
ajcp-3197	145	4	a	a	DET
ajcp-3197	145	5	l.	l.	PROPN
ajcp-3197	145	6	,	,	PUNCT
ajcp-3197	145	7	2	2	NUM
ajcp-3197	145	8	02	02	NUM
ajcp-3197	145	9	1	1	NUM
ajcp-3197	145	10	60	60	NUM
ajcp-3197	145	11	a	a	DET
ajcp-3197	145	12	nd	nd	NOUN
ajcp-3197	145	13	a	a	DET
ajcp-3197	145	14	bo	bo	NOUN
ajcp-3197	145	15	ve	ve	PROPN
ajcp-3197	145	16	12	12	NUM
ajcp-3197	145	17	6	6	NUM
ajcp-3197	145	18	u	u	NOUN
ajcp-3197	145	19	ni	ni	PROPN
ajcp-3197	145	20	ve	ve	VERB
ajcp-3197	145	21	rs	rs	PROPN
ajcp-3197	145	22	ity	ity	PROPN
ajcp-3197	145	23	o	o	X
ajcp-3197	145	24	f	f	X
ajcp-3197	145	25	po	po	PROPN
ajcp-3197	145	26	rt	rt	PROPN
ajcp-3197	145	27	-h	-h	PROPN
ajcp-3197	145	28	ar	ar	PROPN
ajcp-3197	145	29	co	co	NOUN
ajcp-3197	145	30	ur	ur	PROPN
ajcp-3197	145	31	t	t	PROPN
ajcp-3197	145	32	te	te	INTJ
ajcp-3197	145	33	ac	ac	PROPN
ajcp-3197	146	1	hi	hi	INTJ
ajcp-3197	146	2	ng	ng	PROPN
ajcp-3197	147	1	h	h	PROPN
ajcp-3197	147	2	os	os	NOUN
ajcp-3197	148	1	pi	pi	NOUN
ajcp-3197	148	2	ta	ta	PROPN
ajcp-3197	149	1	l	l	PROPN
ajcp-3197	149	2	,	,	PUNCT
ajcp-3197	149	3	po	po	PROPN
ajcp-3197	149	4	rt	rt	PROPN
ajcp-3197	149	5	h	h	PROPN
ajcp-3197	149	6	ar	ar	PROPN
ajcp-3197	149	7	co	co	PROPN
ajcp-3197	149	8	ur	ur	PROPN
ajcp-3197	149	9	t	t	PROPN
ajcp-3197	149	10	,	,	PUNCT
ajcp-3197	149	11	ri	ri	PROPN
ajcp-3197	149	12	ve	ve	VERB
ajcp-3197	149	13	rs	rs	PROPN
ajcp-3197	149	14	s	s	NOUN
ajcp-3197	149	15	ta	ta	X
ajcp-3197	149	16	te	te	PROPN
ajcp-3197	149	17	/	/	PUNCT
ajcp-3197	149	18	so	so	ADV
ajcp-3197	149	19	ut	ut	PROPN
ajcp-3197	149	20	hso	hso	PROPN
ajcp-3197	149	21	ut	ut	PROPN
ajcp-3197	149	22	h	h	PROPN
ajcp-3197	149	23	c	c	PROPN
ajcp-3197	149	24	ro	ro	INTJ
ajcp-3197	150	1	ss	ss	INTJ
ajcp-3197	150	2	-s	-s	PUNCT
ajcp-3197	151	1	ec	ec	PROPN
ajcp-3197	151	2	tio	tio	NOUN
ajcp-3197	151	3	na	na	PROPN
ajcp-3197	151	4	l	l	NOUN
ajcp-3197	151	5	s	s	NOUN
ajcp-3197	151	6	am	be	AUX
ajcp-3197	151	7	pl	pl	NOUN
ajcp-3197	151	8	in	in	ADP
ajcp-3197	151	9	g	g	PROPN
ajcp-3197	151	10	19	19	NUM
ajcp-3197	151	11	.8	.8	NUM
ajcp-3197	151	12	%	%	NOUN
ajcp-3197	151	13	c	c	NOUN
ajcp-3197	151	14	hl	hl	NOUN
ajcp-3197	152	1	or	or	CCONJ
ajcp-3197	152	2	oq	oq	INTJ
ajcp-3197	152	3	ui	ui	PROPN
ajcp-3197	152	4	ne	ne	PROPN
ajcp-3197	152	5	,	,	PUNCT
ajcp-3197	152	6	a	a	DET
ajcp-3197	152	7	m	m	NOUN
ajcp-3197	152	8	lo	lo	NOUN
ajcp-3197	152	9	di	di	NOUN
ajcp-3197	152	10	pi	pi	PROPN
ajcp-3197	152	11	ne	ne	PROPN
ajcp-3197	152	12	in	in	ADP
ajcp-3197	152	13	te	te	PROPN
ajcp-3197	152	14	gu	gu	NOUN
ajcp-3197	152	15	m	m	PROPN
ajcp-3197	152	16	en	en	ADP
ajcp-3197	152	17	ta	ta	X
ajcp-3197	152	18	ry	ry	PROPN
ajcp-3197	152	19	/s	/s	VERB
ajcp-3197	152	20	ki	ki	PROPN
ajcp-3197	152	21	n	n	CCONJ
ajcp-3197	152	22	,	,	PUNCT
ajcp-3197	152	23	c	c	PROPN
ajcp-3197	152	24	en	en	X
ajcp-3197	152	25	tra	tra	PROPN
ajcp-3197	152	26	l	l	PROPN
ajcp-3197	152	27	n	n	CCONJ
ajcp-3197	152	28	er	er	INTJ
ajcp-3197	152	29	vo	vo	INTJ
ajcp-3197	152	30	us	we	PRON
ajcp-3197	152	31	s	s	VERB
ajcp-3197	152	32	ys	ys	NOUN
ajcp-3197	152	33	te	te	PROPN
ajcp-3197	152	34	m	m	PRON
ajcp-3197	152	35	,	,	PUNCT
ajcp-3197	152	36	g	g	PROPN
ajcp-3197	152	37	as	as	ADP
ajcp-3197	152	38	tro	tro	NOUN
ajcp-3197	152	39	in	in	ADP
ajcp-3197	152	40	te	te	PROPN
ajcp-3197	152	41	st	st	PROPN
ajcp-3197	152	42	in	in	ADP
ajcp-3197	152	43	al	al	PROPN
ajcp-3197	152	44	sy	sy	PROPN
ajcp-3197	152	45	st	st	PROPN
ajcp-3197	153	1	em	em	PROPN
ajcp-3197	153	2	sa	sa	PROPN
ajcp-3197	153	3	ka	ka	PROPN
ajcp-3197	153	4	et	et	PROPN
ajcp-3197	153	5	a	a	DET
ajcp-3197	153	6	l.	l.	PROPN
ajcp-3197	153	7	,	,	PUNCT
ajcp-3197	153	8	(	(	PUNCT
ajcp-3197	153	9	2	2	NUM
ajcp-3197	153	10	01	01	NUM
ajcp-3197	153	11	7	7	NUM
ajcp-3197	153	12	;	;	PUNCT
ajcp-3197	153	13	20	20	NUM
ajcp-3197	153	14	18	18	NUM
ajcp-3197	153	15	)	)	PUNCT
ajcp-3197	153	16	60	60	NUM
ajcp-3197	153	17	a	a	DET
ajcp-3197	153	18	nd	nd	INTJ
ajcp-3197	153	19	a	a	DET
ajcp-3197	153	20	bo	bo	NOUN
ajcp-3197	153	21	ve	ve	PROPN
ajcp-3197	153	22	26	26	NUM
ajcp-3197	153	23	8	8	NUM
ajcp-3197	153	24	n	n	NUM
ajcp-3197	153	25	ot	ot	NOUN
ajcp-3197	153	26	s	s	X
ajcp-3197	153	27	ta	ta	X
ajcp-3197	153	28	te	te	PROPN
ajcp-3197	154	1	d	d	PROPN
ajcp-3197	154	2	c	c	PROPN
ajcp-3197	154	3	ro	ro	INTJ
ajcp-3197	154	4	ss	ss	INTJ
ajcp-3197	154	5	-s	-s	PROPN
ajcp-3197	154	6	ec	ec	PROPN
ajcp-3197	154	7	tio	tio	NOUN
ajcp-3197	154	8	na	na	PROPN
ajcp-3197	154	9	l	l	NOUN
ajcp-3197	154	10	re	re	X
ajcp-3197	154	11	tro	tro	NOUN
ajcp-3197	154	12	sp	sp	ADP
ajcp-3197	154	13	ec	ec	PROPN
ajcp-3197	154	14	tiv	tiv	PROPN
ajcp-3197	154	15	e	e	PROPN
ajcp-3197	154	16	13	13	NUM
ajcp-3197	154	17	.8	.8	NUM
ajcp-3197	154	18	%	%	NOUN
ajcp-3197	154	19	n	n	PRON
ajcp-3197	154	20	sa	sa	PROPN
ajcp-3197	155	1	i	i	PROPN
ajcp-3197	155	2	d	d	PROPN
ajcp-3197	155	3	s	s	PROPN
ajcp-3197	156	1	(	(	PUNCT
ajcp-3197	156	2	d	d	X
ajcp-3197	156	3	ic	ic	PROPN
ajcp-3197	156	4	lo	lo	PROPN
ajcp-3197	156	5	fe	fe	INTJ
ajcp-3197	156	6	na	na	X
ajcp-3197	156	7	c	c	NOUN
ajcp-3197	156	8	)	)	PUNCT
ajcp-3197	156	9	,	,	PUNCT
ajcp-3197	156	10	ca	ca	AUX
ajcp-3197	156	11	rd	rd	PROPN
ajcp-3197	156	12	io	io	PROPN
ajcp-3197	156	13	va	va	PROPN
ajcp-3197	156	14	sc	sc	PROPN
ajcp-3197	156	15	ul	ul	PROPN
ajcp-3197	156	16	ar	ar	PROPN
ajcp-3197	156	17	m	m	PROPN
ajcp-3197	156	18	ed	ed	PROPN
ajcp-3197	156	19	ic	ic	PROPN
ajcp-3197	156	20	at	at	ADP
ajcp-3197	156	21	io	io	PROPN
ajcp-3197	156	22	ns	ns	INTJ
ajcp-3197	156	23	d	d	PROPN
ajcp-3197	156	24	ig	ig	PROPN
ajcp-3197	156	25	es	es	PROPN
ajcp-3197	156	26	tiv	tiv	PROPN
ajcp-3197	156	27	e	e	PROPN
ajcp-3197	156	28	sy	sy	PROPN
ajcp-3197	156	29	st	st	PROPN
ajcp-3197	156	30	em	em	PRON
ajcp-3197	156	31	,	,	PUNCT
ajcp-3197	156	32	va	va	PROPN
ajcp-3197	156	33	sc	sc	PROPN
ajcp-3197	156	34	ul	ul	INTJ
ajcp-3197	156	35	ar	ar	PROPN
ajcp-3197	156	36	sy	sy	PROPN
ajcp-3197	156	37	st	st	PROPN
ajcp-3197	156	38	em	em	PRON
ajcp-3197	156	39	,	,	PUNCT
ajcp-3197	156	40	ne	ne	PROPN
ajcp-3197	156	41	rv	rv	PROPN
ajcp-3197	156	42	ou	ou	ADP
ajcp-3197	156	43	s	s	PROPN
ajcp-3197	156	44	s	s	X
ajcp-3197	156	45	ys	ys	NOUN
ajcp-3197	156	46	te	te	PROPN
ajcp-3197	156	47	m	m	PROPN
ajcp-3197	156	48	a	a	DET
ajcp-3197	156	49	de	de	X
ajcp-3197	156	50	da	da	X
ajcp-3197	156	51	po	po	PROPN
ajcp-3197	156	52	et	et	PROPN
ajcp-3197	156	53	a	a	DET
ajcp-3197	156	54	l.	l.	PROPN
ajcp-3197	156	55	,	,	PUNCT
ajcp-3197	156	56	20	20	NUM
ajcp-3197	156	57	21	21	NUM
ajcp-3197	156	58	(	(	PUNCT
ajcp-3197	156	59	2	2	NUM
ajcp-3197	156	60	01	01	NUM
ajcp-3197	156	61	220	220	NUM
ajcp-3197	156	62	13	13	NUM
ajcp-3197	156	63	)	)	PUNCT
ajcp-3197	156	64	60	60	NUM
ajcp-3197	156	65	a	a	DET
ajcp-3197	156	66	nd	nd	INTJ
ajcp-3197	156	67	a	a	DET
ajcp-3197	156	68	bo	bo	NOUN
ajcp-3197	156	69	ve	ve	PROPN
ajcp-3197	156	70	12	12	NUM
ajcp-3197	156	71	80	80	NUM
ajcp-3197	156	72	(	(	PUNCT
ajcp-3197	156	73	t	t	PROPN
ajcp-3197	156	74	ot	ot	NOUN
ajcp-3197	156	75	al	al	PROPN
ajcp-3197	156	76	a	a	DET
ajcp-3197	156	77	du	du	PROPN
ajcp-3197	156	78	lt	lt	X
ajcp-3197	156	79	po	po	PROPN
ajcp-3197	156	80	pu	pu	PROPN
ajcp-3197	156	81	la	la	PROPN
ajcp-3197	156	82	tio	tio	PROPN
ajcp-3197	156	83	n	n	CCONJ
ajcp-3197	156	84	)	)	PUNCT
ajcp-3197	156	85	41	41	NUM
ajcp-3197	156	86	8	8	NUM
ajcp-3197	156	87	(	(	PUNCT
ajcp-3197	156	88	e	e	X
ajcp-3197	156	89	ld	ld	PROPN
ajcp-3197	156	90	er	er	INTJ
ajcp-3197	156	91	ly	ly	X
ajcp-3197	156	92	po	po	X
ajcp-3197	156	93	pu	pu	PROPN
ajcp-3197	156	94	la	la	PROPN
ajcp-3197	156	95	tio	tio	PROPN
ajcp-3197	156	96	n	n	CCONJ
ajcp-3197	156	97	)	)	PUNCT
ajcp-3197	156	98	u	u	PROPN
ajcp-3197	156	99	ni	ni	PROPN
ajcp-3197	156	100	ve	ve	AUX
ajcp-3197	156	101	rs	rs	PROPN
ajcp-3197	156	102	ity	ity	PROPN
ajcp-3197	156	103	c	c	PROPN
ajcp-3197	156	104	ol	ol	PROPN
ajcp-3197	156	105	le	le	X
ajcp-3197	156	106	ge	ge	PROPN
ajcp-3197	157	1	h	h	PROPN
ajcp-3197	157	2	os	os	INTJ
ajcp-3197	158	1	pi	pi	NOUN
ajcp-3197	158	2	ta	ta	PROPN
ajcp-3197	159	1	l	l	PROPN
ajcp-3197	159	2	,	,	PUNCT
ajcp-3197	159	3	ib	ib	PROPN
ajcp-3197	159	4	ad	ad	NOUN
ajcp-3197	159	5	an	an	DET
ajcp-3197	159	6	/	/	SYM
ajcp-3197	159	7	so	so	ADV
ajcp-3197	159	8	ut	ut	PROPN
ajcp-3197	159	9	hw	hw	PROPN
ajcp-3197	159	10	es	es	PROPN
ajcp-3197	159	11	t	t	PROPN
ajcp-3197	159	12	pr	pr	INTJ
ajcp-3197	160	1	os	os	INTJ
ajcp-3197	161	1	pe	pe	INTJ
ajcp-3197	161	2	ct	ct	NUM
ajcp-3197	161	3	iv	iv	NUM
ajcp-3197	162	1	e	e	NOUN
ajcp-3197	162	2	co	co	NOUN
ajcp-3197	162	3	ho	ho	PROPN
ajcp-3197	162	4	rt	rt	PROPN
ajcp-3197	162	5	st	st	PROPN
ajcp-3197	162	6	ud	ud	INTJ
ajcp-3197	162	7	y	y	PROPN
ajcp-3197	162	8	4	4	NUM
ajcp-3197	162	9	.	.	NOUN
ajcp-3197	162	10	9	9	NUM
ajcp-3197	162	11	%	%	NOUN
ajcp-3197	162	12	n	n	NOUN
ajcp-3197	162	13	sa	sa	NOUN
ajcp-3197	163	1	i	i	PROPN
ajcp-3197	163	2	d	d	PROPN
ajcp-3197	163	3	s	s	PROPN
ajcp-3197	163	4	,	,	PUNCT
ajcp-3197	163	5	hy	hy	PROPN
ajcp-3197	163	6	po	po	INTJ
ajcp-3197	163	7	gl	gl	INTJ
ajcp-3197	164	1	yc	yc	VERB
ajcp-3197	164	2	em	em	PRON
ajcp-3197	164	3	ic	ic	PROPN
ajcp-3197	164	4	,	,	PUNCT
ajcp-3197	164	5	an	an	DET
ajcp-3197	164	6	tib	tib	NOUN
ajcp-3197	164	7	ac	ac	NOUN
ajcp-3197	164	8	te	te	PROPN
ajcp-3197	164	9	ria	ria	PROPN
ajcp-3197	164	10	l	l	PROPN
ajcp-3197	164	11	g	g	PROPN
ajcp-3197	164	12	as	as	ADP
ajcp-3197	164	13	tro	tro	NOUN
ajcp-3197	164	14	in	in	ADP
ajcp-3197	164	15	te	te	PROPN
ajcp-3197	164	16	st	st	PROPN
ajcp-3197	164	17	in	in	ADP
ajcp-3197	164	18	al	al	PROPN
ajcp-3197	164	19	,	,	PUNCT
ajcp-3197	164	20	ce	ce	PROPN
ajcp-3197	164	21	nt	not	PART
ajcp-3197	164	22	ra	ra	PROPN
ajcp-3197	164	23	l	l	NOUN
ajcp-3197	165	1	n	n	CCONJ
ajcp-3197	165	2	er	er	INTJ
ajcp-3197	165	3	vo	vo	INTJ
ajcp-3197	165	4	us	us	PROPN
ajcp-3197	166	1	sy	sy	INTJ
ajcp-3197	166	2	st	st	PROPN
ajcp-3197	166	3	em	em	PRON
ajcp-3197	166	4	,	,	PUNCT
ajcp-3197	167	1	a	a	DET
ajcp-3197	167	2	nd	nd	INTJ
ajcp-3197	167	3	sk	sk	VERB
ajcp-3197	167	4	in	in	ADP
ajcp-3197	167	5	/	/	SYM
ajcp-3197	167	6	cu	cu	PROPN
ajcp-3197	167	7	ta	ta	X
ajcp-3197	167	8	ne	ne	PROPN
ajcp-3197	167	9	ou	ou	PROPN
ajcp-3197	167	10	s	s	PROPN
ajcp-3197	167	11	s	s	PROPN
ajcp-3197	167	12	ys	ys	NOUN
ajcp-3197	167	13	te	te	PROPN
ajcp-3197	167	14	m	m	PROPN
ajcp-3197	167	15	pa	pa	PROPN
ajcp-3197	167	16	ge	ge	PROPN
ajcp-3197	167	17	5	5	NUM
ajcp-3197	167	18	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	167	19	am	be	AUX
ajcp-3197	167	20	.	.	PUNCT
ajcp-3197	168	1	j.	j.	PROPN
ajcp-3197	168	2	chem	chem	PROPN
ajcp-3197	168	3	.	.	PUNCT
ajcp-3197	169	1	pharm	pharm	PROPN
ajcp-3197	169	2	.	.	PUNCT
ajcp-3197	170	1	3(1	3(1	NUM
ajcp-3197	170	2	)	)	PUNCT
ajcp-3197	171	1	1	1	NUM
ajcp-3197	171	2	-	-	SYM
ajcp-3197	171	3	11	11	NUM
ajcp-3197	171	4	,	,	PUNCT
ajcp-3197	171	5	2024	2024	NUM
ajcp-3197	171	6	n	n	NOUN
ajcp-3197	171	7	w	w	NOUN
ajcp-3197	171	8	an	an	PRON
ajcp-3197	171	9	i	i	PROPN
ajcp-3197	171	10	&	&	CCONJ
ajcp-3197	171	11	is	be	AUX
ajcp-3197	171	12	ah	ah	INTJ
ajcp-3197	171	13	,	,	PUNCT
ajcp-3197	171	14	2	2	NUM
ajcp-3197	171	15	01	01	NUM
ajcp-3197	171	16	7	7	NUM
ajcp-3197	171	17	(	(	PUNCT
ajcp-3197	171	18	2	2	NUM
ajcp-3197	171	19	00	00	NUM
ajcp-3197	171	20	9	9	NUM
ajcp-3197	171	21	)	)	PUNCT
ajcp-3197	171	22	65	65	NUM
ajcp-3197	171	23	a	a	DET
ajcp-3197	171	24	nd	nd	NOUN
ajcp-3197	171	25	a	a	DET
ajcp-3197	171	26	bo	bo	NOUN
ajcp-3197	171	27	ve	ve	PROPN
ajcp-3197	171	28	34	34	NUM
ajcp-3197	171	29	5	5	NUM
ajcp-3197	171	30	n	n	ADV
ajcp-3197	171	31	na	na	ADP
ajcp-3197	171	32	m	m	PROPN
ajcp-3197	171	33	di	di	X
ajcp-3197	171	34	a	a	DET
ajcp-3197	171	35	zi	zi	NOUN
ajcp-3197	172	1	ki	ki	PROPN
ajcp-3197	172	2	w	w	PROPN
ajcp-3197	172	3	e	e	PROPN
ajcp-3197	172	4	u	u	PROPN
ajcp-3197	172	5	ni	ni	PROPN
ajcp-3197	172	6	ve	ve	AUX
ajcp-3197	172	7	rs	rs	PROPN
ajcp-3197	172	8	ity	ity	PROPN
ajcp-3197	172	9	te	te	INTJ
ajcp-3197	172	10	ac	ac	INTJ
ajcp-3197	172	11	hi	hi	INTJ
ajcp-3197	172	12	ng	ng	PROPN
ajcp-3197	173	1	h	h	PROPN
ajcp-3197	173	2	os	os	NOUN
ajcp-3197	174	1	pi	pi	NOUN
ajcp-3197	174	2	ta	ta	PROPN
ajcp-3197	174	3	l	l	PROPN
ajcp-3197	174	4	,	,	PUNCT
ajcp-3197	174	5	n	n	PROPN
ajcp-3197	174	6	ne	ne	PROPN
ajcp-3197	174	7	w	w	PROPN
ajcp-3197	174	8	i/	i/	PROPN
ajcp-3197	175	1	so	so	ADV
ajcp-3197	175	2	ut	ut	PROPN
ajcp-3197	175	3	he	he	PRON
ajcp-3197	175	4	as	as	SCONJ
ajcp-3197	175	5	t	t	PROPN
ajcp-3197	175	6	pr	pr	NOUN
ajcp-3197	175	7	os	os	INTJ
ajcp-3197	176	1	pe	pe	INTJ
ajcp-3197	176	2	ct	ct	NUM
ajcp-3197	176	3	iv	iv	NUM
ajcp-3197	176	4	e	e	PROPN
ajcp-3197	176	5	st	st	PROPN
ajcp-3197	176	6	ud	ud	INTJ
ajcp-3197	176	7	y	y	PROPN
ajcp-3197	176	8	6	6	NUM
ajcp-3197	176	9	.	.	PUNCT
ajcp-3197	176	10	7	7	NUM
ajcp-3197	176	11	%	%	NOUN
ajcp-3197	176	12	n	n	PRON
ajcp-3197	176	13	sa	sa	NOUN
ajcp-3197	177	1	i	i	PROPN
ajcp-3197	177	2	d	d	PROPN
ajcp-3197	177	3	s	s	PROPN
ajcp-3197	177	4	,	,	PUNCT
ajcp-3197	177	5	st	st	PROPN
ajcp-3197	178	1	er	er	INTJ
ajcp-3197	178	2	oi	oi	INTJ
ajcp-3197	178	3	ds	ds	PROPN
ajcp-3197	178	4	,	,	PUNCT
ajcp-3197	178	5	a	a	DET
ajcp-3197	178	6	nd	nd	NOUN
ajcp-3197	178	7	hy	hy	NOUN
ajcp-3197	178	8	po	po	INTJ
ajcp-3197	178	9	gl	gl	INTJ
ajcp-3197	179	1	yc	yc	VERB
ajcp-3197	179	2	em	em	PRON
ajcp-3197	179	3	ic	ic	PROPN
ajcp-3197	179	4	a	a	DET
ajcp-3197	179	5	ge	ge	PROPN
ajcp-3197	180	1	nt	nt	PROPN
ajcp-3197	180	2	s	s	PROPN
ajcp-3197	180	3	g	g	NOUN
ajcp-3197	180	4	as	as	ADP
ajcp-3197	180	5	tro	tro	NOUN
ajcp-3197	180	6	in	in	ADP
ajcp-3197	180	7	te	te	PROPN
ajcp-3197	180	8	st	st	PROPN
ajcp-3197	180	9	in	in	ADP
ajcp-3197	180	10	al	al	PROPN
ajcp-3197	180	11	sy	sy	PROPN
ajcp-3197	180	12	st	st	PROPN
ajcp-3197	180	13	em	em	PRON
ajcp-3197	180	14	,	,	PUNCT
ajcp-3197	180	15	c	c	PROPN
ajcp-3197	180	16	en	en	X
ajcp-3197	180	17	tra	tra	PROPN
ajcp-3197	180	18	l	l	PROPN
ajcp-3197	180	19	ne	ne	PROPN
ajcp-3197	180	20	rv	rv	PROPN
ajcp-3197	180	21	ou	ou	ADP
ajcp-3197	180	22	s	s	NOUN
ajcp-3197	180	23	s	s	X
ajcp-3197	180	24	ys	ys	NOUN
ajcp-3197	180	25	te	te	PROPN
ajcp-3197	180	26	m	m	PRON
ajcp-3197	180	27	,	,	PUNCT
ajcp-3197	181	1	e	e	PROPN
ajcp-3197	181	2	nd	nd	NOUN
ajcp-3197	181	3	oc	oc	PROPN
ajcp-3197	181	4	rin	rin	PROPN
ajcp-3197	181	5	e	e	PROPN
ajcp-3197	182	1	an	an	PROPN
ajcp-3197	182	2	d	d	X
ajcp-3197	182	3	m	m	VERB
ajcp-3197	182	4	et	et	NOUN
ajcp-3197	182	5	ab	ab	PROPN
ajcp-3197	182	6	ol	ol	PROPN
ajcp-3197	182	7	ic	ic	PROPN
ajcp-3197	182	8	sy	sy	PROPN
ajcp-3197	182	9	st	st	PROPN
ajcp-3197	182	10	em	em	PROPN
ajcp-3197	182	11	e	e	PROPN
ajcp-3197	182	12	ze	ze	PROPN
ajcp-3197	182	13	et	et	PROPN
ajcp-3197	182	14	a	a	DET
ajcp-3197	182	15	l.	l.	PROPN
ajcp-3197	182	16	,	,	PUNCT
ajcp-3197	182	17	2	2	NUM
ajcp-3197	182	18	01	01	NUM
ajcp-3197	182	19	1	1	NUM
ajcp-3197	182	20	(	(	PUNCT
ajcp-3197	182	21	2	2	NUM
ajcp-3197	182	22	00	00	NUM
ajcp-3197	182	23	8)	8)	NUM
ajcp-3197	182	24	60	60	NUM
ajcp-3197	182	25	a	a	DET
ajcp-3197	182	26	nd	nd	NOUN
ajcp-3197	182	27	a	a	DET
ajcp-3197	182	28	bo	bo	NOUN
ajcp-3197	182	29	ve	ve	PROPN
ajcp-3197	182	30	37	37	NUM
ajcp-3197	182	31	5	5	NUM
ajcp-3197	182	32	o	o	NOUN
ajcp-3197	182	33	la	la	INTJ
ajcp-3197	182	34	bi	bi	NOUN
ajcp-3197	182	35	si	si	PROPN
ajcp-3197	182	36	o	o	X
ajcp-3197	182	37	na	na	INTJ
ajcp-3197	182	38	ba	ba	PROPN
ajcp-3197	182	39	nj	nj	INTJ
ajcp-3197	183	1	o	o	NOUN
ajcp-3197	184	1	u	u	PRON
ajcp-3197	184	2	ni	ni	PROPN
ajcp-3197	184	3	ve	ve	AUX
ajcp-3197	184	4	rs	rs	PROPN
ajcp-3197	184	5	ity	ity	PROPN
ajcp-3197	184	6	t	t	PROPN
ajcp-3197	184	7	ea	ea	PROPN
ajcp-3197	184	8	ch	ch	NOUN
ajcp-3197	184	9	in	in	ADP
ajcp-3197	184	10	g	g	PROPN
ajcp-3197	184	11	h	h	NOUN
ajcp-3197	184	12	os	os	NOUN
ajcp-3197	184	13	pi	pi	NOUN
ajcp-3197	184	14	ta	ta	PROPN
ajcp-3197	184	15	l	l	PROPN
ajcp-3197	184	16	,	,	PUNCT
ajcp-3197	184	17	sa	sa	PROPN
ajcp-3197	184	18	ga	ga	PROPN
ajcp-3197	184	19	m	m	PROPN
ajcp-3197	184	20	u	u	PROPN
ajcp-3197	184	21	,	,	PUNCT
ajcp-3197	184	22	o	o	PROPN
ajcp-3197	184	23	gu	gu	PROPN
ajcp-3197	184	24	n	n	PROPN
ajcp-3197	184	25	st	st	PROPN
ajcp-3197	184	26	at	at	ADP
ajcp-3197	184	27	e/	e/	ADV
ajcp-3197	184	28	so	so	ADV
ajcp-3197	184	29	ut	ut	PROPN
ajcp-3197	184	30	hw	hw	PROPN
ajcp-3197	184	31	es	es	PROPN
ajcp-3197	184	32	t	t	PROPN
ajcp-3197	184	33	re	re	X
ajcp-3197	184	34	tro	tro	NOUN
ajcp-3197	184	35	sp	sp	ADP
ajcp-3197	184	36	ec	ec	PROPN
ajcp-3197	184	37	tiv	tiv	PROPN
ajcp-3197	184	38	e	e	PROPN
ajcp-3197	185	1	an	an	PROPN
ajcp-3197	185	2	d	d	NOUN
ajcp-3197	185	3	pr	pr	PUNCT
ajcp-3197	186	1	os	os	INTJ
ajcp-3197	186	2	pe	pe	INTJ
ajcp-3197	187	1	ct	ct	NUM
ajcp-3197	187	2	iv	iv	NUM
ajcp-3197	188	1	e	e	X
ajcp-3197	188	2	31	31	NUM
ajcp-3197	188	3	.1	.1	NUM
ajcp-3197	188	4	%	%	NOUN
ajcp-3197	188	5	c	c	PROPN
ajcp-3197	188	6	ar	ar	PROPN
ajcp-3197	188	7	di	di	PROPN
ajcp-3197	188	8	ov	ov	PROPN
ajcp-3197	188	9	as	as	ADP
ajcp-3197	188	10	cu	cu	PROPN
ajcp-3197	188	11	la	la	PROPN
ajcp-3197	188	12	r	r	PROPN
ajcp-3197	188	13	m	m	VERB
ajcp-3197	188	14	ed	ed	NOUN
ajcp-3197	188	15	ic	ic	PROPN
ajcp-3197	188	16	at	at	ADP
ajcp-3197	188	17	io	io	PROPN
ajcp-3197	188	18	ns	ns	PROPN
ajcp-3197	188	19	n	n	INTJ
ajcp-3197	188	20	ot	ot	NOUN
ajcp-3197	188	21	sp	sp	ADP
ajcp-3197	188	22	ec	ec	PROPN
ajcp-3197	188	23	ifi	ifi	PROPN
ajcp-3197	188	24	ed	ed	PROPN
ajcp-3197	188	25	table	table	NOUN
ajcp-3197	188	26	2	2	NUM
ajcp-3197	188	27	:	:	PUNCT
ajcp-3197	188	28	summary	summary	NOUN
ajcp-3197	188	29	of	of	ADP
ajcp-3197	188	30	the	the	DET
ajcp-3197	188	31	factors	factor	NOUN
ajcp-3197	188	32	responsible	responsible	ADJ
ajcp-3197	188	33	for	for	ADP
ajcp-3197	188	34	adrs	adr	NOUN
ajcp-3197	188	35	in	in	ADP
ajcp-3197	188	36	the	the	DET
ajcp-3197	188	37	included	include	VERB
ajcp-3197	188	38	studies	study	NOUN
ajcp-3197	188	39	author	author	NOUN
ajcp-3197	188	40	(	(	PUNCT
ajcp-3197	188	41	year	year	NOUN
ajcp-3197	188	42	conducted	conduct	VERB
ajcp-3197	188	43	)	)	PUNCT
ajcp-3197	188	44	factors	factor	NOUN
ajcp-3197	188	45	responsible	responsible	ADJ
ajcp-3197	188	46	for	for	ADP
ajcp-3197	188	47	adr	adr	PROPN
ajcp-3197	188	48	akhideno	akhideno	PROPN
ajcp-3197	188	49	et	et	PROPN
ajcp-3197	188	50	al	al	PROPN
ajcp-3197	188	51	.	.	PROPN
ajcp-3197	188	52	,	,	PUNCT
ajcp-3197	188	53	2018	2018	NUM
ajcp-3197	188	54	(	(	PUNCT
ajcp-3197	188	55	2013	2013	NUM
ajcp-3197	188	56	-	-	SYM
ajcp-3197	188	57	2014	2014	NUM
ajcp-3197	188	58	)	)	PUNCT
ajcp-3197	188	59	number	number	NOUN
ajcp-3197	188	60	of	of	ADP
ajcp-3197	188	61	medications	medication	NOUN
ajcp-3197	188	62	number	number	NOUN
ajcp-3197	188	63	of	of	ADP
ajcp-3197	188	64	co	co	NOUN
ajcp-3197	188	65	-	-	NOUN
ajcp-3197	188	66	morbidities	morbidity	NOUN
ajcp-3197	188	67	amadi	amadi	NOUN
ajcp-3197	188	68	et	et	PROPN
ajcp-3197	188	69	al	al	PROPN
ajcp-3197	188	70	.	.	PROPN
ajcp-3197	188	71	,	,	PUNCT
ajcp-3197	188	72	2021	2021	NUM
ajcp-3197	188	73	polypharmacy	polypharmacy	NOUN
ajcp-3197	188	74	multi	multi	ADJ
ajcp-3197	188	75	-	-	ADJ
ajcp-3197	188	76	morbidity	morbidity	NOUN
ajcp-3197	188	77	alcohol	alcohol	NOUN
ajcp-3197	188	78	intake	intake	NOUN
ajcp-3197	188	79	saka	saka	PROPN
ajcp-3197	188	80	et	et	PROPN
ajcp-3197	188	81	al	al	PROPN
ajcp-3197	188	82	.	.	PROPN
ajcp-3197	188	83	,	,	PUNCT
ajcp-3197	188	84	(	(	PUNCT
ajcp-3197	188	85	2018	2018	NUM
ajcp-3197	188	86	;	;	PUNCT
ajcp-3197	188	87	2017	2017	NUM
ajcp-3197	188	88	)	)	PUNCT
ajcp-3197	188	89	abrupt	abrupt	ADJ
ajcp-3197	188	90	stoppage	stoppage	NOUN
ajcp-3197	188	91	of	of	ADP
ajcp-3197	188	92	medications	medication	NOUN
ajcp-3197	188	93	use	use	NOUN
ajcp-3197	188	94	of	of	ADP
ajcp-3197	188	95	antiemetics	antiemetic	NOUN
ajcp-3197	188	96	decreased	decrease	VERB
ajcp-3197	188	97	potassium	potassium	NOUN
ajcp-3197	188	98	levels	level	NOUN
ajcp-3197	188	99	below	below	ADP
ajcp-3197	188	100	2.5mmol	2.5mmol	NUM
ajcp-3197	188	101	/	/	SYM
ajcp-3197	188	102	l	l	NOUN
ajcp-3197	188	103	adedapo	adedapo	NOUN
ajcp-3197	188	104	et	et	PROPN
ajcp-3197	188	105	al	al	PROPN
ajcp-3197	188	106	.	.	PROPN
ajcp-3197	188	107	,	,	PUNCT
ajcp-3197	188	108	2021	2021	NUM
ajcp-3197	188	109	(	(	PUNCT
ajcp-3197	188	110	2012	2012	NUM
ajcp-3197	188	111	-	-	SYM
ajcp-3197	188	112	2013	2013	NUM
ajcp-3197	188	113	)	)	PUNCT
ajcp-3197	188	114	outpatient	outpatient	NOUN
ajcp-3197	188	115	medication	medication	NOUN
ajcp-3197	188	116	errors	error	NOUN
ajcp-3197	188	117	overdose	overdose	ADP
ajcp-3197	188	118	self	self	NOUN
ajcp-3197	188	119	-	-	PUNCT
ajcp-3197	188	120	medication	medication	NOUN
ajcp-3197	188	121	and	and	CCONJ
ajcp-3197	188	122	drug	drug	NOUN
ajcp-3197	188	123	misuse	misuse	NOUN
ajcp-3197	188	124	multi	multi	ADJ
ajcp-3197	188	125	-	-	ADJ
ajcp-3197	188	126	morbidity	morbidity	ADJ
ajcp-3197	188	127	duration	duration	NOUN
ajcp-3197	188	128	of	of	ADP
ajcp-3197	188	129	hospital	hospital	NOUN
ajcp-3197	188	130	stay	stay	NOUN
ajcp-3197	188	131	polypharmacy	polypharmacy	NOUN
ajcp-3197	188	132	(	(	PUNCT
ajcp-3197	188	133	≥3	≥3	NOUN
ajcp-3197	188	134	medications	medication	NOUN
ajcp-3197	188	135	)	)	PUNCT
ajcp-3197	188	136	nwani	nwani	PROPN
ajcp-3197	188	137	&	&	CCONJ
ajcp-3197	188	138	isah	isah	PROPN
ajcp-3197	188	139	,	,	PUNCT
ajcp-3197	188	140	2017	2017	NUM
ajcp-3197	188	141	(	(	PUNCT
ajcp-3197	188	142	2009	2009	NUM
ajcp-3197	188	143	)	)	PUNCT
ajcp-3197	188	144	not	not	PART
ajcp-3197	188	145	reported	report	VERB
ajcp-3197	188	146	eze	eze	PROPN
ajcp-3197	188	147	et	et	PROPN
ajcp-3197	188	148	al	al	PROPN
ajcp-3197	188	149	.	.	PROPN
ajcp-3197	188	150	,	,	PUNCT
ajcp-3197	188	151	2011	2011	NUM
ajcp-3197	188	152	(	(	PUNCT
ajcp-3197	188	153	2008	2008	NUM
ajcp-3197	188	154	)	)	PUNCT
ajcp-3197	188	155	polypharmacy	polypharmacy	NOUN
ajcp-3197	188	156	(	(	PUNCT
ajcp-3197	188	157	≥5	≥5	NUM
ajcp-3197	188	158	medications	medication	NOUN
ajcp-3197	188	159	)	)	PUNCT
ajcp-3197	188	160	in	in	ADP
ajcp-3197	188	161	one	one	NUM
ajcp-3197	188	162	study	study	NOUN
ajcp-3197	188	163	on	on	ADP
ajcp-3197	188	164	the	the	DET
ajcp-3197	188	165	general	general	ADJ
ajcp-3197	188	166	adult	adult	NOUN
ajcp-3197	188	167	population	population	NOUN
ajcp-3197	188	168	(	(	PUNCT
ajcp-3197	188	169	aged	aged	ADJ
ajcp-3197	188	170	17	17	NUM
ajcp-3197	188	171	years	year	NOUN
ajcp-3197	188	172	and	and	CCONJ
ajcp-3197	188	173	older	old	ADJ
ajcp-3197	188	174	)	)	PUNCT
ajcp-3197	188	175	,	,	PUNCT
ajcp-3197	188	176	elderly	elderly	ADJ
ajcp-3197	188	177	patients	patient	NOUN
ajcp-3197	188	178	(	(	PUNCT
ajcp-3197	188	179	65	65	NUM
ajcp-3197	188	180	and	and	CCONJ
ajcp-3197	188	181	older	old	ADJ
ajcp-3197	188	182	)	)	PUNCT
ajcp-3197	188	183	accounted	account	VERB
ajcp-3197	188	184	for	for	ADP
ajcp-3197	188	185	24.7	24.7	NUM
ajcp-3197	188	186	%	%	NOUN
ajcp-3197	188	187	of	of	ADP
ajcp-3197	188	188	the	the	DET
ajcp-3197	188	189	study	study	NOUN
ajcp-3197	188	190	participants	participant	NOUN
ajcp-3197	188	191	,	,	PUNCT
ajcp-3197	188	192	and	and	CCONJ
ajcp-3197	188	193	adverse	adverse	ADJ
ajcp-3197	188	194	drug	drug	NOUN
ajcp-3197	188	195	reactions	reaction	NOUN
ajcp-3197	188	196	were	be	AUX
ajcp-3197	188	197	observed	observe	VERB
ajcp-3197	188	198	in	in	ADP
ajcp-3197	188	199	22	22	NUM
ajcp-3197	188	200	%	%	NOUN
ajcp-3197	188	201	of	of	ADP
ajcp-3197	188	202	these	these	DET
ajcp-3197	188	203	elderly	elderly	ADJ
ajcp-3197	188	204	patients	patient	NOUN
ajcp-3197	188	205	.	.	PUNCT
ajcp-3197	189	1	although	although	SCONJ
ajcp-3197	189	2	the	the	DET
ajcp-3197	189	3	specific	specific	ADJ
ajcp-3197	189	4	drug	drug	NOUN
ajcp-3197	189	5	most	most	ADV
ajcp-3197	189	6	implicated	implicate	VERB
ajcp-3197	189	7	in	in	ADP
ajcp-3197	189	8	elderly	elderly	ADJ
ajcp-3197	189	9	patients	patient	NOUN
ajcp-3197	189	10	was	be	AUX
ajcp-3197	189	11	not	not	PART
ajcp-3197	189	12	specified	specify	VERB
ajcp-3197	189	13	,	,	PUNCT
ajcp-3197	189	14	the	the	DET
ajcp-3197	189	15	drugs	drug	NOUN
ajcp-3197	189	16	most	most	ADV
ajcp-3197	189	17	frequently	frequently	ADV
ajcp-3197	189	18	associated	associate	VERB
ajcp-3197	189	19	with	with	ADP
ajcp-3197	189	20	adverse	adverse	ADJ
ajcp-3197	189	21	drug	drug	NOUN
ajcp-3197	189	22	reactions	reaction	NOUN
ajcp-3197	189	23	in	in	ADP
ajcp-3197	189	24	the	the	DET
ajcp-3197	189	25	general	general	ADJ
ajcp-3197	189	26	adult	adult	NOUN
ajcp-3197	189	27	population	population	NOUN
ajcp-3197	189	28	were	be	AUX
ajcp-3197	189	29	insulin	insulin	NOUN
ajcp-3197	189	30	(	(	PUNCT
ajcp-3197	189	31	27.5	27.5	NUM
ajcp-3197	189	32	%	%	NOUN
ajcp-3197	189	33	)	)	PUNCT
ajcp-3197	189	34	,	,	PUNCT
ajcp-3197	189	35	nsaids	nsaid	NOUN
ajcp-3197	189	36	(	(	PUNCT
ajcp-3197	189	37	19.6	19.6	NUM
ajcp-3197	189	38	%	%	NOUN
ajcp-3197	189	39	)	)	PUNCT
ajcp-3197	189	40	,	,	PUNCT
ajcp-3197	189	41	antihypertensives	antihypertensive	NOUN
ajcp-3197	189	42	(	(	PUNCT
ajcp-3197	189	43	15.7	15.7	NUM
ajcp-3197	189	44	%	%	NOUN
ajcp-3197	189	45	)	)	PUNCT
ajcp-3197	189	46	,	,	PUNCT
ajcp-3197	189	47	and	and	CCONJ
ajcp-3197	189	48	antimalarials	antimalarial	NOUN
ajcp-3197	189	49	.	.	PUNCT
ajcp-3197	190	1	age	age	NOUN
ajcp-3197	190	2	was	be	AUX
ajcp-3197	190	3	found	find	VERB
ajcp-3197	190	4	to	to	PART
ajcp-3197	190	5	be	be	AUX
ajcp-3197	190	6	a	a	DET
ajcp-3197	190	7	significant	significant	ADJ
ajcp-3197	190	8	risk	risk	NOUN
ajcp-3197	190	9	factor	factor	NOUN
ajcp-3197	190	10	for	for	ADP
ajcp-3197	190	11	adverse	adverse	ADJ
ajcp-3197	190	12	reactions	reaction	NOUN
ajcp-3197	190	13	to	to	ADP
ajcp-3197	190	14	medications	medication	NOUN
ajcp-3197	190	15	among	among	ADP
ajcp-3197	190	16	the	the	DET
ajcp-3197	190	17	elderly	elderly	ADJ
ajcp-3197	190	18	,	,	PUNCT
ajcp-3197	190	19	with	with	ADP
ajcp-3197	190	20	those	those	DET
ajcp-3197	190	21	aged	age	VERB
ajcp-3197	190	22	65	65	NUM
ajcp-3197	190	23	years	year	NOUN
ajcp-3197	190	24	and	and	CCONJ
ajcp-3197	190	25	older	old	ADJ
ajcp-3197	190	26	being	be	AUX
ajcp-3197	190	27	at	at	ADP
ajcp-3197	190	28	a	a	DET
ajcp-3197	190	29	higher	high	ADJ
ajcp-3197	190	30	risk	risk	NOUN
ajcp-3197	190	31	than	than	ADP
ajcp-3197	190	32	younger	young	ADJ
ajcp-3197	190	33	patients	patient	NOUN
ajcp-3197	190	34	(	(	PUNCT
ajcp-3197	190	35	akhideno	akhideno	VERB
ajcp-3197	190	36	et	et	PROPN
ajcp-3197	190	37	al	al	PROPN
ajcp-3197	190	38	.	.	PROPN
ajcp-3197	190	39	,	,	PUNCT
ajcp-3197	190	40	2018	2018	NUM
ajcp-3197	190	41	)	)	PUNCT
ajcp-3197	190	42	.	.	PUNCT
ajcp-3197	191	1	a	a	DET
ajcp-3197	191	2	prospective	prospective	ADJ
ajcp-3197	191	3	cohort	cohort	NOUN
ajcp-3197	191	4	study	study	NOUN
ajcp-3197	191	5	was	be	AUX
ajcp-3197	191	6	conducted	conduct	VERB
ajcp-3197	191	7	,	,	PUNCT
ajcp-3197	191	8	involving	involve	VERB
ajcp-3197	191	9	a	a	DET
ajcp-3197	191	10	total	total	NOUN
ajcp-3197	191	11	of	of	ADP
ajcp-3197	191	12	1,280	1,280	NUM
ajcp-3197	191	13	adult	adult	NOUN
ajcp-3197	191	14	patients	patient	NOUN
ajcp-3197	191	15	who	who	PRON
ajcp-3197	191	16	were	be	AUX
ajcp-3197	191	17	admitted	admit	VERB
ajcp-3197	191	18	to	to	ADP
ajcp-3197	191	19	the	the	DET
ajcp-3197	191	20	hospital	hospital	NOUN
ajcp-3197	191	21	.	.	PUNCT
ajcp-3197	192	1	it	it	PRON
ajcp-3197	192	2	was	be	AUX
ajcp-3197	192	3	found	find	VERB
ajcp-3197	192	4	that	that	SCONJ
ajcp-3197	192	5	patients	patient	NOUN
ajcp-3197	192	6	aged	age	VERB
ajcp-3197	192	7	60	60	NUM
ajcp-3197	192	8	and	and	CCONJ
ajcp-3197	192	9	older	old	ADJ
ajcp-3197	192	10	constituted	constitute	VERB
ajcp-3197	192	11	approximately	approximately	ADV
ajcp-3197	192	12	one	one	NUM
ajcp-3197	192	13	-	-	PUNCT
ajcp-3197	192	14	third	third	NOUN
ajcp-3197	192	15	(	(	PUNCT
ajcp-3197	192	16	32.7	32.7	NUM
ajcp-3197	192	17	%	%	NOUN
ajcp-3197	192	18	)	)	PUNCT
ajcp-3197	192	19	of	of	ADP
ajcp-3197	192	20	the	the	DET
ajcp-3197	192	21	study	study	NOUN
ajcp-3197	192	22	participants	participant	NOUN
ajcp-3197	192	23	.	.	PUNCT
ajcp-3197	193	1	among	among	ADP
ajcp-3197	193	2	patients	patient	NOUN
ajcp-3197	193	3	aged	age	VERB
ajcp-3197	193	4	65	65	NUM
ajcp-3197	193	5	years	year	NOUN
ajcp-3197	193	6	and	and	CCONJ
ajcp-3197	193	7	older	old	ADJ
ajcp-3197	193	8	,	,	PUNCT
ajcp-3197	193	9	4.9	4.9	NUM
ajcp-3197	193	10	%	%	NOUN
ajcp-3197	193	11	experienced	experience	VERB
ajcp-3197	193	12	adverse	adverse	ADJ
ajcp-3197	193	13	drug	drug	NOUN
ajcp-3197	193	14	reactions	reaction	NOUN
ajcp-3197	193	15	that	that	PRON
ajcp-3197	193	16	resulted	result	VERB
ajcp-3197	193	17	in	in	ADP
ajcp-3197	193	18	hospitalization	hospitalization	NOUN
ajcp-3197	193	19	,	,	PUNCT
ajcp-3197	193	20	while	while	SCONJ
ajcp-3197	193	21	1.3	1.3	NUM
ajcp-3197	193	22	%	%	NOUN
ajcp-3197	193	23	developed	develop	VERB
ajcp-3197	193	24	adverse	adverse	ADJ
ajcp-3197	193	25	drug	drug	NOUN
ajcp-3197	193	26	reactions	reaction	NOUN
ajcp-3197	193	27	during	during	ADP
ajcp-3197	193	28	their	their	PRON
ajcp-3197	193	29	admission	admission	NOUN
ajcp-3197	193	30	.	.	PUNCT
ajcp-3197	194	1	the	the	DET
ajcp-3197	194	2	study	study	NOUN
ajcp-3197	194	3	did	do	AUX
ajcp-3197	194	4	not	not	PART
ajcp-3197	194	5	specify	specify	VERB
ajcp-3197	194	6	the	the	DET
ajcp-3197	194	7	most	most	ADV
ajcp-3197	194	8	affected	affected	ADJ
ajcp-3197	194	9	organ	organ	NOUN
ajcp-3197	194	10	or	or	CCONJ
ajcp-3197	194	11	system	system	NOUN
ajcp-3197	194	12	or	or	CCONJ
ajcp-3197	194	13	the	the	DET
ajcp-3197	194	14	specific	specific	ADJ
ajcp-3197	194	15	classes	class	NOUN
ajcp-3197	194	16	of	of	ADP
ajcp-3197	194	17	drugs	drug	NOUN
ajcp-3197	194	18	implicated	implicate	VERB
ajcp-3197	194	19	in	in	ADP
ajcp-3197	194	20	adverse	adverse	ADJ
ajcp-3197	194	21	drug	drug	NOUN
ajcp-3197	194	22	reactions	reaction	NOUN
ajcp-3197	194	23	in	in	ADP
ajcp-3197	194	24	the	the	DET
ajcp-3197	194	25	older	old	ADJ
ajcp-3197	194	26	population	population	NOUN
ajcp-3197	194	27	,	,	PUNCT
ajcp-3197	194	28	but	but	CCONJ
ajcp-3197	194	29	in	in	ADP
ajcp-3197	194	30	the	the	DET
ajcp-3197	194	31	general	general	ADJ
ajcp-3197	194	32	adult	adult	NOUN
ajcp-3197	194	33	population	population	NOUN
ajcp-3197	194	34	,	,	PUNCT
ajcp-3197	194	35	the	the	DET
ajcp-3197	194	36	most	most	ADV
ajcp-3197	194	37	implicated	implicated	ADJ
ajcp-3197	194	38	drug	drug	NOUN
ajcp-3197	194	39	classes	class	NOUN
ajcp-3197	194	40	were	be	AUX
ajcp-3197	194	41	nsaids	nsaid	NOUN
ajcp-3197	194	42	,	,	PUNCT
ajcp-3197	194	43	antidiabetics	antidiabetic	NOUN
ajcp-3197	194	44	,	,	PUNCT
ajcp-3197	194	45	and	and	CCONJ
ajcp-3197	194	46	antibacterials	antibacterial	NOUN
ajcp-3197	194	47	.	.	PUNCT
ajcp-3197	195	1	the	the	DET
ajcp-3197	195	2	gastrointestinal	gastrointestinal	ADJ
ajcp-3197	195	3	tract	tract	NOUN
ajcp-3197	195	4	,	,	PUNCT
ajcp-3197	195	5	central	central	ADJ
ajcp-3197	195	6	nervous	nervous	ADJ
ajcp-3197	195	7	pa	pa	PROPN
ajcp-3197	195	8	ge	ge	PROPN
ajcp-3197	195	9	6	6	NUM
ajcp-3197	195	10	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	195	11	am	be	AUX
ajcp-3197	195	12	.	.	PUNCT
ajcp-3197	196	1	j.	j.	PROPN
ajcp-3197	196	2	chem	chem	PROPN
ajcp-3197	196	3	.	.	PUNCT
ajcp-3197	197	1	pharm	pharm	PROPN
ajcp-3197	197	2	.	.	PUNCT
ajcp-3197	198	1	3(1	3(1	NUM
ajcp-3197	198	2	)	)	PUNCT
ajcp-3197	198	3	1	1	NUM
ajcp-3197	198	4	-	-	SYM
ajcp-3197	198	5	11	11	NUM
ajcp-3197	198	6	,	,	PUNCT
ajcp-3197	198	7	2024	2024	NUM
ajcp-3197	198	8	system	system	NOUN
ajcp-3197	198	9	,	,	PUNCT
ajcp-3197	198	10	and	and	CCONJ
ajcp-3197	198	11	skin	skin	NOUN
ajcp-3197	198	12	were	be	AUX
ajcp-3197	198	13	the	the	DET
ajcp-3197	198	14	organs	organ	NOUN
ajcp-3197	198	15	and	and	CCONJ
ajcp-3197	198	16	systems	system	NOUN
ajcp-3197	198	17	most	most	ADV
ajcp-3197	198	18	commonly	commonly	ADV
ajcp-3197	198	19	affected	affect	VERB
ajcp-3197	198	20	(	(	PUNCT
ajcp-3197	198	21	akhideno	akhideno	VERB
ajcp-3197	198	22	et	et	PROPN
ajcp-3197	198	23	al	al	PROPN
ajcp-3197	198	24	.	.	PROPN
ajcp-3197	198	25	,	,	PUNCT
ajcp-3197	198	26	2018	2018	NUM
ajcp-3197	198	27	)	)	PUNCT
ajcp-3197	198	28	.	.	PUNCT
ajcp-3197	199	1	in	in	ADP
ajcp-3197	199	2	a	a	DET
ajcp-3197	199	3	retrospective	retrospective	ADJ
ajcp-3197	199	4	cross	cross	ADJ
ajcp-3197	199	5	-	-	ADJ
ajcp-3197	199	6	sectional	sectional	ADJ
ajcp-3197	199	7	study	study	NOUN
ajcp-3197	199	8	of	of	ADP
ajcp-3197	199	9	elderly	elderly	ADJ
ajcp-3197	199	10	patients	patient	NOUN
ajcp-3197	199	11	,	,	PUNCT
ajcp-3197	199	12	out	out	ADP
ajcp-3197	199	13	of	of	ADP
ajcp-3197	199	14	268	268	NUM
ajcp-3197	199	15	admitted	admit	VERB
ajcp-3197	199	16	patients	patient	NOUN
ajcp-3197	199	17	,	,	PUNCT
ajcp-3197	199	18	43	43	NUM
ajcp-3197	199	19	cases	case	NOUN
ajcp-3197	199	20	of	of	ADP
ajcp-3197	199	21	adverse	adverse	ADJ
ajcp-3197	199	22	drug	drug	NOUN
ajcp-3197	199	23	reactions	reaction	NOUN
ajcp-3197	199	24	(	(	PUNCT
ajcp-3197	199	25	13.8	13.8	NUM
ajcp-3197	199	26	%	%	NOUN
ajcp-3197	199	27	)	)	PUNCT
ajcp-3197	199	28	were	be	AUX
ajcp-3197	199	29	reported	report	VERB
ajcp-3197	199	30	,	,	PUNCT
ajcp-3197	199	31	with	with	ADP
ajcp-3197	199	32	the	the	DET
ajcp-3197	199	33	digestive	digestive	ADJ
ajcp-3197	199	34	system	system	NOUN
ajcp-3197	199	35	being	be	AUX
ajcp-3197	199	36	the	the	DET
ajcp-3197	199	37	most	most	ADV
ajcp-3197	199	38	affected	affect	VERB
ajcp-3197	199	39	by	by	ADP
ajcp-3197	199	40	these	these	DET
ajcp-3197	199	41	reactions	reaction	NOUN
ajcp-3197	199	42	.	.	PUNCT
ajcp-3197	200	1	only	only	ADV
ajcp-3197	200	2	9.3	9.3	NUM
ajcp-3197	200	3	%	%	NOUN
ajcp-3197	200	4	of	of	ADP
ajcp-3197	200	5	the	the	DET
ajcp-3197	200	6	total	total	ADJ
ajcp-3197	200	7	observed	observed	ADJ
ajcp-3197	200	8	cases	case	NOUN
ajcp-3197	200	9	were	be	AUX
ajcp-3197	200	10	formally	formally	ADV
ajcp-3197	200	11	documented	document	VERB
ajcp-3197	200	12	as	as	ADP
ajcp-3197	200	13	adverse	adverse	ADJ
ajcp-3197	200	14	drug	drug	NOUN
ajcp-3197	200	15	reactions	reaction	NOUN
ajcp-3197	200	16	.	.	PUNCT
ajcp-3197	201	1	the	the	DET
ajcp-3197	201	2	most	most	ADV
ajcp-3197	201	3	implicated	implicated	ADJ
ajcp-3197	201	4	medication	medication	NOUN
ajcp-3197	201	5	in	in	ADP
ajcp-3197	201	6	these	these	DET
ajcp-3197	201	7	reactions	reaction	NOUN
ajcp-3197	201	8	was	be	AUX
ajcp-3197	201	9	diclofenac	diclofenac	ADJ
ajcp-3197	201	10	(	(	PUNCT
ajcp-3197	201	11	saka	saka	PROPN
ajcp-3197	201	12	et	et	PROPN
ajcp-3197	201	13	al	al	PROPN
ajcp-3197	201	14	.	.	PROPN
ajcp-3197	201	15	,	,	PUNCT
ajcp-3197	201	16	2018	2018	NUM
ajcp-3197	201	17	)	)	PUNCT
ajcp-3197	201	18	.	.	PUNCT
ajcp-3197	202	1	another	another	DET
ajcp-3197	202	2	study	study	NOUN
ajcp-3197	202	3	found	find	VERB
ajcp-3197	202	4	that	that	SCONJ
ajcp-3197	202	5	19.8	19.8	NUM
ajcp-3197	202	6	%	%	NOUN
ajcp-3197	202	7	of	of	ADP
ajcp-3197	202	8	the	the	DET
ajcp-3197	202	9	elderly	elderly	ADJ
ajcp-3197	202	10	population	population	NOUN
ajcp-3197	202	11	experienced	experience	VERB
ajcp-3197	202	12	adverse	adverse	ADJ
ajcp-3197	202	13	drug	drug	NOUN
ajcp-3197	202	14	reactions	reaction	NOUN
ajcp-3197	202	15	.	.	PUNCT
ajcp-3197	203	1	the	the	DET
ajcp-3197	203	2	most	most	ADV
ajcp-3197	203	3	common	common	ADJ
ajcp-3197	203	4	adverse	adverse	ADJ
ajcp-3197	203	5	reactions	reaction	NOUN
ajcp-3197	203	6	included	include	VERB
ajcp-3197	203	7	itching	itching	NOUN
ajcp-3197	203	8	(	(	PUNCT
ajcp-3197	203	9	22	22	NUM
ajcp-3197	203	10	%	%	NOUN
ajcp-3197	203	11	)	)	PUNCT
ajcp-3197	203	12	,	,	PUNCT
ajcp-3197	203	13	drowsiness	drowsiness	NOUN
ajcp-3197	203	14	,	,	PUNCT
ajcp-3197	203	15	dizziness	dizziness	NOUN
ajcp-3197	203	16	,	,	PUNCT
ajcp-3197	203	17	and	and	CCONJ
ajcp-3197	203	18	restlessness	restlessness	NOUN
ajcp-3197	203	19	.	.	PUNCT
ajcp-3197	204	1	the	the	DET
ajcp-3197	204	2	drug	drug	NOUN
ajcp-3197	204	3	most	most	ADV
ajcp-3197	204	4	implicated	implicate	VERB
ajcp-3197	204	5	in	in	ADP
ajcp-3197	204	6	these	these	DET
ajcp-3197	204	7	reactions	reaction	NOUN
ajcp-3197	204	8	was	be	AUX
ajcp-3197	204	9	chloroquine	chloroquine	ADJ
ajcp-3197	204	10	,	,	PUNCT
ajcp-3197	204	11	and	and	CCONJ
ajcp-3197	204	12	hypertension	hypertension	NOUN
ajcp-3197	204	13	was	be	AUX
ajcp-3197	204	14	a	a	DET
ajcp-3197	204	15	major	major	ADJ
ajcp-3197	204	16	medical	medical	ADJ
ajcp-3197	204	17	ailment	ailment	NOUN
ajcp-3197	204	18	.	.	PUNCT
ajcp-3197	205	1	it	it	PRON
ajcp-3197	205	2	was	be	AUX
ajcp-3197	205	3	observed	observe	VERB
ajcp-3197	205	4	that	that	SCONJ
ajcp-3197	205	5	96	96	NUM
ajcp-3197	205	6	%	%	NOUN
ajcp-3197	205	7	of	of	ADP
ajcp-3197	205	8	the	the	DET
ajcp-3197	205	9	patients	patient	NOUN
ajcp-3197	205	10	had	have	VERB
ajcp-3197	205	11	multiple	multiple	ADJ
ajcp-3197	205	12	morbidities	morbidity	NOUN
ajcp-3197	205	13	,	,	PUNCT
ajcp-3197	205	14	and	and	CCONJ
ajcp-3197	205	15	96	96	NUM
ajcp-3197	205	16	%	%	NOUN
ajcp-3197	205	17	of	of	ADP
ajcp-3197	205	18	those	those	PRON
ajcp-3197	205	19	with	with	ADP
ajcp-3197	205	20	adverse	adverse	ADJ
ajcp-3197	205	21	drug	drug	NOUN
ajcp-3197	205	22	reactions	reaction	NOUN
ajcp-3197	205	23	were	be	AUX
ajcp-3197	205	24	taking	take	VERB
ajcp-3197	205	25	more	more	ADJ
ajcp-3197	205	26	than	than	ADP
ajcp-3197	205	27	five	five	NUM
ajcp-3197	205	28	drugs	drug	NOUN
ajcp-3197	205	29	,	,	PUNCT
ajcp-3197	205	30	compared	compare	VERB
ajcp-3197	205	31	to	to	ADP
ajcp-3197	205	32	86.14	86.14	NUM
ajcp-3197	205	33	%	%	NOUN
ajcp-3197	205	34	of	of	ADP
ajcp-3197	205	35	those	those	PRON
ajcp-3197	205	36	without	without	ADP
ajcp-3197	205	37	adverse	adverse	ADJ
ajcp-3197	205	38	drug	drug	NOUN
ajcp-3197	205	39	reactions	reaction	NOUN
ajcp-3197	205	40	(	(	PUNCT
ajcp-3197	205	41	nwani	nwani	PROPN
ajcp-3197	205	42	&	&	CCONJ
ajcp-3197	205	43	isah	isah	PROPN
ajcp-3197	205	44	,	,	PUNCT
ajcp-3197	205	45	2017	2017	NUM
ajcp-3197	205	46	)	)	PUNCT
ajcp-3197	205	47	.	.	PUNCT
ajcp-3197	206	1	another	another	DET
ajcp-3197	206	2	prospective	prospective	ADJ
ajcp-3197	206	3	study	study	NOUN
ajcp-3197	206	4	evaluated	evaluate	VERB
ajcp-3197	206	5	345	345	NUM
ajcp-3197	206	6	patients	patient	NOUN
ajcp-3197	206	7	aged	age	VERB
ajcp-3197	206	8	65	65	NUM
ajcp-3197	206	9	years	year	NOUN
ajcp-3197	206	10	and	and	CCONJ
ajcp-3197	206	11	older	old	ADJ
ajcp-3197	206	12	.	.	PUNCT
ajcp-3197	207	1	out	out	ADP
ajcp-3197	207	2	of	of	ADP
ajcp-3197	207	3	these	these	DET
ajcp-3197	207	4	patients	patient	NOUN
ajcp-3197	207	5	,	,	PUNCT
ajcp-3197	207	6	23	23	NUM
ajcp-3197	207	7	(	(	PUNCT
ajcp-3197	207	8	6.7	6.7	NUM
ajcp-3197	207	9	%	%	NOUN
ajcp-3197	207	10	)	)	PUNCT
ajcp-3197	207	11	experienced	experience	VERB
ajcp-3197	207	12	adverse	adverse	ADJ
ajcp-3197	207	13	drug	drug	NOUN
ajcp-3197	207	14	reactions	reaction	NOUN
ajcp-3197	207	15	,	,	PUNCT
ajcp-3197	207	16	with	with	ADP
ajcp-3197	207	17	73.9	73.9	NUM
ajcp-3197	207	18	%	%	NOUN
ajcp-3197	207	19	of	of	ADP
ajcp-3197	207	20	these	these	DET
ajcp-3197	207	21	cases	case	NOUN
ajcp-3197	207	22	recovering	recover	VERB
ajcp-3197	207	23	and	and	CCONJ
ajcp-3197	207	24	26.1	26.1	NUM
ajcp-3197	207	25	%	%	NOUN
ajcp-3197	207	26	resulting	result	VERB
ajcp-3197	207	27	in	in	ADP
ajcp-3197	207	28	death	death	NOUN
ajcp-3197	207	29	.	.	PUNCT
ajcp-3197	208	1	the	the	DET
ajcp-3197	208	2	most	most	ADV
ajcp-3197	208	3	common	common	ADJ
ajcp-3197	208	4	adverse	adverse	ADJ
ajcp-3197	208	5	drug	drug	NOUN
ajcp-3197	208	6	reaction	reaction	NOUN
ajcp-3197	208	7	observed	observe	VERB
ajcp-3197	208	8	was	be	AUX
ajcp-3197	208	9	gastrointestinal	gastrointestinal	ADJ
ajcp-3197	208	10	bleeding	bleeding	NOUN
ajcp-3197	208	11	(	(	PUNCT
ajcp-3197	208	12	39.1	39.1	NUM
ajcp-3197	208	13	%	%	NOUN
ajcp-3197	208	14	)	)	PUNCT
ajcp-3197	208	15	.	.	PUNCT
ajcp-3197	209	1	the	the	DET
ajcp-3197	209	2	most	most	ADV
ajcp-3197	209	3	implicated	implicated	ADJ
ajcp-3197	209	4	drug	drug	NOUN
ajcp-3197	209	5	classes	class	NOUN
ajcp-3197	209	6	were	be	AUX
ajcp-3197	209	7	nsaids	nsaid	NOUN
ajcp-3197	209	8	,	,	PUNCT
ajcp-3197	209	9	steroids	steroid	NOUN
ajcp-3197	209	10	,	,	PUNCT
ajcp-3197	209	11	and	and	CCONJ
ajcp-3197	209	12	hypoglycemic	hypoglycemic	ADJ
ajcp-3197	209	13	agents	agent	NOUN
ajcp-3197	209	14	.	.	PUNCT
ajcp-3197	210	1	the	the	DET
ajcp-3197	210	2	gastrointestinal	gastrointestinal	ADJ
ajcp-3197	210	3	system	system	NOUN
ajcp-3197	210	4	,	,	PUNCT
ajcp-3197	210	5	central	central	ADJ
ajcp-3197	210	6	nervous	nervous	ADJ
ajcp-3197	210	7	system	system	NOUN
ajcp-3197	210	8	,	,	PUNCT
ajcp-3197	210	9	and	and	CCONJ
ajcp-3197	210	10	endocrine	endocrine	NOUN
ajcp-3197	210	11	and	and	CCONJ
ajcp-3197	210	12	metabolic	metabolic	NOUN
ajcp-3197	210	13	systems	system	NOUN
ajcp-3197	210	14	were	be	AUX
ajcp-3197	210	15	the	the	DET
ajcp-3197	210	16	organ	organ	NOUN
ajcp-3197	210	17	systems	system	NOUN
ajcp-3197	210	18	most	most	ADV
ajcp-3197	210	19	frequently	frequently	ADV
ajcp-3197	210	20	involved	involve	VERB
ajcp-3197	210	21	.	.	PUNCT
ajcp-3197	211	1	adverse	adverse	ADJ
ajcp-3197	211	2	drug	drug	NOUN
ajcp-3197	211	3	reactions	reaction	NOUN
ajcp-3197	211	4	were	be	AUX
ajcp-3197	211	5	responsible	responsible	ADJ
ajcp-3197	211	6	for	for	ADP
ajcp-3197	211	7	1.7	1.7	NUM
ajcp-3197	211	8	%	%	NOUN
ajcp-3197	211	9	of	of	ADP
ajcp-3197	211	10	deaths	death	NOUN
ajcp-3197	211	11	among	among	ADP
ajcp-3197	211	12	elderly	elderly	ADJ
ajcp-3197	211	13	patients	patient	NOUN
ajcp-3197	211	14	who	who	PRON
ajcp-3197	211	15	were	be	AUX
ajcp-3197	211	16	admitted	admit	VERB
ajcp-3197	211	17	to	to	ADP
ajcp-3197	211	18	the	the	DET
ajcp-3197	211	19	hospital	hospital	NOUN
ajcp-3197	211	20	(	(	PUNCT
ajcp-3197	211	21	nwani	nwani	PROPN
ajcp-3197	211	22	&	&	CCONJ
ajcp-3197	211	23	isah	isah	PROPN
ajcp-3197	211	24	,	,	PUNCT
ajcp-3197	211	25	2017	2017	NUM
ajcp-3197	211	26	)	)	PUNCT
ajcp-3197	211	27	.	.	PUNCT
ajcp-3197	212	1	a	a	DET
ajcp-3197	212	2	study	study	NOUN
ajcp-3197	212	3	conducted	conduct	VERB
ajcp-3197	212	4	by	by	ADP
ajcp-3197	212	5	(	(	PUNCT
ajcp-3197	212	6	eze	eze	PROPN
ajcp-3197	212	7	et	et	PROPN
ajcp-3197	212	8	al	al	PROPN
ajcp-3197	212	9	.	.	PROPN
ajcp-3197	212	10	,	,	PUNCT
ajcp-3197	212	11	2011	2011	NUM
ajcp-3197	212	12	)	)	PUNCT
ajcp-3197	212	13	focused	focus	VERB
ajcp-3197	212	14	on	on	ADP
ajcp-3197	212	15	identifying	identify	VERB
ajcp-3197	212	16	drug	drug	NOUN
ajcp-3197	212	17	therapy	therapy	NOUN
ajcp-3197	212	18	problems	problem	NOUN
ajcp-3197	212	19	(	(	PUNCT
ajcp-3197	212	20	dtps	dtps	NOUN
ajcp-3197	212	21	)	)	PUNCT
ajcp-3197	212	22	among	among	ADP
ajcp-3197	212	23	elderly	elderly	ADJ
ajcp-3197	212	24	inpatients	inpatient	NOUN
ajcp-3197	212	25	.	.	PUNCT
ajcp-3197	213	1	the	the	DET
ajcp-3197	213	2	study	study	NOUN
ajcp-3197	213	3	utilized	utilize	VERB
ajcp-3197	213	4	both	both	CCONJ
ajcp-3197	213	5	retrospective	retrospective	ADJ
ajcp-3197	213	6	and	and	CCONJ
ajcp-3197	213	7	prospective	prospective	ADJ
ajcp-3197	213	8	methods	method	NOUN
ajcp-3197	213	9	.	.	PUNCT
ajcp-3197	214	1	it	it	PRON
ajcp-3197	214	2	reported	report	VERB
ajcp-3197	214	3	that	that	SCONJ
ajcp-3197	214	4	31.1	31.1	NUM
ajcp-3197	214	5	%	%	NOUN
ajcp-3197	214	6	of	of	ADP
ajcp-3197	214	7	the	the	DET
ajcp-3197	214	8	total	total	ADJ
ajcp-3197	214	9	dtps	dtps	NOUN
ajcp-3197	214	10	recorded	record	VERB
ajcp-3197	214	11	was	be	AUX
ajcp-3197	214	12	adverse	adverse	ADJ
ajcp-3197	214	13	drug	drug	NOUN
ajcp-3197	214	14	reactions	reaction	NOUN
ajcp-3197	214	15	,	,	PUNCT
ajcp-3197	214	16	but	but	CCONJ
ajcp-3197	214	17	it	it	PRON
ajcp-3197	214	18	did	do	AUX
ajcp-3197	214	19	not	not	PART
ajcp-3197	214	20	provide	provide	VERB
ajcp-3197	214	21	further	further	ADJ
ajcp-3197	214	22	details	detail	NOUN
ajcp-3197	214	23	on	on	ADP
ajcp-3197	214	24	the	the	DET
ajcp-3197	214	25	drug	drug	NOUN
ajcp-3197	214	26	classes	class	NOUN
ajcp-3197	214	27	responsible	responsible	ADJ
ajcp-3197	214	28	.	.	PUNCT
ajcp-3197	215	1	however	however	ADV
ajcp-3197	215	2	,	,	PUNCT
ajcp-3197	215	3	cardiovascular	cardiovascular	ADJ
ajcp-3197	215	4	medications	medication	NOUN
ajcp-3197	215	5	were	be	AUX
ajcp-3197	215	6	the	the	DET
ajcp-3197	215	7	therapeutic	therapeutic	ADJ
ajcp-3197	215	8	group	group	NOUN
ajcp-3197	215	9	most	most	ADV
ajcp-3197	215	10	commonly	commonly	ADV
ajcp-3197	215	11	associated	associate	VERB
ajcp-3197	215	12	with	with	ADP
ajcp-3197	215	13	dtps	dtps	NOUN
ajcp-3197	215	14	.	.	PUNCT
ajcp-3197	216	1	this	this	DET
ajcp-3197	216	2	present	present	ADJ
ajcp-3197	216	3	study	study	NOUN
ajcp-3197	216	4	evaluated	evaluate	VERB
ajcp-3197	216	5	the	the	DET
ajcp-3197	216	6	prevalence	prevalence	NOUN
ajcp-3197	216	7	of	of	ADP
ajcp-3197	216	8	adverse	adverse	ADJ
ajcp-3197	216	9	drug	drug	NOUN
ajcp-3197	216	10	reactions	reaction	NOUN
ajcp-3197	216	11	among	among	ADP
ajcp-3197	216	12	the	the	DET
ajcp-3197	216	13	elderly	elderly	ADJ
ajcp-3197	216	14	in	in	ADP
ajcp-3197	216	15	nigeria	nigeria	PROPN
ajcp-3197	216	16	,	,	PUNCT
ajcp-3197	216	17	and	and	CCONJ
ajcp-3197	216	18	revealed	reveal	VERB
ajcp-3197	216	19	a	a	DET
ajcp-3197	216	20	wide	wide	ADJ
ajcp-3197	216	21	variation	variation	NOUN
ajcp-3197	216	22	in	in	ADP
ajcp-3197	216	23	the	the	DET
ajcp-3197	216	24	prevalence	prevalence	NOUN
ajcp-3197	216	25	of	of	ADP
ajcp-3197	216	26	adrs	adrs	PROPN
ajcp-3197	216	27	.	.	PUNCT
ajcp-3197	217	1	this	this	DET
ajcp-3197	217	2	variability	variability	NOUN
ajcp-3197	217	3	may	may	AUX
ajcp-3197	217	4	be	be	AUX
ajcp-3197	217	5	due	due	ADJ
ajcp-3197	217	6	to	to	ADP
ajcp-3197	217	7	factors	factor	NOUN
ajcp-3197	217	8	such	such	ADJ
ajcp-3197	217	9	as	as	ADP
ajcp-3197	217	10	differences	difference	NOUN
ajcp-3197	217	11	in	in	ADP
ajcp-3197	217	12	the	the	DET
ajcp-3197	217	13	methods	method	NOUN
ajcp-3197	217	14	used	use	VERB
ajcp-3197	217	15	to	to	PART
ajcp-3197	217	16	identify	identify	VERB
ajcp-3197	217	17	an	an	DET
ajcp-3197	217	18	adr	adr	PROPN
ajcp-3197	217	19	,	,	PUNCT
ajcp-3197	217	20	the	the	DET
ajcp-3197	217	21	sample	sample	NOUN
ajcp-3197	217	22	size	size	NOUN
ajcp-3197	217	23	and	and	CCONJ
ajcp-3197	217	24	study	study	NOUN
ajcp-3197	217	25	design	design	NOUN
ajcp-3197	217	26	.	.	PUNCT
ajcp-3197	218	1	in	in	ADP
ajcp-3197	218	2	this	this	DET
ajcp-3197	218	3	review	review	NOUN
ajcp-3197	218	4	,	,	PUNCT
ajcp-3197	218	5	some	some	PRON
ajcp-3197	218	6	of	of	ADP
ajcp-3197	218	7	the	the	DET
ajcp-3197	218	8	studies	study	NOUN
ajcp-3197	218	9	relied	rely	VERB
ajcp-3197	218	10	on	on	ADP
ajcp-3197	218	11	the	the	DET
ajcp-3197	218	12	identification	identification	NOUN
ajcp-3197	218	13	of	of	ADP
ajcp-3197	218	14	adrs	adr	NOUN
ajcp-3197	218	15	during	during	ADP
ajcp-3197	218	16	routine	routine	ADJ
ajcp-3197	218	17	hospital	hospital	NOUN
ajcp-3197	218	18	care	care	NOUN
ajcp-3197	218	19	or	or	CCONJ
ajcp-3197	218	20	on	on	ADP
ajcp-3197	218	21	self	self	NOUN
ajcp-3197	218	22	-	-	PUNCT
ajcp-3197	218	23	reporting	report	VERB
ajcp-3197	218	24	methods	method	NOUN
ajcp-3197	218	25	.	.	PUNCT
ajcp-3197	219	1	however	however	ADV
ajcp-3197	219	2	,	,	PUNCT
ajcp-3197	219	3	this	this	PRON
ajcp-3197	219	4	is	be	AUX
ajcp-3197	219	5	prone	prone	ADJ
ajcp-3197	219	6	to	to	ADP
ajcp-3197	219	7	under	under	NOUN
ajcp-3197	219	8	-	-	PUNCT
ajcp-3197	219	9	identification	identification	NOUN
ajcp-3197	219	10	and	and	CCONJ
ajcp-3197	219	11	under	under	NOUN
ajcp-3197	219	12	-	-	PUNCT
ajcp-3197	219	13	reporting	reporting	NOUN
ajcp-3197	219	14	of	of	ADP
ajcp-3197	219	15	adrs	adr	NOUN
ajcp-3197	219	16	,	,	PUNCT
ajcp-3197	219	17	and	and	CCONJ
ajcp-3197	219	18	such	such	ADJ
ajcp-3197	219	19	methods	method	NOUN
ajcp-3197	219	20	are	be	AUX
ajcp-3197	219	21	likely	likely	ADJ
ajcp-3197	219	22	to	to	PART
ajcp-3197	219	23	underestimate	underestimate	VERB
ajcp-3197	219	24	the	the	DET
ajcp-3197	219	25	true	true	ADJ
ajcp-3197	219	26	prevalence	prevalence	NOUN
ajcp-3197	219	27	of	of	ADP
ajcp-3197	219	28	adrs	adrs	PROPN
ajcp-3197	219	29	(	(	PUNCT
ajcp-3197	219	30	kongkaew	kongkaew	PROPN
ajcp-3197	219	31	et	et	PROPN
ajcp-3197	219	32	al	al	PROPN
ajcp-3197	219	33	.	.	PROPN
ajcp-3197	219	34	,	,	PUNCT
ajcp-3197	219	35	2008	2008	NUM
ajcp-3197	219	36	;	;	PUNCT
ajcp-3197	219	37	brvar	brvar	NOUN
ajcp-3197	219	38	et	et	PROPN
ajcp-3197	219	39	al	al	PROPN
ajcp-3197	219	40	.	.	PROPN
ajcp-3197	219	41	,	,	PUNCT
ajcp-3197	219	42	2009	2009	NUM
ajcp-3197	219	43	;	;	PUNCT
ajcp-3197	219	44	ramia	ramia	VERB
ajcp-3197	219	45	et	et	PROPN
ajcp-3197	219	46	al	al	PROPN
ajcp-3197	219	47	.	.	PROPN
ajcp-3197	219	48	,	,	PUNCT
ajcp-3197	219	49	2021	2021	NUM
ajcp-3197	219	50	)	)	PUNCT
ajcp-3197	219	51	.	.	PUNCT
ajcp-3197	220	1	these	these	DET
ajcp-3197	220	2	results	result	NOUN
ajcp-3197	220	3	are	be	AUX
ajcp-3197	220	4	similar	similar	ADJ
ajcp-3197	220	5	to	to	ADP
ajcp-3197	220	6	the	the	DET
ajcp-3197	220	7	results	result	NOUN
ajcp-3197	220	8	of	of	ADP
ajcp-3197	220	9	a	a	DET
ajcp-3197	220	10	systematic	systematic	ADJ
ajcp-3197	220	11	review	review	NOUN
ajcp-3197	220	12	of	of	ADP
ajcp-3197	220	13	adr	adr	PROPN
ajcp-3197	220	14	in	in	ADP
ajcp-3197	220	15	the	the	DET
ajcp-3197	220	16	elderly	elderly	ADJ
ajcp-3197	220	17	(	(	PUNCT
ajcp-3197	220	18	alhawassi	alhawassi	INTJ
ajcp-3197	220	19	et	et	PROPN
ajcp-3197	220	20	al	al	PROPN
ajcp-3197	220	21	.	.	PROPN
ajcp-3197	220	22	,	,	PUNCT
ajcp-3197	220	23	2014	2014	NUM
ajcp-3197	220	24	)	)	PUNCT
ajcp-3197	220	25	.	.	PUNCT
ajcp-3197	221	1	nsaids	nsaid	NOUN
ajcp-3197	221	2	are	be	AUX
ajcp-3197	221	3	one	one	NUM
ajcp-3197	221	4	of	of	ADP
ajcp-3197	221	5	the	the	DET
ajcp-3197	221	6	most	most	ADV
ajcp-3197	221	7	commonly	commonly	ADV
ajcp-3197	221	8	used	use	VERB
ajcp-3197	221	9	class	class	NOUN
ajcp-3197	221	10	of	of	ADP
ajcp-3197	221	11	drugs	drug	NOUN
ajcp-3197	221	12	for	for	ADP
ajcp-3197	221	13	self	self	NOUN
ajcp-3197	221	14	-	-	PUNCT
ajcp-3197	221	15	medication	medication	NOUN
ajcp-3197	221	16	(	(	PUNCT
ajcp-3197	221	17	oriavwote	oriavwote	NOUN
ajcp-3197	221	18	&	&	CCONJ
ajcp-3197	221	19	ikwuka	ikwuka	PROPN
ajcp-3197	221	20	,	,	PUNCT
ajcp-3197	221	21	2022	2022	NUM
ajcp-3197	221	22	)	)	PUNCT
ajcp-3197	221	23	.	.	PUNCT
ajcp-3197	222	1	nsaids	nsaid	NOUN
ajcp-3197	222	2	are	be	AUX
ajcp-3197	222	3	implicated	implicate	VERB
ajcp-3197	222	4	in	in	ADP
ajcp-3197	222	5	most	most	ADJ
ajcp-3197	222	6	of	of	ADP
ajcp-3197	222	7	the	the	DET
ajcp-3197	222	8	adrs	adr	NOUN
ajcp-3197	222	9	and	and	CCONJ
ajcp-3197	222	10	are	be	AUX
ajcp-3197	222	11	the	the	DET
ajcp-3197	222	12	major	major	ADJ
ajcp-3197	222	13	causes	cause	NOUN
ajcp-3197	222	14	of	of	ADP
ajcp-3197	222	15	peptic	peptic	ADJ
ajcp-3197	222	16	ulcer	ulcer	NOUN
ajcp-3197	222	17	diseases	disease	NOUN
ajcp-3197	222	18	and	and	CCONJ
ajcp-3197	222	19	worsening	worsen	VERB
ajcp-3197	222	20	hypertensive	hypertensive	ADJ
ajcp-3197	222	21	conditions	condition	NOUN
ajcp-3197	222	22	(	(	PUNCT
ajcp-3197	222	23	drini	drini	NOUN
ajcp-3197	222	24	,	,	PUNCT
ajcp-3197	222	25	2017	2017	NUM
ajcp-3197	222	26	)	)	PUNCT
ajcp-3197	222	27	.	.	PUNCT
ajcp-3197	223	1	similar	similar	ADJ
ajcp-3197	223	2	to	to	ADP
ajcp-3197	223	3	(	(	PUNCT
ajcp-3197	223	4	kongkaew	kongkaew	PROPN
ajcp-3197	223	5	et	et	PROPN
ajcp-3197	223	6	al	al	PROPN
ajcp-3197	223	7	.	.	PROPN
ajcp-3197	223	8	,	,	PUNCT
ajcp-3197	223	9	2008	2008	NUM
ajcp-3197	223	10	;	;	PUNCT
ajcp-3197	223	11	oscanoa	oscanoa	PART
ajcp-3197	223	12	et	et	PROPN
ajcp-3197	223	13	al	al	PROPN
ajcp-3197	223	14	.	.	PROPN
ajcp-3197	223	15	,	,	PUNCT
ajcp-3197	223	16	2017	2017	NUM
ajcp-3197	223	17	;	;	PUNCT
ajcp-3197	223	18	hadia	hadia	PROPN
ajcp-3197	223	19	et	et	PROPN
ajcp-3197	223	20	al	al	PROPN
ajcp-3197	223	21	.	.	PROPN
ajcp-3197	223	22	,	,	PUNCT
ajcp-3197	223	23	2022	2022	NUM
ajcp-3197	223	24	)	)	PUNCT
ajcp-3197	223	25	,	,	PUNCT
ajcp-3197	223	26	nsaids	nsaid	NOUN
ajcp-3197	223	27	and	and	CCONJ
ajcp-3197	223	28	cardiovascular	cardiovascular	ADJ
ajcp-3197	223	29	medications	medication	NOUN
ajcp-3197	223	30	caused	cause	VERB
ajcp-3197	223	31	most	most	ADJ
ajcp-3197	223	32	adrs	adr	NOUN
ajcp-3197	223	33	in	in	ADP
ajcp-3197	223	34	the	the	DET
ajcp-3197	223	35	elderly	elderly	ADJ
ajcp-3197	223	36	.	.	PUNCT
ajcp-3197	224	1	however	however	ADV
ajcp-3197	224	2	,	,	PUNCT
ajcp-3197	224	3	(	(	PUNCT
ajcp-3197	224	4	jennings	jennings	PROPN
ajcp-3197	224	5	et	et	PROPN
ajcp-3197	224	6	al	al	PROPN
ajcp-3197	224	7	.	.	PROPN
ajcp-3197	224	8	,	,	PUNCT
ajcp-3197	224	9	2020	2020	NUM
ajcp-3197	224	10	)	)	PUNCT
ajcp-3197	224	11	reported	report	VERB
ajcp-3197	224	12	diuretics	diuretic	NOUN
ajcp-3197	224	13	and	and	CCONJ
ajcp-3197	224	14	antibacterials	antibacterial	NOUN
ajcp-3197	224	15	for	for	ADP
ajcp-3197	224	16	systemic	systemic	ADJ
ajcp-3197	224	17	use	use	NOUN
ajcp-3197	224	18	as	as	ADP
ajcp-3197	224	19	the	the	DET
ajcp-3197	224	20	most	most	ADV
ajcp-3197	224	21	implicated	implicated	ADJ
ajcp-3197	224	22	medications	medication	NOUN
ajcp-3197	224	23	.	.	PUNCT
ajcp-3197	225	1	polypharmacy	polypharmacy	NOUN
ajcp-3197	225	2	has	have	AUX
ajcp-3197	225	3	also	also	ADV
ajcp-3197	225	4	been	be	AUX
ajcp-3197	225	5	shown	show	VERB
ajcp-3197	225	6	by	by	ADP
ajcp-3197	225	7	other	other	ADJ
ajcp-3197	225	8	systematic	systematic	ADJ
ajcp-3197	225	9	reviews	review	NOUN
ajcp-3197	225	10	conducted	conduct	VERB
ajcp-3197	225	11	on	on	ADP
ajcp-3197	225	12	the	the	DET
ajcp-3197	225	13	elderly	elderly	ADJ
ajcp-3197	225	14	as	as	ADP
ajcp-3197	225	15	the	the	DET
ajcp-3197	225	16	major	major	ADJ
ajcp-3197	225	17	risk	risk	NOUN
ajcp-3197	225	18	factor	factor	NOUN
ajcp-3197	225	19	for	for	ADP
ajcp-3197	225	20	adrs	adr	NOUN
ajcp-3197	225	21	in	in	ADP
ajcp-3197	225	22	the	the	DET
ajcp-3197	225	23	elderly	elderly	ADJ
ajcp-3197	225	24	population	population	NOUN
ajcp-3197	225	25	(	(	PUNCT
ajcp-3197	225	26	davies	davy	NOUN
ajcp-3197	225	27	et	et	PROPN
ajcp-3197	225	28	al	al	PROPN
ajcp-3197	225	29	.	.	PROPN
ajcp-3197	225	30	,	,	PUNCT
ajcp-3197	225	31	2020	2020	NUM
ajcp-3197	225	32	;	;	PUNCT
ajcp-3197	225	33	hadia	hadia	PROPN
ajcp-3197	225	34	et	et	PROPN
ajcp-3197	225	35	al	al	PROPN
ajcp-3197	225	36	.	.	PROPN
ajcp-3197	225	37	,	,	PUNCT
ajcp-3197	225	38	2022	2022	NUM
ajcp-3197	225	39	)	)	PUNCT
ajcp-3197	225	40	.	.	PUNCT
ajcp-3197	226	1	the	the	DET
ajcp-3197	226	2	incidence	incidence	NOUN
ajcp-3197	226	3	and	and	CCONJ
ajcp-3197	226	4	prevalence	prevalence	NOUN
ajcp-3197	226	5	of	of	ADP
ajcp-3197	226	6	adrs	adrs	PROPN
ajcp-3197	226	7	is	be	AUX
ajcp-3197	226	8	under	under	ADV
ajcp-3197	226	9	-	-	PUNCT
ajcp-3197	226	10	reported	report	VERB
ajcp-3197	226	11	in	in	ADP
ajcp-3197	226	12	nigeria	nigeria	PROPN
ajcp-3197	226	13	,	,	PUNCT
ajcp-3197	226	14	particularly	particularly	ADV
ajcp-3197	226	15	among	among	ADP
ajcp-3197	226	16	the	the	DET
ajcp-3197	226	17	geriatric	geriatric	ADJ
ajcp-3197	226	18	population	population	NOUN
ajcp-3197	226	19	(	(	PUNCT
ajcp-3197	226	20	ogar	ogar	NOUN
ajcp-3197	226	21	et	et	PROPN
ajcp-3197	226	22	al	al	PROPN
ajcp-3197	226	23	.	.	PROPN
ajcp-3197	226	24	,	,	PUNCT
ajcp-3197	226	25	2019	2019	NUM
ajcp-3197	226	26	)	)	PUNCT
ajcp-3197	226	27	.	.	PUNCT
ajcp-3197	227	1	according	accord	VERB
ajcp-3197	227	2	to	to	ADP
ajcp-3197	227	3	a	a	DET
ajcp-3197	227	4	study	study	NOUN
ajcp-3197	227	5	conducted	conduct	VERB
ajcp-3197	227	6	in	in	ADP
ajcp-3197	227	7	nigeria	nigeria	PROPN
ajcp-3197	227	8	,	,	PUNCT
ajcp-3197	227	9	only	only	ADV
ajcp-3197	227	10	32	32	NUM
ajcp-3197	227	11	%	%	NOUN
ajcp-3197	227	12	of	of	ADP
ajcp-3197	227	13	health	health	NOUN
ajcp-3197	227	14	professionals	professional	NOUN
ajcp-3197	227	15	report	report	VERB
ajcp-3197	227	16	adverse	adverse	ADJ
ajcp-3197	227	17	drug	drug	NOUN
ajcp-3197	227	18	reactions	reaction	NOUN
ajcp-3197	227	19	(	(	PUNCT
ajcp-3197	227	20	okezie	okezie	PROPN
ajcp-3197	227	21	&	&	CCONJ
ajcp-3197	227	22	olufunmilayo	olufunmilayo	PROPN
ajcp-3197	227	23	,	,	PUNCT
ajcp-3197	227	24	2008	2008	NUM
ajcp-3197	227	25	)	)	PUNCT
ajcp-3197	227	26	.	.	PUNCT
ajcp-3197	228	1	several	several	ADJ
ajcp-3197	228	2	reasons	reason	NOUN
ajcp-3197	228	3	have	have	AUX
ajcp-3197	228	4	been	be	AUX
ajcp-3197	228	5	identified	identify	VERB
ajcp-3197	228	6	for	for	ADP
ajcp-3197	228	7	the	the	DET
ajcp-3197	228	8	under	under	NOUN
ajcp-3197	228	9	-	-	PUNCT
ajcp-3197	228	10	reporting	reporting	NOUN
ajcp-3197	228	11	of	of	ADP
ajcp-3197	228	12	adrs	adrs	PROPN
ajcp-3197	228	13	in	in	ADP
ajcp-3197	228	14	nigeria	nigeria	PROPN
ajcp-3197	228	15	,	,	PUNCT
ajcp-3197	228	16	including	include	VERB
ajcp-3197	228	17	staff	staff	NOUN
ajcp-3197	228	18	shortages	shortage	NOUN
ajcp-3197	228	19	,	,	PUNCT
ajcp-3197	228	20	time	time	NOUN
ajcp-3197	228	21	required	require	VERB
ajcp-3197	228	22	to	to	PART
ajcp-3197	228	23	assess	assess	VERB
ajcp-3197	228	24	and	and	CCONJ
ajcp-3197	228	25	submit	submit	VERB
ajcp-3197	228	26	reports	report	NOUN
ajcp-3197	228	27	,	,	PUNCT
ajcp-3197	228	28	lack	lack	NOUN
ajcp-3197	228	29	of	of	ADP
ajcp-3197	228	30	information	information	NOUN
ajcp-3197	228	31	,	,	PUNCT
ajcp-3197	228	32	difficulties	difficulty	NOUN
ajcp-3197	228	33	in	in	ADP
ajcp-3197	228	34	diagnosing	diagnose	VERB
ajcp-3197	228	35	or	or	CCONJ
ajcp-3197	228	36	identifying	identify	VERB
ajcp-3197	228	37	adverse	adverse	ADJ
ajcp-3197	228	38	reactions	reaction	NOUN
ajcp-3197	228	39	,	,	PUNCT
ajcp-3197	228	40	ignorance	ignorance	NOUN
ajcp-3197	228	41	of	of	ADP
ajcp-3197	228	42	the	the	DET
ajcp-3197	228	43	importance	importance	NOUN
ajcp-3197	228	44	of	of	ADP
ajcp-3197	228	45	reporting	reporting	NOUN
ajcp-3197	228	46	,	,	PUNCT
ajcp-3197	228	47	limited	limited	ADJ
ajcp-3197	228	48	or	or	CCONJ
ajcp-3197	228	49	no	no	DET
ajcp-3197	228	50	training	training	NOUN
ajcp-3197	228	51	for	for	ADP
ajcp-3197	228	52	healthcare	healthcare	NOUN
ajcp-3197	228	53	workers	worker	NOUN
ajcp-3197	228	54	on	on	ADP
ajcp-3197	228	55	adr	adr	PROPN
ajcp-3197	228	56	observation	observation	NOUN
ajcp-3197	228	57	and	and	CCONJ
ajcp-3197	228	58	reporting	reporting	NOUN
ajcp-3197	228	59	,	,	PUNCT
ajcp-3197	228	60	lack	lack	NOUN
ajcp-3197	228	61	of	of	ADP
ajcp-3197	228	62	awareness	awareness	NOUN
ajcp-3197	228	63	of	of	ADP
ajcp-3197	228	64	the	the	DET
ajcp-3197	228	65	reporting	reporting	NOUN
ajcp-3197	228	66	form	form	NOUN
ajcp-3197	228	67	,	,	PUNCT
ajcp-3197	228	68	poor	poor	ADJ
ajcp-3197	228	69	knowledge	knowledge	NOUN
ajcp-3197	228	70	of	of	ADP
ajcp-3197	228	71	the	the	DET
ajcp-3197	228	72	reporting	reporting	NOUN
ajcp-3197	228	73	procedure	procedure	NOUN
ajcp-3197	228	74	,	,	PUNCT
ajcp-3197	228	75	and	and	CCONJ
ajcp-3197	228	76	uncertainty	uncertainty	NOUN
ajcp-3197	228	77	of	of	ADP
ajcp-3197	228	78	causality	causality	NOUN
ajcp-3197	228	79	(	(	PUNCT
ajcp-3197	228	80	aderemi	aderemi	PROPN
ajcp-3197	228	81	-	-	PUNCT
ajcp-3197	228	82	williams	williams	PROPN
ajcp-3197	228	83	et	et	PROPN
ajcp-3197	228	84	al	al	PROPN
ajcp-3197	228	85	.	.	PROPN
ajcp-3197	228	86	,	,	PUNCT
ajcp-3197	228	87	2015	2015	NUM
ajcp-3197	228	88	;	;	PUNCT
ajcp-3197	228	89	miediegha	miediegha	PROPN
ajcp-3197	228	90	&	&	CCONJ
ajcp-3197	228	91	bunu	bunu	PROPN
ajcp-3197	228	92	,	,	PUNCT
ajcp-3197	228	93	2020	2020	NUM
ajcp-3197	228	94	;	;	PUNCT
ajcp-3197	228	95	okezie	okezie	PROPN
ajcp-3197	228	96	&	&	CCONJ
ajcp-3197	228	97	olufunmilayo	olufunmilayo	PROPN
ajcp-3197	228	98	,	,	PUNCT
ajcp-3197	228	99	2008	2008	NUM
ajcp-3197	228	100	;	;	PUNCT
ajcp-3197	228	101	oreagba	oreagba	PROPN
ajcp-3197	228	102	et	et	PROPN
ajcp-3197	228	103	al	al	PROPN
ajcp-3197	228	104	.	.	PROPN
ajcp-3197	228	105	,	,	PUNCT
ajcp-3197	228	106	2015	2015	NUM
ajcp-3197	228	107	)	)	PUNCT
ajcp-3197	228	108	.	.	PUNCT
ajcp-3197	229	1	the	the	DET
ajcp-3197	229	2	poor	poor	ADJ
ajcp-3197	229	3	knowledge	knowledge	NOUN
ajcp-3197	229	4	of	of	ADP
ajcp-3197	229	5	healthcare	healthcare	NOUN
ajcp-3197	229	6	professionals	professional	NOUN
ajcp-3197	229	7	regarding	regard	VERB
ajcp-3197	229	8	adrs	adrs	PROPN
ajcp-3197	229	9	is	be	AUX
ajcp-3197	229	10	a	a	DET
ajcp-3197	229	11	cause	cause	NOUN
ajcp-3197	229	12	for	for	ADP
ajcp-3197	229	13	concern	concern	NOUN
ajcp-3197	229	14	.	.	PUNCT
ajcp-3197	230	1	in	in	ADP
ajcp-3197	230	2	a	a	DET
ajcp-3197	230	3	study	study	NOUN
ajcp-3197	230	4	by	by	ADP
ajcp-3197	230	5	(	(	PUNCT
ajcp-3197	230	6	adisa	adisa	NOUN
ajcp-3197	230	7	&	&	CCONJ
ajcp-3197	230	8	omitogun	omitogun	PROPN
ajcp-3197	230	9	,	,	PUNCT
ajcp-3197	230	10	2019	2019	NUM
ajcp-3197	230	11	)	)	PUNCT
ajcp-3197	230	12	,	,	PUNCT
ajcp-3197	230	13	only	only	ADV
ajcp-3197	230	14	15	15	NUM
ajcp-3197	230	15	%	%	NOUN
ajcp-3197	230	16	of	of	ADP
ajcp-3197	230	17	healthcare	healthcare	NOUN
ajcp-3197	230	18	workers	worker	NOUN
ajcp-3197	230	19	had	have	VERB
ajcp-3197	230	20	adequate	adequate	ADJ
ajcp-3197	230	21	knowledge	knowledge	NOUN
ajcp-3197	230	22	of	of	ADP
ajcp-3197	230	23	adrs	adr	NOUN
ajcp-3197	230	24	.	.	PUNCT
ajcp-3197	231	1	in	in	ADP
ajcp-3197	231	2	another	another	DET
ajcp-3197	231	3	study	study	NOUN
ajcp-3197	231	4	,	,	PUNCT
ajcp-3197	231	5	only	only	ADV
ajcp-3197	231	6	24.9	24.9	NUM
ajcp-3197	231	7	%	%	NOUN
ajcp-3197	231	8	of	of	ADP
ajcp-3197	231	9	respondents	respondent	NOUN
ajcp-3197	231	10	were	be	AUX
ajcp-3197	231	11	aware	aware	ADJ
ajcp-3197	231	12	of	of	ADP
ajcp-3197	231	13	the	the	DET
ajcp-3197	231	14	national	national	PROPN
ajcp-3197	231	15	adr	adr	PROPN
ajcp-3197	231	16	reporting	reporting	NOUN
ajcp-3197	231	17	form	form	NOUN
ajcp-3197	231	18	(	(	PUNCT
ajcp-3197	231	19	commonly	commonly	ADV
ajcp-3197	231	20	known	know	VERB
ajcp-3197	231	21	as	as	ADP
ajcp-3197	231	22	the	the	DET
ajcp-3197	231	23	yellow	yellow	ADJ
ajcp-3197	231	24	form	form	NOUN
ajcp-3197	231	25	)	)	PUNCT
ajcp-3197	231	26	,	,	PUNCT
ajcp-3197	231	27	and	and	CCONJ
ajcp-3197	231	28	just	just	ADV
ajcp-3197	231	29	20.1	20.1	NUM
ajcp-3197	231	30	%	%	NOUN
ajcp-3197	231	31	had	have	AUX
ajcp-3197	231	32	received	receive	VERB
ajcp-3197	231	33	training	training	NOUN
ajcp-3197	231	34	in	in	ADP
ajcp-3197	231	35	pharmacovigilance	pharmacovigilance	NOUN
ajcp-3197	231	36	(	(	PUNCT
ajcp-3197	231	37	udoye	udoye	VERB
ajcp-3197	231	38	et	et	PROPN
ajcp-3197	231	39	al	al	PROPN
ajcp-3197	231	40	.	.	PROPN
ajcp-3197	231	41	,	,	PUNCT
ajcp-3197	231	42	2018	2018	NUM
ajcp-3197	231	43	)	)	PUNCT
ajcp-3197	231	44	.	.	PUNCT
ajcp-3197	232	1	another	another	DET
ajcp-3197	232	2	challenge	challenge	NOUN
ajcp-3197	232	3	is	be	AUX
ajcp-3197	232	4	developing	develop	VERB
ajcp-3197	232	5	policies	policy	NOUN
ajcp-3197	232	6	and	and	CCONJ
ajcp-3197	232	7	appointing	appoint	VERB
ajcp-3197	232	8	staff	staff	NOUN
ajcp-3197	232	9	who	who	PRON
ajcp-3197	232	10	can	can	AUX
ajcp-3197	232	11	understand	understand	VERB
ajcp-3197	232	12	and	and	CCONJ
ajcp-3197	232	13	respond	respond	VERB
ajcp-3197	232	14	to	to	ADP
ajcp-3197	232	15	the	the	DET
ajcp-3197	232	16	needs	need	NOUN
ajcp-3197	232	17	of	of	ADP
ajcp-3197	232	18	the	the	DET
ajcp-3197	232	19	aging	age	VERB
ajcp-3197	232	20	population	population	NOUN
ajcp-3197	232	21	.	.	PUNCT
ajcp-3197	233	1	there	there	PRON
ajcp-3197	233	2	are	be	VERB
ajcp-3197	233	3	limited	limited	ADJ
ajcp-3197	233	4	centers	center	NOUN
ajcp-3197	233	5	dedicated	dedicate	VERB
ajcp-3197	233	6	to	to	ADP
ajcp-3197	233	7	the	the	DET
ajcp-3197	233	8	care	care	NOUN
ajcp-3197	233	9	of	of	ADP
ajcp-3197	233	10	geriatric	geriatric	ADJ
ajcp-3197	233	11	patients	patient	NOUN
ajcp-3197	233	12	in	in	ADP
ajcp-3197	233	13	nigeria	nigeria	PROPN
ajcp-3197	233	14	,	,	PUNCT
ajcp-3197	233	15	resulting	result	VERB
ajcp-3197	233	16	in	in	ADP
ajcp-3197	233	17	inadequate	inadequate	ADJ
ajcp-3197	233	18	attention	attention	NOUN
ajcp-3197	233	19	to	to	ADP
ajcp-3197	233	20	their	their	PRON
ajcp-3197	233	21	specific	specific	ADJ
ajcp-3197	233	22	needs	need	NOUN
ajcp-3197	233	23	before	before	ADP
ajcp-3197	233	24	initiating	initiate	VERB
ajcp-3197	233	25	treatment	treatment	NOUN
ajcp-3197	233	26	.	.	PUNCT
ajcp-3197	234	1	often	often	ADV
ajcp-3197	234	2	,	,	PUNCT
ajcp-3197	234	3	they	they	PRON
ajcp-3197	234	4	are	be	AUX
ajcp-3197	234	5	treated	treat	VERB
ajcp-3197	234	6	alongside	alongside	ADP
ajcp-3197	234	7	adult	adult	NOUN
ajcp-3197	234	8	patients	patient	NOUN
ajcp-3197	234	9	under	under	ADP
ajcp-3197	234	10	the	the	DET
ajcp-3197	234	11	age	age	NOUN
ajcp-3197	234	12	of	of	ADP
ajcp-3197	234	13	60	60	NUM
ajcp-3197	234	14	.	.	PUNCT
ajcp-3197	235	1	the	the	DET
ajcp-3197	235	2	prevalence	prevalence	NOUN
ajcp-3197	235	3	of	of	ADP
ajcp-3197	235	4	polypharmacy	polypharmacy	NOUN
ajcp-3197	235	5	and	and	CCONJ
ajcp-3197	235	6	the	the	DET
ajcp-3197	235	7	prescription	prescription	NOUN
ajcp-3197	235	8	of	of	ADP
ajcp-3197	235	9	potentially	potentially	ADV
ajcp-3197	235	10	inappropriate	inappropriate	ADJ
ajcp-3197	235	11	medications	medication	NOUN
ajcp-3197	235	12	(	(	PUNCT
ajcp-3197	235	13	pims	pims	PROPN
ajcp-3197	235	14	)	)	PUNCT
ajcp-3197	235	15	pose	pose	VERB
ajcp-3197	235	16	significant	significant	ADJ
ajcp-3197	235	17	problems	problem	NOUN
ajcp-3197	235	18	in	in	ADP
ajcp-3197	235	19	the	the	DET
ajcp-3197	235	20	pharmacotherapy	pharmacotherapy	NOUN
ajcp-3197	235	21	of	of	ADP
ajcp-3197	235	22	older	old	ADJ
ajcp-3197	235	23	adults	adult	NOUN
ajcp-3197	235	24	,	,	PUNCT
ajcp-3197	235	25	leading	lead	VERB
ajcp-3197	235	26	to	to	ADP
ajcp-3197	235	27	a	a	DET
ajcp-3197	235	28	significant	significant	ADJ
ajcp-3197	235	29	increase	increase	NOUN
ajcp-3197	235	30	in	in	ADP
ajcp-3197	235	31	adrs	adr	NOUN
ajcp-3197	235	32	among	among	ADP
ajcp-3197	235	33	the	the	DET
ajcp-3197	235	34	elderly	elderly	ADJ
ajcp-3197	235	35	.	.	PUNCT
ajcp-3197	236	1	studies	study	NOUN
ajcp-3197	236	2	conducted	conduct	VERB
ajcp-3197	236	3	on	on	ADP
ajcp-3197	236	4	the	the	DET
ajcp-3197	236	5	elderly	elderly	ADJ
ajcp-3197	236	6	in	in	ADP
ajcp-3197	236	7	nigeria	nigeria	PROPN
ajcp-3197	236	8	have	have	AUX
ajcp-3197	236	9	reported	report	VERB
ajcp-3197	236	10	high	high	ADJ
ajcp-3197	236	11	rates	rate	NOUN
ajcp-3197	236	12	of	of	ADP
ajcp-3197	236	13	polypharmacy	polypharmacy	NOUN
ajcp-3197	236	14	and	and	CCONJ
ajcp-3197	236	15	pims	pims	PROPN
ajcp-3197	236	16	,	,	PUNCT
ajcp-3197	236	17	resulting	result	VERB
ajcp-3197	236	18	in	in	ADP
ajcp-3197	236	19	a	a	DET
ajcp-3197	236	20	high	high	ADJ
ajcp-3197	236	21	incidence	incidence	NOUN
ajcp-3197	236	22	of	of	ADP
ajcp-3197	236	23	adverse	adverse	ADJ
ajcp-3197	236	24	drug	drug	NOUN
ajcp-3197	236	25	reactions	reaction	NOUN
ajcp-3197	236	26	(	(	PUNCT
ajcp-3197	236	27	borodo	borodo	NOUN
ajcp-3197	236	28	et	et	PROPN
ajcp-3197	236	29	al	al	PROPN
ajcp-3197	236	30	.	.	PROPN
ajcp-3197	236	31	,	,	PUNCT
ajcp-3197	236	32	2022	2022	NUM
ajcp-3197	236	33	)	)	PUNCT
ajcp-3197	236	34	.	.	PUNCT
ajcp-3197	237	1	the	the	DET
ajcp-3197	237	2	negative	negative	ADJ
ajcp-3197	237	3	impact	impact	NOUN
ajcp-3197	237	4	of	of	ADP
ajcp-3197	237	5	adverse	adverse	ADJ
ajcp-3197	237	6	drug	drug	NOUN
ajcp-3197	237	7	reactions	reaction	NOUN
ajcp-3197	237	8	on	on	ADP
ajcp-3197	237	9	health	health	NOUN
ajcp-3197	237	10	outcomes	outcome	NOUN
ajcp-3197	237	11	in	in	ADP
ajcp-3197	237	12	the	the	DET
ajcp-3197	237	13	geriatric	geriatric	ADJ
ajcp-3197	237	14	population	population	NOUN
ajcp-3197	237	15	can	can	AUX
ajcp-3197	237	16	not	not	PART
ajcp-3197	237	17	be	be	AUX
ajcp-3197	237	18	overstated	overstate	VERB
ajcp-3197	237	19	.	.	PUNCT
ajcp-3197	238	1	in	in	ADP
ajcp-3197	238	2	developing	develop	VERB
ajcp-3197	238	3	countries	country	NOUN
ajcp-3197	238	4	like	like	ADP
ajcp-3197	238	5	nigeria	nigeria	PROPN
ajcp-3197	238	6	,	,	PUNCT
ajcp-3197	238	7	these	these	DET
ajcp-3197	238	8	effects	effect	NOUN
ajcp-3197	238	9	are	be	AUX
ajcp-3197	238	10	more	more	ADV
ajcp-3197	238	11	pronounced	pronounced	ADJ
ajcp-3197	238	12	due	due	ADJ
ajcp-3197	238	13	to	to	ADP
ajcp-3197	238	14	high	high	ADJ
ajcp-3197	238	15	health	health	NOUN
ajcp-3197	238	16	outcome	outcome	NOUN
ajcp-3197	238	17	indicators	indicator	NOUN
ajcp-3197	238	18	.	.	PUNCT
ajcp-3197	239	1	older	old	ADJ
ajcp-3197	239	2	adults	adult	NOUN
ajcp-3197	239	3	are	be	AUX
ajcp-3197	239	4	more	more	ADV
ajcp-3197	239	5	susceptible	susceptible	ADJ
ajcp-3197	239	6	to	to	ADP
ajcp-3197	239	7	adrs	adr	NOUN
ajcp-3197	239	8	compared	compare	VERB
ajcp-3197	239	9	to	to	ADP
ajcp-3197	239	10	younger	young	ADJ
ajcp-3197	239	11	adults	adult	NOUN
ajcp-3197	239	12	due	due	ADJ
ajcp-3197	239	13	to	to	ADP
ajcp-3197	239	14	the	the	DET
ajcp-3197	239	15	increased	increase	VERB
ajcp-3197	239	16	risk	risk	NOUN
ajcp-3197	239	17	associated	associate	VERB
ajcp-3197	239	18	with	with	ADP
ajcp-3197	239	19	aging	aging	NOUN
ajcp-3197	239	20	.	.	PUNCT
ajcp-3197	240	1	it	it	PRON
ajcp-3197	240	2	has	have	AUX
ajcp-3197	240	3	been	be	AUX
ajcp-3197	240	4	suggested	suggest	VERB
ajcp-3197	240	5	that	that	SCONJ
ajcp-3197	240	6	adrs	adr	NOUN
ajcp-3197	240	7	should	should	AUX
ajcp-3197	240	8	be	be	AUX
ajcp-3197	240	9	treated	treat	VERB
ajcp-3197	240	10	as	as	ADP
ajcp-3197	240	11	a	a	DET
ajcp-3197	240	12	geriatric	geriatric	ADJ
ajcp-3197	240	13	syndrome	syndrome	NOUN
ajcp-3197	240	14	in	in	ADP
ajcp-3197	240	15	themselves	themselves	PRON
ajcp-3197	240	16	.	.	PUNCT
ajcp-3197	241	1	the	the	DET
ajcp-3197	241	2	potential	potential	ADJ
ajcp-3197	241	3	consequences	consequence	NOUN
ajcp-3197	241	4	of	of	ADP
ajcp-3197	241	5	adverse	adverse	ADJ
ajcp-3197	241	6	drug	drug	NOUN
ajcp-3197	241	7	reactions	reaction	NOUN
ajcp-3197	241	8	(	(	PUNCT
ajcp-3197	241	9	adrs	adr	NOUN
ajcp-3197	241	10	)	)	PUNCT
ajcp-3197	241	11	are	be	AUX
ajcp-3197	241	12	multifaceted	multifaceted	ADJ
ajcp-3197	241	13	and	and	CCONJ
ajcp-3197	241	14	include	include	VERB
ajcp-3197	241	15	longer	long	ADJ
ajcp-3197	241	16	hospital	hospital	NOUN
ajcp-3197	241	17	stays	stay	NOUN
ajcp-3197	241	18	,	,	PUNCT
ajcp-3197	241	19	which	which	PRON
ajcp-3197	241	20	in	in	ADP
ajcp-3197	241	21	pa	pa	PROPN
ajcp-3197	241	22	ge	ge	PROPN
ajcp-3197	241	23	7	7	NUM
ajcp-3197	241	24	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	241	25	am	be	AUX
ajcp-3197	241	26	.	.	PUNCT
ajcp-3197	242	1	j.	j.	PROPN
ajcp-3197	242	2	chem	chem	PROPN
ajcp-3197	242	3	.	.	PUNCT
ajcp-3197	243	1	pharm	pharm	PROPN
ajcp-3197	243	2	.	.	PUNCT
ajcp-3197	244	1	3(1	3(1	NUM
ajcp-3197	244	2	)	)	PUNCT
ajcp-3197	244	3	1	1	NUM
ajcp-3197	244	4	-	-	SYM
ajcp-3197	244	5	11	11	NUM
ajcp-3197	244	6	,	,	PUNCT
ajcp-3197	244	7	2024	2024	NUM
ajcp-3197	244	8	turn	turn	NOUN
ajcp-3197	244	9	increase	increase	NOUN
ajcp-3197	244	10	morbidity	morbidity	NOUN
ajcp-3197	244	11	and	and	CCONJ
ajcp-3197	244	12	mortality	mortality	NOUN
ajcp-3197	244	13	rates	rate	NOUN
ajcp-3197	244	14	,	,	PUNCT
ajcp-3197	244	15	as	as	ADV
ajcp-3197	244	16	well	well	ADV
ajcp-3197	244	17	as	as	ADP
ajcp-3197	244	18	healthcare	healthcare	NOUN
ajcp-3197	244	19	costs	cost	NOUN
ajcp-3197	244	20	(	(	PUNCT
ajcp-3197	244	21	fasipe	fasipe	VERB
ajcp-3197	244	22	et	et	PROPN
ajcp-3197	244	23	al	al	PROPN
ajcp-3197	244	24	.	.	PROPN
ajcp-3197	244	25	,	,	PUNCT
ajcp-3197	244	26	2019	2019	NUM
ajcp-3197	244	27	)	)	PUNCT
ajcp-3197	244	28	.	.	PUNCT
ajcp-3197	245	1	strategies	strategy	NOUN
ajcp-3197	245	2	must	must	AUX
ajcp-3197	245	3	be	be	AUX
ajcp-3197	245	4	put	put	VERB
ajcp-3197	245	5	in	in	ADP
ajcp-3197	245	6	place	place	NOUN
ajcp-3197	245	7	to	to	PART
ajcp-3197	245	8	reduce	reduce	VERB
ajcp-3197	245	9	the	the	DET
ajcp-3197	245	10	incidence	incidence	NOUN
ajcp-3197	245	11	of	of	ADP
ajcp-3197	245	12	adrs	adrs	PROPN
ajcp-3197	245	13	(	(	PUNCT
ajcp-3197	245	14	adverse	adverse	ADJ
ajcp-3197	245	15	drug	drug	NOUN
ajcp-3197	245	16	reactions	reaction	NOUN
ajcp-3197	245	17	)	)	PUNCT
ajcp-3197	245	18	among	among	ADP
ajcp-3197	245	19	the	the	DET
ajcp-3197	245	20	elderly	elderly	ADJ
ajcp-3197	245	21	in	in	ADP
ajcp-3197	245	22	nigeria	nigeria	PROPN
ajcp-3197	245	23	.	.	PUNCT
ajcp-3197	246	1	one	one	NUM
ajcp-3197	246	2	of	of	ADP
ajcp-3197	246	3	the	the	DET
ajcp-3197	246	4	first	first	ADJ
ajcp-3197	246	5	steps	step	NOUN
ajcp-3197	246	6	in	in	ADP
ajcp-3197	246	7	reducing	reduce	VERB
ajcp-3197	246	8	the	the	DET
ajcp-3197	246	9	incidence	incidence	NOUN
ajcp-3197	246	10	of	of	ADP
ajcp-3197	246	11	adrs	adrs	PROPN
ajcp-3197	246	12	in	in	ADP
ajcp-3197	246	13	nigeria	nigeria	PROPN
ajcp-3197	246	14	would	would	AUX
ajcp-3197	246	15	be	be	AUX
ajcp-3197	246	16	the	the	DET
ajcp-3197	246	17	proper	proper	ADJ
ajcp-3197	246	18	reporting	reporting	NOUN
ajcp-3197	246	19	of	of	ADP
ajcp-3197	246	20	cases	case	NOUN
ajcp-3197	246	21	.	.	PUNCT
ajcp-3197	247	1	this	this	PRON
ajcp-3197	247	2	would	would	AUX
ajcp-3197	247	3	help	help	VERB
ajcp-3197	247	4	to	to	PART
ajcp-3197	247	5	identify	identify	VERB
ajcp-3197	247	6	the	the	DET
ajcp-3197	247	7	particular	particular	ADJ
ajcp-3197	247	8	classes	class	NOUN
ajcp-3197	247	9	of	of	ADP
ajcp-3197	247	10	drugs	drug	NOUN
ajcp-3197	247	11	responsible	responsible	ADJ
ajcp-3197	247	12	for	for	ADP
ajcp-3197	247	13	adverse	adverse	ADJ
ajcp-3197	247	14	drug	drug	NOUN
ajcp-3197	247	15	reactions	reaction	NOUN
ajcp-3197	247	16	in	in	ADP
ajcp-3197	247	17	geriatrics	geriatric	NOUN
ajcp-3197	247	18	,	,	PUNCT
ajcp-3197	247	19	and	and	CCONJ
ajcp-3197	247	20	strategies	strategy	NOUN
ajcp-3197	247	21	can	can	AUX
ajcp-3197	247	22	be	be	AUX
ajcp-3197	247	23	put	put	VERB
ajcp-3197	247	24	in	in	ADP
ajcp-3197	247	25	place	place	NOUN
ajcp-3197	247	26	to	to	PART
ajcp-3197	247	27	reduce	reduce	VERB
ajcp-3197	247	28	their	their	PRON
ajcp-3197	247	29	use	use	NOUN
ajcp-3197	247	30	or	or	CCONJ
ajcp-3197	247	31	research	research	VERB
ajcp-3197	247	32	safer	safe	ADJ
ajcp-3197	247	33	pharmacological	pharmacological	ADJ
ajcp-3197	247	34	alternatives	alternative	NOUN
ajcp-3197	247	35	.	.	PUNCT
ajcp-3197	248	1	a	a	DET
ajcp-3197	248	2	study	study	NOUN
ajcp-3197	248	3	in	in	ADP
ajcp-3197	248	4	the	the	DET
ajcp-3197	248	5	united	united	PROPN
ajcp-3197	248	6	states	states	PROPN
ajcp-3197	248	7	among	among	ADP
ajcp-3197	248	8	adults	adult	NOUN
ajcp-3197	248	9	aged	age	VERB
ajcp-3197	248	10	≥65	≥65	NUM
ajcp-3197	248	11	years	year	NOUN
ajcp-3197	248	12	observed	observe	VERB
ajcp-3197	248	13	that	that	SCONJ
ajcp-3197	248	14	three	three	NUM
ajcp-3197	248	15	drug	drug	NOUN
ajcp-3197	248	16	groups	group	NOUN
ajcp-3197	248	17	medicines	medicine	NOUN
ajcp-3197	248	18	that	that	PRON
ajcp-3197	248	19	help	help	AUX
ajcp-3197	248	20	prevent	prevent	VERB
ajcp-3197	248	21	blood	blood	NOUN
ajcp-3197	248	22	clots	clot	NOUN
ajcp-3197	248	23	,	,	PUNCT
ajcp-3197	248	24	antidiabetic	antidiabetic	ADJ
ajcp-3197	248	25	medications	medication	NOUN
ajcp-3197	248	26	,	,	PUNCT
ajcp-3197	248	27	and	and	CCONJ
ajcp-3197	248	28	medications	medication	NOUN
ajcp-3197	248	29	with	with	ADP
ajcp-3197	248	30	morphine	morphine	NOUN
ajcp-3197	248	31	-	-	PUNCT
ajcp-3197	248	32	like	like	ADJ
ajcp-3197	248	33	effects	effect	NOUN
ajcp-3197	248	34	were	be	AUX
ajcp-3197	248	35	found	find	VERB
ajcp-3197	248	36	to	to	PART
ajcp-3197	248	37	be	be	AUX
ajcp-3197	248	38	involved	involve	VERB
ajcp-3197	248	39	in	in	ADP
ajcp-3197	248	40	about	about	ADV
ajcp-3197	248	41	60	60	NUM
ajcp-3197	248	42	%	%	NOUN
ajcp-3197	248	43	of	of	ADP
ajcp-3197	248	44	emergency	emergency	NOUN
ajcp-3197	248	45	department	department	NOUN
ajcp-3197	248	46	visits	visit	NOUN
ajcp-3197	248	47	for	for	ADP
ajcp-3197	248	48	adverse	adverse	ADJ
ajcp-3197	248	49	drug	drug	NOUN
ajcp-3197	248	50	reactions	reaction	NOUN
ajcp-3197	248	51	(	(	PUNCT
ajcp-3197	248	52	shehab	shehab	PROPN
ajcp-3197	248	53	et	et	PROPN
ajcp-3197	248	54	al	al	PROPN
ajcp-3197	248	55	.	.	PROPN
ajcp-3197	248	56	,	,	PUNCT
ajcp-3197	248	57	2016	2016	NUM
ajcp-3197	248	58	)	)	PUNCT
ajcp-3197	248	59	.	.	PUNCT
ajcp-3197	249	1	the	the	DET
ajcp-3197	249	2	reporting	reporting	NOUN
ajcp-3197	249	3	of	of	ADP
ajcp-3197	249	4	adverse	adverse	ADJ
ajcp-3197	249	5	drug	drug	NOUN
ajcp-3197	249	6	reactions	reaction	NOUN
ajcp-3197	249	7	in	in	ADP
ajcp-3197	249	8	africa	africa	PROPN
ajcp-3197	249	9	has	have	AUX
ajcp-3197	249	10	been	be	AUX
ajcp-3197	249	11	strengthened	strengthen	VERB
ajcp-3197	249	12	through	through	ADP
ajcp-3197	249	13	the	the	DET
ajcp-3197	249	14	establishment	establishment	NOUN
ajcp-3197	249	15	of	of	ADP
ajcp-3197	249	16	“	"	PUNCT
ajcp-3197	249	17	national	national	ADJ
ajcp-3197	249	18	pharmacovigilance	pharmacovigilance	NOUN
ajcp-3197	249	19	centers	center	NOUN
ajcp-3197	249	20	(	(	PUNCT
ajcp-3197	249	21	npcs	npc	NOUN
ajcp-3197	249	22	)	)	PUNCT
ajcp-3197	249	23	”	"	PUNCT
ajcp-3197	249	24	in	in	ADP
ajcp-3197	249	25	several	several	ADJ
ajcp-3197	249	26	countries	country	NOUN
ajcp-3197	249	27	(	(	PUNCT
ajcp-3197	249	28	ogar	ogar	NOUN
ajcp-3197	249	29	et	et	PROPN
ajcp-3197	249	30	al	al	PROPN
ajcp-3197	249	31	.	.	PROPN
ajcp-3197	249	32	,	,	PUNCT
ajcp-3197	249	33	2019	2019	NUM
ajcp-3197	249	34	)	)	PUNCT
ajcp-3197	249	35	.	.	PUNCT
ajcp-3197	250	1	the	the	DET
ajcp-3197	250	2	npc	npc	PROPN
ajcp-3197	250	3	in	in	ADP
ajcp-3197	250	4	nigeria	nigeria	PROPN
ajcp-3197	250	5	has	have	AUX
ajcp-3197	250	6	made	make	VERB
ajcp-3197	250	7	available	available	ADJ
ajcp-3197	250	8	procedures	procedure	NOUN
ajcp-3197	250	9	for	for	ADP
ajcp-3197	250	10	the	the	DET
ajcp-3197	250	11	proper	proper	ADJ
ajcp-3197	250	12	reporting	reporting	NOUN
ajcp-3197	250	13	of	of	ADP
ajcp-3197	250	14	adrs	adrs	PROPN
ajcp-3197	250	15	(	(	PUNCT
ajcp-3197	250	16	npc	npc	NOUN
ajcp-3197	250	17	,	,	PUNCT
ajcp-3197	250	18	2014	2014	NUM
ajcp-3197	250	19	)	)	PUNCT
ajcp-3197	250	20	.	.	PUNCT
ajcp-3197	251	1	furthermore	furthermore	ADV
ajcp-3197	251	2	,	,	PUNCT
ajcp-3197	251	3	activities	activity	NOUN
ajcp-3197	251	4	and	and	CCONJ
ajcp-3197	251	5	programs	program	NOUN
ajcp-3197	251	6	such	such	ADJ
ajcp-3197	251	7	as	as	ADP
ajcp-3197	251	8	public	public	ADJ
ajcp-3197	251	9	enlightenment	enlightenment	NOUN
ajcp-3197	251	10	and	and	CCONJ
ajcp-3197	251	11	education	education	NOUN
ajcp-3197	251	12	of	of	ADP
ajcp-3197	251	13	patients	patient	NOUN
ajcp-3197	251	14	and	and	CCONJ
ajcp-3197	251	15	caregivers	caregiver	NOUN
ajcp-3197	251	16	on	on	ADP
ajcp-3197	251	17	adrs	adr	NOUN
ajcp-3197	251	18	,	,	PUNCT
ajcp-3197	251	19	as	as	ADV
ajcp-3197	251	20	well	well	ADV
ajcp-3197	251	21	as	as	ADP
ajcp-3197	251	22	spontaneous	spontaneous	ADJ
ajcp-3197	251	23	reporting	reporting	NOUN
ajcp-3197	251	24	of	of	ADP
ajcp-3197	251	25	adrs	adr	NOUN
ajcp-3197	251	26	by	by	ADP
ajcp-3197	251	27	health	health	NOUN
ajcp-3197	251	28	professionals	professional	NOUN
ajcp-3197	251	29	,	,	PUNCT
ajcp-3197	251	30	should	should	AUX
ajcp-3197	251	31	be	be	AUX
ajcp-3197	251	32	implemented	implement	VERB
ajcp-3197	251	33	to	to	PART
ajcp-3197	251	34	increase	increase	VERB
ajcp-3197	251	35	the	the	DET
ajcp-3197	251	36	reporting	reporting	NOUN
ajcp-3197	251	37	rate	rate	NOUN
ajcp-3197	251	38	.	.	PUNCT
ajcp-3197	252	1	the	the	DET
ajcp-3197	252	2	poor	poor	ADJ
ajcp-3197	252	3	knowledge	knowledge	NOUN
ajcp-3197	252	4	of	of	ADP
ajcp-3197	252	5	adrs	adr	NOUN
ajcp-3197	252	6	among	among	ADP
ajcp-3197	252	7	healthcare	healthcare	NOUN
ajcp-3197	252	8	workers	worker	NOUN
ajcp-3197	252	9	highlights	highlight	VERB
ajcp-3197	252	10	the	the	DET
ajcp-3197	252	11	need	need	NOUN
ajcp-3197	252	12	for	for	ADP
ajcp-3197	252	13	continuous	continuous	ADJ
ajcp-3197	252	14	mandatory	mandatory	ADJ
ajcp-3197	252	15	education	education	NOUN
ajcp-3197	252	16	and	and	CCONJ
ajcp-3197	252	17	training	training	NOUN
ajcp-3197	252	18	of	of	ADP
ajcp-3197	252	19	health	health	NOUN
ajcp-3197	252	20	workers	worker	NOUN
ajcp-3197	252	21	on	on	ADP
ajcp-3197	252	22	adverse	adverse	ADJ
ajcp-3197	252	23	drug	drug	NOUN
ajcp-3197	252	24	reactions	reaction	NOUN
ajcp-3197	252	25	and	and	CCONJ
ajcp-3197	252	26	pharmacovigilance	pharmacovigilance	NOUN
ajcp-3197	252	27	concepts	concept	NOUN
ajcp-3197	252	28	.	.	PUNCT
ajcp-3197	253	1	the	the	DET
ajcp-3197	253	2	curriculum	curriculum	NOUN
ajcp-3197	253	3	of	of	ADP
ajcp-3197	253	4	health	health	NOUN
ajcp-3197	253	5	professionals	professional	NOUN
ajcp-3197	253	6	during	during	ADP
ajcp-3197	253	7	undergraduate	undergraduate	ADJ
ajcp-3197	253	8	training	training	NOUN
ajcp-3197	253	9	should	should	AUX
ajcp-3197	253	10	also	also	ADV
ajcp-3197	253	11	emphasize	emphasize	VERB
ajcp-3197	253	12	the	the	DET
ajcp-3197	253	13	identification	identification	NOUN
ajcp-3197	253	14	,	,	PUNCT
ajcp-3197	253	15	prevention	prevention	NOUN
ajcp-3197	253	16	,	,	PUNCT
ajcp-3197	253	17	and	and	CCONJ
ajcp-3197	253	18	documentation	documentation	NOUN
ajcp-3197	253	19	of	of	ADP
ajcp-3197	253	20	adverse	adverse	ADJ
ajcp-3197	253	21	drug	drug	NOUN
ajcp-3197	253	22	reactions	reaction	NOUN
ajcp-3197	253	23	.	.	PUNCT
ajcp-3197	254	1	to	to	PART
ajcp-3197	254	2	tackle	tackle	VERB
ajcp-3197	254	3	the	the	DET
ajcp-3197	254	4	problem	problem	NOUN
ajcp-3197	254	5	of	of	ADP
ajcp-3197	254	6	limited	limited	ADJ
ajcp-3197	254	7	centers	center	NOUN
ajcp-3197	254	8	dedicated	dedicate	VERB
ajcp-3197	254	9	to	to	ADP
ajcp-3197	254	10	the	the	DET
ajcp-3197	254	11	care	care	NOUN
ajcp-3197	254	12	of	of	ADP
ajcp-3197	254	13	geriatric	geriatric	ADJ
ajcp-3197	254	14	patients	patient	NOUN
ajcp-3197	254	15	,	,	PUNCT
ajcp-3197	254	16	the	the	DET
ajcp-3197	254	17	leadership	leadership	NOUN
ajcp-3197	254	18	of	of	ADP
ajcp-3197	254	19	various	various	ADJ
ajcp-3197	254	20	hospitals	hospital	NOUN
ajcp-3197	254	21	and	and	CCONJ
ajcp-3197	254	22	clinics	clinic	NOUN
ajcp-3197	254	23	should	should	AUX
ajcp-3197	254	24	advocate	advocate	VERB
ajcp-3197	254	25	for	for	ADP
ajcp-3197	254	26	the	the	DET
ajcp-3197	254	27	establishment	establishment	NOUN
ajcp-3197	254	28	of	of	ADP
ajcp-3197	254	29	geriatric	geriatric	ADJ
ajcp-3197	254	30	centers	center	NOUN
ajcp-3197	254	31	in	in	ADP
ajcp-3197	254	32	their	their	PRON
ajcp-3197	254	33	facilities	facility	NOUN
ajcp-3197	254	34	equipped	equip	VERB
ajcp-3197	254	35	with	with	ADP
ajcp-3197	254	36	trained	train	VERB
ajcp-3197	254	37	staff	staff	NOUN
ajcp-3197	254	38	across	across	ADP
ajcp-3197	254	39	all	all	DET
ajcp-3197	254	40	states	state	NOUN
ajcp-3197	254	41	in	in	ADP
ajcp-3197	254	42	nigeria	nigeria	PROPN
ajcp-3197	254	43	.	.	PUNCT
ajcp-3197	255	1	reducing	reduce	VERB
ajcp-3197	255	2	pill	pill	NOUN
ajcp-3197	255	3	burden	burden	NOUN
ajcp-3197	255	4	,	,	PUNCT
ajcp-3197	255	5	referred	refer	VERB
ajcp-3197	255	6	to	to	ADP
ajcp-3197	255	7	as	as	ADP
ajcp-3197	255	8	deprescribing	deprescribe	VERB
ajcp-3197	255	9	,	,	PUNCT
ajcp-3197	255	10	is	be	AUX
ajcp-3197	255	11	one	one	NUM
ajcp-3197	255	12	of	of	ADP
ajcp-3197	255	13	the	the	DET
ajcp-3197	255	14	most	most	ADV
ajcp-3197	255	15	effective	effective	ADJ
ajcp-3197	255	16	steps	step	NOUN
ajcp-3197	255	17	to	to	ADP
ajcp-3197	255	18	reducing	reduce	VERB
ajcp-3197	255	19	adverse	adverse	ADJ
ajcp-3197	255	20	drug	drug	NOUN
ajcp-3197	255	21	reactions	reaction	NOUN
ajcp-3197	255	22	among	among	ADP
ajcp-3197	255	23	the	the	DET
ajcp-3197	255	24	elderly	elderly	ADJ
ajcp-3197	255	25	.	.	PUNCT
ajcp-3197	256	1	deprescribing	deprescribe	VERB
ajcp-3197	256	2	refers	refer	NOUN
ajcp-3197	256	3	to	to	ADP
ajcp-3197	256	4	the	the	DET
ajcp-3197	256	5	process	process	NOUN
ajcp-3197	256	6	of	of	ADP
ajcp-3197	256	7	withholding	withhold	VERB
ajcp-3197	256	8	unnecessary	unnecessary	ADJ
ajcp-3197	256	9	medicines	medicine	NOUN
ajcp-3197	256	10	or	or	CCONJ
ajcp-3197	256	11	minimizing	minimize	VERB
ajcp-3197	256	12	their	their	PRON
ajcp-3197	256	13	dosages	dosage	NOUN
ajcp-3197	256	14	at	at	ADP
ajcp-3197	256	15	the	the	DET
ajcp-3197	256	16	discretion	discretion	NOUN
ajcp-3197	256	17	of	of	ADP
ajcp-3197	256	18	a	a	DET
ajcp-3197	256	19	healthcare	healthcare	NOUN
ajcp-3197	256	20	professional	professional	NOUN
ajcp-3197	256	21	,	,	PUNCT
ajcp-3197	256	22	probably	probably	ADV
ajcp-3197	256	23	a	a	DET
ajcp-3197	256	24	medical	medical	ADJ
ajcp-3197	256	25	doctor	doctor	NOUN
ajcp-3197	256	26	or	or	CCONJ
ajcp-3197	256	27	a	a	DET
ajcp-3197	256	28	pharmacist	pharmacist	NOUN
ajcp-3197	256	29	.	.	PUNCT
ajcp-3197	257	1	this	this	PRON
ajcp-3197	257	2	is	be	AUX
ajcp-3197	257	3	aimed	aim	VERB
ajcp-3197	257	4	at	at	ADP
ajcp-3197	257	5	managing	manage	VERB
ajcp-3197	257	6	polypharmacy	polypharmacy	NOUN
ajcp-3197	257	7	and	and	CCONJ
ajcp-3197	257	8	in	in	ADP
ajcp-3197	257	9	turn	turn	NOUN
ajcp-3197	257	10	,	,	PUNCT
ajcp-3197	257	11	improving	improve	VERB
ajcp-3197	257	12	health	health	NOUN
ajcp-3197	257	13	outcomes	outcome	NOUN
ajcp-3197	257	14	.	.	PUNCT
ajcp-3197	258	1	there	there	PRON
ajcp-3197	258	2	should	should	AUX
ajcp-3197	258	3	be	be	AUX
ajcp-3197	258	4	an	an	DET
ajcp-3197	258	5	increase	increase	NOUN
ajcp-3197	258	6	in	in	ADP
ajcp-3197	258	7	awareness	awareness	NOUN
ajcp-3197	258	8	among	among	ADP
ajcp-3197	258	9	nigerian	nigerian	ADJ
ajcp-3197	258	10	prescribers	prescriber	NOUN
ajcp-3197	258	11	regarding	regard	VERB
ajcp-3197	258	12	rational	rational	ADJ
ajcp-3197	258	13	prescribing	prescribing	NOUN
ajcp-3197	258	14	(	(	PUNCT
ajcp-3197	258	15	oli	oli	PROPN
ajcp-3197	258	16	et	et	PROPN
ajcp-3197	258	17	al	al	PROPN
ajcp-3197	258	18	.	.	PROPN
ajcp-3197	258	19	,	,	PUNCT
ajcp-3197	258	20	2021	2021	NUM
ajcp-3197	258	21	)	)	PUNCT
ajcp-3197	258	22	and	and	CCONJ
ajcp-3197	258	23	the	the	DET
ajcp-3197	258	24	use	use	NOUN
ajcp-3197	258	25	of	of	ADP
ajcp-3197	258	26	checklists	checklist	NOUN
ajcp-3197	258	27	(	(	PUNCT
ajcp-3197	258	28	or	or	CCONJ
ajcp-3197	258	29	trigger	trigger	NOUN
ajcp-3197	258	30	tools	tool	NOUN
ajcp-3197	258	31	)	)	PUNCT
ajcp-3197	258	32	for	for	ADP
ajcp-3197	258	33	adr	adr	PROPN
ajcp-3197	258	34	detection	detection	NOUN
ajcp-3197	258	35	among	among	ADP
ajcp-3197	258	36	the	the	DET
ajcp-3197	258	37	elderly	elderly	ADJ
ajcp-3197	258	38	(	(	PUNCT
ajcp-3197	258	39	borodo	borodo	NOUN
ajcp-3197	258	40	et	et	PROPN
ajcp-3197	258	41	al	al	PROPN
ajcp-3197	258	42	.	.	PROPN
ajcp-3197	258	43	,	,	PUNCT
ajcp-3197	258	44	2022	2022	NUM
ajcp-3197	258	45	)	)	PUNCT
ajcp-3197	258	46	.	.	PUNCT
ajcp-3197	259	1	reports	report	NOUN
ajcp-3197	259	2	on	on	ADP
ajcp-3197	259	3	the	the	DET
ajcp-3197	259	4	incidence	incidence	NOUN
ajcp-3197	259	5	of	of	ADP
ajcp-3197	259	6	adverse	adverse	ADJ
ajcp-3197	259	7	drug	drug	NOUN
ajcp-3197	259	8	reactions	reaction	NOUN
ajcp-3197	259	9	in	in	ADP
ajcp-3197	259	10	the	the	DET
ajcp-3197	259	11	geriatric	geriatric	ADJ
ajcp-3197	259	12	population	population	NOUN
ajcp-3197	259	13	in	in	ADP
ajcp-3197	259	14	nigeria	nigeria	PROPN
ajcp-3197	259	15	are	be	AUX
ajcp-3197	259	16	very	very	ADV
ajcp-3197	259	17	limited	limited	ADJ
ajcp-3197	259	18	.	.	PUNCT
ajcp-3197	260	1	thus	thus	ADV
ajcp-3197	260	2	far	far	ADV
ajcp-3197	260	3	,	,	PUNCT
ajcp-3197	260	4	only	only	ADV
ajcp-3197	260	5	two	two	NUM
ajcp-3197	260	6	reports	report	NOUN
ajcp-3197	260	7	are	be	AUX
ajcp-3197	260	8	documented	document	VERB
ajcp-3197	260	9	solely	solely	ADV
ajcp-3197	260	10	on	on	ADP
ajcp-3197	260	11	adrs	adr	NOUN
ajcp-3197	260	12	in	in	ADP
ajcp-3197	260	13	geriatrics	geriatric	NOUN
ajcp-3197	260	14	in	in	ADP
ajcp-3197	260	15	nigeria	nigeria	PROPN
ajcp-3197	260	16	.	.	PUNCT
ajcp-3197	261	1	most	most	ADJ
ajcp-3197	261	2	studies	study	NOUN
ajcp-3197	261	3	are	be	AUX
ajcp-3197	261	4	focused	focus	VERB
ajcp-3197	261	5	on	on	ADP
ajcp-3197	261	6	adrs	adr	NOUN
ajcp-3197	261	7	in	in	ADP
ajcp-3197	261	8	the	the	DET
ajcp-3197	261	9	general	general	ADJ
ajcp-3197	261	10	adult	adult	NOUN
ajcp-3197	261	11	population	population	NOUN
ajcp-3197	261	12	and	and	CCONJ
ajcp-3197	261	13	potentially	potentially	ADV
ajcp-3197	261	14	inappropriate	inappropriate	ADJ
ajcp-3197	261	15	prescribing	prescribing	NOUN
ajcp-3197	261	16	.	.	PUNCT
ajcp-3197	262	1	however	however	ADV
ajcp-3197	262	2	,	,	PUNCT
ajcp-3197	262	3	high	high	ADJ
ajcp-3197	262	4	quality	quality	NOUN
ajcp-3197	262	5	reports	report	NOUN
ajcp-3197	262	6	investigating	investigate	VERB
ajcp-3197	262	7	the	the	DET
ajcp-3197	262	8	drug	drug	NOUN
ajcp-3197	262	9	classes	class	NOUN
ajcp-3197	262	10	most	most	ADV
ajcp-3197	262	11	responsible	responsible	ADJ
ajcp-3197	262	12	for	for	ADP
ajcp-3197	262	13	adrs	adr	NOUN
ajcp-3197	262	14	in	in	ADP
ajcp-3197	262	15	the	the	DET
ajcp-3197	262	16	elderly	elderly	ADJ
ajcp-3197	262	17	are	be	AUX
ajcp-3197	262	18	lacking	lack	VERB
ajcp-3197	262	19	.	.	PUNCT
ajcp-3197	263	1	furthermore	furthermore	ADV
ajcp-3197	263	2	,	,	PUNCT
ajcp-3197	263	3	interventions	intervention	NOUN
ajcp-3197	263	4	to	to	PART
ajcp-3197	263	5	reduce	reduce	VERB
ajcp-3197	263	6	adrs	adr	NOUN
ajcp-3197	263	7	and	and	CCONJ
ajcp-3197	263	8	improve	improve	VERB
ajcp-3197	263	9	healthcare	healthcare	NOUN
ajcp-3197	263	10	among	among	ADP
ajcp-3197	263	11	geriatric	geriatric	ADJ
ajcp-3197	263	12	patients	patient	NOUN
ajcp-3197	263	13	in	in	ADP
ajcp-3197	263	14	nigeria	nigeria	PROPN
ajcp-3197	263	15	are	be	AUX
ajcp-3197	263	16	limited	limited	ADJ
ajcp-3197	263	17	.	.	PUNCT
ajcp-3197	264	1	this	this	DET
ajcp-3197	264	2	present	present	ADJ
ajcp-3197	264	3	study	study	NOUN
ajcp-3197	264	4	is	be	AUX
ajcp-3197	264	5	not	not	PART
ajcp-3197	264	6	without	without	ADP
ajcp-3197	264	7	limitations	limitation	NOUN
ajcp-3197	264	8	as	as	SCONJ
ajcp-3197	264	9	it	it	PRON
ajcp-3197	264	10	utilized	utilize	VERB
ajcp-3197	264	11	heterogeneous	heterogeneous	ADJ
ajcp-3197	264	12	studies	study	NOUN
ajcp-3197	264	13	(	(	PUNCT
ajcp-3197	264	14	prospective	prospective	ADJ
ajcp-3197	264	15	,	,	PUNCT
ajcp-3197	264	16	retrospective	retrospective	ADJ
ajcp-3197	264	17	,	,	PUNCT
ajcp-3197	264	18	and	and	CCONJ
ajcp-3197	264	19	mixed	mixed	ADJ
ajcp-3197	264	20	)	)	PUNCT
ajcp-3197	264	21	in	in	ADP
ajcp-3197	264	22	the	the	DET
ajcp-3197	264	23	review	review	NOUN
ajcp-3197	264	24	and	and	CCONJ
ajcp-3197	264	25	this	this	PRON
ajcp-3197	264	26	poses	pose	VERB
ajcp-3197	264	27	a	a	DET
ajcp-3197	264	28	bias	bias	NOUN
ajcp-3197	264	29	.	.	PUNCT
ajcp-3197	265	1	although	although	SCONJ
ajcp-3197	265	2	retrospective	retrospective	ADJ
ajcp-3197	265	3	studies	study	NOUN
ajcp-3197	265	4	have	have	AUX
ajcp-3197	265	5	been	be	AUX
ajcp-3197	265	6	shown	show	VERB
ajcp-3197	265	7	to	to	PART
ajcp-3197	265	8	detect	detect	VERB
ajcp-3197	265	9	lower	low	ADJ
ajcp-3197	265	10	adrs	adr	NOUN
ajcp-3197	265	11	compared	compare	VERB
ajcp-3197	265	12	to	to	ADP
ajcp-3197	265	13	prospective	prospective	ADJ
ajcp-3197	265	14	studies	study	NOUN
ajcp-3197	265	15	because	because	SCONJ
ajcp-3197	265	16	they	they	PRON
ajcp-3197	265	17	are	be	AUX
ajcp-3197	265	18	subject	subject	ADJ
ajcp-3197	265	19	to	to	ADP
ajcp-3197	265	20	failure	failure	NOUN
ajcp-3197	265	21	in	in	ADP
ajcp-3197	265	22	gathering	gathering	NOUN
ajcp-3197	265	23	and	and	CCONJ
ajcp-3197	265	24	proper	proper	ADJ
ajcp-3197	265	25	documentation	documentation	NOUN
ajcp-3197	265	26	of	of	ADP
ajcp-3197	265	27	data	datum	NOUN
ajcp-3197	265	28	in	in	ADP
ajcp-3197	265	29	the	the	DET
ajcp-3197	265	30	medical	medical	ADJ
ajcp-3197	265	31	charts	chart	NOUN
ajcp-3197	265	32	(	(	PUNCT
ajcp-3197	265	33	de	de	X
ajcp-3197	265	34	figueiredo	figueiredo	X
ajcp-3197	265	35	et	et	PROPN
ajcp-3197	265	36	al	al	PROPN
ajcp-3197	265	37	.	.	PROPN
ajcp-3197	265	38	,	,	PUNCT
ajcp-3197	265	39	2017	2017	NUM
ajcp-3197	265	40	)	)	PUNCT
ajcp-3197	265	41	,	,	PUNCT
ajcp-3197	265	42	however	however	ADV
ajcp-3197	265	43	,	,	PUNCT
ajcp-3197	265	44	this	this	PRON
ajcp-3197	265	45	was	be	AUX
ajcp-3197	265	46	not	not	PART
ajcp-3197	265	47	so	so	ADV
ajcp-3197	265	48	in	in	ADP
ajcp-3197	265	49	this	this	DET
ajcp-3197	265	50	present	present	ADJ
ajcp-3197	265	51	study	study	NOUN
ajcp-3197	265	52	as	as	ADP
ajcp-3197	265	53	those	those	PRON
ajcp-3197	265	54	that	that	PRON
ajcp-3197	265	55	used	use	VERB
ajcp-3197	265	56	a	a	DET
ajcp-3197	265	57	prospective	prospective	ADJ
ajcp-3197	265	58	study	study	NOUN
ajcp-3197	265	59	design	design	NOUN
ajcp-3197	265	60	had	have	VERB
ajcp-3197	265	61	lower	low	ADJ
ajcp-3197	265	62	adr	adr	PROPN
ajcp-3197	265	63	prevalence	prevalence	NOUN
ajcp-3197	265	64	rates	rate	NOUN
ajcp-3197	265	65	compared	compare	VERB
ajcp-3197	265	66	to	to	ADP
ajcp-3197	265	67	those	those	PRON
ajcp-3197	265	68	with	with	ADP
ajcp-3197	265	69	a	a	DET
ajcp-3197	265	70	retrospective	retrospective	ADJ
ajcp-3197	265	71	design	design	NOUN
ajcp-3197	265	72	.	.	PUNCT
ajcp-3197	266	1	another	another	DET
ajcp-3197	266	2	limitation	limitation	NOUN
ajcp-3197	266	3	of	of	ADP
ajcp-3197	266	4	this	this	DET
ajcp-3197	266	5	present	present	ADJ
ajcp-3197	266	6	study	study	NOUN
ajcp-3197	266	7	is	be	AUX
ajcp-3197	266	8	the	the	DET
ajcp-3197	266	9	variation	variation	NOUN
ajcp-3197	266	10	in	in	ADP
ajcp-3197	266	11	the	the	DET
ajcp-3197	266	12	age	age	NOUN
ajcp-3197	266	13	brackets	bracket	NOUN
ajcp-3197	266	14	of	of	ADP
ajcp-3197	266	15	the	the	DET
ajcp-3197	266	16	elderly	elderly	ADJ
ajcp-3197	266	17	patients	patient	NOUN
ajcp-3197	266	18	included	include	VERB
ajcp-3197	266	19	in	in	ADP
ajcp-3197	266	20	the	the	DET
ajcp-3197	266	21	review	review	NOUN
ajcp-3197	266	22	.	.	PUNCT
ajcp-3197	267	1	there	there	PRON
ajcp-3197	267	2	is	be	VERB
ajcp-3197	267	3	a	a	DET
ajcp-3197	267	4	need	need	NOUN
ajcp-3197	267	5	for	for	ADP
ajcp-3197	267	6	further	further	ADJ
ajcp-3197	267	7	studies	study	NOUN
ajcp-3197	267	8	on	on	ADP
ajcp-3197	267	9	the	the	DET
ajcp-3197	267	10	detection	detection	NOUN
ajcp-3197	267	11	of	of	ADP
ajcp-3197	267	12	adrs	adr	NOUN
ajcp-3197	267	13	and	and	CCONJ
ajcp-3197	267	14	trigger	trigger	NOUN
ajcp-3197	267	15	tools	tool	NOUN
ajcp-3197	267	16	/	/	SYM
ajcp-3197	267	17	medications	medication	NOUN
ajcp-3197	267	18	that	that	PRON
ajcp-3197	267	19	cause	cause	VERB
ajcp-3197	267	20	a	a	DET
ajcp-3197	267	21	significant	significant	ADJ
ajcp-3197	267	22	burden	burden	NOUN
ajcp-3197	267	23	of	of	ADP
ajcp-3197	267	24	morbidity	morbidity	NOUN
ajcp-3197	267	25	and	and	CCONJ
ajcp-3197	267	26	mortality	mortality	NOUN
ajcp-3197	267	27	in	in	ADP
ajcp-3197	267	28	nigeria	nigeria	PROPN
ajcp-3197	267	29	’s	’s	PART
ajcp-3197	267	30	geriatric	geriatric	ADJ
ajcp-3197	267	31	population	population	NOUN
ajcp-3197	267	32	.	.	PUNCT
ajcp-3197	268	1	conclusion	conclusion	NOUN
ajcp-3197	268	2	the	the	DET
ajcp-3197	268	3	geriatrics	geriatric	NOUN
ajcp-3197	268	4	are	be	AUX
ajcp-3197	268	5	highly	highly	ADV
ajcp-3197	268	6	susceptible	susceptible	ADJ
ajcp-3197	268	7	to	to	ADP
ajcp-3197	268	8	adverse	adverse	ADJ
ajcp-3197	268	9	drug	drug	NOUN
ajcp-3197	268	10	reactions	reaction	NOUN
ajcp-3197	268	11	due	due	ADP
ajcp-3197	268	12	to	to	ADP
ajcp-3197	268	13	the	the	DET
ajcp-3197	268	14	decline	decline	NOUN
ajcp-3197	268	15	in	in	ADP
ajcp-3197	268	16	cellular	cellular	ADJ
ajcp-3197	268	17	functions	function	NOUN
ajcp-3197	268	18	,	,	PUNCT
ajcp-3197	268	19	comorbid	comorbid	NOUN
ajcp-3197	268	20	conditions	condition	NOUN
ajcp-3197	268	21	,	,	PUNCT
ajcp-3197	268	22	and	and	CCONJ
ajcp-3197	268	23	polypharmacy	polypharmacy	NOUN
ajcp-3197	268	24	.	.	PUNCT
ajcp-3197	269	1	these	these	DET
ajcp-3197	269	2	factors	factor	NOUN
ajcp-3197	269	3	contribute	contribute	VERB
ajcp-3197	269	4	to	to	ADP
ajcp-3197	269	5	increased	increase	VERB
ajcp-3197	269	6	risk	risk	NOUN
ajcp-3197	269	7	of	of	ADP
ajcp-3197	269	8	hospitalizations	hospitalization	NOUN
ajcp-3197	269	9	and	and	CCONJ
ajcp-3197	269	10	deaths	death	NOUN
ajcp-3197	269	11	resulting	result	VERB
ajcp-3197	269	12	from	from	ADP
ajcp-3197	269	13	medication	medication	NOUN
ajcp-3197	269	14	-	-	PUNCT
ajcp-3197	269	15	related	relate	VERB
ajcp-3197	269	16	adverse	adverse	ADJ
ajcp-3197	269	17	events	event	NOUN
ajcp-3197	269	18	.	.	PUNCT
ajcp-3197	270	1	despite	despite	SCONJ
ajcp-3197	270	2	the	the	DET
ajcp-3197	270	3	high	high	ADJ
ajcp-3197	270	4	risks	risk	NOUN
ajcp-3197	270	5	involved	involve	VERB
ajcp-3197	270	6	,	,	PUNCT
ajcp-3197	270	7	approaches	approach	NOUN
ajcp-3197	270	8	to	to	ADP
ajcp-3197	270	9	addressing	address	VERB
ajcp-3197	270	10	adrs	adr	NOUN
ajcp-3197	270	11	have	have	AUX
ajcp-3197	270	12	not	not	PART
ajcp-3197	270	13	focused	focus	VERB
ajcp-3197	270	14	solely	solely	ADV
ajcp-3197	270	15	on	on	ADP
ajcp-3197	270	16	the	the	DET
ajcp-3197	270	17	geriatric	geriatric	ADJ
ajcp-3197	270	18	population	population	NOUN
ajcp-3197	270	19	.	.	PUNCT
ajcp-3197	271	1	interventional	interventional	ADJ
ajcp-3197	271	2	studies	study	NOUN
ajcp-3197	271	3	on	on	ADP
ajcp-3197	271	4	safer	safe	ADJ
ajcp-3197	271	5	non	non	ADJ
ajcp-3197	271	6	-	-	ADJ
ajcp-3197	271	7	pharmacological	pharmacological	ADJ
ajcp-3197	271	8	and	and	CCONJ
ajcp-3197	271	9	pharmacological	pharmacological	ADJ
ajcp-3197	271	10	alternatives	alternative	NOUN
ajcp-3197	271	11	to	to	ADP
ajcp-3197	271	12	drug	drug	NOUN
ajcp-3197	271	13	classes	class	NOUN
ajcp-3197	271	14	associated	associate	VERB
ajcp-3197	271	15	with	with	ADP
ajcp-3197	271	16	adrs	adr	NOUN
ajcp-3197	271	17	are	be	AUX
ajcp-3197	271	18	necessary	necessary	ADJ
ajcp-3197	271	19	in	in	ADP
ajcp-3197	271	20	order	order	NOUN
ajcp-3197	271	21	to	to	PART
ajcp-3197	271	22	reduce	reduce	VERB
ajcp-3197	271	23	the	the	DET
ajcp-3197	271	24	occurrence	occurrence	NOUN
ajcp-3197	271	25	of	of	ADP
ajcp-3197	271	26	adrs	adr	NOUN
ajcp-3197	271	27	among	among	ADP
ajcp-3197	271	28	the	the	DET
ajcp-3197	271	29	geriatric	geriatric	ADJ
ajcp-3197	271	30	population	population	NOUN
ajcp-3197	271	31	in	in	ADP
ajcp-3197	271	32	nigeria	nigeria	PROPN
ajcp-3197	271	33	.	.	PUNCT
ajcp-3197	272	1	acknowledgments	acknowledgment	NOUN
ajcp-3197	272	2	special	special	ADJ
ajcp-3197	272	3	thanks	thank	NOUN
ajcp-3197	272	4	to	to	ADP
ajcp-3197	272	5	everyone	everyone	PRON
ajcp-3197	272	6	who	who	PRON
ajcp-3197	272	7	contributed	contribute	VERB
ajcp-3197	272	8	in	in	ADP
ajcp-3197	272	9	one	one	NUM
ajcp-3197	272	10	way	way	NOUN
ajcp-3197	272	11	or	or	CCONJ
ajcp-3197	272	12	the	the	DET
ajcp-3197	272	13	other	other	ADJ
ajcp-3197	272	14	to	to	PART
ajcp-3197	272	15	make	make	VERB
ajcp-3197	272	16	this	this	DET
ajcp-3197	272	17	research	research	NOUN
ajcp-3197	272	18	a	a	DET
ajcp-3197	272	19	success	success	NOUN
ajcp-3197	272	20	.	.	PUNCT
ajcp-3197	273	1	your	your	PRON
ajcp-3197	273	2	assistance	assistance	NOUN
ajcp-3197	273	3	in	in	ADP
ajcp-3197	273	4	conducting	conduct	VERB
ajcp-3197	273	5	this	this	DET
ajcp-3197	273	6	research	research	NOUN
ajcp-3197	273	7	is	be	AUX
ajcp-3197	273	8	highly	highly	ADV
ajcp-3197	273	9	appreciated	appreciated	ADJ
ajcp-3197	273	10	.	.	PUNCT
ajcp-3197	274	1	references	reference	NOUN
ajcp-3197	274	2	adedapo	adedapo	NOUN
ajcp-3197	274	3	,	,	PUNCT
ajcp-3197	274	4	a.	a.	PROPN
ajcp-3197	274	5	d.	d.	PROPN
ajcp-3197	274	6	,	,	PUNCT
ajcp-3197	274	7	adedeji	adedeji	NOUN
ajcp-3197	274	8	,	,	PUNCT
ajcp-3197	274	9	w.	w.	PROPN
ajcp-3197	274	10	a.	a.	PROPN
ajcp-3197	274	11	,	,	PUNCT
ajcp-3197	274	12	adedapo	adedapo	PROPN
ajcp-3197	274	13	,	,	PUNCT
ajcp-3197	274	14	i.	i.	PROPN
ajcp-3197	274	15	a.	a.	PROPN
ajcp-3197	274	16	,	,	PUNCT
ajcp-3197	274	17	&	&	CCONJ
ajcp-3197	274	18	adedapo	adedapo	PROPN
ajcp-3197	274	19	,	,	PUNCT
ajcp-3197	274	20	k.	k.	PROPN
ajcp-3197	274	21	s.	s.	PROPN
ajcp-3197	274	22	(	(	PUNCT
ajcp-3197	274	23	2021	2021	NUM
ajcp-3197	274	24	)	)	PUNCT
ajcp-3197	274	25	.	.	PUNCT
ajcp-3197	275	1	cohort	cohort	NOUN
ajcp-3197	275	2	study	study	NOUN
ajcp-3197	275	3	on	on	ADP
ajcp-3197	275	4	adverse	adverse	ADJ
ajcp-3197	275	5	drug	drug	NOUN
ajcp-3197	275	6	reactions	reaction	NOUN
ajcp-3197	275	7	in	in	ADP
ajcp-3197	275	8	adults	adult	NOUN
ajcp-3197	275	9	admitted	admit	VERB
ajcp-3197	275	10	to	to	ADP
ajcp-3197	275	11	the	the	DET
ajcp-3197	275	12	medical	medical	ADJ
ajcp-3197	275	13	wards	ward	NOUN
ajcp-3197	275	14	of	of	ADP
ajcp-3197	275	15	a	a	DET
ajcp-3197	275	16	tertiary	tertiary	ADJ
ajcp-3197	275	17	hospital	hospital	NOUN
ajcp-3197	275	18	in	in	ADP
ajcp-3197	275	19	nigeria	nigeria	PROPN
ajcp-3197	275	20	:	:	PUNCT
ajcp-3197	276	1	prevalence	prevalence	NOUN
ajcp-3197	276	2	,	,	PUNCT
ajcp-3197	276	3	incidence	incidence	NOUN
ajcp-3197	276	4	,	,	PUNCT
ajcp-3197	276	5	risk	risk	NOUN
ajcp-3197	276	6	factors	factor	NOUN
ajcp-3197	276	7	and	and	CCONJ
ajcp-3197	276	8	fatality	fatality	NOUN
ajcp-3197	276	9	.	.	PUNCT
ajcp-3197	277	1	british	british	ADJ
ajcp-3197	277	2	journal	journal	PROPN
ajcp-3197	277	3	of	of	ADP
ajcp-3197	277	4	clinical	clinical	ADJ
ajcp-3197	277	5	pharmacology	pharmacology	NOUN
ajcp-3197	277	6	,	,	PUNCT
ajcp-3197	277	7	87(4	87(4	NUM
ajcp-3197	277	8	)	)	PUNCT
ajcp-3197	277	9	,	,	PUNCT
ajcp-3197	277	10	1878	1878	NUM
ajcp-3197	277	11	-	-	SYM
ajcp-3197	277	12	1889	1889	NUM
ajcp-3197	277	13	.	.	PUNCT
ajcp-3197	278	1	https://doi	https://doi	PROPN
ajcp-3197	278	2	.	.	PUNCT
ajcp-3197	278	3	org/10.1111	org/10.1111	PROPN
ajcp-3197	278	4	/	/	SYM
ajcp-3197	278	5	bcp.14577	bcp.14577	PROPN
ajcp-3197	278	6	.	.	PUNCT
ajcp-3197	279	1	aderemi	aderemi	PROPN
ajcp-3197	279	2	-	-	PUNCT
ajcp-3197	279	3	williams	williams	PROPN
ajcp-3197	279	4	,	,	PUNCT
ajcp-3197	279	5	r.	r.	PROPN
ajcp-3197	279	6	,	,	PUNCT
ajcp-3197	279	7	awodele	awodele	PROPN
ajcp-3197	279	8	,	,	PUNCT
ajcp-3197	279	9	o.	o.	PROPN
ajcp-3197	279	10	,	,	PUNCT
ajcp-3197	279	11	&	&	CCONJ
ajcp-3197	279	12	boyle	boyle	PROPN
ajcp-3197	279	13	,	,	PUNCT
ajcp-3197	279	14	c.	c.	PROPN
ajcp-3197	279	15	(	(	PUNCT
ajcp-3197	279	16	2015	2015	NUM
ajcp-3197	279	17	)	)	PUNCT
ajcp-3197	279	18	.	.	PUNCT
ajcp-3197	280	1	adverse	adverse	ADJ
ajcp-3197	280	2	drug	drug	NOUN
ajcp-3197	280	3	reactions	reaction	NOUN
ajcp-3197	280	4	amongst	amongst	ADP
ajcp-3197	280	5	adult	adult	NOUN
ajcp-3197	280	6	patients	patient	NOUN
ajcp-3197	280	7	admitted	admit	VERB
ajcp-3197	280	8	in	in	ADP
ajcp-3197	280	9	lagos	lagos	PROPN
ajcp-3197	280	10	state	state	NOUN
ajcp-3197	280	11	university	university	PROPN
ajcp-3197	280	12	teaching	teaching	NOUN
ajcp-3197	280	13	hospital	hospital	NOUN
ajcp-3197	280	14	lagos	lago	NOUN
ajcp-3197	280	15	,	,	PUNCT
ajcp-3197	280	16	nigeria	nigeria	PROPN
ajcp-3197	280	17	.	.	PUNCT
ajcp-3197	281	1	current	current	ADJ
ajcp-3197	281	2	drug	drug	NOUN
ajcp-3197	281	3	safety	safety	NOUN
ajcp-3197	281	4	,	,	PUNCT
ajcp-3197	281	5	10(2	10(2	NUM
ajcp-3197	281	6	)	)	PUNCT
ajcp-3197	281	7	,	,	PUNCT
ajcp-3197	281	8	136	136	NUM
ajcp-3197	281	9	-	-	SYM
ajcp-3197	281	10	144	144	NUM
ajcp-3197	281	11	.	.	PUNCT
ajcp-3197	282	1	https://doi.org/10.2174/1574886309666140601211	https://doi.org/10.2174/1574886309666140601211	X
ajcp-3197	283	1	211	211	NUM
ajcp-3197	283	2	.	.	PUNCT
ajcp-3197	284	1	adisa	adisa	PROPN
ajcp-3197	284	2	,	,	PUNCT
ajcp-3197	284	3	r.	r.	PROPN
ajcp-3197	284	4	,	,	PUNCT
ajcp-3197	284	5	&	&	CCONJ
ajcp-3197	284	6	omitogun	omitogun	PROPN
ajcp-3197	284	7	,	,	PUNCT
ajcp-3197	284	8	t.	t.	PROPN
ajcp-3197	284	9	i.	i.	PROPN
ajcp-3197	284	10	(	(	PUNCT
ajcp-3197	284	11	2019	2019	NUM
ajcp-3197	284	12	)	)	PUNCT
ajcp-3197	284	13	.	.	PUNCT
ajcp-3197	285	1	awareness	awareness	NOUN
ajcp-3197	285	2	,	,	PUNCT
ajcp-3197	285	3	knowledge	knowledge	NOUN
ajcp-3197	285	4	,	,	PUNCT
ajcp-3197	285	5	attitude	attitude	NOUN
ajcp-3197	285	6	and	and	CCONJ
ajcp-3197	285	7	practice	practice	NOUN
ajcp-3197	285	8	of	of	ADP
ajcp-3197	285	9	adverse	adverse	ADJ
ajcp-3197	285	10	drug	drug	NOUN
ajcp-3197	285	11	reaction	reaction	NOUN
ajcp-3197	285	12	reporting	report	VERB
ajcp-3197	285	13	among	among	ADP
ajcp-3197	285	14	health	health	NOUN
ajcp-3197	285	15	workers	worker	NOUN
ajcp-3197	285	16	and	and	CCONJ
ajcp-3197	285	17	patients	patient	NOUN
ajcp-3197	285	18	in	in	ADP
ajcp-3197	285	19	selected	select	VERB
ajcp-3197	285	20	primary	primary	ADJ
ajcp-3197	285	21	healthcare	healthcare	NOUN
ajcp-3197	285	22	centres	centre	NOUN
ajcp-3197	285	23	in	in	ADP
ajcp-3197	285	24	ibadan	ibadan	PROPN
ajcp-3197	285	25	,	,	PUNCT
ajcp-3197	285	26	southwestern	southwestern	PROPN
ajcp-3197	285	27	nigeria	nigeria	PROPN
ajcp-3197	285	28	.	.	PUNCT
ajcp-3197	286	1	bmc	bmc	PROPN
ajcp-3197	286	2	health	health	PROPN
ajcp-3197	286	3	services	service	NOUN
ajcp-3197	286	4	research	research	NOUN
ajcp-3197	286	5	,	,	PUNCT
ajcp-3197	286	6	19	19	NUM
ajcp-3197	286	7	,	,	PUNCT
ajcp-3197	286	8	1	1	NUM
ajcp-3197	286	9	-	-	SYM
ajcp-3197	286	10	14	14	NUM
ajcp-3197	286	11	.	.	PUNCT
ajcp-3197	286	12	https://doi.org/10.1186/s12913-019-4775-9	https://doi.org/10.1186/s12913-019-4775-9	NUM
ajcp-3197	286	13	.	.	PUNCT
ajcp-3197	287	1	akhideno	akhideno	NOUN
ajcp-3197	287	2	,	,	PUNCT
ajcp-3197	287	3	p.	p.	PROPN
ajcp-3197	287	4	e.	e.	PROPN
ajcp-3197	287	5	,	,	PUNCT
ajcp-3197	287	6	fasipe	fasipe	VERB
ajcp-3197	287	7	,	,	PUNCT
ajcp-3197	287	8	o.	o.	PROPN
ajcp-3197	287	9	j.	j.	PROPN
ajcp-3197	287	10	,	,	PUNCT
ajcp-3197	287	11	&	&	CCONJ
ajcp-3197	287	12	isah	isah	PROPN
ajcp-3197	287	13	,	,	PUNCT
ajcp-3197	287	14	a.	a.	NOUN
ajcp-3197	287	15	o.	o.	PROPN
ajcp-3197	287	16	(	(	PUNCT
ajcp-3197	287	17	2018	2018	NUM
ajcp-3197	287	18	)	)	PUNCT
ajcp-3197	287	19	.	.	PUNCT
ajcp-3197	288	1	the	the	DET
ajcp-3197	288	2	pa	pa	PROPN
ajcp-3197	288	3	ge	ge	PROPN
ajcp-3197	288	4	8	8	NUM
ajcp-3197	288	5	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	288	6	am	be	AUX
ajcp-3197	288	7	.	.	PUNCT
ajcp-3197	289	1	j.	j.	PROPN
ajcp-3197	289	2	chem	chem	PROPN
ajcp-3197	289	3	.	.	PUNCT
ajcp-3197	290	1	pharm	pharm	PROPN
ajcp-3197	290	2	.	.	PUNCT
ajcp-3197	291	1	3(1	3(1	NUM
ajcp-3197	291	2	)	)	PUNCT
ajcp-3197	291	3	1	1	NUM
ajcp-3197	291	4	-	-	SYM
ajcp-3197	291	5	11	11	NUM
ajcp-3197	291	6	,	,	PUNCT
ajcp-3197	291	7	2024	2024	NUM
ajcp-3197	291	8	incidence	incidence	NOUN
ajcp-3197	291	9	and	and	CCONJ
ajcp-3197	291	10	prevalence	prevalence	NOUN
ajcp-3197	291	11	of	of	ADP
ajcp-3197	291	12	adverse	adverse	ADJ
ajcp-3197	291	13	drug	drug	NOUN
ajcp-3197	291	14	reactions	reaction	NOUN
ajcp-3197	291	15	among	among	ADP
ajcp-3197	291	16	medical	medical	ADJ
ajcp-3197	291	17	inpatients	inpatient	NOUN
ajcp-3197	291	18	in	in	ADP
ajcp-3197	291	19	a	a	DET
ajcp-3197	291	20	nigerian	nigerian	ADJ
ajcp-3197	291	21	university	university	NOUN
ajcp-3197	291	22	teaching	teaching	NOUN
ajcp-3197	291	23	hospital	hospital	NOUN
ajcp-3197	291	24	.	.	PUNCT
ajcp-3197	292	1	journal	journal	NOUN
ajcp-3197	292	2	of	of	ADP
ajcp-3197	292	3	current	current	ADJ
ajcp-3197	292	4	research	research	NOUN
ajcp-3197	292	5	in	in	ADP
ajcp-3197	292	6	scientific	scientific	ADJ
ajcp-3197	292	7	medicine	medicine	NOUN
ajcp-3197	292	8	,	,	PUNCT
ajcp-3197	292	9	4(2	4(2	NUM
ajcp-3197	292	10	)	)	PUNCT
ajcp-3197	292	11	,	,	PUNCT
ajcp-3197	292	12	86	86	NUM
ajcp-3197	292	13	-	-	SYM
ajcp-3197	292	14	93	93	NUM
ajcp-3197	292	15	.	.	PUNCT
ajcp-3197	293	1	alhawassi	alhawassi	ADJ
ajcp-3197	293	2	,	,	PUNCT
ajcp-3197	293	3	t.	t.	NOUN
ajcp-3197	293	4	m.	m.	NOUN
ajcp-3197	293	5	,	,	PUNCT
ajcp-3197	293	6	krass	krass	PROPN
ajcp-3197	293	7	,	,	PUNCT
ajcp-3197	293	8	i.	i.	PROPN
ajcp-3197	293	9	,	,	PUNCT
ajcp-3197	293	10	bajorek	bajorek	PROPN
ajcp-3197	293	11	,	,	PUNCT
ajcp-3197	293	12	b.	b.	PROPN
ajcp-3197	294	1	v.	v.	PROPN
ajcp-3197	294	2	,	,	PUNCT
ajcp-3197	294	3	&	&	CCONJ
ajcp-3197	294	4	pont	pont	PROPN
ajcp-3197	294	5	,	,	PUNCT
ajcp-3197	294	6	l.	l.	PROPN
ajcp-3197	294	7	g.	g.	PROPN
ajcp-3197	294	8	(	(	PUNCT
ajcp-3197	294	9	2014	2014	NUM
ajcp-3197	294	10	)	)	PUNCT
ajcp-3197	294	11	.	.	PUNCT
ajcp-3197	295	1	a	a	DET
ajcp-3197	295	2	systematic	systematic	ADJ
ajcp-3197	295	3	review	review	NOUN
ajcp-3197	295	4	of	of	ADP
ajcp-3197	295	5	the	the	DET
ajcp-3197	295	6	prevalence	prevalence	NOUN
ajcp-3197	295	7	and	and	CCONJ
ajcp-3197	295	8	risk	risk	NOUN
ajcp-3197	295	9	factors	factor	NOUN
ajcp-3197	295	10	for	for	ADP
ajcp-3197	295	11	adverse	adverse	ADJ
ajcp-3197	295	12	drug	drug	NOUN
ajcp-3197	295	13	reactions	reaction	NOUN
ajcp-3197	295	14	in	in	ADP
ajcp-3197	295	15	the	the	DET
ajcp-3197	295	16	elderly	elderly	ADJ
ajcp-3197	295	17	in	in	ADP
ajcp-3197	295	18	the	the	DET
ajcp-3197	295	19	acute	acute	NOUN
ajcp-3197	295	20	care	care	NOUN
ajcp-3197	295	21	setting	setting	NOUN
ajcp-3197	295	22	.	.	PUNCT
ajcp-3197	296	1	clinical	clinical	ADJ
ajcp-3197	296	2	interventions	intervention	NOUN
ajcp-3197	296	3	in	in	ADP
ajcp-3197	296	4	aging	age	VERB
ajcp-3197	296	5	,	,	PUNCT
ajcp-3197	296	6	9	9	NUM
ajcp-3197	296	7	,	,	PUNCT
ajcp-3197	296	8	2079	2079	NUM
ajcp-3197	296	9	-	-	SYM
ajcp-3197	296	10	2086	2086	NUM
ajcp-3197	296	11	.	.	PUNCT
ajcp-3197	297	1	https://doi.org/10.2147/cia.s71178	https://doi.org/10.2147/cia.s71178	NOUN
ajcp-3197	297	2	.	.	PUNCT
ajcp-3197	298	1	ama	ama	PROPN
ajcp-3197	298	2	,	,	PUNCT
ajcp-3197	298	3	m.	m.	NOUN
ajcp-3197	298	4	i.	i.	PROPN
ajcp-3197	298	5	,	,	PUNCT
ajcp-3197	298	6	ikwuka	ikwuka	PROPN
ajcp-3197	298	7	,	,	PUNCT
ajcp-3197	298	8	a.	a.	NOUN
ajcp-3197	298	9	o.	o.	PROPN
ajcp-3197	298	10	,	,	PUNCT
ajcp-3197	298	11	udeh	udeh	PROPN
ajcp-3197	298	12	,	,	PUNCT
ajcp-3197	298	13	f.	f.	PROPN
ajcp-3197	298	14	c.	c.	PROPN
ajcp-3197	298	15	,	,	PUNCT
ajcp-3197	298	16	ekechi	ekechi	NOUN
ajcp-3197	298	17	,	,	PUNCT
ajcp-3197	298	18	h.	h.	PROPN
ajcp-3197	298	19	o.	o.	PROPN
ajcp-3197	298	20	,	,	PUNCT
ajcp-3197	298	21	&	&	CCONJ
ajcp-3197	298	22	eteudo	eteudo	PROPN
ajcp-3197	298	23	,	,	PUNCT
ajcp-3197	298	24	a.	a.	NOUN
ajcp-3197	298	25	n.	n.	NOUN
ajcp-3197	298	26	(	(	PUNCT
ajcp-3197	298	27	2023	2023	NUM
ajcp-3197	298	28	)	)	PUNCT
ajcp-3197	298	29	.	.	PUNCT
ajcp-3197	299	1	sperm	sperm	NOUN
ajcp-3197	299	2	parameters	parameter	NOUN
ajcp-3197	299	3	and	and	CCONJ
ajcp-3197	299	4	testicular	testicular	ADJ
ajcp-3197	299	5	histology	histology	NOUN
ajcp-3197	299	6	of	of	ADP
ajcp-3197	299	7	male	male	PROPN
ajcp-3197	299	8	wistar	wistar	PROPN
ajcp-3197	299	9	rats	rat	NOUN
ajcp-3197	299	10	treated	treat	VERB
ajcp-3197	299	11	with	with	ADP
ajcp-3197	299	12	phoenix	phoenix	PROPN
ajcp-3197	299	13	dactylifera	dactylifera	PROPN
ajcp-3197	299	14	after	after	ADP
ajcp-3197	299	15	consumption	consumption	NOUN
ajcp-3197	299	16	of	of	ADP
ajcp-3197	299	17	local	local	ADJ
ajcp-3197	299	18	mmahi	mmahi	NOUN
ajcp-3197	299	19	salt	salt	NOUN
ajcp-3197	299	20	.	.	PUNCT
ajcp-3197	300	1	american	american	ADJ
ajcp-3197	300	2	journal	journal	PROPN
ajcp-3197	300	3	of	of	ADP
ajcp-3197	300	4	bioscience	bioscience	NOUN
ajcp-3197	300	5	and	and	CCONJ
ajcp-3197	300	6	bioinformatics	bioinformatics	NOUN
ajcp-3197	300	7	,	,	PUNCT
ajcp-3197	300	8	2(1	2(1	NUM
ajcp-3197	300	9	)	)	PUNCT
ajcp-3197	300	10	,	,	PUNCT
ajcp-3197	300	11	4151	4151	NUM
ajcp-3197	300	12	.	.	PUNCT
ajcp-3197	301	1	https://doi.org/10.54536/ajbb.v2i1.2275	https://doi.org/10.54536/ajbb.v2i1.2275	PROPN
ajcp-3197	301	2	.	.	PROPN
ajcp-3197	301	3	amadi	amadi	PROPN
ajcp-3197	301	4	,	,	PUNCT
ajcp-3197	301	5	e.	e.	PROPN
ajcp-3197	301	6	s.	s.	PROPN
ajcp-3197	301	7	,	,	PUNCT
ajcp-3197	301	8	pepple	pepple	PROPN
ajcp-3197	301	9	,	,	PUNCT
ajcp-3197	301	10	e.	e.	PROPN
ajcp-3197	301	11	f.	f.	PROPN
ajcp-3197	301	12	,	,	PUNCT
ajcp-3197	301	13	otike	otike	ADJ
ajcp-3197	301	14	-	-	PUNCT
ajcp-3197	301	15	odibi	odibi	NOUN
ajcp-3197	301	16	,	,	PUNCT
ajcp-3197	301	17	b.	b.	PROPN
ajcp-3197	301	18	,	,	PUNCT
ajcp-3197	301	19	&	&	CCONJ
ajcp-3197	301	20	bellgam	bellgam	PROPN
ajcp-3197	301	21	,	,	PUNCT
ajcp-3197	301	22	h.	h.	PROPN
ajcp-3197	301	23	i.	i.	PROPN
ajcp-3197	301	24	(	(	PUNCT
ajcp-3197	301	25	2021	2021	NUM
ajcp-3197	301	26	)	)	PUNCT
ajcp-3197	301	27	.	.	PUNCT
ajcp-3197	302	1	adverse	adverse	ADJ
ajcp-3197	302	2	drug	drug	NOUN
ajcp-3197	302	3	reactions	reaction	NOUN
ajcp-3197	302	4	amongst	amongst	ADV
ajcp-3197	302	5	admitted	admit	VERB
ajcp-3197	302	6	advanced	advanced	ADJ
ajcp-3197	302	7	age	age	NOUN
ajcp-3197	302	8	africans	africans	PROPN
ajcp-3197	302	9	.	.	PUNCT
ajcp-3197	303	1	world	world	PROPN
ajcp-3197	303	2	journal	journal	PROPN
ajcp-3197	303	3	of	of	ADP
ajcp-3197	303	4	advanced	advanced	ADJ
ajcp-3197	303	5	research	research	NOUN
ajcp-3197	303	6	and	and	CCONJ
ajcp-3197	303	7	reviews	review	NOUN
ajcp-3197	303	8	,	,	PUNCT
ajcp-3197	303	9	12(3	12(3	NUM
ajcp-3197	303	10	)	)	PUNCT
ajcp-3197	303	11	,	,	PUNCT
ajcp-3197	303	12	427	427	NUM
ajcp-3197	303	13	-	-	SYM
ajcp-3197	303	14	433	433	NUM
ajcp-3197	303	15	.	.	PUNCT
ajcp-3197	304	1	https://	https://	PROPN
ajcp-3197	304	2	doi.org/10.30574/wjarr.2021.12.3.0712	doi.org/10.30574/wjarr.2021.12.3.0712	PROPN
ajcp-3197	304	3	.	.	PUNCT
ajcp-3197	305	1	aronson	aronson	PROPN
ajcp-3197	305	2	,	,	PUNCT
ajcp-3197	305	3	j.	j.	PROPN
ajcp-3197	305	4	k.	k.	PROPN
ajcp-3197	305	5	,	,	PUNCT
ajcp-3197	305	6	&	&	CCONJ
ajcp-3197	305	7	ferner	ferner	PROPN
ajcp-3197	305	8	,	,	PUNCT
ajcp-3197	305	9	r.	r.	PROPN
ajcp-3197	305	10	e.	e.	PROPN
ajcp-3197	305	11	(	(	PUNCT
ajcp-3197	305	12	2005	2005	NUM
ajcp-3197	305	13	)	)	PUNCT
ajcp-3197	305	14	.	.	PUNCT
ajcp-3197	306	1	clarification	clarification	NOUN
ajcp-3197	306	2	of	of	ADP
ajcp-3197	306	3	terminology	terminology	NOUN
ajcp-3197	306	4	in	in	ADP
ajcp-3197	306	5	drug	drug	NOUN
ajcp-3197	306	6	safety	safety	NOUN
ajcp-3197	306	7	.	.	PUNCT
ajcp-3197	307	1	drug	drug	NOUN
ajcp-3197	307	2	safety	safety	NOUN
ajcp-3197	307	3	,	,	PUNCT
ajcp-3197	307	4	28	28	NUM
ajcp-3197	307	5	,	,	PUNCT
ajcp-3197	307	6	851	851	NUM
ajcp-3197	307	7	-	-	SYM
ajcp-3197	307	8	870	870	NUM
ajcp-3197	307	9	.	.	PUNCT
ajcp-3197	308	1	baysah	baysah	NOUN
ajcp-3197	308	2	,	,	PUNCT
ajcp-3197	308	3	p.	p.	NOUN
ajcp-3197	308	4	v.	v.	PROPN
ajcp-3197	308	5	,	,	PUNCT
ajcp-3197	308	6	ikwuka	ikwuka	PROPN
ajcp-3197	308	7	,	,	PUNCT
ajcp-3197	308	8	a.	a.	NOUN
ajcp-3197	308	9	o.	o.	PROPN
ajcp-3197	308	10	,	,	PUNCT
ajcp-3197	308	11	udeh	udeh	PROPN
ajcp-3197	308	12	,	,	PUNCT
ajcp-3197	308	13	f.	f.	PROPN
ajcp-3197	308	14	c.	c.	PROPN
ajcp-3197	308	15	,	,	PUNCT
ajcp-3197	308	16	bleh	bleh	NOUN
ajcp-3197	308	17	,	,	PUNCT
ajcp-3197	308	18	d.	d.	PROPN
ajcp-3197	308	19	p.	p.	PROPN
ajcp-3197	308	20	,	,	PUNCT
ajcp-3197	308	21	&	&	CCONJ
ajcp-3197	308	22	viloria	viloria	PROPN
ajcp-3197	308	23	,	,	PUNCT
ajcp-3197	308	24	t.	t.	PROPN
ajcp-3197	308	25	(	(	PUNCT
ajcp-3197	308	26	2023	2023	NUM
ajcp-3197	308	27	)	)	PUNCT
ajcp-3197	308	28	.	.	PUNCT
ajcp-3197	309	1	pathophysiological	pathophysiological	ADJ
ajcp-3197	309	2	effects	effect	NOUN
ajcp-3197	309	3	of	of	ADP
ajcp-3197	309	4	alcohol	alcohol	NOUN
ajcp-3197	309	5	and	and	CCONJ
ajcp-3197	309	6	tobacco	tobacco	NOUN
ajcp-3197	309	7	consumption	consumption	NOUN
ajcp-3197	309	8	on	on	ADP
ajcp-3197	309	9	semen	semen	NOUN
ajcp-3197	309	10	parameters	parameter	NOUN
ajcp-3197	309	11	of	of	ADP
ajcp-3197	309	12	men	man	NOUN
ajcp-3197	309	13	attending	attend	VERB
ajcp-3197	309	14	a	a	DET
ajcp-3197	309	15	fertility	fertility	NOUN
ajcp-3197	309	16	clinic	clinic	NOUN
ajcp-3197	309	17	in	in	ADP
ajcp-3197	309	18	west	west	PROPN
ajcp-3197	309	19	africa	africa	PROPN
ajcp-3197	309	20	.	.	PUNCT
ajcp-3197	310	1	american	american	PROPN
ajcp-3197	310	2	journal	journal	PROPN
ajcp-3197	310	3	of	of	ADP
ajcp-3197	310	4	biomedical	biomedical	ADJ
ajcp-3197	310	5	and	and	CCONJ
ajcp-3197	310	6	life	life	NOUN
ajcp-3197	310	7	sciences	science	NOUN
ajcp-3197	310	8	,	,	PUNCT
ajcp-3197	310	9	11(4	11(4	NUM
ajcp-3197	310	10	)	)	PUNCT
ajcp-3197	310	11	,	,	PUNCT
ajcp-3197	310	12	73	73	NUM
ajcp-3197	310	13	-	-	SYM
ajcp-3197	310	14	81	81	NUM
ajcp-3197	310	15	.	.	PUNCT
ajcp-3197	311	1	https://doi.org/10.11648/j	https://doi.org/10.11648/j	PROPN
ajcp-3197	311	2	.	.	PUNCT
ajcp-3197	312	1	ajbls.20231104.13	ajbls.20231104.13	PROPN
ajcp-3197	312	2	.	.	PUNCT
ajcp-3197	312	3	borodo	borodo	PROPN
ajcp-3197	312	4	,	,	PUNCT
ajcp-3197	312	5	s.	s.	PROPN
ajcp-3197	312	6	b.	b.	PROPN
ajcp-3197	312	7	,	,	PUNCT
ajcp-3197	312	8	jatau	jatau	PROPN
ajcp-3197	312	9	,	,	PUNCT
ajcp-3197	312	10	a.	a.	NOUN
ajcp-3197	312	11	i.	i.	PROPN
ajcp-3197	312	12	,	,	PUNCT
ajcp-3197	312	13	mohammed	mohammed	PROPN
ajcp-3197	312	14	,	,	PUNCT
ajcp-3197	312	15	m.	m.	NOUN
ajcp-3197	312	16	,	,	PUNCT
ajcp-3197	312	17	aminu	aminu	PROPN
ajcp-3197	312	18	,	,	PUNCT
ajcp-3197	312	19	n.	n.	PROPN
ajcp-3197	312	20	,	,	PUNCT
ajcp-3197	312	21	shitu	shitu	PROPN
ajcp-3197	312	22	,	,	PUNCT
ajcp-3197	312	23	z.	z.	PROPN
ajcp-3197	312	24	,	,	PUNCT
ajcp-3197	312	25	&	&	CCONJ
ajcp-3197	312	26	sha’aban	sha’aban	PROPN
ajcp-3197	312	27	,	,	PUNCT
ajcp-3197	312	28	a.	a.	NOUN
ajcp-3197	312	29	(	(	PUNCT
ajcp-3197	312	30	2022	2022	NUM
ajcp-3197	312	31	)	)	PUNCT
ajcp-3197	312	32	.	.	PUNCT
ajcp-3197	313	1	the	the	DET
ajcp-3197	313	2	burden	burden	NOUN
ajcp-3197	313	3	of	of	ADP
ajcp-3197	313	4	polypharmacy	polypharmacy	NOUN
ajcp-3197	313	5	and	and	CCONJ
ajcp-3197	313	6	potentially	potentially	ADV
ajcp-3197	313	7	inappropriate	inappropriate	ADJ
ajcp-3197	313	8	medication	medication	NOUN
ajcp-3197	313	9	in	in	ADP
ajcp-3197	313	10	nigeria	nigeria	PROPN
ajcp-3197	313	11	:	:	PUNCT
ajcp-3197	313	12	a	a	DET
ajcp-3197	313	13	clarion	clarion	NOUN
ajcp-3197	313	14	call	call	NOUN
ajcp-3197	313	15	for	for	ADP
ajcp-3197	313	16	deprescribing	deprescribe	VERB
ajcp-3197	313	17	practice	practice	NOUN
ajcp-3197	313	18	.	.	PUNCT
ajcp-3197	314	1	bulletin	bulletin	NOUN
ajcp-3197	314	2	of	of	ADP
ajcp-3197	314	3	the	the	DET
ajcp-3197	314	4	national	national	ADJ
ajcp-3197	314	5	research	research	PROPN
ajcp-3197	314	6	centre	centre	PROPN
ajcp-3197	314	7	,	,	PUNCT
ajcp-3197	314	8	46(1	46(1	PROPN
ajcp-3197	314	9	)	)	PUNCT
ajcp-3197	314	10	,	,	PUNCT
ajcp-3197	314	11	1	1	NUM
ajcp-3197	314	12	-	-	SYM
ajcp-3197	314	13	8	8	NUM
ajcp-3197	314	14	.	.	PUNCT
ajcp-3197	314	15	https://doi.org/10.1186/s42269-022-00864-3	https://doi.org/10.1186/s42269-022-00864-3	PROPN
ajcp-3197	314	16	.	.	PUNCT
ajcp-3197	315	1	brvar	brvar	PROPN
ajcp-3197	315	2	,	,	PUNCT
ajcp-3197	315	3	m.	m.	NOUN
ajcp-3197	315	4	,	,	PUNCT
ajcp-3197	315	5	fokter	fokter	NOUN
ajcp-3197	315	6	,	,	PUNCT
ajcp-3197	315	7	n.	n.	NOUN
ajcp-3197	315	8	,	,	PUNCT
ajcp-3197	315	9	bunc	bunc	NOUN
ajcp-3197	315	10	,	,	PUNCT
ajcp-3197	315	11	m.	m.	NOUN
ajcp-3197	315	12	,	,	PUNCT
ajcp-3197	315	13	&	&	CCONJ
ajcp-3197	315	14	mozina	mozina	PROPN
ajcp-3197	315	15	,	,	PUNCT
ajcp-3197	315	16	m.	m.	NOUN
ajcp-3197	315	17	(	(	PUNCT
ajcp-3197	315	18	2009	2009	NUM
ajcp-3197	315	19	)	)	PUNCT
ajcp-3197	315	20	.	.	PUNCT
ajcp-3197	316	1	the	the	DET
ajcp-3197	316	2	frequency	frequency	NOUN
ajcp-3197	316	3	of	of	ADP
ajcp-3197	316	4	adverse	adverse	ADJ
ajcp-3197	316	5	drug	drug	NOUN
ajcp-3197	316	6	reaction	reaction	NOUN
ajcp-3197	316	7	related	relate	VERB
ajcp-3197	316	8	admissions	admission	NOUN
ajcp-3197	316	9	according	accord	VERB
ajcp-3197	316	10	to	to	ADP
ajcp-3197	316	11	method	method	NOUN
ajcp-3197	316	12	of	of	ADP
ajcp-3197	316	13	detection	detection	NOUN
ajcp-3197	316	14	,	,	PUNCT
ajcp-3197	316	15	admission	admission	NOUN
ajcp-3197	316	16	urgency	urgency	NOUN
ajcp-3197	316	17	and	and	CCONJ
ajcp-3197	316	18	medical	medical	ADJ
ajcp-3197	316	19	department	department	PROPN
ajcp-3197	316	20	specialty	specialty	NOUN
ajcp-3197	316	21	.	.	PUNCT
ajcp-3197	317	1	bmc	bmc	ADJ
ajcp-3197	317	2	clinical	clinical	ADJ
ajcp-3197	317	3	pharmacology	pharmacology	NOUN
ajcp-3197	317	4	,	,	PUNCT
ajcp-3197	317	5	9	9	NUM
ajcp-3197	317	6	,	,	PUNCT
ajcp-3197	317	7	1	1	NUM
ajcp-3197	317	8	-	-	SYM
ajcp-3197	317	9	8	8	NUM
ajcp-3197	317	10	.	.	PUNCT
ajcp-3197	317	11	charlesworth	charlesworth	NOUN
ajcp-3197	317	12	,	,	PUNCT
ajcp-3197	317	13	c.	c.	PROPN
ajcp-3197	317	14	j.	j.	PROPN
ajcp-3197	317	15	,	,	PUNCT
ajcp-3197	317	16	smit	smit	PROPN
ajcp-3197	317	17	,	,	PUNCT
ajcp-3197	317	18	e.	e.	PROPN
ajcp-3197	317	19	,	,	PUNCT
ajcp-3197	317	20	lee	lee	PROPN
ajcp-3197	317	21	,	,	PUNCT
ajcp-3197	317	22	d.	d.	PROPN
ajcp-3197	317	23	s.	s.	PROPN
ajcp-3197	317	24	,	,	PUNCT
ajcp-3197	317	25	alramadhan	alramadhan	PROPN
ajcp-3197	317	26	,	,	PUNCT
ajcp-3197	317	27	f.	f.	PROPN
ajcp-3197	317	28	,	,	PUNCT
ajcp-3197	317	29	&	&	CCONJ
ajcp-3197	317	30	odden	odden	ADJ
ajcp-3197	317	31	,	,	PUNCT
ajcp-3197	317	32	m.	m.	NOUN
ajcp-3197	317	33	c.	c.	PROPN
ajcp-3197	317	34	(	(	PUNCT
ajcp-3197	317	35	2015	2015	NUM
ajcp-3197	317	36	)	)	PUNCT
ajcp-3197	317	37	.	.	PUNCT
ajcp-3197	318	1	polypharmacy	polypharmacy	NOUN
ajcp-3197	318	2	among	among	ADP
ajcp-3197	318	3	adults	adult	NOUN
ajcp-3197	318	4	aged	age	VERB
ajcp-3197	318	5	65	65	NUM
ajcp-3197	318	6	years	year	NOUN
ajcp-3197	318	7	and	and	CCONJ
ajcp-3197	318	8	older	old	ADJ
ajcp-3197	318	9	in	in	ADP
ajcp-3197	318	10	the	the	DET
ajcp-3197	318	11	united	united	PROPN
ajcp-3197	318	12	states	states	PROPN
ajcp-3197	318	13	:	:	PUNCT
ajcp-3197	318	14	1988	1988	NUM
ajcp-3197	318	15	–	–	PUNCT
ajcp-3197	318	16	2010	2010	NUM
ajcp-3197	318	17	.	.	PUNCT
ajcp-3197	319	1	journals	journal	NOUN
ajcp-3197	319	2	of	of	ADP
ajcp-3197	319	3	gerontology	gerontology	NOUN
ajcp-3197	319	4	series	series	PROPN
ajcp-3197	319	5	a	a	PRON
ajcp-3197	319	6	:	:	PUNCT
ajcp-3197	319	7	biomedical	biomedical	ADJ
ajcp-3197	319	8	sciences	sciences	PROPN
ajcp-3197	319	9	and	and	CCONJ
ajcp-3197	319	10	medical	medical	ADJ
ajcp-3197	319	11	sciences	science	NOUN
ajcp-3197	319	12	,	,	PUNCT
ajcp-3197	319	13	70(8	70(8	NUM
ajcp-3197	319	14	)	)	PUNCT
ajcp-3197	319	15	,	,	PUNCT
ajcp-3197	319	16	989	989	NUM
ajcp-3197	319	17	-	-	SYM
ajcp-3197	319	18	995	995	NUM
ajcp-3197	319	19	.	.	PUNCT
ajcp-3197	320	1	https://doi.org/	https://doi.org/	VERB
ajcp-3197	320	2	10.1093	10.1093	NUM
ajcp-3197	320	3	/	/	SYM
ajcp-3197	320	4	gerona	gerona	PROPN
ajcp-3197	320	5	/	/	SYM
ajcp-3197	320	6	glv013	glv013	PROPN
ajcp-3197	320	7	.	.	PUNCT
ajcp-3197	321	1	cohen	cohen	PROPN
ajcp-3197	321	2	,	,	PUNCT
ajcp-3197	321	3	j.	j.	PROPN
ajcp-3197	321	4	(	(	PUNCT
ajcp-3197	321	5	1968	1968	NUM
ajcp-3197	321	6	)	)	PUNCT
ajcp-3197	321	7	.	.	PUNCT
ajcp-3197	322	1	weighted	weight	VERB
ajcp-3197	322	2	kappa	kappa	ADJ
ajcp-3197	322	3	:	:	PUNCT
ajcp-3197	322	4	nominal	nominal	ADJ
ajcp-3197	322	5	scale	scale	NOUN
ajcp-3197	322	6	agreement	agreement	NOUN
ajcp-3197	322	7	provision	provision	NOUN
ajcp-3197	322	8	for	for	ADP
ajcp-3197	322	9	scaled	scale	VERB
ajcp-3197	322	10	disagreement	disagreement	NOUN
ajcp-3197	322	11	or	or	CCONJ
ajcp-3197	322	12	partial	partial	ADJ
ajcp-3197	322	13	credit	credit	NOUN
ajcp-3197	322	14	.	.	PUNCT
ajcp-3197	323	1	psychological	psychological	ADJ
ajcp-3197	323	2	bulletin	bulletin	NOUN
ajcp-3197	323	3	,	,	PUNCT
ajcp-3197	323	4	70(4	70(4	NUM
ajcp-3197	323	5	)	)	PUNCT
ajcp-3197	323	6	,	,	PUNCT
ajcp-3197	323	7	213	213	NUM
ajcp-3197	323	8	.	.	PUNCT
ajcp-3197	324	1	https://	https://	PROPN
ajcp-3197	324	2	doi.org/10.1037/h0026256	doi.org/10.1037/h0026256	PROPN
ajcp-3197	324	3	.	.	PUNCT
ajcp-3197	324	4	coleman	coleman	PROPN
ajcp-3197	324	5	,	,	PUNCT
ajcp-3197	324	6	j.	j.	PROPN
ajcp-3197	324	7	j.	j.	PROPN
ajcp-3197	324	8	,	,	PUNCT
ajcp-3197	324	9	&	&	CCONJ
ajcp-3197	324	10	pontefract	pontefract	PROPN
ajcp-3197	324	11	,	,	PUNCT
ajcp-3197	324	12	s.	s.	PROPN
ajcp-3197	324	13	k.	k.	PROPN
ajcp-3197	324	14	(	(	PUNCT
ajcp-3197	324	15	2016	2016	NUM
ajcp-3197	324	16	)	)	PUNCT
ajcp-3197	324	17	.	.	PUNCT
ajcp-3197	325	1	adverse	adverse	ADJ
ajcp-3197	325	2	drug	drug	NOUN
ajcp-3197	325	3	reactions	reaction	NOUN
ajcp-3197	325	4	.	.	PUNCT
ajcp-3197	326	1	clinical	clinical	ADJ
ajcp-3197	326	2	medicine	medicine	NOUN
ajcp-3197	326	3	,	,	PUNCT
ajcp-3197	326	4	16(5	16(5	NUM
ajcp-3197	326	5	)	)	PUNCT
ajcp-3197	326	6	,	,	PUNCT
ajcp-3197	326	7	481	481	NUM
ajcp-3197	326	8	.	.	PUNCT
ajcp-3197	327	1	https://doi	https://doi	NOUN
ajcp-3197	327	2	.	.	PUNCT
ajcp-3197	327	3	org/10.7861	org/10.7861	PROPN
ajcp-3197	327	4	/	/	SYM
ajcp-3197	327	5	clinmedicine.16	clinmedicine.16	PROPN
ajcp-3197	327	6	-	-	PUNCT
ajcp-3197	327	7	5	5	NUM
ajcp-3197	327	8	-	-	SYM
ajcp-3197	327	9	481	481	NUM
ajcp-3197	327	10	.	.	PUNCT
ajcp-3197	328	1	davies	davy	NOUN
ajcp-3197	328	2	,	,	PUNCT
ajcp-3197	328	3	e.	e.	PROPN
ajcp-3197	328	4	a.	a.	PROPN
ajcp-3197	328	5	,	,	PUNCT
ajcp-3197	328	6	&	&	CCONJ
ajcp-3197	328	7	o’mahony	o’mahony	PROPN
ajcp-3197	328	8	,	,	PUNCT
ajcp-3197	328	9	m.	m.	NOUN
ajcp-3197	328	10	s.	s.	PROPN
ajcp-3197	328	11	(	(	PUNCT
ajcp-3197	328	12	2015	2015	NUM
ajcp-3197	328	13	)	)	PUNCT
ajcp-3197	328	14	.	.	PUNCT
ajcp-3197	329	1	adverse	adverse	ADJ
ajcp-3197	329	2	drug	drug	NOUN
ajcp-3197	329	3	reactions	reaction	NOUN
ajcp-3197	329	4	in	in	ADP
ajcp-3197	329	5	special	special	ADJ
ajcp-3197	329	6	populations	population	NOUN
ajcp-3197	329	7	–	–	PUNCT
ajcp-3197	329	8	the	the	DET
ajcp-3197	329	9	elderly	elderly	ADJ
ajcp-3197	329	10	.	.	PUNCT
ajcp-3197	330	1	british	british	ADJ
ajcp-3197	330	2	journal	journal	PROPN
ajcp-3197	330	3	of	of	ADP
ajcp-3197	330	4	clinical	clinical	ADJ
ajcp-3197	330	5	pharmacology	pharmacology	NOUN
ajcp-3197	330	6	,	,	PUNCT
ajcp-3197	330	7	80(4	80(4	NUM
ajcp-3197	330	8	)	)	PUNCT
ajcp-3197	330	9	,	,	PUNCT
ajcp-3197	330	10	796	796	NUM
ajcp-3197	330	11	-	-	SYM
ajcp-3197	330	12	807	807	NUM
ajcp-3197	330	13	.	.	PUNCT
ajcp-3197	331	1	https://	https://	PROPN
ajcp-3197	331	2	doi.org/10.1111/bcp.12596	doi.org/10.1111/bcp.12596	PROPN
ajcp-3197	331	3	.	.	PUNCT
ajcp-3197	332	1	davies	davy	NOUN
ajcp-3197	332	2	,	,	PUNCT
ajcp-3197	332	3	l.	l.	PROPN
ajcp-3197	332	4	e.	e.	PROPN
ajcp-3197	332	5	,	,	PUNCT
ajcp-3197	332	6	spiers	spiers	PROPN
ajcp-3197	332	7	,	,	PUNCT
ajcp-3197	332	8	g.	g.	PROPN
ajcp-3197	332	9	,	,	PUNCT
ajcp-3197	332	10	kingston	kingston	PROPN
ajcp-3197	332	11	,	,	PUNCT
ajcp-3197	332	12	a.	a.	PROPN
ajcp-3197	332	13	,	,	PUNCT
ajcp-3197	332	14	todd	todd	PROPN
ajcp-3197	332	15	,	,	PUNCT
ajcp-3197	332	16	a.	a.	PROPN
ajcp-3197	332	17	,	,	PUNCT
ajcp-3197	332	18	adamson	adamson	PROPN
ajcp-3197	332	19	,	,	PUNCT
ajcp-3197	332	20	j.	j.	PROPN
ajcp-3197	332	21	,	,	PUNCT
ajcp-3197	332	22	&	&	CCONJ
ajcp-3197	332	23	hanratty	hanratty	PROPN
ajcp-3197	332	24	,	,	PUNCT
ajcp-3197	332	25	b.	b.	PROPN
ajcp-3197	332	26	(	(	PUNCT
ajcp-3197	332	27	2020	2020	NUM
ajcp-3197	332	28	)	)	PUNCT
ajcp-3197	332	29	.	.	PUNCT
ajcp-3197	333	1	adverse	adverse	ADJ
ajcp-3197	333	2	outcomes	outcome	NOUN
ajcp-3197	333	3	of	of	ADP
ajcp-3197	333	4	polypharmacy	polypharmacy	NOUN
ajcp-3197	333	5	in	in	ADP
ajcp-3197	333	6	older	old	ADJ
ajcp-3197	333	7	people	people	NOUN
ajcp-3197	333	8	:	:	PUNCT
ajcp-3197	333	9	systematic	systematic	ADJ
ajcp-3197	333	10	review	review	NOUN
ajcp-3197	333	11	of	of	ADP
ajcp-3197	333	12	reviews	review	NOUN
ajcp-3197	333	13	.	.	PUNCT
ajcp-3197	334	1	journal	journal	NOUN
ajcp-3197	334	2	of	of	ADP
ajcp-3197	334	3	the	the	DET
ajcp-3197	334	4	american	american	PROPN
ajcp-3197	334	5	medical	medical	PROPN
ajcp-3197	334	6	directors	directors	PROPN
ajcp-3197	334	7	association	association	PROPN
ajcp-3197	334	8	,	,	PUNCT
ajcp-3197	334	9	21(2	21(2	NUM
ajcp-3197	334	10	)	)	PUNCT
ajcp-3197	334	11	,	,	PUNCT
ajcp-3197	334	12	181	181	NUM
ajcp-3197	334	13	-	-	SYM
ajcp-3197	334	14	187	187	NUM
ajcp-3197	334	15	.	.	PUNCT
ajcp-3197	334	16	de	de	X
ajcp-3197	334	17	figueiredo	figueiredo	PROPN
ajcp-3197	334	18	,	,	PUNCT
ajcp-3197	334	19	t.	t.	PROPN
ajcp-3197	334	20	p.	p.	PROPN
ajcp-3197	334	21	,	,	PUNCT
ajcp-3197	334	22	de	de	PROPN
ajcp-3197	334	23	souza	souza	PROPN
ajcp-3197	334	24	groia	groia	PROPN
ajcp-3197	334	25	,	,	PUNCT
ajcp-3197	334	26	r.	r.	PROPN
ajcp-3197	334	27	c.	c.	PROPN
ajcp-3197	334	28	,	,	PUNCT
ajcp-3197	334	29	barroso	barroso	PROPN
ajcp-3197	334	30	,	,	PUNCT
ajcp-3197	334	31	s.	s.	PROPN
ajcp-3197	334	32	c.	c.	PROPN
ajcp-3197	334	33	c.	c.	PROPN
ajcp-3197	334	34	,	,	PUNCT
ajcp-3197	334	35	do	do	VERB
ajcp-3197	334	36	nascimento	nascimento	PROPN
ajcp-3197	334	37	,	,	PUNCT
ajcp-3197	334	38	m.	m.	NOUN
ajcp-3197	334	39	m.	m.	PROPN
ajcp-3197	334	40	g.	g.	PROPN
ajcp-3197	334	41	,	,	PUNCT
ajcp-3197	334	42	&	&	CCONJ
ajcp-3197	334	43	reis	reis	NOUN
ajcp-3197	334	44	,	,	PUNCT
ajcp-3197	334	45	a.	a.	NOUN
ajcp-3197	334	46	m.	m.	NOUN
ajcp-3197	334	47	m.	m.	NOUN
ajcp-3197	334	48	(	(	PUNCT
ajcp-3197	334	49	2017	2017	NUM
ajcp-3197	334	50	)	)	PUNCT
ajcp-3197	334	51	.	.	PUNCT
ajcp-3197	335	1	factors	factor	NOUN
ajcp-3197	335	2	associated	associate	VERB
ajcp-3197	335	3	with	with	ADP
ajcp-3197	335	4	adverse	adverse	ADJ
ajcp-3197	335	5	drug	drug	NOUN
ajcp-3197	335	6	reactions	reaction	NOUN
ajcp-3197	335	7	in	in	ADP
ajcp-3197	335	8	older	old	ADJ
ajcp-3197	335	9	inpatients	inpatient	NOUN
ajcp-3197	335	10	in	in	ADP
ajcp-3197	335	11	teaching	teach	VERB
ajcp-3197	335	12	hospital	hospital	NOUN
ajcp-3197	335	13	.	.	PUNCT
ajcp-3197	336	1	international	international	ADJ
ajcp-3197	336	2	journal	journal	NOUN
ajcp-3197	336	3	of	of	ADP
ajcp-3197	336	4	clinical	clinical	ADJ
ajcp-3197	336	5	pharmacy	pharmacy	NOUN
ajcp-3197	336	6	,	,	PUNCT
ajcp-3197	336	7	39	39	NUM
ajcp-3197	336	8	,	,	PUNCT
ajcp-3197	336	9	679	679	NUM
ajcp-3197	336	10	-	-	SYM
ajcp-3197	336	11	685	685	NUM
ajcp-3197	336	12	.	.	PUNCT
ajcp-3197	336	13	drini	drini	NOUN
ajcp-3197	336	14	m.	m.	NOUN
ajcp-3197	336	15	(	(	PUNCT
ajcp-3197	336	16	2017	2017	NUM
ajcp-3197	336	17	)	)	PUNCT
ajcp-3197	336	18	.	.	PUNCT
ajcp-3197	337	1	peptic	peptic	ADJ
ajcp-3197	337	2	ulcer	ulcer	NOUN
ajcp-3197	337	3	disease	disease	NOUN
ajcp-3197	337	4	and	and	CCONJ
ajcp-3197	337	5	non	non	ADJ
ajcp-3197	337	6	-	-	ADJ
ajcp-3197	337	7	steroidal	steroidal	ADJ
ajcp-3197	337	8	anti	anti	ADJ
ajcp-3197	337	9	-	-	ADJ
ajcp-3197	337	10	inflammatory	inflammatory	ADJ
ajcp-3197	337	11	drugs	drug	NOUN
ajcp-3197	337	12	.	.	PUNCT
ajcp-3197	338	1	aust	aust	PROPN
ajcp-3197	338	2	prescr	prescr	PROPN
ajcp-3197	338	3	,	,	PUNCT
ajcp-3197	338	4	40(3	40(3	NUM
ajcp-3197	338	5	)	)	PUNCT
ajcp-3197	338	6	,	,	PUNCT
ajcp-3197	338	7	91	91	NUM
ajcp-3197	338	8	-	-	SYM
ajcp-3197	338	9	93	93	NUM
ajcp-3197	338	10	.	.	PUNCT
ajcp-3197	339	1	https://doi.org/10.18773/austprescr.2017.037	https://doi.org/10.18773/austprescr.2017.037	PROPN
ajcp-3197	339	2	.	.	PUNCT
ajcp-3197	340	1	ekechi	ekechi	PROPN
ajcp-3197	340	2	,	,	PUNCT
ajcp-3197	340	3	h.	h.	PROPN
ajcp-3197	340	4	o.	o.	PROPN
ajcp-3197	340	5	,	,	PUNCT
ajcp-3197	340	6	ikwuka	ikwuka	PROPN
ajcp-3197	340	7	,	,	PUNCT
ajcp-3197	340	8	a.	a.	NOUN
ajcp-3197	340	9	o.	o.	PROPN
ajcp-3197	340	10	,	,	PUNCT
ajcp-3197	340	11	udeh	udeh	PROPN
ajcp-3197	340	12	,	,	PUNCT
ajcp-3197	340	13	f.	f.	PROPN
ajcp-3197	340	14	c.	c.	PROPN
ajcp-3197	340	15	,	,	PUNCT
ajcp-3197	340	16	&	&	CCONJ
ajcp-3197	340	17	abraham	abraham	PROPN
ajcp-3197	340	18	,	,	PUNCT
ajcp-3197	340	19	j.	j.	PROPN
ajcp-3197	340	20	c.	c.	PROPN
ajcp-3197	340	21	(	(	PUNCT
ajcp-3197	340	22	2023a	2023a	NUM
ajcp-3197	340	23	)	)	PUNCT
ajcp-3197	340	24	.	.	PUNCT
ajcp-3197	341	1	effects	effect	NOUN
ajcp-3197	341	2	of	of	ADP
ajcp-3197	341	3	ethanol	ethanol	NOUN
ajcp-3197	341	4	extract	extract	NOUN
ajcp-3197	341	5	of	of	ADP
ajcp-3197	341	6	rauwolfia	rauwolfia	NOUN
ajcp-3197	341	7	vomitoria	vomitoria	NOUN
ajcp-3197	341	8	leaf	leaf	NOUN
ajcp-3197	341	9	on	on	ADP
ajcp-3197	341	10	lipid	lipid	NOUN
ajcp-3197	341	11	profile	profile	NOUN
ajcp-3197	341	12	and	and	CCONJ
ajcp-3197	341	13	cerebellar	cerebellar	ADJ
ajcp-3197	341	14	histology	histology	NOUN
ajcp-3197	341	15	in	in	ADP
ajcp-3197	341	16	cisplatin	cisplatin	NOUN
ajcp-3197	341	17	-	-	PUNCT
ajcp-3197	341	18	induced	induce	VERB
ajcp-3197	341	19	oxidative	oxidative	ADJ
ajcp-3197	341	20	stress	stress	NOUN
ajcp-3197	341	21	.	.	PUNCT
ajcp-3197	342	1	british	british	ADJ
ajcp-3197	342	2	journal	journal	PROPN
ajcp-3197	342	3	of	of	ADP
ajcp-3197	342	4	medical	medical	ADJ
ajcp-3197	342	5	and	and	CCONJ
ajcp-3197	342	6	health	health	NOUN
ajcp-3197	342	7	research	research	NOUN
ajcp-3197	342	8	,	,	PUNCT
ajcp-3197	342	9	10(5	10(5	NUM
ajcp-3197	342	10	)	)	PUNCT
ajcp-3197	342	11	,	,	PUNCT
ajcp-3197	342	12	1639	1639	NUM
ajcp-3197	342	13	.	.	PUNCT
ajcp-3197	343	1	https://doi.org/10.5281/zenodo.8042521	https://doi.org/10.5281/zenodo.8042521	VERB
ajcp-3197	343	2	.	.	PUNCT
ajcp-3197	343	3	ekechi	ekechi	PROPN
ajcp-3197	343	4	,	,	PUNCT
ajcp-3197	343	5	h.	h.	PROPN
ajcp-3197	343	6	o.	o.	PROPN
ajcp-3197	343	7	,	,	PUNCT
ajcp-3197	343	8	ikwuka	ikwuka	PROPN
ajcp-3197	343	9	,	,	PUNCT
ajcp-3197	343	10	a.	a.	NOUN
ajcp-3197	343	11	o.	o.	PROPN
ajcp-3197	343	12	,	,	PUNCT
ajcp-3197	343	13	udeh	udeh	PROPN
ajcp-3197	343	14	,	,	PUNCT
ajcp-3197	343	15	f.	f.	PROPN
ajcp-3197	343	16	c.	c.	PROPN
ajcp-3197	343	17	,	,	PUNCT
ajcp-3197	343	18	epete	epete	NOUN
ajcp-3197	343	19	,	,	PUNCT
ajcp-3197	343	20	m.	m.	NOUN
ajcp-3197	343	21	a.	a.	PROPN
ajcp-3197	343	22	,	,	PUNCT
ajcp-3197	343	23	&	&	CCONJ
ajcp-3197	343	24	uche	uche	PROPN
ajcp-3197	343	25	,	,	PUNCT
ajcp-3197	344	1	v.	v.	PROPN
ajcp-3197	344	2	u.	u.	PROPN
ajcp-3197	344	3	(	(	PUNCT
ajcp-3197	344	4	2023)b	2023)b	NUM
ajcp-3197	344	5	.	.	PUNCT
ajcp-3197	345	1	hepatorenal	hepatorenal	ADJ
ajcp-3197	345	2	protective	protective	ADJ
ajcp-3197	345	3	functions	function	NOUN
ajcp-3197	345	4	of	of	ADP
ajcp-3197	345	5	coconut	coconut	NOUN
ajcp-3197	345	6	water	water	NOUN
ajcp-3197	345	7	in	in	ADP
ajcp-3197	345	8	alloxan	alloxan	NOUN
ajcp-3197	345	9	-	-	PUNCT
ajcp-3197	345	10	induced	induce	VERB
ajcp-3197	345	11	type	type	NOUN
ajcp-3197	345	12	1	1	NUM
ajcp-3197	345	13	diabetes	diabetes	NOUN
ajcp-3197	345	14	mellitus	mellitus	NOUN
ajcp-3197	345	15	.	.	PUNCT
ajcp-3197	346	1	world	world	PROPN
ajcp-3197	346	2	journal	journal	PROPN
ajcp-3197	346	3	of	of	ADP
ajcp-3197	346	4	current	current	ADJ
ajcp-3197	346	5	medical	medical	ADJ
ajcp-3197	346	6	and	and	CCONJ
ajcp-3197	346	7	pharmaceutical	pharmaceutical	NOUN
ajcp-3197	346	8	research	research	NOUN
ajcp-3197	346	9	,	,	PUNCT
ajcp-3197	346	10	5(4	5(4	NUM
ajcp-3197	346	11	)	)	PUNCT
ajcp-3197	346	12	,	,	PUNCT
ajcp-3197	346	13	114	114	NUM
ajcp-3197	346	14	-	-	SYM
ajcp-3197	346	15	122	122	NUM
ajcp-3197	346	16	.	.	PUNCT
ajcp-3197	347	1	https://doi.org/10.37022/wjcmpr.v5i4.276	https://doi.org/10.37022/wjcmpr.v5i4.276	NOUN
ajcp-3197	347	2	.	.	PUNCT
ajcp-3197	348	1	eze	eze	PROPN
ajcp-3197	348	2	,	,	PUNCT
ajcp-3197	348	3	u.	u.	PROPN
ajcp-3197	348	4	i.	i.	PROPN
ajcp-3197	348	5	h.	h.	PROPN
ajcp-3197	348	6	,	,	PUNCT
ajcp-3197	348	7	oparah	oparah	PROPN
ajcp-3197	348	8	,	,	PUNCT
ajcp-3197	348	9	c.	c.	PROPN
ajcp-3197	348	10	a.	a.	PROPN
ajcp-3197	348	11	,	,	PUNCT
ajcp-3197	348	12	&	&	CCONJ
ajcp-3197	348	13	lawal	lawal	PROPN
ajcp-3197	348	14	,	,	PUNCT
ajcp-3197	348	15	f.	f.	PROPN
ajcp-3197	348	16	a.	a.	PROPN
ajcp-3197	349	1	(	(	PUNCT
ajcp-3197	349	2	2011	2011	NUM
ajcp-3197	349	3	)	)	PUNCT
ajcp-3197	349	4	.	.	PUNCT
ajcp-3197	350	1	identification	identification	NOUN
ajcp-3197	350	2	of	of	ADP
ajcp-3197	350	3	drug	drug	NOUN
ajcp-3197	350	4	therapy	therapy	NOUN
ajcp-3197	350	5	problems	problem	NOUN
ajcp-3197	350	6	among	among	ADP
ajcp-3197	350	7	elderly	elderly	ADJ
ajcp-3197	350	8	in	in	ADP
ajcp-3197	350	9	-	-	PUNCT
ajcp-3197	350	10	patients	patient	NOUN
ajcp-3197	350	11	of	of	ADP
ajcp-3197	350	12	a	a	DET
ajcp-3197	350	13	nigerian	nigerian	ADJ
ajcp-3197	350	14	teaching	teaching	NOUN
ajcp-3197	350	15	hospital	hospital	NOUN
ajcp-3197	350	16	.	.	PUNCT
ajcp-3197	351	1	nigerian	nigerian	ADJ
ajcp-3197	351	2	journal	journal	PROPN
ajcp-3197	351	3	of	of	ADP
ajcp-3197	351	4	pharmaceutical	pharmaceutical	NOUN
ajcp-3197	351	5	research	research	NOUN
ajcp-3197	351	6	,	,	PUNCT
ajcp-3197	351	7	9(1	9(1	NUM
ajcp-3197	351	8	)	)	PUNCT
ajcp-3197	351	9	,	,	PUNCT
ajcp-3197	351	10	49	49	NUM
ajcp-3197	351	11	-	-	SYM
ajcp-3197	351	12	56	56	NUM
ajcp-3197	351	13	.	.	PUNCT
ajcp-3197	352	1	fasipe	fasipe	NOUN
ajcp-3197	352	2	,	,	PUNCT
ajcp-3197	352	3	o.	o.	PROPN
ajcp-3197	352	4	j.	j.	PROPN
ajcp-3197	352	5	,	,	PUNCT
ajcp-3197	352	6	akhideno	akhideno	PROPN
ajcp-3197	352	7	,	,	PUNCT
ajcp-3197	352	8	p.	p.	PROPN
ajcp-3197	352	9	e.	e.	PROPN
ajcp-3197	352	10	,	,	PUNCT
ajcp-3197	352	11	&	&	CCONJ
ajcp-3197	352	12	owhin	owhin	PROPN
ajcp-3197	352	13	,	,	PUNCT
ajcp-3197	352	14	o.	o.	PROPN
ajcp-3197	352	15	s.	s.	PROPN
ajcp-3197	352	16	(	(	PUNCT
ajcp-3197	352	17	2019	2019	NUM
ajcp-3197	352	18	)	)	PUNCT
ajcp-3197	352	19	.	.	PUNCT
ajcp-3197	353	1	the	the	DET
ajcp-3197	353	2	observed	observed	ADJ
ajcp-3197	353	3	effect	effect	NOUN
ajcp-3197	353	4	of	of	ADP
ajcp-3197	353	5	adverse	adverse	ADJ
ajcp-3197	353	6	drug	drug	NOUN
ajcp-3197	353	7	reactions	reaction	NOUN
ajcp-3197	353	8	on	on	ADP
ajcp-3197	353	9	the	the	DET
ajcp-3197	353	10	length	length	NOUN
ajcp-3197	353	11	of	of	ADP
ajcp-3197	353	12	hospital	hospital	NOUN
ajcp-3197	353	13	stay	stay	NOUN
ajcp-3197	353	14	among	among	ADP
ajcp-3197	353	15	medical	medical	ADJ
ajcp-3197	353	16	inpatients	inpatient	NOUN
ajcp-3197	353	17	in	in	ADP
ajcp-3197	353	18	a	a	DET
ajcp-3197	353	19	nigerian	nigerian	ADJ
ajcp-3197	353	20	university	university	NOUN
ajcp-3197	353	21	teaching	teaching	NOUN
ajcp-3197	353	22	hospital	hospital	NOUN
ajcp-3197	353	23	.	.	PUNCT
ajcp-3197	354	1	toxicology	toxicology	NOUN
ajcp-3197	354	2	research	research	NOUN
ajcp-3197	354	3	and	and	CCONJ
ajcp-3197	354	4	application	application	NOUN
ajcp-3197	354	5	,	,	PUNCT
ajcp-3197	354	6	3	3	NUM
ajcp-3197	354	7	,	,	PUNCT
ajcp-3197	354	8	2397847319850451	2397847319850451	NUM
ajcp-3197	354	9	.	.	PUNCT
ajcp-3197	355	1	https://doi.org/10.1177/2397847319850451	https://doi.org/10.1177/2397847319850451	NOUN
ajcp-3197	355	2	.	.	PUNCT
ajcp-3197	356	1	hadia	hadia	PROPN
ajcp-3197	356	2	,	,	PUNCT
ajcp-3197	356	3	r.	r.	PROPN
ajcp-3197	356	4	,	,	PUNCT
ajcp-3197	356	5	joshi	joshi	PROPN
ajcp-3197	356	6	,	,	PUNCT
ajcp-3197	356	7	d.	d.	PROPN
ajcp-3197	356	8	,	,	PUNCT
ajcp-3197	356	9	bhil	bhil	PROPN
ajcp-3197	356	10	,	,	PUNCT
ajcp-3197	356	11	d.	d.	PROPN
ajcp-3197	356	12	,	,	PUNCT
ajcp-3197	356	13	&	&	CCONJ
ajcp-3197	356	14	maheshwari	maheshwari	PROPN
ajcp-3197	356	15	,	,	PUNCT
ajcp-3197	356	16	r.	r.	PROPN
ajcp-3197	356	17	(	(	PUNCT
ajcp-3197	356	18	2022	2022	NUM
ajcp-3197	356	19	)	)	PUNCT
ajcp-3197	356	20	.	.	PUNCT
ajcp-3197	357	1	incidence	incidence	NOUN
ajcp-3197	357	2	of	of	ADP
ajcp-3197	357	3	adverse	adverse	ADJ
ajcp-3197	357	4	drug	drug	NOUN
ajcp-3197	357	5	reactions	reaction	NOUN
ajcp-3197	357	6	among	among	ADP
ajcp-3197	357	7	elderly	elderly	ADJ
ajcp-3197	357	8	patients	patient	NOUN
ajcp-3197	357	9	:	:	PUNCT
ajcp-3197	357	10	a	a	DET
ajcp-3197	357	11	systematic	systematic	ADJ
ajcp-3197	357	12	review	review	NOUN
ajcp-3197	357	13	and	and	CCONJ
ajcp-3197	357	14	meta	meta	ADJ
ajcp-3197	357	15	-	-	PUNCT
ajcp-3197	357	16	analysis	analysis	NOUN
ajcp-3197	357	17	.	.	PUNCT
ajcp-3197	358	1	journal	journal	NOUN
ajcp-3197	358	2	of	of	ADP
ajcp-3197	358	3	the	the	DET
ajcp-3197	358	4	scientific	scientific	ADJ
ajcp-3197	358	5	society	society	NOUN
ajcp-3197	358	6	,	,	PUNCT
ajcp-3197	358	7	49(2	49(2	NUM
ajcp-3197	358	8	)	)	PUNCT
ajcp-3197	358	9	,	,	PUNCT
ajcp-3197	358	10	91	91	NUM
ajcp-3197	358	11	-	-	SYM
ajcp-3197	358	12	102	102	NUM
ajcp-3197	358	13	.	.	PUNCT
ajcp-3197	359	1	ikwuka	ikwuka	PROPN
ajcp-3197	359	2	,	,	PUNCT
ajcp-3197	359	3	a.	a.	NOUN
ajcp-3197	359	4	o.	o.	NOUN
ajcp-3197	359	5	(	(	PUNCT
ajcp-3197	359	6	2015	2015	NUM
ajcp-3197	359	7	)	)	PUNCT
ajcp-3197	359	8	.	.	PUNCT
ajcp-3197	360	1	risk	risk	NOUN
ajcp-3197	360	2	factors	factor	NOUN
ajcp-3197	360	3	for	for	ADP
ajcp-3197	360	4	the	the	DET
ajcp-3197	360	5	pathogenesis	pathogenesis	NOUN
ajcp-3197	360	6	of	of	ADP
ajcp-3197	360	7	diabetes	diabetes	NOUN
ajcp-3197	360	8	mellitus	mellitus	NOUN
ajcp-3197	360	9	type	type	VERB
ajcp-3197	360	10	2	2	NUM
ajcp-3197	360	11	.	.	PUNCT
ajcp-3197	360	12	materials	material	NOUN
ajcp-3197	360	13	of	of	ADP
ajcp-3197	360	14	84th	84th	ADJ
ajcp-3197	360	15	scientific	scientific	ADJ
ajcp-3197	360	16	and	and	CCONJ
ajcp-3197	360	17	practical	practical	ADJ
ajcp-3197	360	18	conference	conference	NOUN
ajcp-3197	360	19	of	of	ADP
ajcp-3197	360	20	students	student	NOUN
ajcp-3197	360	21	and	and	CCONJ
ajcp-3197	360	22	young	young	ADJ
ajcp-3197	360	23	scientists	scientist	NOUN
ajcp-3197	360	24	with	with	ADP
ajcp-3197	360	25	international	international	ADJ
ajcp-3197	360	26	participation	participation	NOUN
ajcp-3197	360	27	“	"	PUNCT
ajcp-3197	360	28	innovations	innovation	NOUN
ajcp-3197	360	29	in	in	ADP
ajcp-3197	360	30	medicine	medicine	NOUN
ajcp-3197	360	31	”	"	PUNCT
ajcp-3197	360	32	,	,	PUNCT
ajcp-3197	360	33	p.	p.	NOUN
ajcp-3197	360	34	19	19	NUM
ajcp-3197	360	35	.	.	PUNCT
ajcp-3197	361	1	available	available	ADJ
ajcp-3197	361	2	online	online	ADV
ajcp-3197	361	3	:	:	PUNCT
ajcp-3197	361	4	http://www.ifnmu.edu.ua/images/	http://www.ifnmu.edu.ua/images/	PROPN
ajcp-3197	361	5	snt	snt	PROPN
ajcp-3197	361	6	/	/	SYM
ajcp-3197	361	7	files	files	PROPN
ajcp-3197	361	8	/	/	SYM
ajcp-3197	361	9	konferenciya	konferenciya	NOUN
ajcp-3197	361	10	/	/	SYM
ajcp-3197	361	11	tezu_2015.pdf	tezu_2015.pdf	NOUN
ajcp-3197	361	12	ikwuka	ikwuka	NOUN
ajcp-3197	361	13	,	,	PUNCT
ajcp-3197	361	14	a.	a.	NOUN
ajcp-3197	361	15	o.	o.	PROPN
ajcp-3197	361	16	(	(	PUNCT
ajcp-3197	361	17	2017a	2017a	NUM
ajcp-3197	361	18	)	)	PUNCT
ajcp-3197	361	19	.	.	PUNCT
ajcp-3197	362	1	dyslipidemia	dyslipidemia	VERB
ajcp-3197	362	2	risk	risk	NOUN
ajcp-3197	362	3	severity	severity	NOUN
ajcp-3197	362	4	in	in	ADP
ajcp-3197	362	5	patients	patient	NOUN
ajcp-3197	362	6	with	with	ADP
ajcp-3197	362	7	diabetes	diabetes	NOUN
ajcp-3197	362	8	mellitus	mellitus	NOUN
ajcp-3197	362	9	type	type	VERB
ajcp-3197	362	10	2	2	NUM
ajcp-3197	362	11	and	and	CCONJ
ajcp-3197	362	12	essential	essential	ADJ
ajcp-3197	362	13	hypertension	hypertension	NOUN
ajcp-3197	362	14	.	.	PUNCT
ajcp-3197	363	1	journal	journal	NOUN
ajcp-3197	363	2	of	of	ADP
ajcp-3197	363	3	the	the	DET
ajcp-3197	363	4	21st	21st	ADJ
ajcp-3197	363	5	international	international	ADJ
ajcp-3197	363	6	medical	medical	ADJ
ajcp-3197	363	7	congress	congress	PROPN
ajcp-3197	363	8	of	of	ADP
ajcp-3197	363	9	students	student	NOUN
ajcp-3197	363	10	and	and	CCONJ
ajcp-3197	363	11	young	young	ADJ
ajcp-3197	363	12	scientists	scientist	NOUN
ajcp-3197	363	13	,	,	PUNCT
ajcp-3197	363	14	p.	p.	NOUN
ajcp-3197	363	15	59	59	NUM
ajcp-3197	363	16	.	.	PUNCT
ajcp-3197	364	1	ikwuka	ikwuka	PROPN
ajcp-3197	364	2	,	,	PUNCT
ajcp-3197	364	3	a.	a.	NOUN
ajcp-3197	364	4	o.	o.	NOUN
ajcp-3197	364	5	(	(	PUNCT
ajcp-3197	364	6	2017b	2017b	NUM
ajcp-3197	364	7	)	)	PUNCT
ajcp-3197	364	8	.	.	PUNCT
ajcp-3197	365	1	effectiveness	effectiveness	NOUN
ajcp-3197	365	2	of	of	ADP
ajcp-3197	365	3	dapagliflozin	dapagliflozin	PROPN
ajcp-3197	365	4	in	in	ADP
ajcp-3197	365	5	patients	patient	NOUN
ajcp-3197	365	6	with	with	ADP
ajcp-3197	365	7	diabetes	diabetes	NOUN
ajcp-3197	365	8	mellitus	mellitus	NOUN
ajcp-3197	365	9	type	type	VERB
ajcp-3197	365	10	2	2	NUM
ajcp-3197	365	11	and	and	CCONJ
ajcp-3197	365	12	essential	essential	ADJ
ajcp-3197	365	13	hypertension	hypertension	NOUN
ajcp-3197	365	14	.	.	PUNCT
ajcp-3197	366	1	book	book	NOUN
ajcp-3197	366	2	of	of	ADP
ajcp-3197	366	3	abstracts	abstract	NOUN
ajcp-3197	366	4	of	of	ADP
ajcp-3197	366	5	the	the	DET
ajcp-3197	366	6	7th	7th	ADJ
ajcp-3197	366	7	international	international	ADJ
ajcp-3197	366	8	students	student	NOUN
ajcp-3197	366	9	’	'	PUNCT
ajcp-3197	366	10	scientific	scientific	ADJ
ajcp-3197	366	11	conference	conference	NOUN
ajcp-3197	366	12	of	of	ADP
ajcp-3197	366	13	young	young	ADJ
ajcp-3197	366	14	medical	medical	ADJ
ajcp-3197	366	15	researchers	researcher	NOUN
ajcp-3197	366	16	,	,	PUNCT
ajcp-3197	366	17	p.	p.	NOUN
ajcp-3197	366	18	102	102	NUM
ajcp-3197	366	19	.	.	PUNCT
ajcp-3197	367	1	available	available	ADJ
ajcp-3197	367	2	online	online	ADV
ajcp-3197	368	1	:	:	PUNCT
ajcp-3197	368	2	http://www.stn.umed.wroc	http://www.stn.umed.wroc	NOUN
ajcp-3197	368	3	.	.	PUNCT
ajcp-3197	369	1	pl	pl	NOUN
ajcp-3197	369	2	/	/	SYM
ajcp-3197	369	3	files	file	NOUN
ajcp-3197	369	4	/	/	SYM
ajcp-3197	369	5	lm	lm	ADJ
ajcp-3197	369	6	/	/	SYM
ajcp-3197	369	7	accepted_papers.16113.pdf	accepted_papers.16113.pdf	PROPN
ajcp-3197	369	8	ikwuka	ikwuka	NOUN
ajcp-3197	369	9	,	,	PUNCT
ajcp-3197	369	10	a.	a.	NOUN
ajcp-3197	369	11	o.	o.	NOUN
ajcp-3197	369	12	(	(	PUNCT
ajcp-3197	369	13	2017c	2017c	NUM
ajcp-3197	369	14	)	)	PUNCT
ajcp-3197	369	15	.	.	PUNCT
ajcp-3197	370	1	influence	influence	NOUN
ajcp-3197	370	2	of	of	ADP
ajcp-3197	370	3	dyslipidemia	dyslipidemia	NOUN
ajcp-3197	370	4	in	in	ADP
ajcp-3197	370	5	patients	patient	NOUN
ajcp-3197	370	6	with	with	ADP
ajcp-3197	370	7	diabetes	diabetes	NOUN
ajcp-3197	370	8	mellitus	mellitus	NOUN
ajcp-3197	370	9	type	type	VERB
ajcp-3197	370	10	2	2	NUM
ajcp-3197	370	11	and	and	CCONJ
ajcp-3197	370	12	essential	essential	ADJ
ajcp-3197	370	13	hypertension	hypertension	NOUN
ajcp-3197	370	14	.	.	PUNCT
ajcp-3197	371	1	the	the	DET
ajcp-3197	371	2	pharma	pharma	PROPN
ajcp-3197	371	3	innovation	innovation	NOUN
ajcp-3197	371	4	journal	journal	PROPN
ajcp-3197	371	5	,	,	PUNCT
ajcp-3197	371	6	6(3	6(3	NUM
ajcp-3197	371	7	)	)	PUNCT
ajcp-3197	371	8	,	,	PUNCT
ajcp-3197	371	9	101103	101103	NUM
ajcp-3197	371	10	.	.	PUNCT
ajcp-3197	372	1	available	available	ADJ
ajcp-3197	372	2	online	online	ADV
ajcp-3197	372	3	:	:	PUNCT
ajcp-3197	373	1	http://www.thepharmajournal	http://www.thepharmajournal	ADJ
ajcp-3197	373	2	.	.	PUNCT
ajcp-3197	374	1	pa	pa	PROPN
ajcp-3197	374	2	ge	ge	PROPN
ajcp-3197	374	3	9	9	NUM
ajcp-3197	374	4	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	374	5	am	be	AUX
ajcp-3197	374	6	.	.	PUNCT
ajcp-3197	375	1	j.	j.	PROPN
ajcp-3197	375	2	chem	chem	PROPN
ajcp-3197	375	3	.	.	PUNCT
ajcp-3197	376	1	pharm	pharm	PROPN
ajcp-3197	376	2	.	.	PUNCT
ajcp-3197	377	1	3(1	3(1	NUM
ajcp-3197	377	2	)	)	PUNCT
ajcp-3197	377	3	1	1	NUM
ajcp-3197	377	4	-	-	SYM
ajcp-3197	377	5	11	11	NUM
ajcp-3197	377	6	,	,	PUNCT
ajcp-3197	377	7	2024	2024	NUM
ajcp-3197	377	8	com	com	NOUN
ajcp-3197	377	9	/	/	SYM
ajcp-3197	377	10	archives/?year=2017&vol=6&issue=3&part	archives/?year=2017&vol=6&issue=3&part	PROPN
ajcp-3197	377	11	=	=	SYM
ajcp-3197	377	12	b	b	NOUN
ajcp-3197	377	13	ikwuka	ikwuka	NOUN
ajcp-3197	377	14	,	,	PUNCT
ajcp-3197	377	15	a.	a.	NOUN
ajcp-3197	377	16	o.	o.	PROPN
ajcp-3197	377	17	,	,	PUNCT
ajcp-3197	377	18	&	&	CCONJ
ajcp-3197	377	19	haman	haman	PROPN
ajcp-3197	377	20	,	,	PUNCT
ajcp-3197	377	21	i.	i.	PROPN
ajcp-3197	377	22	o.	o.	PROPN
ajcp-3197	377	23	(	(	PUNCT
ajcp-3197	377	24	2017d	2017d	NUM
ajcp-3197	377	25	)	)	PUNCT
ajcp-3197	377	26	.	.	PUNCT
ajcp-3197	378	1	features	feature	NOUN
ajcp-3197	378	2	of	of	ADP
ajcp-3197	378	3	kidney	kidney	NOUN
ajcp-3197	378	4	damage	damage	NOUN
ajcp-3197	378	5	in	in	ADP
ajcp-3197	378	6	patients	patient	NOUN
ajcp-3197	378	7	with	with	ADP
ajcp-3197	378	8	diabetes	diabetes	NOUN
ajcp-3197	378	9	mellitus	mellitus	NOUN
ajcp-3197	378	10	type	type	VERB
ajcp-3197	378	11	2	2	NUM
ajcp-3197	378	12	and	and	CCONJ
ajcp-3197	378	13	essential	essential	ADJ
ajcp-3197	378	14	hypertension	hypertension	NOUN
ajcp-3197	378	15	.	.	PUNCT
ajcp-3197	379	1	journal	journal	NOUN
ajcp-3197	379	2	of	of	ADP
ajcp-3197	379	3	86th	86th	ADJ
ajcp-3197	379	4	scientific	scientific	ADJ
ajcp-3197	379	5	and	and	CCONJ
ajcp-3197	379	6	practical	practical	ADJ
ajcp-3197	379	7	conference	conference	NOUN
ajcp-3197	379	8	of	of	ADP
ajcp-3197	379	9	students	student	NOUN
ajcp-3197	379	10	and	and	CCONJ
ajcp-3197	379	11	young	young	ADJ
ajcp-3197	379	12	scientists	scientist	NOUN
ajcp-3197	379	13	with	with	ADP
ajcp-3197	379	14	international	international	ADJ
ajcp-3197	379	15	participation	participation	NOUN
ajcp-3197	379	16	“	"	PUNCT
ajcp-3197	379	17	innovations	innovation	NOUN
ajcp-3197	379	18	in	in	ADP
ajcp-3197	379	19	medicine	medicine	NOUN
ajcp-3197	379	20	”	"	PUNCT
ajcp-3197	379	21	,	,	PUNCT
ajcp-3197	379	22	p.	p.	NOUN
ajcp-3197	379	23	144	144	NUM
ajcp-3197	379	24	.	.	PUNCT
ajcp-3197	380	1	available	available	ADJ
ajcp-3197	380	2	online	online	ADV
ajcp-3197	380	3	:	:	PUNCT
ajcp-3197	380	4	http://www.ifnmu.edu.ua/	http://www.ifnmu.edu.ua/	PROPN
ajcp-3197	380	5	images	image	NOUN
ajcp-3197	380	6	/	/	SYM
ajcp-3197	380	7	snt/86	snt/86	NOUN
ajcp-3197	380	8	-	-	PUNCT
ajcp-3197	380	9	konf	konf	NOUN
ajcp-3197	380	10	-	-	PUNCT
ajcp-3197	380	11	tezi%20(1).pdf	tezi%20(1).pdf	PROPN
ajcp-3197	380	12	ikwuka	ikwuka	NOUN
ajcp-3197	380	13	,	,	PUNCT
ajcp-3197	380	14	a.	a.	NOUN
ajcp-3197	380	15	o.	o.	PROPN
ajcp-3197	380	16	,	,	PUNCT
ajcp-3197	380	17	virstyuk	virstyuk	NOUN
ajcp-3197	380	18	,	,	PUNCT
ajcp-3197	380	19	n.	n.	PROPN
ajcp-3197	380	20	g.	g.	PROPN
ajcp-3197	380	21	,	,	PUNCT
ajcp-3197	380	22	&	&	CCONJ
ajcp-3197	380	23	luchko	luchko	VERB
ajcp-3197	380	24	,	,	PUNCT
ajcp-3197	380	25	o.	o.	PROPN
ajcp-3197	380	26	r.	r.	PROPN
ajcp-3197	380	27	(	(	PUNCT
ajcp-3197	380	28	2017)e	2017)e	NUM
ajcp-3197	380	29	.	.	PUNCT
ajcp-3197	381	1	features	feature	NOUN
ajcp-3197	381	2	of	of	ADP
ajcp-3197	381	3	the	the	DET
ajcp-3197	381	4	functional	functional	ADJ
ajcp-3197	381	5	state	state	NOUN
ajcp-3197	381	6	of	of	ADP
ajcp-3197	381	7	kidneys	kidney	NOUN
ajcp-3197	381	8	in	in	ADP
ajcp-3197	381	9	patients	patient	NOUN
ajcp-3197	381	10	with	with	ADP
ajcp-3197	381	11	diabetes	diabetes	NOUN
ajcp-3197	381	12	mellitus	mellitus	NOUN
ajcp-3197	381	13	type	type	VERB
ajcp-3197	381	14	2	2	NUM
ajcp-3197	381	15	and	and	CCONJ
ajcp-3197	381	16	essential	essential	ADJ
ajcp-3197	381	17	arterial	arterial	ADJ
ajcp-3197	381	18	hypertension	hypertension	NOUN
ajcp-3197	381	19	.	.	PUNCT
ajcp-3197	382	1	materials	material	NOUN
ajcp-3197	382	2	of	of	ADP
ajcp-3197	382	3	scientific	scientific	ADJ
ajcp-3197	382	4	-	-	PUNCT
ajcp-3197	382	5	practical	practical	ADJ
ajcp-3197	382	6	conference	conference	NOUN
ajcp-3197	382	7	with	with	ADP
ajcp-3197	382	8	international	international	ADJ
ajcp-3197	382	9	participation	participation	NOUN
ajcp-3197	382	10	“	"	PUNCT
ajcp-3197	382	11	babenkivski	babenkivski	ADJ
ajcp-3197	382	12	reading	reading	NOUN
ajcp-3197	382	13	”	"	PUNCT
ajcp-3197	382	14	,	,	PUNCT
ajcp-3197	382	15	p.	p.	NOUN
ajcp-3197	382	16	48	48	NUM
ajcp-3197	382	17	.	.	PUNCT
ajcp-3197	383	1	ikwuka	ikwuka	PROPN
ajcp-3197	383	2	,	,	PUNCT
ajcp-3197	383	3	a.	a.	NOUN
ajcp-3197	383	4	o.	o.	NOUN
ajcp-3197	383	5	(	(	PUNCT
ajcp-3197	383	6	2018a	2018a	NUM
ajcp-3197	383	7	)	)	PUNCT
ajcp-3197	383	8	.	.	PUNCT
ajcp-3197	384	1	clinical	clinical	ADJ
ajcp-3197	384	2	dynamics	dynamic	NOUN
ajcp-3197	384	3	in	in	ADP
ajcp-3197	384	4	patients	patient	NOUN
ajcp-3197	384	5	with	with	ADP
ajcp-3197	384	6	diabetes	diabetes	NOUN
ajcp-3197	384	7	mellitus	mellitus	NOUN
ajcp-3197	384	8	type	type	VERB
ajcp-3197	384	9	2	2	NUM
ajcp-3197	384	10	and	and	CCONJ
ajcp-3197	384	11	concomitant	concomitant	ADJ
ajcp-3197	384	12	essential	essential	ADJ
ajcp-3197	384	13	hypertensive	hypertensive	ADJ
ajcp-3197	384	14	disease	disease	NOUN
ajcp-3197	384	15	treated	treat	VERB
ajcp-3197	384	16	with	with	ADP
ajcp-3197	384	17	dapagliflozin	dapagliflozin	PROPN
ajcp-3197	384	18	.	.	PUNCT
ajcp-3197	385	1	journal	journal	PROPN
ajcp-3197	385	2	of	of	ADP
ajcp-3197	385	3	the	the	DET
ajcp-3197	385	4	22nd	22nd	ADJ
ajcp-3197	385	5	international	international	PROPN
ajcp-3197	385	6	medical	medical	ADJ
ajcp-3197	385	7	congress	congress	PROPN
ajcp-3197	385	8	of	of	ADP
ajcp-3197	385	9	students	student	NOUN
ajcp-3197	385	10	and	and	CCONJ
ajcp-3197	385	11	young	young	ADJ
ajcp-3197	385	12	scientists	scientist	NOUN
ajcp-3197	385	13	,	,	PUNCT
ajcp-3197	385	14	p.	p.	NOUN
ajcp-3197	385	15	32	32	NUM
ajcp-3197	385	16	.	.	PUNCT
ajcp-3197	386	1	ikwuka	ikwuka	PROPN
ajcp-3197	386	2	,	,	PUNCT
ajcp-3197	386	3	a.	a.	NOUN
ajcp-3197	386	4	o.	o.	NOUN
ajcp-3197	386	5	(	(	PUNCT
ajcp-3197	386	6	2018b	2018b	NUM
ajcp-3197	386	7	)	)	PUNCT
ajcp-3197	386	8	.	.	PUNCT
ajcp-3197	387	1	clinical	clinical	ADJ
ajcp-3197	387	2	effectiveness	effectiveness	NOUN
ajcp-3197	387	3	of	of	ADP
ajcp-3197	387	4	sglt2	sglt2	ADJ
ajcp-3197	387	5	inhibitors	inhibitor	NOUN
ajcp-3197	387	6	in	in	ADP
ajcp-3197	387	7	patients	patient	NOUN
ajcp-3197	387	8	with	with	ADP
ajcp-3197	387	9	diabetes	diabetes	NOUN
ajcp-3197	387	10	mellitus	mellitus	NOUN
ajcp-3197	387	11	type	type	VERB
ajcp-3197	387	12	2	2	NUM
ajcp-3197	387	13	and	and	CCONJ
ajcp-3197	387	14	essential	essential	ADJ
ajcp-3197	387	15	hypertensive	hypertensive	ADJ
ajcp-3197	387	16	disease	disease	NOUN
ajcp-3197	387	17	.	.	PUNCT
ajcp-3197	388	1	endocrine	endocrine	ADJ
ajcp-3197	388	2	practice	practice	NOUN
ajcp-3197	388	3	,	,	PUNCT
ajcp-3197	388	4	24(1	24(1	NUM
ajcp-3197	388	5	)	)	PUNCT
ajcp-3197	388	6	,	,	PUNCT
ajcp-3197	388	7	74	74	NUM
ajcp-3197	388	8	.	.	PUNCT
ajcp-3197	389	1	https://doi.org/10.1016/s1530891x(20)47129-0	https://doi.org/10.1016/s1530891x(20)47129-0	PROPN
ajcp-3197	389	2	.	.	PUNCT
ajcp-3197	390	1	ikwuka	ikwuka	PROPN
ajcp-3197	390	2	,	,	PUNCT
ajcp-3197	390	3	a.	a.	NOUN
ajcp-3197	390	4	o.	o.	NOUN
ajcp-3197	390	5	(	(	PUNCT
ajcp-3197	390	6	2018c	2018c	NUM
ajcp-3197	390	7	)	)	PUNCT
ajcp-3197	390	8	.	.	PUNCT
ajcp-3197	391	1	features	feature	NOUN
ajcp-3197	391	2	of	of	ADP
ajcp-3197	391	3	kidney	kidney	NOUN
ajcp-3197	391	4	damage	damage	NOUN
ajcp-3197	391	5	in	in	ADP
ajcp-3197	391	6	patients	patient	NOUN
ajcp-3197	391	7	with	with	ADP
ajcp-3197	391	8	arterial	arterial	ADJ
ajcp-3197	391	9	hypertension	hypertension	NOUN
ajcp-3197	391	10	and	and	CCONJ
ajcp-3197	391	11	type	type	NOUN
ajcp-3197	391	12	2	2	NUM
ajcp-3197	391	13	diabetes	diabetes	NOUN
ajcp-3197	391	14	mellitus	mellitus	NOUN
ajcp-3197	391	15	and	and	CCONJ
ajcp-3197	391	16	optimization	optimization	NOUN
ajcp-3197	391	17	of	of	ADP
ajcp-3197	391	18	treatment	treatment	NOUN
ajcp-3197	391	19	.	.	PUNCT
ajcp-3197	392	1	specialized	specialized	ADJ
ajcp-3197	392	2	academic	academic	ADJ
ajcp-3197	392	3	council	council	PROPN
ajcp-3197	392	4	ifnmu	ifnmu	NOUN
ajcp-3197	392	5	,	,	PUNCT
ajcp-3197	392	6	available	available	ADJ
ajcp-3197	392	7	online	online	ADV
ajcp-3197	392	8	:	:	PUNCT
ajcp-3197	392	9	http://	http://	PROPN
ajcp-3197	392	10	www.ifnmu.edu.ua/images/zagalna_informacia/	www.ifnmu.edu.ua/images/zagalna_informacia/	PROPN
ajcp-3197	392	11	spec_vcheni_radi/2017	spec_vcheni_radi/2017	ADV
ajcp-3197	392	12	-	-	PUNCT
ajcp-3197	392	13	2019/%d0%9420.601.01/	2019/%d0%9420.601.01/	NUM
ajcp-3197	392	14	ikvuka	ikvuka	ADJ
ajcp-3197	392	15	/	/	SYM
ajcp-3197	392	16	avtoreferat.pdf	avtoreferat.pdf	X
ajcp-3197	392	17	ikwuka	ikwuka	NOUN
ajcp-3197	392	18	,	,	PUNCT
ajcp-3197	392	19	a.	a.	NOUN
ajcp-3197	392	20	o.	o.	PROPN
ajcp-3197	392	21	,	,	PUNCT
ajcp-3197	392	22	&	&	CCONJ
ajcp-3197	392	23	paliy	paliy	PROPN
ajcp-3197	392	24	,	,	PUNCT
ajcp-3197	392	25	yu	yu	PROPN
ajcp-3197	392	26	.	.	PUNCT
ajcp-3197	392	27	(	(	PUNCT
ajcp-3197	392	28	2018d	2018d	NUM
ajcp-3197	392	29	)	)	PUNCT
ajcp-3197	392	30	.	.	PUNCT
ajcp-3197	393	1	structural	structural	ADJ
ajcp-3197	393	2	changes	change	NOUN
ajcp-3197	393	3	of	of	ADP
ajcp-3197	393	4	the	the	DET
ajcp-3197	393	5	left	left	ADJ
ajcp-3197	393	6	ventricular	ventricular	ADJ
ajcp-3197	393	7	myocardium	myocardium	NOUN
ajcp-3197	393	8	in	in	ADP
ajcp-3197	393	9	patients	patient	NOUN
ajcp-3197	393	10	with	with	ADP
ajcp-3197	393	11	essential	essential	ADJ
ajcp-3197	393	12	arterial	arterial	ADJ
ajcp-3197	393	13	hypertension	hypertension	NOUN
ajcp-3197	393	14	and	and	CCONJ
ajcp-3197	393	15	diabetes	diabetes	NOUN
ajcp-3197	393	16	mellitus	mellitus	NOUN
ajcp-3197	393	17	type	type	VERB
ajcp-3197	393	18	2	2	NUM
ajcp-3197	393	19	.	.	PUNCT
ajcp-3197	393	20	abstracts	abstract	NOUN
ajcp-3197	393	21	of	of	ADP
ajcp-3197	393	22	the	the	DET
ajcp-3197	393	23	87th	87th	ADJ
ajcp-3197	393	24	scientific	scientific	ADJ
ajcp-3197	393	25	conference	conference	NOUN
ajcp-3197	393	26	of	of	ADP
ajcp-3197	393	27	students	student	NOUN
ajcp-3197	393	28	and	and	CCONJ
ajcp-3197	393	29	young	young	ADJ
ajcp-3197	393	30	scientists	scientist	NOUN
ajcp-3197	393	31	with	with	ADP
ajcp-3197	393	32	international	international	ADJ
ajcp-3197	393	33	participation	participation	NOUN
ajcp-3197	393	34	“	"	PUNCT
ajcp-3197	393	35	innovations	innovation	NOUN
ajcp-3197	393	36	in	in	ADP
ajcp-3197	393	37	medicine	medicine	NOUN
ajcp-3197	393	38	”	"	PUNCT
ajcp-3197	393	39	,	,	PUNCT
ajcp-3197	393	40	p.	p.	NOUN
ajcp-3197	393	41	25	25	NUM
ajcp-3197	393	42	-	-	SYM
ajcp-3197	393	43	26	26	NUM
ajcp-3197	393	44	.	.	PUNCT
ajcp-3197	394	1	available	available	ADJ
ajcp-3197	394	2	online	online	ADV
ajcp-3197	394	3	:	:	PUNCT
ajcp-3197	394	4	https://www.ifnmu.edu.ua/images/snt/	https://www.ifnmu.edu.ua/images/snt/	PROPN
ajcp-3197	394	5	zaproshennia_eng.pdf	zaproshennia_eng.pdf	PROPN
ajcp-3197	394	6	ikwuka	ikwuka	PROPN
ajcp-3197	394	7	,	,	PUNCT
ajcp-3197	394	8	a.	a.	NOUN
ajcp-3197	394	9	o.	o.	NOUN
ajcp-3197	394	10	(	(	PUNCT
ajcp-3197	394	11	2019a	2019a	NUM
ajcp-3197	394	12	)	)	PUNCT
ajcp-3197	394	13	.	.	PUNCT
ajcp-3197	395	1	clinical	clinical	ADJ
ajcp-3197	395	2	dynamics	dynamic	NOUN
ajcp-3197	395	3	of	of	ADP
ajcp-3197	395	4	nephropathy	nephropathy	NOUN
ajcp-3197	395	5	in	in	ADP
ajcp-3197	395	6	patients	patient	NOUN
ajcp-3197	395	7	with	with	ADP
ajcp-3197	395	8	diabetes	diabetes	NOUN
ajcp-3197	395	9	mellitus	mellitus	NOUN
ajcp-3197	395	10	type	type	VERB
ajcp-3197	395	11	2	2	NUM
ajcp-3197	395	12	and	and	CCONJ
ajcp-3197	395	13	concomitant	concomitant	ADJ
ajcp-3197	395	14	essential	essential	ADJ
ajcp-3197	395	15	hypertensive	hypertensive	ADJ
ajcp-3197	395	16	disease	disease	NOUN
ajcp-3197	395	17	.	.	PUNCT
ajcp-3197	396	1	clinical	clinical	ADJ
ajcp-3197	396	2	medicine	medicine	NOUN
ajcp-3197	396	3	,	,	PUNCT
ajcp-3197	396	4	19(2	19(2	NUM
ajcp-3197	396	5	)	)	PUNCT
ajcp-3197	396	6	,	,	PUNCT
ajcp-3197	396	7	s39	s39	X
ajcp-3197	396	8	.	.	PUNCT
ajcp-3197	397	1	https://doi.org/10.7861/	https://doi.org/10.7861/	PROPN
ajcp-3197	397	2	clinmedicine.19	clinmedicine.19	NOUN
ajcp-3197	397	3	-	-	PUNCT
ajcp-3197	397	4	2	2	NUM
ajcp-3197	397	5	-	-	PUNCT
ajcp-3197	397	6	s39	s39	NOUN
ajcp-3197	397	7	.	.	PUNCT
ajcp-3197	398	1	ikwuka	ikwuka	PROPN
ajcp-3197	398	2	,	,	PUNCT
ajcp-3197	398	3	a.	a.	NOUN
ajcp-3197	398	4	o.	o.	NOUN
ajcp-3197	398	5	(	(	PUNCT
ajcp-3197	398	6	2019b	2019b	NUM
ajcp-3197	398	7	)	)	PUNCT
ajcp-3197	398	8	.	.	PUNCT
ajcp-3197	399	1	clinical	clinical	ADJ
ajcp-3197	399	2	effectiveness	effectiveness	NOUN
ajcp-3197	399	3	of	of	ADP
ajcp-3197	399	4	glp-1	glp-1	NOUN
ajcp-3197	399	5	ras	ras	X
ajcp-3197	399	6	in	in	ADP
ajcp-3197	399	7	patients	patient	NOUN
ajcp-3197	399	8	with	with	ADP
ajcp-3197	399	9	metabolic	metabolic	NOUN
ajcp-3197	399	10	syndrome	syndrome	NOUN
ajcp-3197	399	11	diseases	disease	NOUN
ajcp-3197	399	12	.	.	PUNCT
ajcp-3197	400	1	endocrine	endocrine	ADJ
ajcp-3197	400	2	practice	practice	NOUN
ajcp-3197	400	3	,	,	PUNCT
ajcp-3197	400	4	25(1	25(1	NUM
ajcp-3197	400	5	)	)	PUNCT
ajcp-3197	400	6	,	,	PUNCT
ajcp-3197	400	7	104	104	NUM
ajcp-3197	400	8	-	-	SYM
ajcp-3197	400	9	105	105	NUM
ajcp-3197	400	10	.	.	PUNCT
ajcp-3197	401	1	https://doi	https://doi	X
ajcp-3197	401	2	.	.	PUNCT
ajcp-3197	402	1	org/10.1016	org/10.1016	PROPN
ajcp-3197	402	2	/	/	SYM
ajcp-3197	402	3	s1530	s1530	NUM
ajcp-3197	402	4	-	-	PUNCT
ajcp-3197	402	5	891x(20)46611	891x(20)46611	NOUN
ajcp-3197	402	6	-	-	PUNCT
ajcp-3197	402	7	x.	x.	NOUN
ajcp-3197	402	8	ikwuka	ikwuka	PROPN
ajcp-3197	402	9	,	,	PUNCT
ajcp-3197	402	10	a.	a.	NOUN
ajcp-3197	402	11	o.	o.	PROPN
ajcp-3197	402	12	,	,	PUNCT
ajcp-3197	402	13	&	&	CCONJ
ajcp-3197	402	14	virstyuk	virstyuk	PROPN
ajcp-3197	402	15	,	,	PUNCT
ajcp-3197	402	16	n.	n.	PROPN
ajcp-3197	402	17	g.	g.	PROPN
ajcp-3197	402	18	(	(	PUNCT
ajcp-3197	402	19	2019c	2019c	NUM
ajcp-3197	402	20	)	)	PUNCT
ajcp-3197	402	21	.	.	PUNCT
ajcp-3197	403	1	pattern	pattern	NOUN
ajcp-3197	403	2	of	of	ADP
ajcp-3197	403	3	cardiac	cardiac	ADJ
ajcp-3197	403	4	remodelling	remodelling	NOUN
ajcp-3197	403	5	of	of	ADP
ajcp-3197	403	6	the	the	DET
ajcp-3197	403	7	left	left	ADJ
ajcp-3197	403	8	ventricle	ventricle	NOUN
ajcp-3197	403	9	in	in	ADP
ajcp-3197	403	10	patients	patient	NOUN
ajcp-3197	403	11	with	with	ADP
ajcp-3197	403	12	essential	essential	ADJ
ajcp-3197	403	13	hypertensive	hypertensive	ADJ
ajcp-3197	403	14	disease	disease	NOUN
ajcp-3197	403	15	and	and	CCONJ
ajcp-3197	403	16	concomitant	concomitant	ADJ
ajcp-3197	403	17	type	type	NOUN
ajcp-3197	403	18	2	2	NUM
ajcp-3197	403	19	diabetes	diabetes	NOUN
ajcp-3197	403	20	mellitus	mellitus	NOUN
ajcp-3197	403	21	.	.	PUNCT
ajcp-3197	404	1	clinical	clinical	ADJ
ajcp-3197	404	2	medicine	medicine	NOUN
ajcp-3197	404	3	,	,	PUNCT
ajcp-3197	404	4	19(3	19(3	NUM
ajcp-3197	404	5	)	)	PUNCT
ajcp-3197	404	6	,	,	PUNCT
ajcp-3197	404	7	s92	s92	NOUN
ajcp-3197	404	8	.	.	PUNCT
ajcp-3197	405	1	https://doi.org/10.7861/clinmedicine.19-3-s92	https://doi.org/10.7861/clinmedicine.19-3-s92	PROPN
ajcp-3197	405	2	.	.	PUNCT
ajcp-3197	406	1	ikwuka	ikwuka	PROPN
ajcp-3197	406	2	,	,	PUNCT
ajcp-3197	406	3	a.	a.	NOUN
ajcp-3197	406	4	o.	o.	PROPN
ajcp-3197	406	5	,	,	PUNCT
ajcp-3197	406	6	&	&	CCONJ
ajcp-3197	406	7	virstyuk	virstyuk	PROPN
ajcp-3197	406	8	,	,	PUNCT
ajcp-3197	406	9	n.	n.	NOUN
ajcp-3197	406	10	g.	g.	PROPN
ajcp-3197	406	11	(	(	PUNCT
ajcp-3197	406	12	2021	2021	NUM
ajcp-3197	406	13	)	)	PUNCT
ajcp-3197	406	14	.	.	PUNCT
ajcp-3197	407	1	influence	influence	NOUN
ajcp-3197	407	2	of	of	ADP
ajcp-3197	407	3	sglt2	sglt2	ADJ
ajcp-3197	407	4	inhibitor	inhibitor	NOUN
ajcp-3197	407	5	and	and	CCONJ
ajcp-3197	407	6	a2rb	a2rb	PUNCT
ajcp-3197	407	7	(	(	PUNCT
ajcp-3197	407	8	at1	at1	PROPN
ajcp-3197	407	9	)	)	PUNCT
ajcp-3197	407	10	on	on	ADP
ajcp-3197	407	11	fibrogenesis	fibrogenesis	ADJ
ajcp-3197	407	12	and	and	CCONJ
ajcp-3197	407	13	heart	heart	NOUN
ajcp-3197	407	14	failure	failure	NOUN
ajcp-3197	407	15	in	in	ADP
ajcp-3197	407	16	patients	patient	NOUN
ajcp-3197	407	17	with	with	ADP
ajcp-3197	407	18	essential	essential	ADJ
ajcp-3197	407	19	hypertensive	hypertensive	ADJ
ajcp-3197	407	20	disease	disease	NOUN
ajcp-3197	407	21	combined	combine	VERB
ajcp-3197	407	22	with	with	ADP
ajcp-3197	407	23	diabetes	diabetes	NOUN
ajcp-3197	407	24	mellitus	mellitus	NOUN
ajcp-3197	407	25	type	type	VERB
ajcp-3197	407	26	2	2	NUM
ajcp-3197	407	27	.	.	PUNCT
ajcp-3197	408	1	e	e	X
ajcp-3197	408	2	-	-	NOUN
ajcp-3197	408	3	poster	poster	NOUN
ajcp-3197	408	4	no	no	INTJ
ajcp-3197	408	5	.	.	NOUN
ajcp-3197	409	1	143	143	NUM
ajcp-3197	409	2	of	of	ADP
ajcp-3197	409	3	the	the	DET
ajcp-3197	409	4	44th	44th	ADJ
ajcp-3197	409	5	&	&	CCONJ
ajcp-3197	409	6	45th	45th	ADJ
ajcp-3197	409	7	annual	annual	ADJ
ajcp-3197	409	8	general	general	ADJ
ajcp-3197	409	9	and	and	CCONJ
ajcp-3197	409	10	scientific	scientific	ADJ
ajcp-3197	409	11	meeting	meeting	NOUN
ajcp-3197	409	12	of	of	ADP
ajcp-3197	409	13	the	the	DET
ajcp-3197	409	14	west	west	PROPN
ajcp-3197	409	15	african	african	PROPN
ajcp-3197	409	16	college	college	PROPN
ajcp-3197	409	17	of	of	ADP
ajcp-3197	409	18	physicians	physician	NOUN
ajcp-3197	409	19	(	(	PUNCT
ajcp-3197	409	20	wacp	wacp	PROPN
ajcp-3197	409	21	)	)	PUNCT
ajcp-3197	409	22	,	,	PUNCT
ajcp-3197	409	23	1	1	NUM
ajcp-3197	409	24	3	3	NUM
ajcp-3197	409	25	november	november	PROPN
ajcp-3197	409	26	,	,	PUNCT
ajcp-3197	409	27	2021	2021	NUM
ajcp-3197	409	28	.	.	PUNCT
ajcp-3197	410	1	https://	https://	NOUN
ajcp-3197	410	2	doi.org/	doi.org/	ADV
ajcp-3197	410	3	10.13140	10.13140	NUM
ajcp-3197	410	4	/	/	SYM
ajcp-3197	410	5	rg.2.2.26912.87047	rg.2.2.26912.87047	PROPN
ajcp-3197	410	6	.	.	PUNCT
ajcp-3197	410	7	ikwuka	ikwuka	PROPN
ajcp-3197	410	8	,	,	PUNCT
ajcp-3197	410	9	a.	a.	NOUN
ajcp-3197	410	10	o.	o.	PROPN
ajcp-3197	410	11	,	,	PUNCT
ajcp-3197	410	12	&	&	CCONJ
ajcp-3197	410	13	virstyuk	virstyuk	PROPN
ajcp-3197	410	14	,	,	PUNCT
ajcp-3197	410	15	n.	n.	NOUN
ajcp-3197	410	16	(	(	PUNCT
ajcp-3197	410	17	2022	2022	NUM
ajcp-3197	410	18	)	)	PUNCT
ajcp-3197	410	19	.	.	PUNCT
ajcp-3197	411	1	prognostic	prognostic	ADJ
ajcp-3197	411	2	markers	marker	NOUN
ajcp-3197	411	3	of	of	ADP
ajcp-3197	411	4	nephropathy	nephropathy	NOUN
ajcp-3197	411	5	in	in	ADP
ajcp-3197	411	6	patients	patient	NOUN
ajcp-3197	411	7	with	with	ADP
ajcp-3197	411	8	dual	dual	ADJ
ajcp-3197	411	9	metabolic	metabolic	NOUN
ajcp-3197	411	10	syndrome	syndrome	NOUN
ajcp-3197	411	11	diseases	disease	NOUN
ajcp-3197	411	12	(	(	PUNCT
ajcp-3197	411	13	essential	essential	ADJ
ajcp-3197	411	14	hypertensive	hypertensive	ADJ
ajcp-3197	411	15	disease	disease	NOUN
ajcp-3197	411	16	and	and	CCONJ
ajcp-3197	411	17	concomitant	concomitant	ADJ
ajcp-3197	411	18	type	type	NOUN
ajcp-3197	411	19	2	2	NUM
ajcp-3197	411	20	diabetes	diabetes	NOUN
ajcp-3197	411	21	mellitus	mellitus	NOUN
ajcp-3197	411	22	)	)	PUNCT
ajcp-3197	411	23	.	.	PUNCT
ajcp-3197	412	1	endocrine	endocrine	ADJ
ajcp-3197	412	2	practice	practice	NOUN
ajcp-3197	412	3	,	,	PUNCT
ajcp-3197	412	4	28(5	28(5	NUM
ajcp-3197	412	5	)	)	PUNCT
ajcp-3197	412	6	,	,	PUNCT
ajcp-3197	412	7	s65	s65	NOUN
ajcp-3197	412	8	-	-	PUNCT
ajcp-3197	412	9	s66	s66	NOUN
ajcp-3197	412	10	.	.	PUNCT
ajcp-3197	413	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ajcp-3197	413	2	.	.	PUNCT
ajcp-3197	414	1	eprac.2022.03.164	eprac.2022.03.164	NOUN
ajcp-3197	414	2	.	.	PUNCT
ajcp-3197	415	1	ikwuka	ikwuka	PROPN
ajcp-3197	415	2	,	,	PUNCT
ajcp-3197	415	3	a.	a.	NOUN
ajcp-3197	415	4	o.	o.	NOUN
ajcp-3197	415	5	(	(	PUNCT
ajcp-3197	415	6	2023a	2023a	NUM
ajcp-3197	415	7	)	)	PUNCT
ajcp-3197	415	8	.	.	PUNCT
ajcp-3197	416	1	dr	dr	PROPN
ajcp-3197	416	2	.	.	PROPN
ajcp-3197	416	3	aloy	aloy	PROPN
ajcp-3197	416	4	’s	’s	PART
ajcp-3197	416	5	core	core	ADJ
ajcp-3197	416	6	essential	essential	ADJ
ajcp-3197	416	7	series	series	NOUN
ajcp-3197	416	8	(	(	PUNCT
ajcp-3197	416	9	daces	dace	NOUN
ajcp-3197	416	10	)	)	PUNCT
ajcp-3197	416	11	medical	medical	ADJ
ajcp-3197	416	12	genetics	genetic	NOUN
ajcp-3197	416	13	.	.	PUNCT
ajcp-3197	417	1	1st	1st	PROPN
ajcp-3197	417	2	edition	edition	PROPN
ajcp-3197	417	3	.	.	PUNCT
ajcp-3197	418	1	science	science	NOUN
ajcp-3197	418	2	and	and	CCONJ
ajcp-3197	418	3	education	education	NOUN
ajcp-3197	418	4	publishing	publishing	NOUN
ajcp-3197	418	5	,	,	PUNCT
ajcp-3197	418	6	usa	usa	PROPN
ajcp-3197	418	7	,	,	PUNCT
ajcp-3197	418	8	p.	p.	NOUN
ajcp-3197	418	9	9	9	NUM
ajcp-3197	418	10	-	-	SYM
ajcp-3197	418	11	10	10	NUM
ajcp-3197	418	12	.	.	PUNCT
ajcp-3197	419	1	isbn	isbn	ADJ
ajcp-3197	419	2	:	:	PUNCT
ajcp-3197	419	3	978	978	NUM
ajcp-3197	419	4	-	-	SYM
ajcp-3197	419	5	1958293	1958293	NUM
ajcp-3197	419	6	-	-	PUNCT
ajcp-3197	419	7	02	02	NUM
ajcp-3197	419	8	-	-	PUNCT
ajcp-3197	419	9	7	7	NUM
ajcp-3197	419	10	.	.	PUNCT
ajcp-3197	419	11	ikwuka	ikwuka	PROPN
ajcp-3197	419	12	,	,	PUNCT
ajcp-3197	419	13	a.	a.	NOUN
ajcp-3197	419	14	o.	o.	NOUN
ajcp-3197	419	15	(	(	PUNCT
ajcp-3197	419	16	2023b	2023b	NUM
ajcp-3197	419	17	)	)	PUNCT
ajcp-3197	419	18	.	.	PUNCT
ajcp-3197	420	1	dr	dr	PROPN
ajcp-3197	420	2	.	.	PROPN
ajcp-3197	420	3	aloy	aloy	PROPN
ajcp-3197	420	4	’s	’s	PART
ajcp-3197	420	5	core	core	ADJ
ajcp-3197	420	6	essential	essential	ADJ
ajcp-3197	420	7	series	series	NOUN
ajcp-3197	420	8	(	(	PUNCT
ajcp-3197	420	9	daces	dace	NOUN
ajcp-3197	420	10	)	)	PUNCT
ajcp-3197	420	11	immunology	immunology	NOUN
ajcp-3197	420	12	.	.	PUNCT
ajcp-3197	421	1	1st	1st	PROPN
ajcp-3197	421	2	edition	edition	PROPN
ajcp-3197	421	3	.	.	PUNCT
ajcp-3197	422	1	science	science	NOUN
ajcp-3197	422	2	and	and	CCONJ
ajcp-3197	422	3	education	education	NOUN
ajcp-3197	422	4	publishing	publishing	NOUN
ajcp-3197	422	5	,	,	PUNCT
ajcp-3197	422	6	usa	usa	PROPN
ajcp-3197	422	7	,	,	PUNCT
ajcp-3197	422	8	p.	p.	NOUN
ajcp-3197	422	9	48	48	NUM
ajcp-3197	422	10	.	.	PUNCT
ajcp-3197	423	1	isbn	isbn	ADJ
ajcp-3197	423	2	:	:	PUNCT
ajcp-3197	423	3	978	978	NUM
ajcp-3197	423	4	-	-	SYM
ajcp-3197	423	5	978795	978795	NUM
ajcp-3197	423	6	-	-	PUNCT
ajcp-3197	423	7	866	866	NUM
ajcp-3197	423	8	-	-	SYM
ajcp-3197	423	9	7	7	NUM
ajcp-3197	423	10	.	.	PUNCT
ajcp-3197	424	1	ikwuka	ikwuka	PROPN
ajcp-3197	424	2	,	,	PUNCT
ajcp-3197	424	3	a.	a.	NOUN
ajcp-3197	424	4	o.	o.	PROPN
ajcp-3197	424	5	,	,	PUNCT
ajcp-3197	424	6	&	&	CCONJ
ajcp-3197	424	7	virstyuk	virstyuk	PROPN
ajcp-3197	424	8	,	,	PUNCT
ajcp-3197	424	9	n.	n.	NOUN
ajcp-3197	424	10	(	(	PUNCT
ajcp-3197	424	11	2023c	2023c	NUM
ajcp-3197	424	12	)	)	PUNCT
ajcp-3197	424	13	.	.	PUNCT
ajcp-3197	425	1	patterns	pattern	NOUN
ajcp-3197	425	2	and	and	CCONJ
ajcp-3197	425	3	influence	influence	NOUN
ajcp-3197	425	4	of	of	ADP
ajcp-3197	425	5	cardio	cardio	NOUN
ajcp-3197	425	6	-	-	PUNCT
ajcp-3197	425	7	metabolic	metabolic	NOUN
ajcp-3197	425	8	insufficiency	insufficiency	NOUN
ajcp-3197	425	9	in	in	ADP
ajcp-3197	425	10	patients	patient	NOUN
ajcp-3197	425	11	with	with	ADP
ajcp-3197	425	12	essential	essential	ADJ
ajcp-3197	425	13	hypertensive	hypertensive	ADJ
ajcp-3197	425	14	disease	disease	NOUN
ajcp-3197	425	15	and	and	CCONJ
ajcp-3197	425	16	concomitant	concomitant	ADJ
ajcp-3197	425	17	type	type	NOUN
ajcp-3197	425	18	2	2	NUM
ajcp-3197	425	19	diabetes	diabetes	NOUN
ajcp-3197	425	20	mellitus	mellitus	NOUN
ajcp-3197	425	21	.	.	PUNCT
ajcp-3197	426	1	https://	https://	PROPN
ajcp-3197	426	2	doi.org/(5	doi.org/(5	PROPN
ajcp-3197	426	3	)	)	PUNCT
ajcp-3197	426	4	,	,	PUNCT
ajcp-3197	426	5	s32	s32	PROPN
ajcp-3197	426	6	-	-	PUNCT
ajcp-3197	426	7	s33	s33	NOUN
ajcp-3197	426	8	.	.	PUNCT
ajcp-3197	427	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ajcp-3197	427	2	.	.	PUNCT
ajcp-3197	428	1	eprac.2023.03.076	eprac.2023.03.076	NUM
ajcp-3197	428	2	.	.	PUNCT
ajcp-3197	429	1	ikwuka	ikwuka	PROPN
ajcp-3197	429	2	,	,	PUNCT
ajcp-3197	429	3	a.	a.	NOUN
ajcp-3197	429	4	o.	o.	PROPN
ajcp-3197	429	5	,	,	PUNCT
ajcp-3197	429	6	virstyuk	virstyuk	NOUN
ajcp-3197	429	7	,	,	PUNCT
ajcp-3197	429	8	n.	n.	PROPN
ajcp-3197	429	9	g.	g.	PROPN
ajcp-3197	429	10	,	,	PUNCT
ajcp-3197	429	11	luchko	luchko	VERB
ajcp-3197	429	12	,	,	PUNCT
ajcp-3197	429	13	o.	o.	PROPN
ajcp-3197	429	14	r.	r.	PROPN
ajcp-3197	429	15	,	,	PUNCT
ajcp-3197	429	16	&	&	CCONJ
ajcp-3197	429	17	kobitovych	kobitovych	PROPN
ajcp-3197	429	18	,	,	PUNCT
ajcp-3197	429	19	i.	i.	PROPN
ajcp-3197	429	20	(	(	PUNCT
ajcp-3197	429	21	2023d	2023d	NUM
ajcp-3197	429	22	)	)	PUNCT
ajcp-3197	429	23	.	.	PUNCT
ajcp-3197	430	1	heterogeneity	heterogeneity	NOUN
ajcp-3197	430	2	of	of	ADP
ajcp-3197	430	3	renal	renal	ADJ
ajcp-3197	430	4	pathogenicity	pathogenicity	NOUN
ajcp-3197	430	5	on	on	ADP
ajcp-3197	430	6	the	the	DET
ajcp-3197	430	7	background	background	NOUN
ajcp-3197	430	8	of	of	ADP
ajcp-3197	430	9	asymptomatic	asymptomatic	ADJ
ajcp-3197	430	10	hyperuricemia	hyperuricemia	NOUN
ajcp-3197	430	11	in	in	ADP
ajcp-3197	430	12	patients	patient	NOUN
ajcp-3197	430	13	with	with	ADP
ajcp-3197	430	14	dual	dual	ADJ
ajcp-3197	430	15	metabolic	metabolic	NOUN
ajcp-3197	430	16	syndrome	syndrome	NOUN
ajcp-3197	430	17	diseases	disease	NOUN
ajcp-3197	430	18	(	(	PUNCT
ajcp-3197	430	19	essential	essential	ADJ
ajcp-3197	430	20	hypertensive	hypertensive	ADJ
ajcp-3197	430	21	disease	disease	NOUN
ajcp-3197	430	22	and	and	CCONJ
ajcp-3197	430	23	type	type	NOUN
ajcp-3197	430	24	2	2	NUM
ajcp-3197	430	25	diabetes	diabetes	NOUN
ajcp-3197	430	26	mellitus	mellitus	NOUN
ajcp-3197	430	27	)	)	PUNCT
ajcp-3197	430	28	.	.	PUNCT
ajcp-3197	431	1	british	british	ADJ
ajcp-3197	431	2	journal	journal	PROPN
ajcp-3197	431	3	of	of	ADP
ajcp-3197	431	4	medical	medical	ADJ
ajcp-3197	431	5	and	and	CCONJ
ajcp-3197	431	6	health	health	NOUN
ajcp-3197	431	7	research	research	NOUN
ajcp-3197	431	8	,	,	PUNCT
ajcp-3197	431	9	10(2	10(2	NUM
ajcp-3197	431	10	)	)	PUNCT
ajcp-3197	431	11	,	,	PUNCT
ajcp-3197	431	12	1	1	NUM
ajcp-3197	431	13	-	-	SYM
ajcp-3197	431	14	9	9	NUM
ajcp-3197	431	15	.	.	PUNCT
ajcp-3197	432	1	https://doi	https://doi	NOUN
ajcp-3197	432	2	.	.	PUNCT
ajcp-3197	433	1	org/10.5281	org/10.5281	PROPN
ajcp-3197	433	2	/	/	SYM
ajcp-3197	433	3	zenodo.7690636	zenodo.7690636	PROPN
ajcp-3197	433	4	.	.	NOUN
ajcp-3197	433	5	ikwuka	ikwuka	PROPN
ajcp-3197	433	6	,	,	PUNCT
ajcp-3197	433	7	a.	a.	NOUN
ajcp-3197	433	8	o.	o.	NOUN
ajcp-3197	433	9	(	(	PUNCT
ajcp-3197	433	10	2023e	2023e	NUM
ajcp-3197	433	11	)	)	PUNCT
ajcp-3197	433	12	.	.	PUNCT
ajcp-3197	434	1	dr	dr	PROPN
ajcp-3197	434	2	.	.	PROPN
ajcp-3197	434	3	aloy	aloy	PROPN
ajcp-3197	434	4	’s	’s	PART
ajcp-3197	434	5	core	core	ADJ
ajcp-3197	434	6	essential	essential	ADJ
ajcp-3197	434	7	series	series	NOUN
ajcp-3197	434	8	(	(	PUNCT
ajcp-3197	434	9	daces	dace	NOUN
ajcp-3197	434	10	)	)	PUNCT
ajcp-3197	434	11	hematology	hematology	NOUN
ajcp-3197	434	12	.	.	PUNCT
ajcp-3197	435	1	1st	1st	PROPN
ajcp-3197	435	2	edition	edition	PROPN
ajcp-3197	435	3	.	.	PUNCT
ajcp-3197	436	1	science	science	NOUN
ajcp-3197	436	2	and	and	CCONJ
ajcp-3197	436	3	education	education	NOUN
ajcp-3197	436	4	publishing	publishing	NOUN
ajcp-3197	436	5	,	,	PUNCT
ajcp-3197	436	6	usa	usa	PROPN
ajcp-3197	436	7	,	,	PUNCT
ajcp-3197	436	8	p.	p.	NOUN
ajcp-3197	436	9	47	47	NUM
ajcp-3197	436	10	-	-	SYM
ajcp-3197	436	11	60	60	NUM
ajcp-3197	436	12	.	.	PUNCT
ajcp-3197	437	1	isbn	isbn	ADJ
ajcp-3197	437	2	:	:	PUNCT
ajcp-3197	437	3	978	978	NUM
ajcp-3197	437	4	-	-	SYM
ajcp-3197	437	5	1958293	1958293	NUM
ajcp-3197	437	6	-	-	PUNCT
ajcp-3197	437	7	09	09	NUM
ajcp-3197	437	8	-	-	PUNCT
ajcp-3197	437	9	6	6	NUM
ajcp-3197	437	10	.	.	PUNCT
ajcp-3197	438	1	ikwuka	ikwuka	PROPN
ajcp-3197	438	2	,	,	PUNCT
ajcp-3197	438	3	a.	a.	NOUN
ajcp-3197	438	4	o.	o.	PROPN
ajcp-3197	438	5	,	,	PUNCT
ajcp-3197	438	6	omoju	omoju	PROPN
ajcp-3197	438	7	,	,	PUNCT
ajcp-3197	438	8	d.	d.	PROPN
ajcp-3197	438	9	i.	i.	PROPN
ajcp-3197	438	10	,	,	PUNCT
ajcp-3197	438	11	&	&	CCONJ
ajcp-3197	438	12	mahanera	mahanera	NOUN
ajcp-3197	438	13	,	,	PUNCT
ajcp-3197	438	14	o.	o.	PROPN
ajcp-3197	438	15	k.	k.	PROPN
ajcp-3197	438	16	(	(	PUNCT
ajcp-3197	438	17	2023	2023	NUM
ajcp-3197	438	18	)	)	PUNCT
ajcp-3197	438	19	f.	f.	NOUN
ajcp-3197	438	20	profiling	profiling	NOUN
ajcp-3197	438	21	of	of	ADP
ajcp-3197	438	22	clinical	clinical	ADJ
ajcp-3197	438	23	dynamics	dynamic	NOUN
ajcp-3197	438	24	of	of	ADP
ajcp-3197	438	25	type	type	NOUN
ajcp-3197	438	26	2	2	NUM
ajcp-3197	438	27	diabetes	diabetes	NOUN
ajcp-3197	438	28	mellitus	mellitus	NOUN
ajcp-3197	438	29	in	in	ADP
ajcp-3197	438	30	patients	patient	NOUN
ajcp-3197	438	31	:	:	PUNCT
ajcp-3197	438	32	a	a	DET
ajcp-3197	438	33	perspective	perspective	ADJ
ajcp-3197	438	34	review	review	NOUN
ajcp-3197	438	35	.	.	PUNCT
ajcp-3197	439	1	world	world	PROPN
ajcp-3197	439	2	journal	journal	PROPN
ajcp-3197	439	3	of	of	ADP
ajcp-3197	439	4	current	current	ADJ
ajcp-3197	439	5	medical	medical	ADJ
ajcp-3197	439	6	and	and	CCONJ
ajcp-3197	439	7	pharmaceutical	pharmaceutical	NOUN
ajcp-3197	439	8	research	research	NOUN
ajcp-3197	439	9	,	,	PUNCT
ajcp-3197	439	10	5(5	5(5	NUM
ajcp-3197	439	11	)	)	PUNCT
ajcp-3197	439	12	,	,	PUNCT
ajcp-3197	439	13	210	210	NUM
ajcp-3197	439	14	-	-	SYM
ajcp-3197	439	15	218	218	NUM
ajcp-3197	439	16	.	.	PUNCT
ajcp-3197	440	1	https://doi.org/10.37022/wjcmpr	https://doi.org/10.37022/wjcmpr	NOUN
ajcp-3197	440	2	.	.	PUNCT
ajcp-3197	441	1	v5i5.294	v5i5.294	PROPN
ajcp-3197	441	2	.	.	PUNCT
ajcp-3197	442	1	ikwuka	ikwuka	PROPN
ajcp-3197	442	2	,	,	PUNCT
ajcp-3197	442	3	a.	a.	NOUN
ajcp-3197	442	4	o.	o.	PROPN
ajcp-3197	442	5	,	,	PUNCT
ajcp-3197	442	6	virstyuk	virstyuk	NOUN
ajcp-3197	442	7	,	,	PUNCT
ajcp-3197	442	8	n.	n.	NOUN
ajcp-3197	442	9	,	,	PUNCT
ajcp-3197	442	10	luchko	luchko	VERB
ajcp-3197	442	11	,	,	PUNCT
ajcp-3197	442	12	o.	o.	PROPN
ajcp-3197	442	13	,	,	PUNCT
ajcp-3197	442	14	&	&	CCONJ
ajcp-3197	442	15	kobitovych	kobitovych	PROPN
ajcp-3197	442	16	,	,	PUNCT
ajcp-3197	442	17	i.	i.	PROPN
ajcp-3197	442	18	(	(	PUNCT
ajcp-3197	442	19	2024	2024	NUM
ajcp-3197	442	20	)	)	PUNCT
ajcp-3197	442	21	.	.	PUNCT
ajcp-3197	443	1	optimization	optimization	NOUN
ajcp-3197	443	2	of	of	ADP
ajcp-3197	443	3	treatment	treatment	NOUN
ajcp-3197	443	4	in	in	ADP
ajcp-3197	443	5	msd	msd	NOUN
ajcp-3197	443	6	patients	patient	NOUN
ajcp-3197	443	7	using	use	VERB
ajcp-3197	443	8	a	a	DET
ajcp-3197	443	9	combination	combination	NOUN
ajcp-3197	443	10	of	of	ADP
ajcp-3197	443	11	hmg	hmg	NOUN
ajcp-3197	443	12	-	-	PUNCT
ajcp-3197	443	13	coa	coa	NOUN
ajcp-3197	443	14	reductase	reductase	NOUN
ajcp-3197	443	15	inhibitor	inhibitor	NOUN
ajcp-3197	443	16	,	,	PUNCT
ajcp-3197	443	17	sglt-2	sglt-2	NUM
ajcp-3197	443	18	inhibitor	inhibitor	NOUN
ajcp-3197	443	19	and	and	CCONJ
ajcp-3197	443	20	a2rb	a2rb	PUNCT
ajcp-3197	443	21	(	(	PUNCT
ajcp-3197	443	22	at1	at1	PROPN
ajcp-3197	443	23	):	):	PUNCT
ajcp-3197	443	24	resultant	resultant	VERB
ajcp-3197	443	25	clinical	clinical	ADJ
ajcp-3197	443	26	effectiveness	effectiveness	NOUN
ajcp-3197	443	27	.	.	PUNCT
ajcp-3197	444	1	endocrine	endocrine	ADJ
ajcp-3197	444	2	practice	practice	NOUN
ajcp-3197	444	3	,	,	PUNCT
ajcp-3197	444	4	30(5	30(5	NUM
ajcp-3197	444	5	)	)	PUNCT
ajcp-3197	444	6	,	,	PUNCT
ajcp-3197	444	7	s60	s60	NOUN
ajcp-3197	444	8	-	-	PUNCT
ajcp-3197	444	9	s61	s61	NOUN
ajcp-3197	444	10	.	.	PUNCT
ajcp-3197	445	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ajcp-3197	445	2	.	.	PUNCT
ajcp-3197	446	1	eprac.2024.03.243	eprac.2024.03.243	INTJ
ajcp-3197	446	2	.	.	PUNCT
ajcp-3197	447	1	inya	inya	PROPN
ajcp-3197	447	2	,	,	PUNCT
ajcp-3197	447	3	a.	a.	NOUN
ajcp-3197	447	4	u.	u.	PROPN
ajcp-3197	447	5	,	,	PUNCT
ajcp-3197	447	6	achara	achara	PROPN
ajcp-3197	447	7	,	,	PUNCT
ajcp-3197	447	8	a.	a.	PROPN
ajcp-3197	447	9	p.	p.	PROPN
ajcp-3197	447	10	,	,	PUNCT
ajcp-3197	447	11	ikwuka	ikwuka	PROPN
ajcp-3197	447	12	,	,	PUNCT
ajcp-3197	447	13	a.	a.	NOUN
ajcp-3197	447	14	o.	o.	PROPN
ajcp-3197	447	15	,	,	PUNCT
ajcp-3197	447	16	udeh	udeh	PROPN
ajcp-3197	447	17	,	,	PUNCT
ajcp-3197	447	18	f.	f.	PROPN
ajcp-3197	447	19	c.	c.	PROPN
ajcp-3197	447	20	,	,	PUNCT
ajcp-3197	447	21	chikadibia	chikadibia	PROPN
ajcp-3197	447	22	,	,	PUNCT
ajcp-3197	447	23	u.	u.	PROPN
ajcp-3197	447	24	,	,	PUNCT
ajcp-3197	447	25	&	&	CCONJ
ajcp-3197	447	26	onazi	onazi	ADJ
ajcp-3197	447	27	,	,	PUNCT
ajcp-3197	447	28	o.	o.	NOUN
ajcp-3197	447	29	(	(	PUNCT
ajcp-3197	447	30	2023a	2023a	NUM
ajcp-3197	447	31	)	)	PUNCT
ajcp-3197	447	32	.	.	PUNCT
ajcp-3197	448	1	clinical	clinical	ADJ
ajcp-3197	448	2	dynamics	dynamic	NOUN
ajcp-3197	448	3	of	of	ADP
ajcp-3197	448	4	anemia	anemia	NOUN
ajcp-3197	448	5	in	in	ADP
ajcp-3197	448	6	pregnancy	pregnancy	NOUN
ajcp-3197	448	7	:	:	PUNCT
ajcp-3197	448	8	a	a	DET
ajcp-3197	448	9	16	16	NUM
ajcp-3197	448	10	-	-	PUNCT
ajcp-3197	448	11	week	week	NOUN
ajcp-3197	448	12	cross	cross	ADJ
ajcp-3197	448	13	-	-	ADJ
ajcp-3197	448	14	sectional	sectional	ADJ
ajcp-3197	448	15	study	study	NOUN
ajcp-3197	448	16	of	of	ADP
ajcp-3197	448	17	pregnant	pregnant	ADJ
ajcp-3197	448	18	women	woman	NOUN
ajcp-3197	448	19	who	who	PRON
ajcp-3197	448	20	attended	attend	VERB
ajcp-3197	448	21	antenatal	antenatal	ADJ
ajcp-3197	448	22	clinic	clinic	NOUN
ajcp-3197	448	23	of	of	ADP
ajcp-3197	448	24	federal	federal	ADJ
ajcp-3197	448	25	medical	medical	ADJ
ajcp-3197	448	26	center	center	NOUN
ajcp-3197	448	27	,	,	PUNCT
ajcp-3197	448	28	keffi	keffi	PROPN
ajcp-3197	448	29	,	,	PUNCT
ajcp-3197	448	30	nasarawa	nasarawa	PROPN
ajcp-3197	448	31	state	state	PROPN
ajcp-3197	448	32	,	,	PUNCT
ajcp-3197	448	33	nigeria	nigeria	PROPN
ajcp-3197	448	34	.	.	PUNCT
ajcp-3197	449	1	american	american	PROPN
ajcp-3197	449	2	journal	journal	PROPN
ajcp-3197	449	3	of	of	ADP
ajcp-3197	449	4	clinical	clinical	ADJ
ajcp-3197	449	5	medicine	medicine	NOUN
ajcp-3197	449	6	research	research	NOUN
ajcp-3197	449	7	,	,	PUNCT
ajcp-3197	449	8	11(1	11(1	NUM
ajcp-3197	449	9	)	)	PUNCT
ajcp-3197	449	10	,	,	PUNCT
ajcp-3197	449	11	1	1	NUM
ajcp-3197	449	12	-	-	SYM
ajcp-3197	449	13	9	9	NUM
ajcp-3197	449	14	.	.	PUNCT
ajcp-3197	450	1	https://doi.org/10.12691/	https://doi.org/10.12691/	PROPN
ajcp-3197	450	2	ajcmr-11	ajcmr-11	PROPN
ajcp-3197	450	3	-	-	PUNCT
ajcp-3197	450	4	1	1	NUM
ajcp-3197	450	5	-	-	SYM
ajcp-3197	450	6	1	1	NUM
ajcp-3197	450	7	.	.	PUNCT
ajcp-3197	451	1	inya	inya	PROPN
ajcp-3197	451	2	,	,	PUNCT
ajcp-3197	451	3	a.	a.	NOUN
ajcp-3197	451	4	u.	u.	PROPN
ajcp-3197	451	5	,	,	PUNCT
ajcp-3197	451	6	achara	achara	PROPN
ajcp-3197	451	7	,	,	PUNCT
ajcp-3197	451	8	a.	a.	PROPN
ajcp-3197	451	9	p.	p.	PROPN
ajcp-3197	451	10	,	,	PUNCT
ajcp-3197	451	11	ikwuka	ikwuka	PROPN
ajcp-3197	451	12	,	,	PUNCT
ajcp-3197	451	13	a.	a.	NOUN
ajcp-3197	451	14	o.	o.	PROPN
ajcp-3197	451	15	,	,	PUNCT
ajcp-3197	451	16	udeh	udeh	PROPN
ajcp-3197	451	17	,	,	PUNCT
ajcp-3197	451	18	f.	f.	PROPN
ajcp-3197	451	19	c.	c.	PROPN
ajcp-3197	451	20	,	,	PUNCT
ajcp-3197	451	21	chi	chi	NOUN
ajcp-3197	451	22	-	-	PUNCT
ajcp-3197	451	23	kadibia	kadibia	ADJ
ajcp-3197	451	24	,	,	PUNCT
ajcp-3197	451	25	u.	u.	PROPN
ajcp-3197	451	26	,	,	PUNCT
ajcp-3197	451	27	&	&	CCONJ
ajcp-3197	451	28	onazi	onazi	ADJ
ajcp-3197	451	29	,	,	PUNCT
ajcp-3197	452	1	o.	o.	NOUN
ajcp-3197	452	2	(	(	PUNCT
ajcp-3197	452	3	2023b	2023b	NUM
ajcp-3197	452	4	)	)	PUNCT
ajcp-3197	452	5	.	.	PUNCT
ajcp-3197	453	1	patterns	pattern	NOUN
ajcp-3197	453	2	,	,	PUNCT
ajcp-3197	453	3	peculiarities	peculiarity	NOUN
ajcp-3197	453	4	and	and	CCONJ
ajcp-3197	453	5	associated	associate	VERB
ajcp-3197	453	6	risk	risk	NOUN
ajcp-3197	453	7	factors	factor	NOUN
ajcp-3197	453	8	of	of	ADP
ajcp-3197	453	9	anemia	anemia	NOUN
ajcp-3197	453	10	pa	pa	PROPN
ajcp-3197	453	11	ge	ge	PROPN
ajcp-3197	453	12	10	10	NUM
ajcp-3197	453	13	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	453	14	am	be	AUX
ajcp-3197	453	15	.	.	PUNCT
ajcp-3197	454	1	j.	j.	PROPN
ajcp-3197	454	2	chem	chem	PROPN
ajcp-3197	454	3	.	.	PUNCT
ajcp-3197	455	1	pharm	pharm	PROPN
ajcp-3197	455	2	.	.	PUNCT
ajcp-3197	456	1	3(1	3(1	NUM
ajcp-3197	456	2	)	)	PUNCT
ajcp-3197	456	3	1	1	NUM
ajcp-3197	456	4	-	-	SYM
ajcp-3197	456	5	11	11	NUM
ajcp-3197	456	6	,	,	PUNCT
ajcp-3197	456	7	2024	2024	NUM
ajcp-3197	456	8	in	in	ADP
ajcp-3197	456	9	pregnancy	pregnancy	NOUN
ajcp-3197	456	10	:	:	PUNCT
ajcp-3197	457	1	a	a	DET
ajcp-3197	457	2	case	case	NOUN
ajcp-3197	457	3	study	study	NOUN
ajcp-3197	457	4	of	of	ADP
ajcp-3197	457	5	pregnant	pregnant	ADJ
ajcp-3197	457	6	women	woman	NOUN
ajcp-3197	457	7	attending	attend	VERB
ajcp-3197	457	8	antenatal	antenatal	ADJ
ajcp-3197	457	9	clinic	clinic	NOUN
ajcp-3197	457	10	in	in	ADP
ajcp-3197	457	11	north	north	NOUN
ajcp-3197	457	12	-	-	PUNCT
ajcp-3197	457	13	central	central	NOUN
ajcp-3197	457	14	nigeria	nigeria	PROPN
ajcp-3197	457	15	.	.	PUNCT
ajcp-3197	458	1	european	european	PROPN
ajcp-3197	458	2	journal	journal	PROPN
ajcp-3197	458	3	of	of	ADP
ajcp-3197	458	4	preventive	preventive	ADJ
ajcp-3197	458	5	medicine	medicine	NOUN
ajcp-3197	458	6	,	,	PUNCT
ajcp-3197	458	7	11(2	11(2	NOUN
ajcp-3197	458	8	)	)	PUNCT
ajcp-3197	458	9	,	,	PUNCT
ajcp-3197	458	10	21	21	NUM
ajcp-3197	458	11	-	-	SYM
ajcp-3197	458	12	31	31	NUM
ajcp-3197	458	13	.	.	PUNCT
ajcp-3197	459	1	https://doi.org/10.11648/j.ejpm.20231102.12	https://doi.org/10.11648/j.ejpm.20231102.12	NOUN
ajcp-3197	459	2	.	.	PUNCT
ajcp-3197	460	1	jaspinder	jaspinder	PROPN
ajcp-3197	460	2	,	,	PUNCT
ajcp-3197	460	3	k.	k.	PROPN
ajcp-3197	460	4	,	,	PUNCT
ajcp-3197	460	5	sargun	sargun	PROPN
ajcp-3197	460	6	,	,	PUNCT
ajcp-3197	460	7	s.	s.	PROPN
ajcp-3197	460	8	,	,	PUNCT
ajcp-3197	460	9	&	&	CCONJ
ajcp-3197	460	10	kawaljit	kawaljit	PROPN
ajcp-3197	460	11	,	,	PUNCT
ajcp-3197	460	12	k.	k.	PROPN
ajcp-3197	460	13	(	(	PUNCT
ajcp-3197	460	14	2014	2014	NUM
ajcp-3197	460	15	)	)	PUNCT
ajcp-3197	460	16	.	.	PUNCT
ajcp-3197	461	1	impact	impact	NOUN
ajcp-3197	461	2	of	of	ADP
ajcp-3197	461	3	age	age	NOUN
ajcp-3197	461	4	on	on	ADP
ajcp-3197	461	5	the	the	DET
ajcp-3197	461	6	prevalence	prevalence	NOUN
ajcp-3197	461	7	of	of	ADP
ajcp-3197	461	8	chronic	chronic	ADJ
ajcp-3197	461	9	diseases	disease	NOUN
ajcp-3197	461	10	in	in	ADP
ajcp-3197	461	11	geriatric	geriatric	ADJ
ajcp-3197	461	12	population	population	NOUN
ajcp-3197	461	13	.	.	PUNCT
ajcp-3197	462	1	international	international	ADJ
ajcp-3197	462	2	research	research	PROPN
ajcp-3197	462	3	journal	journal	NOUN
ajcp-3197	462	4	of	of	ADP
ajcp-3197	462	5	biological	biological	ADJ
ajcp-3197	462	6	sciences	science	NOUN
ajcp-3197	462	7	,	,	PUNCT
ajcp-3197	462	8	3(9	3(9	NUM
ajcp-3197	462	9	)	)	PUNCT
ajcp-3197	462	10	,	,	PUNCT
ajcp-3197	462	11	79	79	NUM
ajcp-3197	462	12	-	-	SYM
ajcp-3197	462	13	85	85	NUM
ajcp-3197	462	14	.	.	PUNCT
ajcp-3197	463	1	jennings	jennings	PROPN
ajcp-3197	463	2	,	,	PUNCT
ajcp-3197	463	3	e.	e.	PROPN
ajcp-3197	463	4	l.	l.	PROPN
ajcp-3197	463	5	,	,	PUNCT
ajcp-3197	463	6	murphy	murphy	PROPN
ajcp-3197	463	7	,	,	PUNCT
ajcp-3197	463	8	k.	k.	PROPN
ajcp-3197	463	9	d.	d.	PROPN
ajcp-3197	463	10	,	,	PUNCT
ajcp-3197	463	11	gallagher	gallagher	PROPN
ajcp-3197	463	12	,	,	PUNCT
ajcp-3197	463	13	p.	p.	PROPN
ajcp-3197	463	14	,	,	PUNCT
ajcp-3197	463	15	&	&	CCONJ
ajcp-3197	463	16	o’mahony	o’mahony	PROPN
ajcp-3197	463	17	,	,	PUNCT
ajcp-3197	463	18	d.	d.	PROPN
ajcp-3197	463	19	(	(	PUNCT
ajcp-3197	463	20	2020	2020	NUM
ajcp-3197	463	21	)	)	PUNCT
ajcp-3197	463	22	.	.	PUNCT
ajcp-3197	464	1	in	in	ADP
ajcp-3197	464	2	-	-	PUNCT
ajcp-3197	464	3	hospital	hospital	NOUN
ajcp-3197	464	4	adverse	adverse	ADJ
ajcp-3197	464	5	drug	drug	NOUN
ajcp-3197	464	6	reactions	reaction	NOUN
ajcp-3197	464	7	in	in	ADP
ajcp-3197	464	8	older	old	ADJ
ajcp-3197	464	9	adults	adult	NOUN
ajcp-3197	464	10	;	;	PUNCT
ajcp-3197	464	11	prevalence	prevalence	NOUN
ajcp-3197	464	12	,	,	PUNCT
ajcp-3197	464	13	presentation	presentation	NOUN
ajcp-3197	464	14	and	and	CCONJ
ajcp-3197	464	15	associated	associated	ADJ
ajcp-3197	464	16	drugs	drug	NOUN
ajcp-3197	464	17	—	—	PUNCT
ajcp-3197	464	18	a	a	DET
ajcp-3197	464	19	systematic	systematic	ADJ
ajcp-3197	464	20	review	review	NOUN
ajcp-3197	464	21	and	and	CCONJ
ajcp-3197	464	22	meta	meta	ADJ
ajcp-3197	464	23	-	-	PUNCT
ajcp-3197	464	24	analysis	analysis	NOUN
ajcp-3197	464	25	.	.	PUNCT
ajcp-3197	465	1	age	age	NOUN
ajcp-3197	465	2	and	and	CCONJ
ajcp-3197	465	3	ageing	ageing	NOUN
ajcp-3197	465	4	,	,	PUNCT
ajcp-3197	465	5	49(6	49(6	NOUN
ajcp-3197	465	6	)	)	PUNCT
ajcp-3197	465	7	,	,	PUNCT
ajcp-3197	465	8	948	948	NUM
ajcp-3197	465	9	-	-	SYM
ajcp-3197	465	10	958	958	NUM
ajcp-3197	465	11	.	.	PUNCT
ajcp-3197	466	1	kongkaew	kongkaew	PROPN
ajcp-3197	466	2	,	,	PUNCT
ajcp-3197	466	3	c.	c.	PROPN
ajcp-3197	466	4	,	,	PUNCT
ajcp-3197	466	5	noyce	noyce	PROPN
ajcp-3197	466	6	,	,	PUNCT
ajcp-3197	466	7	p.	p.	PROPN
ajcp-3197	466	8	r.	r.	PROPN
ajcp-3197	466	9	,	,	PUNCT
ajcp-3197	466	10	&	&	CCONJ
ajcp-3197	466	11	ashcroft	ashcroft	PROPN
ajcp-3197	466	12	,	,	PUNCT
ajcp-3197	466	13	d.	d.	PROPN
ajcp-3197	466	14	m.	m.	PROPN
ajcp-3197	466	15	(	(	PUNCT
ajcp-3197	466	16	2008	2008	NUM
ajcp-3197	466	17	)	)	PUNCT
ajcp-3197	466	18	.	.	PUNCT
ajcp-3197	467	1	hospital	hospital	NOUN
ajcp-3197	467	2	admissions	admission	NOUN
ajcp-3197	467	3	associated	associate	VERB
ajcp-3197	467	4	with	with	ADP
ajcp-3197	467	5	adverse	adverse	ADJ
ajcp-3197	467	6	drug	drug	NOUN
ajcp-3197	467	7	reactions	reaction	NOUN
ajcp-3197	467	8	:	:	PUNCT
ajcp-3197	467	9	a	a	DET
ajcp-3197	467	10	systematic	systematic	ADJ
ajcp-3197	467	11	review	review	NOUN
ajcp-3197	467	12	of	of	ADP
ajcp-3197	467	13	prospective	prospective	ADJ
ajcp-3197	467	14	observational	observational	ADJ
ajcp-3197	467	15	studies	study	NOUN
ajcp-3197	467	16	.	.	PUNCT
ajcp-3197	468	1	annals	annal	NOUN
ajcp-3197	468	2	of	of	ADP
ajcp-3197	468	3	pharmacotherapy	pharmacotherapy	NOUN
ajcp-3197	468	4	,	,	PUNCT
ajcp-3197	468	5	42(78	42(78	PROPN
ajcp-3197	468	6	)	)	PUNCT
ajcp-3197	468	7	,	,	PUNCT
ajcp-3197	468	8	1017	1017	NUM
ajcp-3197	468	9	-	-	SYM
ajcp-3197	468	10	1025	1025	NUM
ajcp-3197	468	11	.	.	PUNCT
ajcp-3197	469	1	mekonnen	mekonnen	NOUN
ajcp-3197	469	2	,	,	PUNCT
ajcp-3197	469	3	a.	a.	PROPN
ajcp-3197	469	4	b.	b.	PROPN
ajcp-3197	469	5	,	,	PUNCT
ajcp-3197	469	6	alhawassi	alhawassi	ADJ
ajcp-3197	469	7	,	,	PUNCT
ajcp-3197	469	8	t.	t.	NOUN
ajcp-3197	469	9	m.	m.	NOUN
ajcp-3197	469	10	,	,	PUNCT
ajcp-3197	469	11	mclachlan	mclachlan	PROPN
ajcp-3197	469	12	,	,	PUNCT
ajcp-3197	469	13	a.	a.	PROPN
ajcp-3197	469	14	j.	j.	PROPN
ajcp-3197	469	15	,	,	PUNCT
ajcp-3197	469	16	&	&	CCONJ
ajcp-3197	469	17	brien	brien	PROPN
ajcp-3197	469	18	,	,	PUNCT
ajcp-3197	469	19	j.	j.	PROPN
ajcp-3197	469	20	a.	a.	PROPN
ajcp-3197	469	21	e.	e.	PROPN
ajcp-3197	469	22	(	(	PUNCT
ajcp-3197	469	23	2018	2018	NUM
ajcp-3197	469	24	)	)	PUNCT
ajcp-3197	469	25	.	.	PUNCT
ajcp-3197	470	1	adverse	adverse	ADJ
ajcp-3197	470	2	drug	drug	NOUN
ajcp-3197	470	3	events	event	NOUN
ajcp-3197	470	4	and	and	CCONJ
ajcp-3197	470	5	medication	medication	NOUN
ajcp-3197	470	6	errors	error	NOUN
ajcp-3197	470	7	in	in	ADP
ajcp-3197	470	8	african	african	ADJ
ajcp-3197	470	9	hospitals	hospital	NOUN
ajcp-3197	470	10	:	:	PUNCT
ajcp-3197	470	11	a	a	DET
ajcp-3197	470	12	systematic	systematic	ADJ
ajcp-3197	470	13	review	review	NOUN
ajcp-3197	470	14	.	.	PUNCT
ajcp-3197	471	1	drugs	drug	NOUN
ajcp-3197	471	2	real	real	ADJ
ajcp-3197	471	3	world	world	NOUN
ajcp-3197	471	4	outcomes	outcome	NOUN
ajcp-3197	471	5	,	,	PUNCT
ajcp-3197	471	6	5	5	NUM
ajcp-3197	471	7	,	,	PUNCT
ajcp-3197	471	8	1	1	NUM
ajcp-3197	471	9	-	-	SYM
ajcp-3197	471	10	24	24	NUM
ajcp-3197	471	11	.	.	PUNCT
ajcp-3197	472	1	https://	https://	PROPN
ajcp-3197	472	2	doi.org/	doi.org/	ADV
ajcp-3197	472	3	10.1007	10.1007	NUM
ajcp-3197	472	4	/	/	SYM
ajcp-3197	472	5	s40801	s40801	NOUN
ajcp-3197	472	6	-	-	PUNCT
ajcp-3197	472	7	017	017	NUM
ajcp-3197	472	8	-	-	PUNCT
ajcp-3197	472	9	0125	0125	NUM
ajcp-3197	472	10	-	-	PUNCT
ajcp-3197	472	11	6	6	NUM
ajcp-3197	472	12	miediegha	miediegha	ADJ
ajcp-3197	472	13	,	,	PUNCT
ajcp-3197	472	14	o.	o.	PROPN
ajcp-3197	472	15	,	,	PUNCT
ajcp-3197	472	16	&	&	CCONJ
ajcp-3197	472	17	bunu	bunu	PROPN
ajcp-3197	472	18	,	,	PUNCT
ajcp-3197	472	19	s.	s.	PROPN
ajcp-3197	472	20	j.	j.	PROPN
ajcp-3197	472	21	(	(	PUNCT
ajcp-3197	472	22	2020	2020	NUM
ajcp-3197	472	23	)	)	PUNCT
ajcp-3197	472	24	.	.	PUNCT
ajcp-3197	473	1	pharmacovigilance	pharmacovigilance	NOUN
ajcp-3197	473	2	framework	framework	NOUN
ajcp-3197	473	3	and	and	CCONJ
ajcp-3197	473	4	extent	extent	NOUN
ajcp-3197	473	5	of	of	ADP
ajcp-3197	473	6	medications	medication	NOUN
ajcp-3197	473	7	adverse	adverse	ADJ
ajcp-3197	473	8	reaction	reaction	NOUN
ajcp-3197	473	9	surveillance	surveillance	NOUN
ajcp-3197	473	10	in	in	ADP
ajcp-3197	473	11	southern	southern	PROPN
ajcp-3197	473	12	nigeria	nigeria	PROPN
ajcp-3197	473	13	.	.	PUNCT
ajcp-3197	474	1	world	world	PROPN
ajcp-3197	474	2	journal	journal	PROPN
ajcp-3197	474	3	of	of	ADP
ajcp-3197	474	4	pharmaceutical	pharmaceutical	NOUN
ajcp-3197	474	5	research	research	NOUN
ajcp-3197	474	6	,	,	PUNCT
ajcp-3197	474	7	9(6	9(6	NUM
ajcp-3197	474	8	)	)	PUNCT
ajcp-3197	474	9	,	,	PUNCT
ajcp-3197	474	10	2009	2009	NUM
ajcp-3197	474	11	-	-	SYM
ajcp-3197	474	12	2017	2017	NUM
ajcp-3197	474	13	.	.	PUNCT
ajcp-3197	475	1	https://doi	https://doi	NOUN
ajcp-3197	475	2	.	.	PUNCT
ajcp-3197	475	3	org/10.20959	org/10.20959	PROPN
ajcp-3197	475	4	/	/	SYM
ajcp-3197	475	5	wjpr20206	wjpr20206	PROPN
ajcp-3197	475	6	-	-	PUNCT
ajcp-3197	475	7	17727	17727	NUM
ajcp-3197	475	8	.	.	PUNCT
ajcp-3197	476	1	musa	musa	PROPN
ajcp-3197	476	2	,	,	PUNCT
ajcp-3197	476	3	s.	s.	PROPN
ajcp-3197	476	4	,	,	PUNCT
ajcp-3197	476	5	ikwuka	ikwuka	PROPN
ajcp-3197	476	6	,	,	PUNCT
ajcp-3197	476	7	a.	a.	NOUN
ajcp-3197	476	8	o.	o.	PROPN
ajcp-3197	476	9	,	,	PUNCT
ajcp-3197	476	10	udeh	udeh	PROPN
ajcp-3197	476	11	,	,	PUNCT
ajcp-3197	476	12	f.	f.	PROPN
ajcp-3197	476	13	c.	c.	PROPN
ajcp-3197	476	14	,	,	PUNCT
ajcp-3197	476	15	musa	musa	PROPN
ajcp-3197	476	16	,	,	PUNCT
ajcp-3197	476	17	a.	a.	NOUN
ajcp-3197	476	18	a.	a.	PROPN
ajcp-3197	476	19	,	,	PUNCT
ajcp-3197	476	20	&	&	CCONJ
ajcp-3197	476	21	chukwuezie	chukwuezie	PROPN
ajcp-3197	476	22	,	,	PUNCT
ajcp-3197	476	23	u.	u.	PROPN
ajcp-3197	476	24	c.	c.	PROPN
ajcp-3197	476	25	(	(	PUNCT
ajcp-3197	476	26	2023	2023	NUM
ajcp-3197	476	27	)	)	PUNCT
ajcp-3197	476	28	.	.	PUNCT
ajcp-3197	477	1	crispr	crispr	ADJ
ajcp-3197	477	2	-	-	PUNCT
ajcp-3197	477	3	cas9	cas9	NOUN
ajcp-3197	477	4	genomic	genomic	NOUN
ajcp-3197	477	5	editing	editing	NOUN
ajcp-3197	477	6	as	as	ADP
ajcp-3197	477	7	an	an	DET
ajcp-3197	477	8	innovation	innovation	NOUN
ajcp-3197	477	9	in	in	ADP
ajcp-3197	477	10	the	the	DET
ajcp-3197	477	11	management	management	NOUN
ajcp-3197	477	12	of	of	ADP
ajcp-3197	477	13	sickle	sickle	NOUN
ajcp-3197	477	14	cell	cell	NOUN
ajcp-3197	477	15	disease	disease	NOUN
ajcp-3197	477	16	:	:	PUNCT
ajcp-3197	477	17	a	a	DET
ajcp-3197	477	18	systematic	systematic	ADJ
ajcp-3197	477	19	review	review	NOUN
ajcp-3197	477	20	.	.	PUNCT
ajcp-3197	478	1	american	american	PROPN
ajcp-3197	478	2	journal	journal	PROPN
ajcp-3197	478	3	of	of	ADP
ajcp-3197	478	4	medical	medical	ADJ
ajcp-3197	478	5	science	science	NOUN
ajcp-3197	478	6	and	and	CCONJ
ajcp-3197	478	7	innovation	innovation	NOUN
ajcp-3197	478	8	,	,	PUNCT
ajcp-3197	478	9	2(2	2(2	NUM
ajcp-3197	478	10	)	)	PUNCT
ajcp-3197	478	11	,	,	PUNCT
ajcp-3197	478	12	36	36	NUM
ajcp-3197	478	13	-	-	SYM
ajcp-3197	478	14	48	48	NUM
ajcp-3197	478	15	.	.	PUNCT
ajcp-3197	479	1	https://doi	https://doi	NOUN
ajcp-3197	479	2	.	.	PUNCT
ajcp-3197	480	1	org/10.54536	org/10.54536	PROPN
ajcp-3197	480	2	/	/	SYM
ajcp-3197	480	3	ajmsi.v2i2.1760	ajmsi.v2i2.1760	PROPN
ajcp-3197	480	4	.	.	PUNCT
ajcp-3197	481	1	national	national	ADJ
ajcp-3197	481	2	pharmacovigilance	pharmacovigilance	PROPN
ajcp-3197	481	3	center	center	PROPN
ajcp-3197	481	4	(	(	PUNCT
ajcp-3197	481	5	npc	npc	PROPN
ajcp-3197	481	6	)	)	PUNCT
ajcp-3197	481	7	,	,	PUNCT
ajcp-3197	481	8	nigeria	nigeria	PROPN
ajcp-3197	481	9	.	.	PUNCT
ajcp-3197	482	1	(	(	PUNCT
ajcp-3197	482	2	2014	2014	NUM
ajcp-3197	482	3	)	)	PUNCT
ajcp-3197	482	4	.	.	PUNCT
ajcp-3197	483	1	guide	guide	VERB
ajcp-3197	483	2	for	for	ADP
ajcp-3197	483	3	reporting	report	VERB
ajcp-3197	483	4	adverse	adverse	ADJ
ajcp-3197	483	5	reactions	reaction	NOUN
ajcp-3197	483	6	to	to	AUX
ajcp-3197	483	7	marketed	market	VERB
ajcp-3197	483	8	drugs	drug	NOUN
ajcp-3197	483	9	.	.	PUNCT
ajcp-3197	484	1	available	available	ADJ
ajcp-3197	484	2	online	online	ADV
ajcp-3197	484	3	:	:	PUNCT
ajcp-3197	484	4	http://www.rrfa.co.za/	http://www.rrfa.co.za/	PROPN
ajcp-3197	484	5	wp	wp	PROPN
ajcp-3197	484	6	-	-	PUNCT
ajcp-3197	484	7	content	content	NOUN
ajcp-3197	484	8	/	/	SYM
ajcp-3197	484	9	uploads/2014/01	uploads/2014/01	NOUN
ajcp-3197	484	10	/	/	SYM
ajcp-3197	484	11	pv	pv	NOUN
ajcp-3197	484	12	-	-	PUNCT
ajcp-3197	484	13	guidelinereceived-2012.pdf	guidelinereceived-2012.pdf	NOUN
ajcp-3197	484	14	nwani	nwani	NOUN
ajcp-3197	484	15	,	,	PUNCT
ajcp-3197	484	16	p.	p.	PROPN
ajcp-3197	484	17	o.	o.	PROPN
ajcp-3197	484	18	,	,	PUNCT
ajcp-3197	484	19	&	&	CCONJ
ajcp-3197	484	20	isah	isah	PROPN
ajcp-3197	484	21	,	,	PUNCT
ajcp-3197	484	22	a.	a.	NOUN
ajcp-3197	484	23	o.	o.	PROPN
ajcp-3197	484	24	(	(	PUNCT
ajcp-3197	484	25	2017	2017	NUM
ajcp-3197	484	26	)	)	PUNCT
ajcp-3197	484	27	.	.	PUNCT
ajcp-3197	485	1	frequency	frequency	NOUN
ajcp-3197	485	2	and	and	CCONJ
ajcp-3197	485	3	patterns	pattern	NOUN
ajcp-3197	485	4	of	of	ADP
ajcp-3197	485	5	adverse	adverse	ADJ
ajcp-3197	485	6	drug	drug	NOUN
ajcp-3197	485	7	reactions	reaction	NOUN
ajcp-3197	485	8	among	among	ADP
ajcp-3197	485	9	elderly	elderly	ADJ
ajcp-3197	485	10	inpatients	inpatient	NOUN
ajcp-3197	485	11	in	in	ADP
ajcp-3197	485	12	a	a	DET
ajcp-3197	485	13	nigerian	nigerian	ADJ
ajcp-3197	485	14	teaching	teaching	NOUN
ajcp-3197	485	15	hospital	hospital	NOUN
ajcp-3197	485	16	.	.	PUNCT
ajcp-3197	486	1	j	j	PROPN
ajcp-3197	486	2	basic	basic	ADJ
ajcp-3197	486	3	clin	clin	PROPN
ajcp-3197	486	4	pharm	pharm	PROPN
ajcp-3197	486	5	,	,	PUNCT
ajcp-3197	486	6	8	8	NUM
ajcp-3197	486	7	,	,	PUNCT
ajcp-3197	486	8	245	245	NUM
ajcp-3197	486	9	-	-	SYM
ajcp-3197	486	10	250	250	NUM
ajcp-3197	486	11	.	.	PUNCT
ajcp-3197	487	1	ogar	ogar	PROPN
ajcp-3197	487	2	,	,	PUNCT
ajcp-3197	487	3	c.	c.	PROPN
ajcp-3197	487	4	k.	k.	PROPN
ajcp-3197	487	5	,	,	PUNCT
ajcp-3197	487	6	abiola	abiola	PROPN
ajcp-3197	487	7	,	,	PUNCT
ajcp-3197	487	8	a.	a.	PROPN
ajcp-3197	487	9	,	,	PUNCT
ajcp-3197	487	10	yuah	yuah	NOUN
ajcp-3197	487	11	,	,	PUNCT
ajcp-3197	487	12	d.	d.	PROPN
ajcp-3197	487	13	,	,	PUNCT
ajcp-3197	487	14	ibrahim	ibrahim	PROPN
ajcp-3197	487	15	,	,	PUNCT
ajcp-3197	487	16	a.	a.	PROPN
ajcp-3197	487	17	,	,	PUNCT
ajcp-3197	487	18	oreagba	oreagba	PROPN
ajcp-3197	487	19	,	,	PUNCT
ajcp-3197	487	20	i.	i.	PROPN
ajcp-3197	487	21	a.	a.	PROPN
ajcp-3197	487	22	,	,	PUNCT
ajcp-3197	487	23	amadi	amadi	PROPN
ajcp-3197	487	24	,	,	PUNCT
ajcp-3197	487	25	e.	e.	PROPN
ajcp-3197	487	26	c	c	PROPN
ajcp-3197	487	27	..	..	PUNCT
ajcp-3197	487	28	&	&	CCONJ
ajcp-3197	487	29	oshikoya	oshikoya	PROPN
ajcp-3197	487	30	,	,	PUNCT
ajcp-3197	487	31	k.	k.	PROPN
ajcp-3197	487	32	a.	a.	PROPN
ajcp-3197	487	33	(	(	PUNCT
ajcp-3197	487	34	2019	2019	NUM
ajcp-3197	487	35	)	)	PUNCT
ajcp-3197	487	36	.	.	PUNCT
ajcp-3197	488	1	a	a	DET
ajcp-3197	488	2	retrospective	retrospective	ADJ
ajcp-3197	488	3	review	review	NOUN
ajcp-3197	488	4	of	of	ADP
ajcp-3197	488	5	serious	serious	ADJ
ajcp-3197	488	6	adverse	adverse	ADJ
ajcp-3197	488	7	drug	drug	NOUN
ajcp-3197	488	8	reaction	reaction	NOUN
ajcp-3197	488	9	reports	report	NOUN
ajcp-3197	488	10	in	in	ADP
ajcp-3197	488	11	the	the	DET
ajcp-3197	488	12	nigerian	nigerian	ADJ
ajcp-3197	488	13	vigiflow	vigiflow	PROPN
ajcp-3197	488	14	database	database	NOUN
ajcp-3197	488	15	from	from	ADP
ajcp-3197	488	16	september	september	PROPN
ajcp-3197	488	17	2004	2004	NUM
ajcp-3197	488	18	to	to	ADP
ajcp-3197	488	19	december	december	PROPN
ajcp-3197	488	20	2016	2016	NUM
ajcp-3197	488	21	.	.	PUNCT
ajcp-3197	489	1	pharmaceutical	pharmaceutical	ADJ
ajcp-3197	489	2	medicine	medicine	NOUN
ajcp-3197	489	3	,	,	PUNCT
ajcp-3197	489	4	33	33	NUM
ajcp-3197	489	5	,	,	PUNCT
ajcp-3197	489	6	145	145	NUM
ajcp-3197	489	7	-	-	SYM
ajcp-3197	489	8	157	157	NUM
ajcp-3197	489	9	.	.	PUNCT
ajcp-3197	490	1	https://doi.org/10.1007/	https://doi.org/10.1007/	PROPN
ajcp-3197	490	2	s40290	s40290	PROPN
ajcp-3197	490	3	-	-	PUNCT
ajcp-3197	490	4	019	019	NUM
ajcp-3197	490	5	-	-	PUNCT
ajcp-3197	490	6	00267	00267	NUM
ajcp-3197	490	7	-	-	PUNCT
ajcp-3197	490	8	2	2	NUM
ajcp-3197	490	9	.	.	X
ajcp-3197	490	10	okezie	okezie	PROPN
ajcp-3197	490	11	,	,	PUNCT
ajcp-3197	490	12	e.	e.	PROPN
ajcp-3197	490	13	o.	o.	PROPN
ajcp-3197	490	14	,	,	PUNCT
ajcp-3197	490	15	&	&	CCONJ
ajcp-3197	490	16	olufunmilayo	olufunmilayo	PROPN
ajcp-3197	490	17	,	,	PUNCT
ajcp-3197	490	18	f.	f.	PROPN
ajcp-3197	490	19	(	(	PUNCT
ajcp-3197	490	20	2008	2008	NUM
ajcp-3197	490	21	)	)	PUNCT
ajcp-3197	490	22	.	.	PUNCT
ajcp-3197	491	1	adverse	adverse	ADJ
ajcp-3197	491	2	drug	drug	NOUN
ajcp-3197	491	3	reactions	reaction	NOUN
ajcp-3197	491	4	reporting	report	VERB
ajcp-3197	491	5	by	by	ADP
ajcp-3197	491	6	physicians	physician	NOUN
ajcp-3197	491	7	in	in	ADP
ajcp-3197	491	8	ibadan	ibadan	PROPN
ajcp-3197	491	9	,	,	PUNCT
ajcp-3197	491	10	nigeria	nigeria	PROPN
ajcp-3197	491	11	.	.	PUNCT
ajcp-3197	492	1	pharmacoepidemiology	pharmacoepidemiology	NOUN
ajcp-3197	492	2	and	and	CCONJ
ajcp-3197	492	3	drug	drug	NOUN
ajcp-3197	492	4	safety	safety	NOUN
ajcp-3197	492	5	,	,	PUNCT
ajcp-3197	492	6	17(5	17(5	NUM
ajcp-3197	492	7	)	)	PUNCT
ajcp-3197	492	8	,	,	PUNCT
ajcp-3197	492	9	517	517	NUM
ajcp-3197	492	10	-	-	SYM
ajcp-3197	492	11	522	522	NUM
ajcp-3197	492	12	.	.	PUNCT
ajcp-3197	493	1	https://doi.org/10.1002/pds.1597	https://doi.org/10.1002/pds.1597	PROPN
ajcp-3197	493	2	.	.	PUNCT
ajcp-3197	494	1	oli	oli	PROPN
ajcp-3197	494	2	,	,	PUNCT
ajcp-3197	494	3	a.	a.	NOUN
ajcp-3197	494	4	n.	n.	NOUN
ajcp-3197	494	5	,	,	PUNCT
ajcp-3197	494	6	onyeaso	onyeaso	NOUN
ajcp-3197	494	7	,	,	PUNCT
ajcp-3197	494	8	n.	n.	NOUN
ajcp-3197	494	9	,	,	PUNCT
ajcp-3197	494	10	emencheta	emencheta	PROPN
ajcp-3197	494	11	,	,	PUNCT
ajcp-3197	494	12	s.	s.	PROPN
ajcp-3197	494	13	c.	c.	PROPN
ajcp-3197	494	14	,	,	PUNCT
ajcp-3197	494	15	ofomata	ofomata	PROPN
ajcp-3197	494	16	,	,	PUNCT
ajcp-3197	494	17	c.	c.	PROPN
ajcp-3197	494	18	m.	m.	NOUN
ajcp-3197	494	19	,	,	PUNCT
ajcp-3197	494	20	kretchy	kretchy	NOUN
ajcp-3197	494	21	,	,	PUNCT
ajcp-3197	494	22	j.	j.	PROPN
ajcp-3197	494	23	p.	p.	PROPN
ajcp-3197	494	24	,	,	PUNCT
ajcp-3197	494	25	okhamafe	okhamafe	PROPN
ajcp-3197	494	26	,	,	PUNCT
ajcp-3197	494	27	a.	a.	NOUN
ajcp-3197	494	28	,	,	PUNCT
ajcp-3197	494	29	&	&	CCONJ
ajcp-3197	494	30	ele	ele	PROPN
ajcp-3197	494	31	,	,	PUNCT
ajcp-3197	494	32	g.	g.	PROPN
ajcp-3197	494	33	n.	n.	PROPN
ajcp-3197	494	34	(	(	PUNCT
ajcp-3197	494	35	2021	2021	NUM
ajcp-3197	494	36	)	)	PUNCT
ajcp-3197	494	37	.	.	PUNCT
ajcp-3197	495	1	evaluating	evaluate	VERB
ajcp-3197	495	2	antimicrobial	antimicrobial	ADJ
ajcp-3197	495	3	prescribing	prescribing	NOUN
ajcp-3197	495	4	in	in	ADP
ajcp-3197	495	5	a	a	DET
ajcp-3197	495	6	tertiary	tertiary	ADJ
ajcp-3197	495	7	healthcare	healthcare	NOUN
ajcp-3197	495	8	institution	institution	NOUN
ajcp-3197	495	9	in	in	ADP
ajcp-3197	495	10	nigeria	nigeria	PROPN
ajcp-3197	495	11	.	.	PUNCT
ajcp-3197	496	1	journal	journal	PROPN
ajcp-3197	496	2	of	of	ADP
ajcp-3197	496	3	pharmaceutical	pharmaceutical	NOUN
ajcp-3197	496	4	policy	policy	NOUN
ajcp-3197	496	5	and	and	CCONJ
ajcp-3197	496	6	practice	practice	NOUN
ajcp-3197	496	7	,	,	PUNCT
ajcp-3197	496	8	14(1	14(1	NUM
ajcp-3197	496	9	)	)	PUNCT
ajcp-3197	496	10	,	,	PUNCT
ajcp-3197	496	11	1	1	NUM
ajcp-3197	496	12	-	-	SYM
ajcp-3197	496	13	6	6	NUM
ajcp-3197	496	14	.	.	PUNCT
ajcp-3197	497	1	oreagba	oreagba	PROPN
ajcp-3197	497	2	,	,	PUNCT
ajcp-3197	497	3	i.	i.	PROPN
ajcp-3197	497	4	a.	a.	PROPN
ajcp-3197	497	5	,	,	PUNCT
ajcp-3197	497	6	bada	bada	PROPN
ajcp-3197	497	7	,	,	PUNCT
ajcp-3197	497	8	s.	s.	PROPN
ajcp-3197	497	9	o.	o.	PROPN
ajcp-3197	497	10	,	,	PUNCT
ajcp-3197	497	11	&	&	CCONJ
ajcp-3197	497	12	chuka	chuka	PROPN
ajcp-3197	497	13	-	-	PUNCT
ajcp-3197	497	14	ebene	ebene	NOUN
ajcp-3197	497	15	,	,	PUNCT
ajcp-3197	497	16	v.	v.	PROPN
ajcp-3197	497	17	(	(	PUNCT
ajcp-3197	497	18	2015	2015	NUM
ajcp-3197	497	19	)	)	PUNCT
ajcp-3197	497	20	.	.	PUNCT
ajcp-3197	498	1	an	an	DET
ajcp-3197	498	2	intensive	intensive	ADJ
ajcp-3197	498	3	study	study	NOUN
ajcp-3197	498	4	of	of	ADP
ajcp-3197	498	5	adverse	adverse	ADJ
ajcp-3197	498	6	events	event	NOUN
ajcp-3197	498	7	in	in	ADP
ajcp-3197	498	8	the	the	DET
ajcp-3197	498	9	medical	medical	ADJ
ajcp-3197	498	10	unit	unit	NOUN
ajcp-3197	498	11	of	of	ADP
ajcp-3197	498	12	a	a	DET
ajcp-3197	498	13	nigerian	nigerian	ADJ
ajcp-3197	498	14	teaching	teaching	NOUN
ajcp-3197	498	15	hospital	hospital	NOUN
ajcp-3197	498	16	.	.	PUNCT
ajcp-3197	499	1	value	value	NOUN
ajcp-3197	499	2	in	in	ADP
ajcp-3197	499	3	health	health	NOUN
ajcp-3197	499	4	,	,	PUNCT
ajcp-3197	499	5	18(3	18(3	NUM
ajcp-3197	499	6	)	)	PUNCT
ajcp-3197	499	7	,	,	PUNCT
ajcp-3197	499	8	a86	a86	PROPN
ajcp-3197	499	9	-	-	PUNCT
ajcp-3197	499	10	a87	a87	NOUN
ajcp-3197	499	11	.	.	PUNCT
ajcp-3197	500	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ajcp-3197	500	2	.	.	PUNCT
ajcp-3197	501	1	jval.2015.03.506	jval.2015.03.506	X
ajcp-3197	501	2	oriavwote	oriavwote	PROPN
ajcp-3197	501	3	,	,	PUNCT
ajcp-3197	501	4	p.	p.	PROPN
ajcp-3197	501	5	e.	e.	PROPN
ajcp-3197	501	6	,	,	PUNCT
ajcp-3197	501	7	&	&	CCONJ
ajcp-3197	501	8	ikwuka	ikwuka	PROPN
ajcp-3197	501	9	,	,	PUNCT
ajcp-3197	501	10	a.	a.	NOUN
ajcp-3197	501	11	o.	o.	NOUN
ajcp-3197	501	12	(	(	PUNCT
ajcp-3197	501	13	2022	2022	NUM
ajcp-3197	501	14	)	)	PUNCT
ajcp-3197	501	15	.	.	PUNCT
ajcp-3197	502	1	patterns	pattern	NOUN
ajcp-3197	502	2	and	and	CCONJ
ajcp-3197	502	3	factors	factor	NOUN
ajcp-3197	502	4	influencing	influence	VERB
ajcp-3197	502	5	self	self	NOUN
ajcp-3197	502	6	-	-	PUNCT
ajcp-3197	502	7	medication	medication	NOUN
ajcp-3197	502	8	among	among	ADP
ajcp-3197	502	9	students	student	NOUN
ajcp-3197	502	10	of	of	ADP
ajcp-3197	502	11	the	the	DET
ajcp-3197	502	12	american	american	PROPN
ajcp-3197	502	13	international	international	PROPN
ajcp-3197	502	14	university	university	PROPN
ajcp-3197	502	15	west	west	PROPN
ajcp-3197	502	16	africa	africa	PROPN
ajcp-3197	502	17	(	(	PUNCT
ajcp-3197	502	18	aiuwa	aiuwa	PROPN
ajcp-3197	502	19	)	)	PUNCT
ajcp-3197	502	20	,	,	PUNCT
ajcp-3197	502	21	the	the	DET
ajcp-3197	502	22	gambia	gambia	NOUN
ajcp-3197	502	23	.	.	PUNCT
ajcp-3197	503	1	european	european	PROPN
ajcp-3197	503	2	journal	journal	PROPN
ajcp-3197	503	3	of	of	ADP
ajcp-3197	503	4	clinical	clinical	ADJ
ajcp-3197	503	5	medicine	medicine	NOUN
ajcp-3197	503	6	,	,	PUNCT
ajcp-3197	503	7	3(2	3(2	NUM
ajcp-3197	503	8	)	)	PUNCT
ajcp-3197	503	9	,	,	PUNCT
ajcp-3197	503	10	33	33	NUM
ajcp-3197	503	11	-	-	SYM
ajcp-3197	503	12	37	37	NUM
ajcp-3197	503	13	.	.	PUNCT
ajcp-3197	504	1	https://doi.org/10.24018/	https://doi.org/10.24018/	PROPN
ajcp-3197	504	2	clinicmed.2022.3.2.181	clinicmed.2022.3.2.181	PROPN
ajcp-3197	504	3	.	.	PUNCT
ajcp-3197	505	1	oscanoa	oscanoa	PROPN
ajcp-3197	505	2	,	,	PUNCT
ajcp-3197	505	3	t.	t.	PROPN
ajcp-3197	505	4	j.	j.	PROPN
ajcp-3197	505	5	,	,	PUNCT
ajcp-3197	505	6	lizaraso	lizaraso	PROPN
ajcp-3197	505	7	,	,	PUNCT
ajcp-3197	505	8	f.	f.	PROPN
ajcp-3197	505	9	,	,	PUNCT
ajcp-3197	505	10	&	&	CCONJ
ajcp-3197	505	11	carvajal	carvajal	PROPN
ajcp-3197	505	12	,	,	PUNCT
ajcp-3197	505	13	a.	a.	NOUN
ajcp-3197	505	14	(	(	PUNCT
ajcp-3197	505	15	2017	2017	NUM
ajcp-3197	505	16	)	)	PUNCT
ajcp-3197	505	17	.	.	PUNCT
ajcp-3197	506	1	hospital	hospital	NOUN
ajcp-3197	506	2	admissions	admission	NOUN
ajcp-3197	506	3	due	due	ADJ
ajcp-3197	506	4	to	to	ADP
ajcp-3197	506	5	adverse	adverse	ADJ
ajcp-3197	506	6	drug	drug	NOUN
ajcp-3197	506	7	reactions	reaction	NOUN
ajcp-3197	506	8	in	in	ADP
ajcp-3197	506	9	the	the	DET
ajcp-3197	506	10	elderly	elderly	ADJ
ajcp-3197	506	11	:	:	PUNCT
ajcp-3197	506	12	a	a	DET
ajcp-3197	506	13	meta	meta	ADJ
ajcp-3197	506	14	-	-	PUNCT
ajcp-3197	506	15	analysis	analysis	NOUN
ajcp-3197	506	16	.	.	PUNCT
ajcp-3197	507	1	european	european	ADJ
ajcp-3197	507	2	journal	journal	PROPN
ajcp-3197	507	3	of	of	ADP
ajcp-3197	507	4	clinical	clinical	ADJ
ajcp-3197	507	5	pharmacology	pharmacology	NOUN
ajcp-3197	507	6	,	,	PUNCT
ajcp-3197	507	7	73	73	NUM
ajcp-3197	507	8	,	,	PUNCT
ajcp-3197	507	9	759	759	NUM
ajcp-3197	507	10	-	-	SYM
ajcp-3197	507	11	770	770	NUM
ajcp-3197	507	12	.	.	PUNCT
ajcp-3197	508	1	prince	prince	PROPN
ajcp-3197	508	2	,	,	PUNCT
ajcp-3197	508	3	m.	m.	PROPN
ajcp-3197	508	4	j.	j.	PROPN
ajcp-3197	508	5	,	,	PUNCT
ajcp-3197	508	6	wu	wu	PROPN
ajcp-3197	508	7	,	,	PUNCT
ajcp-3197	508	8	f.	f.	PROPN
ajcp-3197	508	9	,	,	PUNCT
ajcp-3197	508	10	guo	guo	PROPN
ajcp-3197	508	11	,	,	PUNCT
ajcp-3197	508	12	y.	y.	PROPN
ajcp-3197	508	13	,	,	PUNCT
ajcp-3197	508	14	robledo	robledo	PROPN
ajcp-3197	508	15	,	,	PUNCT
ajcp-3197	508	16	l.	l.	PROPN
ajcp-3197	508	17	m.	m.	PROPN
ajcp-3197	508	18	g.	g.	PROPN
ajcp-3197	508	19	,	,	PUNCT
ajcp-3197	508	20	o’donnell	o’donnell	PROPN
ajcp-3197	508	21	,	,	PUNCT
ajcp-3197	508	22	m.	m.	NOUN
ajcp-3197	508	23	,	,	PUNCT
ajcp-3197	508	24	sullivan	sullivan	PROPN
ajcp-3197	508	25	,	,	PUNCT
ajcp-3197	508	26	r.	r.	PROPN
ajcp-3197	508	27	,	,	PUNCT
ajcp-3197	508	28	&	&	CCONJ
ajcp-3197	508	29	yusuf	yusuf	PROPN
ajcp-3197	508	30	,	,	PUNCT
ajcp-3197	508	31	s.	s.	PROPN
ajcp-3197	508	32	(	(	PUNCT
ajcp-3197	508	33	2015	2015	NUM
ajcp-3197	508	34	)	)	PUNCT
ajcp-3197	508	35	.	.	PUNCT
ajcp-3197	509	1	the	the	DET
ajcp-3197	509	2	burden	burden	NOUN
ajcp-3197	509	3	of	of	ADP
ajcp-3197	509	4	disease	disease	NOUN
ajcp-3197	509	5	in	in	ADP
ajcp-3197	509	6	older	old	ADJ
ajcp-3197	509	7	people	people	NOUN
ajcp-3197	509	8	and	and	CCONJ
ajcp-3197	509	9	implications	implication	NOUN
ajcp-3197	509	10	for	for	ADP
ajcp-3197	509	11	health	health	NOUN
ajcp-3197	509	12	policy	policy	NOUN
ajcp-3197	509	13	and	and	CCONJ
ajcp-3197	509	14	practice	practice	NOUN
ajcp-3197	509	15	.	.	PUNCT
ajcp-3197	510	1	the	the	DET
ajcp-3197	510	2	lancet	lancet	PROPN
ajcp-3197	510	3	,	,	PUNCT
ajcp-3197	510	4	385(9967	385(9967	NUM
ajcp-3197	510	5	)	)	PUNCT
ajcp-3197	510	6	,	,	PUNCT
ajcp-3197	510	7	549562	549562	NUM
ajcp-3197	510	8	.	.	PUNCT
ajcp-3197	511	1	https://doi.org/10.1016/s0140-6736(14)613477	https://doi.org/10.1016/s0140-6736(14)613477	NOUN
ajcp-3197	511	2	.	.	PUNCT
ajcp-3197	511	3	ramia	ramia	NOUN
ajcp-3197	511	4	,	,	PUNCT
ajcp-3197	511	5	e.	e.	PROPN
ajcp-3197	511	6	,	,	PUNCT
ajcp-3197	511	7	zeenny	zeenny	PROPN
ajcp-3197	511	8	,	,	PUNCT
ajcp-3197	511	9	r.	r.	PROPN
ajcp-3197	511	10	m.	m.	PROPN
ajcp-3197	511	11	,	,	PUNCT
ajcp-3197	511	12	hallit	hallit	PROPN
ajcp-3197	511	13	,	,	PUNCT
ajcp-3197	511	14	s.	s.	PROPN
ajcp-3197	511	15	,	,	PUNCT
ajcp-3197	511	16	&	&	CCONJ
ajcp-3197	511	17	salameh	salameh	NOUN
ajcp-3197	511	18	,	,	PUNCT
ajcp-3197	511	19	p.	p.	NOUN
ajcp-3197	511	20	(	(	PUNCT
ajcp-3197	511	21	2021	2021	NUM
ajcp-3197	511	22	)	)	PUNCT
ajcp-3197	511	23	.	.	PUNCT
ajcp-3197	512	1	a	a	DET
ajcp-3197	512	2	population	population	NOUN
ajcp-3197	512	3	-	-	PUNCT
ajcp-3197	512	4	based	base	VERB
ajcp-3197	512	5	study	study	NOUN
ajcp-3197	512	6	of	of	ADP
ajcp-3197	512	7	self	self	NOUN
ajcp-3197	512	8	-	-	PUNCT
ajcp-3197	512	9	reported	report	VERB
ajcp-3197	512	10	adverse	adverse	ADJ
ajcp-3197	512	11	drug	drug	NOUN
ajcp-3197	512	12	events	event	NOUN
ajcp-3197	512	13	among	among	ADP
ajcp-3197	512	14	lebanese	lebanese	ADJ
ajcp-3197	512	15	outpatients	outpatient	NOUN
ajcp-3197	512	16	.	.	PUNCT
ajcp-3197	513	1	scientific	scientific	ADJ
ajcp-3197	513	2	reports	report	NOUN
ajcp-3197	513	3	,	,	PUNCT
ajcp-3197	513	4	11(1	11(1	NUM
ajcp-3197	513	5	)	)	PUNCT
ajcp-3197	513	6	,	,	PUNCT
ajcp-3197	513	7	7921	7921	NUM
ajcp-3197	513	8	.	.	PUNCT
ajcp-3197	514	1	saka	saka	PROPN
ajcp-3197	514	2	,	,	PUNCT
ajcp-3197	514	3	s.	s.	PROPN
ajcp-3197	514	4	a.	a.	PROPN
ajcp-3197	514	5	,	,	PUNCT
ajcp-3197	514	6	nlooto	nlooto	NOUN
ajcp-3197	514	7	,	,	PUNCT
ajcp-3197	514	8	m.	m.	NOUN
ajcp-3197	514	9	,	,	PUNCT
ajcp-3197	514	10	&	&	CCONJ
ajcp-3197	514	11	oosthuizen	oosthuizen	PROPN
ajcp-3197	514	12	,	,	PUNCT
ajcp-3197	514	13	f.	f.	PROPN
ajcp-3197	514	14	(	(	PUNCT
ajcp-3197	514	15	2018	2018	NUM
ajcp-3197	514	16	)	)	PUNCT
ajcp-3197	514	17	.	.	PUNCT
ajcp-3197	515	1	american	american	ADJ
ajcp-3197	515	2	geriatrics	geriatrics	PROPN
ajcp-3197	515	3	society	society	NOUN
ajcp-3197	515	4	-	-	PUNCT
ajcp-3197	515	5	beers	beer	NOUN
ajcp-3197	515	6	criteria	criterion	NOUN
ajcp-3197	515	7	and	and	CCONJ
ajcp-3197	515	8	adverse	adverse	ADJ
ajcp-3197	515	9	drug	drug	NOUN
ajcp-3197	515	10	reactions	reaction	NOUN
ajcp-3197	515	11	:	:	PUNCT
ajcp-3197	515	12	a	a	DET
ajcp-3197	515	13	comparative	comparative	ADJ
ajcp-3197	515	14	cross	cross	ADJ
ajcp-3197	515	15	-	-	ADJ
ajcp-3197	515	16	sectional	sectional	ADJ
ajcp-3197	515	17	study	study	NOUN
ajcp-3197	515	18	of	of	ADP
ajcp-3197	515	19	nigerian	nigerian	PROPN
ajcp-3197	515	20	and	and	CCONJ
ajcp-3197	515	21	south	south	ADJ
ajcp-3197	515	22	african	african	ADJ
ajcp-3197	515	23	older	old	ADJ
ajcp-3197	515	24	inpatients	inpatient	NOUN
ajcp-3197	515	25	.	.	PUNCT
ajcp-3197	516	1	clinical	clinical	ADJ
ajcp-3197	516	2	interventions	intervention	NOUN
ajcp-3197	516	3	in	in	ADP
ajcp-3197	516	4	aging	age	VERB
ajcp-3197	516	5	,	,	PUNCT
ajcp-3197	516	6	13	13	NUM
ajcp-3197	516	7	,	,	PUNCT
ajcp-3197	516	8	2375	2375	NUM
ajcp-3197	516	9	-	-	SYM
ajcp-3197	516	10	2387	2387	NUM
ajcp-3197	516	11	.	.	PUNCT
ajcp-3197	517	1	https://	https://	PROPN
ajcp-3197	517	2	doi.org/10.2147/cia.s176899	doi.org/10.2147/cia.s176899	PROPN
ajcp-3197	517	3	.	.	PUNCT
ajcp-3197	518	1	saka	saka	PROPN
ajcp-3197	518	2	,	,	PUNCT
ajcp-3197	518	3	s.	s.	PROPN
ajcp-3197	518	4	a.	a.	PROPN
ajcp-3197	518	5	,	,	PUNCT
ajcp-3197	518	6	oosthuizen	oosthuizen	PROPN
ajcp-3197	518	7	,	,	PUNCT
ajcp-3197	518	8	f.	f.	PROPN
ajcp-3197	518	9	,	,	PUNCT
ajcp-3197	518	10	&	&	CCONJ
ajcp-3197	518	11	nlooto	nlooto	NOUN
ajcp-3197	518	12	,	,	PUNCT
ajcp-3197	518	13	m.	m.	NOUN
ajcp-3197	518	14	(	(	PUNCT
ajcp-3197	518	15	2017	2017	NUM
ajcp-3197	518	16	)	)	PUNCT
ajcp-3197	518	17	.	.	PUNCT
ajcp-3197	519	1	interventions	intervention	NOUN
ajcp-3197	519	2	towards	towards	ADP
ajcp-3197	519	3	reducing	reduce	VERB
ajcp-3197	519	4	adverse	adverse	ADJ
ajcp-3197	519	5	drug	drug	NOUN
ajcp-3197	519	6	reactions	reaction	NOUN
ajcp-3197	519	7	among	among	ADP
ajcp-3197	519	8	geriatric	geriatric	ADJ
ajcp-3197	519	9	population	population	NOUN
ajcp-3197	519	10	in	in	ADP
ajcp-3197	519	11	africa	africa	PROPN
ajcp-3197	519	12	:	:	PUNCT
ajcp-3197	519	13	a	a	DET
ajcp-3197	519	14	scoping	scope	VERB
ajcp-3197	519	15	review	review	NOUN
ajcp-3197	519	16	of	of	ADP
ajcp-3197	519	17	the	the	DET
ajcp-3197	519	18	literature	literature	NOUN
ajcp-3197	519	19	from	from	ADP
ajcp-3197	519	20	1990–2016	1990–2016	NUM
ajcp-3197	519	21	.	.	PUNCT
ajcp-3197	520	1	pula	pula	PROPN
ajcp-3197	520	2	:	:	PUNCT
ajcp-3197	520	3	botswana	botswana	PROPN
ajcp-3197	520	4	journal	journal	PROPN
ajcp-3197	520	5	of	of	ADP
ajcp-3197	520	6	african	african	ADJ
ajcp-3197	520	7	studies	study	NOUN
ajcp-3197	520	8	,	,	PUNCT
ajcp-3197	520	9	31(1	31(1	NUM
ajcp-3197	520	10	)	)	PUNCT
ajcp-3197	520	11	,	,	PUNCT
ajcp-3197	520	12	180	180	NUM
ajcp-3197	520	13	-	-	SYM
ajcp-3197	520	14	194	194	NUM
ajcp-3197	520	15	.	.	PUNCT
ajcp-3197	521	1	shehab	shehab	PROPN
ajcp-3197	521	2	,	,	PUNCT
ajcp-3197	521	3	n.	n.	NOUN
ajcp-3197	521	4	,	,	PUNCT
ajcp-3197	521	5	lovegrove	lovegrove	PROPN
ajcp-3197	521	6	,	,	PUNCT
ajcp-3197	521	7	m.	m.	PROPN
ajcp-3197	521	8	c.	c.	PROPN
ajcp-3197	521	9	,	,	PUNCT
ajcp-3197	521	10	geller	geller	PROPN
ajcp-3197	521	11	,	,	PUNCT
ajcp-3197	521	12	a.	a.	NOUN
ajcp-3197	521	13	i.	i.	PROPN
ajcp-3197	521	14	,	,	PUNCT
ajcp-3197	521	15	rose	rise	VERB
ajcp-3197	521	16	,	,	PUNCT
ajcp-3197	521	17	k.	k.	PROPN
ajcp-3197	521	18	o.	o.	PROPN
ajcp-3197	521	19	,	,	PUNCT
ajcp-3197	521	20	weidle	weidle	PROPN
ajcp-3197	521	21	,	,	PUNCT
ajcp-3197	521	22	n.	n.	PROPN
ajcp-3197	521	23	j.	j.	PROPN
ajcp-3197	521	24	,	,	PUNCT
ajcp-3197	521	25	&	&	CCONJ
ajcp-3197	521	26	budnitz	budnitz	PROPN
ajcp-3197	521	27	,	,	PUNCT
ajcp-3197	521	28	d.	d.	PROPN
ajcp-3197	521	29	s.	s.	PROPN
ajcp-3197	521	30	(	(	PUNCT
ajcp-3197	521	31	2016	2016	NUM
ajcp-3197	521	32	)	)	PUNCT
ajcp-3197	521	33	.	.	PUNCT
ajcp-3197	522	1	us	us	PROPN
ajcp-3197	522	2	emergency	emergency	PROPN
ajcp-3197	522	3	department	department	PROPN
ajcp-3197	522	4	visits	visit	NOUN
ajcp-3197	522	5	for	for	ADP
ajcp-3197	522	6	outpatient	outpatient	NOUN
ajcp-3197	522	7	adverse	adverse	ADJ
ajcp-3197	522	8	drug	drug	NOUN
ajcp-3197	522	9	events	event	NOUN
ajcp-3197	522	10	,	,	PUNCT
ajcp-3197	522	11	2013	2013	NUM
ajcp-3197	522	12	-	-	SYM
ajcp-3197	522	13	2014	2014	NUM
ajcp-3197	522	14	.	.	PUNCT
ajcp-3197	523	1	jama	jama	PROPN
ajcp-3197	523	2	,	,	PUNCT
ajcp-3197	523	3	316(20	316(20	NUM
ajcp-3197	523	4	)	)	PUNCT
ajcp-3197	523	5	,	,	PUNCT
ajcp-3197	523	6	2115	2115	NUM
ajcp-3197	523	7	-	-	SYM
ajcp-3197	523	8	2125	2125	NUM
ajcp-3197	523	9	.	.	PUNCT
ajcp-3197	524	1	https://doi	https://doi	X
ajcp-3197	524	2	.	.	PUNCT
ajcp-3197	525	1	org/	org/	NOUN
ajcp-3197	525	2	10.1001	10.1001	NUM
ajcp-3197	525	3	/	/	SYM
ajcp-3197	525	4	jama.2016.16201	jama.2016.16201	PROPN
ajcp-3197	525	5	.	.	PUNCT
ajcp-3197	526	1	uche	uche	PROPN
ajcp-3197	526	2	,	,	PUNCT
ajcp-3197	526	3	v.	v.	PROPN
ajcp-3197	526	4	u.	u.	PROPN
ajcp-3197	526	5	,	,	PUNCT
ajcp-3197	526	6	ikwuka	ikwuka	PROPN
ajcp-3197	526	7	,	,	PUNCT
ajcp-3197	526	8	a.	a.	NOUN
ajcp-3197	526	9	o.	o.	PROPN
ajcp-3197	526	10	,	,	PUNCT
ajcp-3197	526	11	udeh	udeh	PROPN
ajcp-3197	526	12	,	,	PUNCT
ajcp-3197	526	13	f.	f.	PROPN
ajcp-3197	526	14	c.	c.	PROPN
ajcp-3197	526	15	,	,	PUNCT
ajcp-3197	526	16	okorocha	okorocha	PROPN
ajcp-3197	526	17	,	,	PUNCT
ajcp-3197	526	18	a.	a.	PROPN
ajcp-3197	526	19	e.	e.	PROPN
ajcp-3197	526	20	,	,	PUNCT
ajcp-3197	526	21	epete	epete	NOUN
ajcp-3197	526	22	,	,	PUNCT
ajcp-3197	526	23	m.	m.	NOUN
ajcp-3197	526	24	a.	a.	PROPN
ajcp-3197	526	25	,	,	PUNCT
ajcp-3197	526	26	ekechi	ekechi	NOUN
ajcp-3197	526	27	,	,	PUNCT
ajcp-3197	526	28	h.	h.	PROPN
ajcp-3197	526	29	o.	o.	PROPN
ajcp-3197	526	30	,	,	PUNCT
ajcp-3197	526	31	abraham	abraham	PROPN
ajcp-3197	526	32	,	,	PUNCT
ajcp-3197	526	33	j.	j.	PROPN
ajcp-3197	526	34	c.	c.	PROPN
ajcp-3197	526	35	,	,	PUNCT
ajcp-3197	526	36	&	&	CCONJ
ajcp-3197	526	37	igwe	igwe	PROPN
ajcp-3197	526	38	,	,	PUNCT
ajcp-3197	526	39	e.	e.	PROPN
ajcp-3197	526	40	c.	c.	PROPN
ajcp-3197	526	41	(	(	PUNCT
ajcp-3197	526	42	2023	2023	NUM
ajcp-3197	526	43	)	)	PUNCT
ajcp-3197	526	44	.	.	PUNCT
ajcp-3197	527	1	associated	associate	VERB
ajcp-3197	527	2	risks	risk	NOUN
ajcp-3197	527	3	and	and	CCONJ
ajcp-3197	527	4	pathogenic	pathogenic	ADJ
ajcp-3197	527	5	effects	effect	NOUN
ajcp-3197	527	6	of	of	ADP
ajcp-3197	527	7	consumption	consumption	NOUN
ajcp-3197	527	8	of	of	ADP
ajcp-3197	527	9	calcium	calcium	NOUN
ajcp-3197	527	10	carbideripened	carbideripene	VERB
ajcp-3197	527	11	banana	banana	NOUN
ajcp-3197	527	12	before	before	ADP
ajcp-3197	527	13	and/or	and/or	CCONJ
ajcp-3197	527	14	during	during	ADP
ajcp-3197	527	15	pregnancy	pregnancy	NOUN
ajcp-3197	527	16	on	on	ADP
ajcp-3197	527	17	maternal	maternal	ADJ
ajcp-3197	527	18	and	and	CCONJ
ajcp-3197	527	19	neonatal	neonatal	ADJ
ajcp-3197	527	20	livers	liver	NOUN
ajcp-3197	527	21	.	.	PUNCT
ajcp-3197	528	1	american	american	ADJ
ajcp-3197	528	2	journal	journal	PROPN
ajcp-3197	528	3	of	of	ADP
ajcp-3197	528	4	food	food	NOUN
ajcp-3197	528	5	science	science	NOUN
ajcp-3197	528	6	and	and	CCONJ
ajcp-3197	528	7	technology	technology	NOUN
ajcp-3197	528	8	,	,	PUNCT
ajcp-3197	528	9	2(2	2(2	NUM
ajcp-3197	528	10	)	)	PUNCT
ajcp-3197	528	11	,	,	PUNCT
ajcp-3197	528	12	54	54	NUM
ajcp-3197	528	13	-	-	SYM
ajcp-3197	528	14	64	64	NUM
ajcp-3197	528	15	.	.	PUNCT
ajcp-3197	529	1	https://doi	https://doi	NOUN
ajcp-3197	529	2	.	.	PUNCT
ajcp-3197	530	1	org/10.54536	org/10.54536	PROPN
ajcp-3197	530	2	/	/	SYM
ajcp-3197	530	3	ajfst.v2i2.2197	ajfst.v2i2.2197	NOUN
ajcp-3197	530	4	.	.	PUNCT
ajcp-3197	530	5	udoye	udoye	PROPN
ajcp-3197	530	6	,	,	PUNCT
ajcp-3197	530	7	j.	j.	PROPN
ajcp-3197	530	8	a.	a.	PROPN
ajcp-3197	530	9	,	,	PUNCT
ajcp-3197	530	10	ozolua	ozolua	PROPN
ajcp-3197	530	11	,	,	PUNCT
ajcp-3197	530	12	r.	r.	PROPN
ajcp-3197	530	13	i.	i.	PROPN
ajcp-3197	530	14	,	,	PUNCT
ajcp-3197	530	15	&	&	CCONJ
ajcp-3197	530	16	nwokike	nwokike	PROPN
ajcp-3197	530	17	,	,	PUNCT
ajcp-3197	530	18	j.	j.	PROPN
ajcp-3197	530	19	(	(	PUNCT
ajcp-3197	530	20	2018	2018	NUM
ajcp-3197	530	21	)	)	PUNCT
ajcp-3197	530	22	.	.	PUNCT
ajcp-3197	531	1	assessment	assessment	NOUN
ajcp-3197	531	2	of	of	ADP
ajcp-3197	531	3	the	the	DET
ajcp-3197	531	4	knowledge	knowledge	NOUN
ajcp-3197	531	5	,	,	PUNCT
ajcp-3197	531	6	attitude	attitude	NOUN
ajcp-3197	531	7	and	and	CCONJ
ajcp-3197	531	8	practice	practice	NOUN
ajcp-3197	531	9	of	of	ADP
ajcp-3197	531	10	pharmacovigilance	pharmacovigilance	NOUN
ajcp-3197	531	11	by	by	ADP
ajcp-3197	531	12	pharmacists	pharmacist	NOUN
ajcp-3197	531	13	in	in	ADP
ajcp-3197	531	14	two	two	NUM
ajcp-3197	531	15	states	state	NOUN
ajcp-3197	531	16	in	in	ADP
ajcp-3197	531	17	southeastern	southeastern	ADJ
ajcp-3197	531	18	nigeria	nigeria	PROPN
ajcp-3197	531	19	.	.	PUNCT
ajcp-3197	532	1	tropical	tropical	ADJ
ajcp-3197	532	2	journal	journal	PROPN
ajcp-3197	532	3	of	of	ADP
ajcp-3197	532	4	pharmaceutical	pharmaceutical	NOUN
ajcp-3197	532	5	research	research	NOUN
ajcp-3197	532	6	,	,	PUNCT
ajcp-3197	532	7	17(5	17(5	NUM
ajcp-3197	532	8	)	)	PUNCT
ajcp-3197	532	9	,	,	PUNCT
ajcp-3197	532	10	937	937	NUM
ajcp-3197	532	11	-	-	SYM
ajcp-3197	532	12	945	945	NUM
ajcp-3197	532	13	.	.	PUNCT
ajcp-3197	533	1	https://doi.org/10.4314/	https://doi.org/10.4314/	PROPN
ajcp-3197	533	2	tjpr.v17i5.25	tjpr.v17i5.25	PROPN
ajcp-3197	533	3	.	.	PUNCT
ajcp-3197	533	4	virstyuk	virstyuk	PROPN
ajcp-3197	533	5	,	,	PUNCT
ajcp-3197	533	6	n.	n.	PROPN
ajcp-3197	533	7	g.	g.	PROPN
ajcp-3197	533	8	,	,	PUNCT
ajcp-3197	533	9	ikwuka	ikwuka	PROPN
ajcp-3197	533	10	,	,	PUNCT
ajcp-3197	533	11	a.	a.	NOUN
ajcp-3197	533	12	o.	o.	PROPN
ajcp-3197	533	13	,	,	PUNCT
ajcp-3197	533	14	haman	haman	PROPN
ajcp-3197	533	15	,	,	PUNCT
ajcp-3197	533	16	i.	i.	PROPN
ajcp-3197	533	17	o.	o.	PROPN
ajcp-3197	533	18	,	,	PUNCT
ajcp-3197	533	19	&	&	CCONJ
ajcp-3197	533	20	adebomi	adebomi	NOUN
ajcp-3197	533	21	,	,	PUNCT
ajcp-3197	533	22	m.	m.	NOUN
ajcp-3197	533	23	s.	s.	PROPN
ajcp-3197	533	24	(	(	PUNCT
ajcp-3197	533	25	2016	2016	NUM
ajcp-3197	533	26	)	)	PUNCT
ajcp-3197	533	27	.	.	PUNCT
ajcp-3197	534	1	diabetes	diabetes	NOUN
ajcp-3197	534	2	mellitus	mellitus	PROPN
ajcp-3197	534	3	type	type	VERB
ajcp-3197	534	4	2	2	NUM
ajcp-3197	534	5	,	,	PUNCT
ajcp-3197	534	6	arterial	arterial	NOUN
ajcp-3197	534	7	pa	pa	PROPN
ajcp-3197	534	8	ge	ge	PROPN
ajcp-3197	534	9	11	11	NUM
ajcp-3197	534	10	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-3197	534	11	am	be	AUX
ajcp-3197	534	12	.	.	PUNCT
ajcp-3197	535	1	j.	j.	PROPN
ajcp-3197	535	2	chem	chem	PROPN
ajcp-3197	535	3	.	.	PUNCT
ajcp-3197	536	1	pharm	pharm	PROPN
ajcp-3197	536	2	.	.	PUNCT
ajcp-3197	537	1	3(1	3(1	NUM
ajcp-3197	537	2	)	)	PUNCT
ajcp-3197	537	3	1	1	NUM
ajcp-3197	537	4	-	-	SYM
ajcp-3197	537	5	11	11	NUM
ajcp-3197	537	6	,	,	PUNCT
ajcp-3197	537	7	2024	2024	NUM
ajcp-3197	537	8	hypertension	hypertension	NOUN
ajcp-3197	537	9	and	and	CCONJ
ajcp-3197	537	10	dyslipidemia	dyslipidemia	NOUN
ajcp-3197	537	11	.	.	PUNCT
ajcp-3197	538	1	materials	material	NOUN
ajcp-3197	538	2	of	of	ADP
ajcp-3197	538	3	2nd	2nd	ADJ
ajcp-3197	538	4	international	international	ADJ
ajcp-3197	538	5	scientific	scientific	ADJ
ajcp-3197	538	6	and	and	CCONJ
ajcp-3197	538	7	practical	practical	ADJ
ajcp-3197	538	8	conference	conference	NOUN
ajcp-3197	538	9	“	"	PUNCT
ajcp-3197	538	10	therapeutic	therapeutic	ADJ
ajcp-3197	538	11	readings	reading	NOUN
ajcp-3197	538	12	:	:	PUNCT
ajcp-3197	538	13	modern	modern	ADJ
ajcp-3197	538	14	aspects	aspect	NOUN
ajcp-3197	538	15	of	of	ADP
ajcp-3197	538	16	diagnosis	diagnosis	NOUN
ajcp-3197	538	17	and	and	CCONJ
ajcp-3197	538	18	treatment	treatment	NOUN
ajcp-3197	538	19	of	of	ADP
ajcp-3197	538	20	diseases	disease	NOUN
ajcp-3197	538	21	of	of	ADP
ajcp-3197	538	22	internal	internal	ADJ
ajcp-3197	538	23	organs	organ	NOUN
ajcp-3197	538	24	”	"	PUNCT
ajcp-3197	538	25	,	,	PUNCT
ajcp-3197	538	26	p.	p.	NOUN
ajcp-3197	538	27	46	46	NUM
ajcp-3197	538	28	-	-	SYM
ajcp-3197	538	29	47	47	NUM
ajcp-3197	538	30	.	.	PUNCT
ajcp-3197	539	1	virstyuk	virstyuk	NOUN
ajcp-3197	539	2	,	,	PUNCT
ajcp-3197	539	3	n.	n.	PROPN
ajcp-3197	539	4	g.	g.	PROPN
ajcp-3197	539	5	,	,	PUNCT
ajcp-3197	539	6	&	&	CCONJ
ajcp-3197	539	7	ikwuka	ikwuka	PROPN
ajcp-3197	539	8	,	,	PUNCT
ajcp-3197	539	9	a.	a.	NOUN
ajcp-3197	539	10	o.	o.	PROPN
ajcp-3197	539	11	(	(	PUNCT
ajcp-3197	539	12	2017a	2017a	NUM
ajcp-3197	539	13	)	)	PUNCT
ajcp-3197	539	14	.	.	PUNCT
ajcp-3197	540	1	diagnostic	diagnostic	ADJ
ajcp-3197	540	2	and	and	CCONJ
ajcp-3197	540	3	prognostic	prognostic	ADJ
ajcp-3197	540	4	markers	marker	NOUN
ajcp-3197	540	5	of	of	ADP
ajcp-3197	540	6	the	the	DET
ajcp-3197	540	7	diabetes	diabetes	NOUN
ajcp-3197	540	8	mellitus	mellitus	NOUN
ajcp-3197	540	9	type	type	VERB
ajcp-3197	540	10	2	2	NUM
ajcp-3197	540	11	course	course	NOUN
ajcp-3197	540	12	in	in	ADP
ajcp-3197	540	13	connection	connection	NOUN
ajcp-3197	540	14	with	with	ADP
ajcp-3197	540	15	essential	essential	ADJ
ajcp-3197	540	16	arterial	arterial	ADJ
ajcp-3197	540	17	hypertension	hypertension	NOUN
ajcp-3197	540	18	taking	take	VERB
ajcp-3197	540	19	into	into	ADP
ajcp-3197	540	20	account	account	NOUN
ajcp-3197	540	21	the	the	DET
ajcp-3197	540	22	kidney	kidney	NOUN
ajcp-3197	540	23	function	function	NOUN
ajcp-3197	540	24	.	.	PUNCT
ajcp-3197	541	1	precarpathian	precarpathian	ADJ
ajcp-3197	541	2	journal	journal	PROPN
ajcp-3197	541	3	pulse	pulse	PROPN
ajcp-3197	541	4	,	,	PUNCT
ajcp-3197	541	5	8(44	8(44	NUM
ajcp-3197	541	6	)	)	PUNCT
ajcp-3197	541	7	,	,	PUNCT
ajcp-3197	541	8	53	53	NUM
ajcp-3197	541	9	-	-	SYM
ajcp-3197	541	10	62	62	NUM
ajcp-3197	541	11	.	.	PUNCT
ajcp-3197	542	1	virstyuk	virstyuk	NOUN
ajcp-3197	542	2	,	,	PUNCT
ajcp-3197	542	3	n.	n.	PROPN
ajcp-3197	542	4	h.	h.	PROPN
ajcp-3197	542	5	,	,	PUNCT
ajcp-3197	542	6	ikwuka	ikwuka	PROPN
ajcp-3197	542	7	,	,	PUNCT
ajcp-3197	542	8	a.	a.	NOUN
ajcp-3197	542	9	o.	o.	PROPN
ajcp-3197	542	10	,	,	PUNCT
ajcp-3197	542	11	losyuk	losyuk	NOUN
ajcp-3197	542	12	,	,	PUNCT
ajcp-3197	542	13	l.	l.	PROPN
ajcp-3197	542	14	v.	v.	PROPN
ajcp-3197	542	15	,	,	PUNCT
ajcp-3197	542	16	kobrynska	kobrynska	PROPN
ajcp-3197	542	17	,	,	PUNCT
ajcp-3197	542	18	o.	o.	PROPN
ajcp-3197	542	19	ya	ya	PROPN
ajcp-3197	542	20	.	.	PROPN
ajcp-3197	542	21	,	,	PUNCT
ajcp-3197	542	22	&	&	CCONJ
ajcp-3197	542	23	markiv	markiv	PROPN
ajcp-3197	542	24	,	,	PUNCT
ajcp-3197	542	25	h.	h.	PROPN
ajcp-3197	542	26	d.	d.	PROPN
ajcp-3197	542	27	(	(	PUNCT
ajcp-3197	542	28	2017b	2017b	NUM
ajcp-3197	542	29	)	)	PUNCT
ajcp-3197	542	30	.	.	PUNCT
ajcp-3197	543	1	dapagliflozin	dapagliflozin	PROPN
ajcp-3197	543	2	utility	utility	NOUN
ajcp-3197	543	3	in	in	ADP
ajcp-3197	543	4	patients	patient	NOUN
ajcp-3197	543	5	with	with	ADP
ajcp-3197	543	6	diabetes	diabetes	NOUN
ajcp-3197	543	7	mellitus	mellitus	NOUN
ajcp-3197	543	8	type	type	VERB
ajcp-3197	543	9	2	2	NUM
ajcp-3197	543	10	and	and	CCONJ
ajcp-3197	543	11	essential	essential	ADJ
ajcp-3197	543	12	hypertensive	hypertensive	ADJ
ajcp-3197	543	13	disease	disease	NOUN
ajcp-3197	543	14	.	.	PUNCT
ajcp-3197	544	1	actual	actual	ADJ
ajcp-3197	544	2	problems	problem	NOUN
ajcp-3197	544	3	of	of	ADP
ajcp-3197	544	4	modern	modern	ADJ
ajcp-3197	544	5	medicine	medicine	NOUN
ajcp-3197	544	6	,	,	PUNCT
ajcp-3197	544	7	4(60)1	4(60)1	PROPN
ajcp-3197	544	8	,	,	PUNCT
ajcp-3197	544	9	76	76	NUM
ajcp-3197	544	10	-	-	SYM
ajcp-3197	544	11	79	79	NUM
ajcp-3197	544	12	.	.	PUNCT
ajcp-3197	545	1	available	available	ADJ
ajcp-3197	545	2	online	online	ADV
ajcp-3197	545	3	:	:	PUNCT
ajcp-3197	546	1	http://www	http://www	PROPN
ajcp-3197	546	2	.	.	PROPN
ajcp-3197	546	3	umsa.edu.ua/journal2stat4_2017_eng.html	umsa.edu.ua/journal2stat4_2017_eng.html	ADJ
ajcp-3197	546	4	virstyuk	virstyuk	NOUN
ajcp-3197	546	5	,	,	PUNCT
ajcp-3197	546	6	n.	n.	PROPN
ajcp-3197	546	7	g.	g.	PROPN
ajcp-3197	546	8	,	,	PUNCT
ajcp-3197	546	9	&	&	CCONJ
ajcp-3197	546	10	ikwuka	ikwuka	PROPN
ajcp-3197	546	11	,	,	PUNCT
ajcp-3197	546	12	a.	a.	NOUN
ajcp-3197	546	13	o.	o.	NOUN
ajcp-3197	546	14	(	(	PUNCT
ajcp-3197	546	15	2018a	2018a	NUM
ajcp-3197	546	16	)	)	PUNCT
ajcp-3197	546	17	.	.	PUNCT
ajcp-3197	547	1	features	feature	NOUN
ajcp-3197	547	2	of	of	ADP
ajcp-3197	547	3	asymptomatic	asymptomatic	ADJ
ajcp-3197	547	4	hyperuricemia	hyperuricemia	NOUN
ajcp-3197	547	5	in	in	ADP
ajcp-3197	547	6	patients	patient	NOUN
ajcp-3197	547	7	with	with	ADP
ajcp-3197	547	8	diabetes	diabetes	NOUN
ajcp-3197	547	9	mellitus	mellitus	NOUN
ajcp-3197	547	10	type	type	VERB
ajcp-3197	547	11	2	2	NUM
ajcp-3197	547	12	and	and	CCONJ
ajcp-3197	547	13	concomitant	concomitant	ADJ
ajcp-3197	547	14	essential	essential	ADJ
ajcp-3197	547	15	arterial	arterial	ADJ
ajcp-3197	547	16	hypertension	hypertension	NOUN
ajcp-3197	547	17	.	.	PUNCT
ajcp-3197	548	1	clinical	clinical	ADJ
ajcp-3197	548	2	and	and	CCONJ
ajcp-3197	548	3	experimental	experimental	ADJ
ajcp-3197	548	4	pathology	pathology	NOUN
ajcp-3197	548	5	,	,	PUNCT
ajcp-3197	548	6	1(63	1(63	NUM
ajcp-3197	548	7	)	)	PUNCT
ajcp-3197	548	8	,	,	PUNCT
ajcp-3197	548	9	22	22	NUM
ajcp-3197	548	10	-	-	SYM
ajcp-3197	548	11	26	26	NUM
ajcp-3197	548	12	.	.	PUNCT
ajcp-3197	549	1	https://doi.org/10.24061/1727-4338	https://doi.org/10.24061/1727-4338	NOUN
ajcp-3197	549	2	.	.	PUNCT
ajcp-3197	550	1	xvii.1.63.2018.5	xvii.1.63.2018.5	PROPN
ajcp-3197	550	2	.	.	PUNCT
ajcp-3197	551	1	virstyuk	virstyuk	PROPN
ajcp-3197	551	2	,	,	PUNCT
ajcp-3197	551	3	n.	n.	PROPN
ajcp-3197	551	4	g.	g.	PROPN
ajcp-3197	551	5	,	,	PUNCT
ajcp-3197	551	6	ikwuka	ikwuka	PROPN
ajcp-3197	551	7	,	,	PUNCT
ajcp-3197	551	8	a.	a.	NOUN
ajcp-3197	551	9	o.	o.	PROPN
ajcp-3197	551	10	,	,	PUNCT
ajcp-3197	551	11	&	&	CCONJ
ajcp-3197	551	12	didushko	didushko	PROPN
ajcp-3197	551	13	,	,	PUNCT
ajcp-3197	551	14	o.	o.	PROPN
ajcp-3197	551	15	m.	m.	NOUN
ajcp-3197	551	16	(	(	PUNCT
ajcp-3197	551	17	2018b	2018b	NUM
ajcp-3197	551	18	)	)	PUNCT
ajcp-3197	551	19	.	.	PUNCT
ajcp-3197	552	1	effect	effect	NOUN
ajcp-3197	552	2	of	of	ADP
ajcp-3197	552	3	dapagliflozin	dapagliflozin	PROPN
ajcp-3197	552	4	on	on	ADP
ajcp-3197	552	5	the	the	DET
ajcp-3197	552	6	level	level	NOUN
ajcp-3197	552	7	of	of	ADP
ajcp-3197	552	8	uric	uric	ADJ
ajcp-3197	552	9	acid	acid	NOUN
ajcp-3197	552	10	during	during	ADP
ajcp-3197	552	11	asymptomatic	asymptomatic	ADJ
ajcp-3197	552	12	hyperuricemia	hyperuricemia	NOUN
ajcp-3197	552	13	in	in	ADP
ajcp-3197	552	14	patients	patient	NOUN
ajcp-3197	552	15	with	with	ADP
ajcp-3197	552	16	diabetes	diabetes	NOUN
ajcp-3197	552	17	mellitus	mellitus	NOUN
ajcp-3197	552	18	type	type	VERB
ajcp-3197	552	19	2	2	NUM
ajcp-3197	552	20	and	and	CCONJ
ajcp-3197	552	21	concomitant	concomitant	ADJ
ajcp-3197	552	22	arterial	arterial	ADJ
ajcp-3197	552	23	hypertension	hypertension	NOUN
ajcp-3197	552	24	.	.	PUNCT
ajcp-3197	553	1	art	art	NOUN
ajcp-3197	553	2	of	of	ADP
ajcp-3197	553	3	medicine	medicine	NOUN
ajcp-3197	553	4	,	,	PUNCT
ajcp-3197	553	5	1(5	1(5	NUM
ajcp-3197	553	6	)	)	PUNCT
ajcp-3197	553	7	,	,	PUNCT
ajcp-3197	553	8	21	21	NUM
ajcp-3197	553	9	-	-	SYM
ajcp-3197	553	10	26	26	NUM
ajcp-3197	553	11	.	.	PUNCT
ajcp-3197	553	12	available	available	ADJ
ajcp-3197	553	13	online	online	ADV
ajcp-3197	553	14	:	:	PUNCT
ajcp-3197	553	15	https://art-of-medicine.ifnmu.edu.ua/index	https://art-of-medicine.ifnmu.edu.ua/index	PROPN
ajcp-3197	553	16	.	.	PUNCT
ajcp-3197	553	17	php	php	PROPN
ajcp-3197	553	18	/	/	SYM
ajcp-3197	553	19	aom	aom	PROPN
ajcp-3197	553	20	/	/	SYM
ajcp-3197	553	21	article	article	NOUN
ajcp-3197	553	22	/	/	SYM
ajcp-3197	553	23	view/179/150	view/179/150	NOUN
ajcp-3197	553	24	virstyuk	virstyuk	NOUN
ajcp-3197	553	25	,	,	PUNCT
ajcp-3197	553	26	n.	n.	PROPN
ajcp-3197	553	27	h.	h.	PROPN
ajcp-3197	553	28	,	,	PUNCT
ajcp-3197	553	29	&	&	CCONJ
ajcp-3197	553	30	ikwuka	ikwuka	PROPN
ajcp-3197	553	31	,	,	PUNCT
ajcp-3197	553	32	a.	a.	NOUN
ajcp-3197	553	33	o.	o.	NOUN
ajcp-3197	553	34	(	(	PUNCT
ajcp-3197	553	35	2018c	2018c	NUM
ajcp-3197	553	36	)	)	PUNCT
ajcp-3197	553	37	.	.	PUNCT
ajcp-3197	554	1	dapagliflozin	dapagliflozin	PROPN
ajcp-3197	554	2	influence	influence	NOUN
ajcp-3197	554	3	on	on	ADP
ajcp-3197	554	4	the	the	DET
ajcp-3197	554	5	clinical	clinical	ADJ
ajcp-3197	554	6	course	course	NOUN
ajcp-3197	554	7	of	of	ADP
ajcp-3197	554	8	diabetes	diabetes	NOUN
ajcp-3197	554	9	mellitus	mellitus	NOUN
ajcp-3197	554	10	type	type	VERB
ajcp-3197	554	11	2	2	NUM
ajcp-3197	554	12	and	and	CCONJ
ajcp-3197	554	13	essential	essential	ADJ
ajcp-3197	554	14	hypertension	hypertension	NOUN
ajcp-3197	554	15	in	in	ADP
ajcp-3197	554	16	patients	patient	NOUN
ajcp-3197	554	17	.	.	PUNCT
ajcp-3197	555	1	recent	recent	ADJ
ajcp-3197	555	2	advances	advance	NOUN
ajcp-3197	555	3	in	in	ADP
ajcp-3197	555	4	environmental	environmental	ADJ
ajcp-3197	555	5	science	science	NOUN
ajcp-3197	555	6	from	from	ADP
ajcp-3197	555	7	the	the	DET
ajcp-3197	555	8	euromediterranean	euromediterranean	ADJ
ajcp-3197	555	9	and	and	CCONJ
ajcp-3197	555	10	surrounding	surround	VERB
ajcp-3197	555	11	regions	region	NOUN
ajcp-3197	555	12	,	,	PUNCT
ajcp-3197	555	13	p.	p.	NOUN
ajcp-3197	555	14	20072008	20072008	NUM
ajcp-3197	555	15	.	.	PUNCT
ajcp-3197	556	1	https://doi.org/10.1007/978-3-319-705484_582	https://doi.org/10.1007/978-3-319-705484_582	NOUN
ajcp-3197	556	2	.	.	PUNCT
ajcp-3197	557	1	virstyuk	virstyuk	PROPN
ajcp-3197	557	2	,	,	PUNCT
ajcp-3197	557	3	n.	n.	PROPN
ajcp-3197	557	4	g.	g.	PROPN
ajcp-3197	557	5	,	,	PUNCT
ajcp-3197	557	6	&	&	CCONJ
ajcp-3197	557	7	ikwuka	ikwuka	PROPN
ajcp-3197	557	8	,	,	PUNCT
ajcp-3197	557	9	a.	a.	NOUN
ajcp-3197	557	10	o.	o.	NOUN
ajcp-3197	557	11	(	(	PUNCT
ajcp-3197	557	12	2019	2019	NUM
ajcp-3197	557	13	)	)	PUNCT
ajcp-3197	557	14	.	.	PUNCT
ajcp-3197	558	1	nephropathic	nephropathic	ADJ
ajcp-3197	558	2	characteristics	characteristic	NOUN
ajcp-3197	558	3	in	in	ADP
ajcp-3197	558	4	patients	patient	NOUN
ajcp-3197	558	5	with	with	ADP
ajcp-3197	558	6	diabetes	diabetes	NOUN
ajcp-3197	558	7	mellitus	mellitus	NOUN
ajcp-3197	558	8	type	type	VERB
ajcp-3197	558	9	2	2	NUM
ajcp-3197	558	10	and	and	CCONJ
ajcp-3197	558	11	essential	essential	ADJ
ajcp-3197	558	12	hypertensive	hypertensive	ADJ
ajcp-3197	558	13	disease	disease	NOUN
ajcp-3197	558	14	.	.	PUNCT
ajcp-3197	559	1	art	art	NOUN
ajcp-3197	559	2	of	of	ADP
ajcp-3197	559	3	medicine	medicine	NOUN
ajcp-3197	559	4	,	,	PUNCT
ajcp-3197	559	5	1(5	1(5	NUM
ajcp-3197	559	6	)	)	PUNCT
ajcp-3197	559	7	,	,	PUNCT
ajcp-3197	559	8	44	44	NUM
ajcp-3197	559	9	-	-	SYM
ajcp-3197	559	10	47	47	NUM
ajcp-3197	559	11	.	.	PUNCT
ajcp-3197	560	1	https://doi.org/10.21802/	https://doi.org/10.21802/	PROPN
ajcp-3197	560	2	artm.2019.1.9.44	artm.2019.1.9.44	PROPN
ajcp-3197	560	3	.	.	PROPN
ajcp-3197	560	4	virstyuk	virstyuk	PROPN
ajcp-3197	560	5	,	,	PUNCT
ajcp-3197	560	6	n.	n.	PROPN
ajcp-3197	560	7	g.	g.	PROPN
ajcp-3197	560	8	,	,	PUNCT
ajcp-3197	560	9	&	&	CCONJ
ajcp-3197	560	10	ikwuka	ikwuka	PROPN
ajcp-3197	560	11	,	,	PUNCT
ajcp-3197	560	12	a.	a.	NOUN
ajcp-3197	560	13	o.	o.	NOUN
ajcp-3197	560	14	(	(	PUNCT
ajcp-3197	560	15	2021a	2021a	NUM
ajcp-3197	560	16	)	)	PUNCT
ajcp-3197	560	17	.	.	PUNCT
ajcp-3197	561	1	asymptomatic	asymptomatic	ADJ
ajcp-3197	561	2	hyperuricemia	hyperuricemia	NOUN
ajcp-3197	561	3	and	and	CCONJ
ajcp-3197	561	4	functional	functional	ADJ
ajcp-3197	561	5	state	state	NOUN
ajcp-3197	561	6	of	of	ADP
ajcp-3197	561	7	the	the	DET
ajcp-3197	561	8	kidneys	kidney	NOUN
ajcp-3197	561	9	in	in	ADP
ajcp-3197	561	10	patients	patient	NOUN
ajcp-3197	561	11	with	with	ADP
ajcp-3197	561	12	essential	essential	ADJ
ajcp-3197	561	13	arterial	arterial	ADJ
ajcp-3197	561	14	hypertension	hypertension	NOUN
ajcp-3197	561	15	and	and	CCONJ
ajcp-3197	561	16	concomitant	concomitant	ADJ
ajcp-3197	561	17	diabetes	diabetes	NOUN
ajcp-3197	561	18	mellitus	mellitus	NOUN
ajcp-3197	561	19	type	type	VERB
ajcp-3197	561	20	2	2	NUM
ajcp-3197	561	21	.	.	PUNCT
ajcp-3197	561	22	european	european	ADJ
ajcp-3197	561	23	journal	journal	PROPN
ajcp-3197	561	24	of	of	ADP
ajcp-3197	561	25	clinical	clinical	ADJ
ajcp-3197	561	26	medicine	medicine	NOUN
ajcp-3197	561	27	,	,	PUNCT
ajcp-3197	561	28	2(3	2(3	NUM
ajcp-3197	561	29	)	)	PUNCT
ajcp-3197	561	30	,	,	PUNCT
ajcp-3197	561	31	100	100	NUM
ajcp-3197	561	32	-	-	SYM
ajcp-3197	561	33	104	104	NUM
ajcp-3197	561	34	.	.	PUNCT
ajcp-3197	562	1	https://doi	https://doi	NOUN
ajcp-3197	562	2	.	.	PUNCT
ajcp-3197	562	3	org/10.24018	org/10.24018	PROPN
ajcp-3197	562	4	/	/	SYM
ajcp-3197	562	5	clinicmed.2021.2.3.65	clinicmed.2021.2.3.65	PROPN
ajcp-3197	562	6	.	.	PUNCT
ajcp-3197	562	7	virstyuk	virstyuk	PROPN
ajcp-3197	562	8	,	,	PUNCT
ajcp-3197	562	9	n.	n.	PROPN
ajcp-3197	562	10	h.	h.	PROPN
ajcp-3197	562	11	,	,	PUNCT
ajcp-3197	562	12	ikwuka	ikwuka	PROPN
ajcp-3197	562	13	,	,	PUNCT
ajcp-3197	562	14	a.	a.	NOUN
ajcp-3197	562	15	o.	o.	PROPN
ajcp-3197	562	16	,	,	PUNCT
ajcp-3197	562	17	luchko	luchko	VERB
ajcp-3197	562	18	,	,	PUNCT
ajcp-3197	562	19	o.	o.	PROPN
ajcp-3197	562	20	r.	r.	PROPN
ajcp-3197	562	21	,	,	PUNCT
ajcp-3197	562	22	&	&	CCONJ
ajcp-3197	562	23	kocherzhat	kocherzhat	PROPN
ajcp-3197	562	24	,	,	PUNCT
ajcp-3197	562	25	o.	o.	PROPN
ajcp-3197	562	26	i.	i.	PROPN
ajcp-3197	562	27	(	(	PUNCT
ajcp-3197	562	28	2021b	2021b	NUM
ajcp-3197	562	29	)	)	PUNCT
ajcp-3197	562	30	.	.	PUNCT
ajcp-3197	563	1	peculiarities	peculiarity	NOUN
ajcp-3197	563	2	of	of	ADP
ajcp-3197	563	3	renal	renal	ADJ
ajcp-3197	563	4	insufficiency	insufficiency	NOUN
ajcp-3197	563	5	in	in	ADP
ajcp-3197	563	6	patients	patient	NOUN
ajcp-3197	563	7	with	with	ADP
ajcp-3197	563	8	diabetes	diabetes	NOUN
ajcp-3197	563	9	mellitus	mellitus	NOUN
ajcp-3197	563	10	type	type	VERB
ajcp-3197	563	11	2	2	NUM
ajcp-3197	563	12	and	and	CCONJ
ajcp-3197	563	13	arterial	arterial	ADJ
ajcp-3197	563	14	hypertension	hypertension	NOUN
ajcp-3197	563	15	.	.	PUNCT
ajcp-3197	564	1	materials	material	NOUN
ajcp-3197	564	2	of	of	ADP
ajcp-3197	564	3	scientific	scientific	ADJ
ajcp-3197	564	4	-	-	PUNCT
ajcp-3197	564	5	practical	practical	ADJ
ajcp-3197	564	6	conference	conference	NOUN
ajcp-3197	564	7	with	with	ADP
ajcp-3197	564	8	international	international	ADJ
ajcp-3197	564	9	participation	participation	NOUN
ajcp-3197	564	10	“	"	PUNCT
ajcp-3197	564	11	achievements	achievement	NOUN
ajcp-3197	564	12	and	and	CCONJ
ajcp-3197	564	13	prospects	prospect	NOUN
ajcp-3197	564	14	of	of	ADP
ajcp-3197	564	15	experimental	experimental	ADJ
ajcp-3197	564	16	and	and	CCONJ
ajcp-3197	564	17	clinical	clinical	ADJ
ajcp-3197	564	18	endocrinology	endocrinology	NOUN
ajcp-3197	564	19	”	"	PUNCT
ajcp-3197	564	20	twentieth	twentieth	ADJ
ajcp-3197	564	21	danilevsky	danilevsky	NOUN
ajcp-3197	564	22	readings	reading	NOUN
ajcp-3197	564	23	,	,	PUNCT
ajcp-3197	564	24	p.	p.	NOUN
ajcp-3197	564	25	86	86	NUM
ajcp-3197	564	26	-	-	SYM
ajcp-3197	564	27	87	87	NUM
ajcp-3197	564	28	.	.	PUNCT
ajcp-3197	565	1	world	world	PROPN
ajcp-3197	565	2	health	health	PROPN
ajcp-3197	565	3	organization	organization	NOUN
ajcp-3197	565	4	(	(	PUNCT
ajcp-3197	565	5	who	who	PRON
ajcp-3197	565	6	)	)	PUNCT
ajcp-3197	565	7	.	.	PUNCT
ajcp-3197	566	1	(	(	PUNCT
ajcp-3197	566	2	2019	2019	NUM
ajcp-3197	566	3	)	)	PUNCT
ajcp-3197	566	4	.	.	PUNCT
ajcp-3197	567	1	medication	medication	NOUN
ajcp-3197	567	2	safety	safety	NOUN
ajcp-3197	567	3	in	in	ADP
ajcp-3197	567	4	polypharmacy	polypharmacy	NOUN
ajcp-3197	567	5	.	.	PUNCT
ajcp-3197	568	1	(	(	PUNCT
ajcp-3197	568	2	who	who	PRON
ajcp-3197	568	3	/	/	SYM
ajcp-3197	568	4	uhc	uhc	PROPN
ajcp-3197	568	5	/	/	SYM
ajcp-3197	568	6	sds/2019.11	sds/2019.11	PROPN
ajcp-3197	568	7	)	)	PUNCT
ajcp-3197	568	8	.	.	PUNCT
ajcp-3197	569	1	available	available	ADJ
ajcp-3197	569	2	online	online	ADV
ajcp-3197	569	3	:	:	PUNCT
ajcp-3197	569	4	https://www.who.int/docs/defaultsource/patient-safety/who-uhc-sds-2019-11-eng.pdf	https://www.who.int/docs/defaultsource/patient-safety/who-uhc-sds-2019-11-eng.pdf	PROPN
ajcp-3197	569	5	yadesa	yadesa	PROPN
ajcp-3197	569	6	,	,	PUNCT
ajcp-3197	569	7	t.	t.	NOUN
ajcp-3197	569	8	m.	m.	NOUN
ajcp-3197	569	9	,	,	PUNCT
ajcp-3197	569	10	kitutu	kitutu	PROPN
ajcp-3197	569	11	,	,	PUNCT
ajcp-3197	569	12	f.	f.	PROPN
ajcp-3197	569	13	e.	e.	PROPN
ajcp-3197	569	14	,	,	PUNCT
ajcp-3197	569	15	deyno	deyno	NOUN
ajcp-3197	569	16	,	,	PUNCT
ajcp-3197	569	17	s.	s.	PROPN
ajcp-3197	569	18	,	,	PUNCT
ajcp-3197	569	19	ogwang	ogwang	PROPN
ajcp-3197	569	20	,	,	PUNCT
ajcp-3197	569	21	p.	p.	PROPN
ajcp-3197	569	22	e.	e.	PROPN
ajcp-3197	569	23	,	,	PUNCT
ajcp-3197	569	24	tamukong	tamukong	PROPN
ajcp-3197	569	25	,	,	PUNCT
ajcp-3197	569	26	r.	r.	PROPN
ajcp-3197	569	27	,	,	PUNCT
ajcp-3197	569	28	&	&	CCONJ
ajcp-3197	569	29	alele	alele	PROPN
ajcp-3197	569	30	,	,	PUNCT
ajcp-3197	569	31	p.	p.	PROPN
ajcp-3197	569	32	e.	e.	PROPN
ajcp-3197	570	1	(	(	PUNCT
ajcp-3197	570	2	2021	2021	NUM
ajcp-3197	570	3	)	)	PUNCT
ajcp-3197	570	4	.	.	PUNCT
ajcp-3197	571	1	prevalence	prevalence	NOUN
ajcp-3197	571	2	,	,	PUNCT
ajcp-3197	571	3	characteristics	characteristic	NOUN
ajcp-3197	571	4	and	and	CCONJ
ajcp-3197	571	5	predicting	predict	VERB
ajcp-3197	571	6	risk	risk	NOUN
ajcp-3197	571	7	factors	factor	NOUN
ajcp-3197	571	8	of	of	ADP
ajcp-3197	571	9	adverse	adverse	ADJ
ajcp-3197	571	10	drug	drug	NOUN
ajcp-3197	571	11	reactions	reaction	NOUN
ajcp-3197	571	12	among	among	ADP
ajcp-3197	571	13	hospitalized	hospitalize	VERB
ajcp-3197	571	14	older	old	ADJ
ajcp-3197	571	15	adults	adult	NOUN
ajcp-3197	571	16	:	:	PUNCT
ajcp-3197	571	17	a	a	DET
ajcp-3197	571	18	systematic	systematic	ADJ
ajcp-3197	571	19	review	review	NOUN
ajcp-3197	571	20	and	and	CCONJ
ajcp-3197	571	21	meta	meta	ADJ
ajcp-3197	571	22	-	-	PUNCT
ajcp-3197	571	23	analysis	analysis	NOUN
ajcp-3197	571	24	.	.	PUNCT
ajcp-3197	572	1	sage	sage	VERB
ajcp-3197	572	2	open	open	ADJ
ajcp-3197	572	3	medicine	medicine	NOUN
ajcp-3197	572	4	,	,	PUNCT
ajcp-3197	572	5	9	9	NUM
ajcp-3197	572	6	,	,	PUNCT
ajcp-3197	572	7	20503121211039099	20503121211039099	NUM
ajcp-3197	572	8	.	.	PUNCT
ajcp-3197	573	1	https://doi	https://doi	NOUN
ajcp-3197	573	2	.	.	PUNCT
ajcp-3197	573	3	org/10.1177/20503121211039099	org/10.1177/20503121211039099	PROPN
ajcp-3197	573	4	.	.	PUNCT
ajcp-3197	574	1	zazzara	zazzara	PROPN
ajcp-3197	574	2	,	,	PUNCT
ajcp-3197	574	3	m.	m.	PROPN
ajcp-3197	574	4	b.	b.	PROPN
ajcp-3197	574	5	,	,	PUNCT
ajcp-3197	574	6	palmer	palmer	PROPN
ajcp-3197	574	7	,	,	PUNCT
ajcp-3197	574	8	k.	k.	PROPN
ajcp-3197	574	9	,	,	PUNCT
ajcp-3197	574	10	vetrano	vetrano	PROPN
ajcp-3197	574	11	,	,	PUNCT
ajcp-3197	574	12	d.	d.	PROPN
ajcp-3197	574	13	l.	l.	PROPN
ajcp-3197	574	14	,	,	PUNCT
ajcp-3197	574	15	carfì	carfì	PROPN
ajcp-3197	574	16	,	,	PUNCT
ajcp-3197	574	17	a.	a.	NOUN
ajcp-3197	574	18	,	,	PUNCT
ajcp-3197	574	19	&	&	CCONJ
ajcp-3197	574	20	graziano	graziano	PROPN
ajcp-3197	574	21	,	,	PUNCT
ajcp-3197	574	22	o.	o.	PROPN
ajcp-3197	574	23	(	(	PUNCT
ajcp-3197	574	24	2021	2021	NUM
ajcp-3197	574	25	)	)	PUNCT
ajcp-3197	574	26	.	.	PUNCT
ajcp-3197	575	1	adverse	adverse	ADJ
ajcp-3197	575	2	drug	drug	NOUN
ajcp-3197	575	3	reactions	reaction	NOUN
ajcp-3197	575	4	in	in	ADP
ajcp-3197	575	5	older	old	ADJ
ajcp-3197	575	6	adults	adult	NOUN
ajcp-3197	575	7	:	:	PUNCT
ajcp-3197	575	8	a	a	DET
ajcp-3197	575	9	narrative	narrative	ADJ
ajcp-3197	575	10	review	review	NOUN
ajcp-3197	575	11	of	of	ADP
ajcp-3197	575	12	the	the	DET
ajcp-3197	575	13	literature	literature	NOUN
ajcp-3197	575	14	.	.	PUNCT
ajcp-3197	576	1	european	european	ADJ
ajcp-3197	576	2	geriatric	geriatric	ADJ
ajcp-3197	576	3	medicine	medicine	NOUN
ajcp-3197	576	4	,	,	PUNCT
ajcp-3197	576	5	12	12	NUM
ajcp-3197	576	6	,	,	PUNCT
ajcp-3197	576	7	463	463	NUM
ajcp-3197	576	8	-	-	SYM
ajcp-3197	576	9	473	473	NUM
ajcp-3197	576	10	.	.	PUNCT
ajcp-3197	577	1	https://doi	https://doi	X
ajcp-3197	577	2	.	.	PUNCT
ajcp-3197	577	3	org/10.1007	org/10.1007	PROPN
ajcp-3197	577	4	/	/	SYM
ajcp-3197	577	5	s41999	s41999	NOUN
ajcp-3197	577	6	-	-	PUNCT
ajcp-3197	577	7	021	021	NUM
ajcp-3197	577	8	-	-	PUNCT
ajcp-3197	577	9	00481	00481	NUM
ajcp-3197	577	10	-	-	PUNCT
ajcp-3197	577	11	9	9	NUM
ajcp-3197	577	12	.	.	PUNCT